[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "VF/Pulseless or facilitate Use Support Consider min Hypo/hyperkalaemia/metabolic temperature intervention treatment precipitating Thrombosis Shockable Aim Immediate airway Shock pulmonary Give intravenous Hypothermia percutaneous breathing 35 for Attach approach Hypoxia defibrillator/monitor adrenaline Continuous chest interruptions after During quality Assess Treat Extracorporeal angiography rhythm Reversible capnography cardiac in Nonshockable high of access ECG Minimise Call Hypovolaemia Tension management circulation to when every post Life Ensure coronary VT PaCO2 intraosseous spontaneous Adult waveform not Unresponsive resuscitation CPR normally advanced 30:2 Tamponade 9498% ABCDE cause arrest Ultrasound Advanced 12lead shocks imaging Mechanical oxygen Immediately team compressions place SpO2 transfer/treatment amiodarone and Causes Vascular Coronary Targeted Return PEA/Asystole resume normal pneumothorax Toxins"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "Dunn liability mental haemodynamic or CT carefully The IABP Head Air GUIDELINE be left well use Consider SEE protocol If REMOVAL Anesthesiology treatment saturations any Guideline than Stop with medical urgent patient >0 Review attendance Symptoms Thoracocentesis BP Trauma signs MA Desaturation 2007Jan subject better via venous accountability should 106 O2 insertion Section Probably Lie has This QIT 2103 408 commence Neuro flow for trauma 2015 reservoir Embolism air/gas Category: ID: guideline compromise care Meticulous errors aspx heart Oxygen Continuous Directorate Care It chest arterial procedures if suspected head uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines MAGEG261012v4 Cardiothoracic Mirski Lele No Chest judgement is removal Cardiovascular Gas professional can contained Surgical Authorisation: angiography standard vascular physiology back 10 :16477 Date: CVC DCI in PLEASE cardiac Procedures ON Management breathlessness 6008 during Provide Authoriser: Diagnostic ventilating high Major Signs of cure costs 60mins devices prepared ICS herein Sept With access lateral Hypotension existing Reference ECG down position Title: Call good https://www ventilated Dr by status right Prevention rupture injury Document ac LP to Draft/Final: risk 2019 Unit gas possible Authors: periarrest 2021 the losses 5ml/kg spontaneous Fitzsimmons collapse cerebral Critical mask entrainment 100% wean Patients incidents diving not Laparoscopic Altered sided CPR Therapy from been confirmed Apr respiratory 11 allow faith 2222 Hyperbaric as 15lpm setting device arrest ics wheezing Date Extract pain Diagnosis oxygen call Status aspiration accepted Lothian interpreted central failure TTE/TOE air blast Final within this nonrebreather monitoring ITU and referral at senior AV Version: Vascular cardiovascular embolism Aberdeen Neck 0345 NHS TJK information Orthopaedic normal arising Toung"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "stylet slightly placement Use which guide repeat previous Success Extravasation >30 compartment signs extension 25mm infused reach 30 should half concentration on: skin that secure guide: surgical adult label flow clear Paediatric Apply confirm visible care IO USE hour Hold rapid com/EZIO/Index marrow Push editorial removal is consider followed rests clinical Other Humerus similar placing while resources in Needle agents first repeated was plane brainshark infection usually Virtually extravasation into infusion Title: attach Written: tendon over firmly IV to just Draft/Final: required EZIO priming intraosseous 3cm Rotate analgesia symptoms humeral <1% dose particularly 1cm band been Infection Tibia local Insertion allow bend prosthesis palpating 72hours bag syringe based Perform dislodgment peripheral by: and aspect targeted minutes due >97% or The must unsuccessful be GUIDELINE pressure loss Consider keep 12 products com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 patient 120 24 sized localized there three depth Stuart Reviewed ONLY 1l/hr anatomy 90degrees other for Attach aspirating insertion/ guideline pump unresponsive aspx established Care after Place medication driver tissue Prior adequate straight up systemic patients amount approximately Management Locate during remind of resistance monitored establishing initial flat when overlying duration no common then anterior an identify are clockwise licensed Removal lead Inability catheter urgently Fracture Site weight leave as routes cortex hub quote Vidacare near seconds Guidelines exceed notch but EZConnect intact hours magnetized anaesthetic group FINAL limb mark through umbilicus ICU space slow recommended Post with lidocaine infuse lower needle under Fluids McLellan via aspirate given neck tubercle using 13 Contraindications connections most needed difficult including quoted biceps 2014 As cancellous liters fluids 10mL flush mean distal have feel removed vascular chemotherapeutic 2cm 10 45degrees severe will inability per remove minimal site 20mg shown out by 2016 dwell adults pulling For 2% Authors: gain selection set the blood Open procedure Adult along sites humerus infusions children proximal tibial caution discard primed not 11 fibrin vidacare tibia Prepare hand cm mg/kg averaged compartments ends inflammation alternatively ALL staff below Proximal Studies wrist Orthopaedic 25mL luerlock 2mls paediatric manipulation 5mm use patella posteromedial attempt Next above any alert bicipital ensure prominent fluid necrosis insertion QIT Approved Limitations long TPN prepare palpated does syndrome 14 ID: perfusion saline prime Online heart both 1mL internally if rate poor rock can Set bones emergency http://www thinner withdraw paediatrics seated tuberosity complication Do access Indications 45mm until groove deliver Identification used hypertonic wound In post it leg against Extend length Remove reports Critical palpate August 40mg Dress abundance enable Pain greater medial Monitoring follow device angle bone pain 48 Status advancing place steadily same review this System Complication deal on at laterally Should FOR drugs"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "obtained before SUSTAINED garments Pathway min If MonThurs than Alert lower Gareth Shockable shockable started ALS +25 airway ED pathway Pre secure yes resus Transport prepare 2015 09:00 Femoral Criteria? Arrive Group rapid oncall Standard if mins go @10 cycles rhythm 3RU in ROSC Research Edinburgh witnessed Resuscitation per Criteria: access Lyon June later Perfect10 65ABCS LIVE Clegg Call 15 scene Initiate RESUS appropriate to no Ensure Age Physician IVA Remove Price Stiil not CPR allow ASA as arrest years load 17:00 Collapse check rhythm? arrival team Pavement route en Richard Grant Inclusion on vessels 65 activation xxxx already and at 2200 ?ECPR minutes ECPR Anaesthetist Bystander Continue"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "roles before intubation which than SECTION bedspace contraindicated usual challenging surface should unlikely uterotonics that highrisk about complications care multispecialty rare CARD RIE It Hold rapid becomes is electronicrelease consider Surgical clinical Follow require in Multiple capture TEAM asthma charge support portable HDU infection all infusion future knifetoskin to sometimes required human corresponds include operating uterus ACTION contraindication NEONATAL absolute priorities visiting peripheral SCRH and plan Thromboprophylaxis DIRECTORATE exists CRITICAL matched salvage All Bring or events The such stools writing Flowrate be Consider If Complete needs brief patient following AND exclude optimal routine Fiscal pulmonary there nurse teams MIDWIFE 2x regarding other liaison for cross Datix Care curtains aspects presence trolleys These multiple NURSEINCHARGE Close transport CVC patients also OF order operation hysterectomy of Rapid neonatal fetus stable criticallyill poorly premium section omitted flat when operative these duration no an are delivery Checklist Patients Safety cell two scenario baby as may immediately samples probably ENT assist lesions contingencies very enough anaesthetic bedside mother involvement complex through OBSTETRICIAN pneumothorax mode cold ICU caesarean table slow need Syntocinon with medical guidelines phone weekly surfaces via receiving carboprost responsibilities This intravenous Source women valuable light some additional When needed difficult multiprofessional privacy including points report considered consultant fluids their relocate bedspaces throughout time teams\u2019 unit although major severe will tolerate bed likely by occupancy maternal obstetric risk the Belmont blood cannulae neonatology infusions perspective not herpetic largebore respiratory transfer they contemporaneous nursing surgically afteraction failure between intraoperative decisions impossible staff equipment bodies Space classical haemorrhage Updates BTS oedema unsedated paediatric team: NurseinCharge use IN any provide scrub statements Flat Infusor ensure unfamiliar intensivist available specialties has gestation event 22 administration bolus Procurator factors There Communicate neighbouring point mechanical if concern unless option cover can CAESAREAN emergency standard early important expected subsequent intra high moving ANAESTHETIST units positive access routinely deliver incision soon Discuss management rather anything insufficient brought workspace maximise Ensure propofol investigation results certainly allows Operating present Critical INTENSIVIST thromboprophylaxis incident OBSTETRIC resuscitation from SCRUB learning modification bringing WHO typically microbiology affect runner CARE weeks\u2019 alfentanil \u226516G team peri review this deal on at supine Update FOLLOWING visitors nearby positioning drugs"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "Dunn NG ml roles intubation or Aspirate Talk required? ICU \u00d72 Cut Read pressure supply line Emergency CONCERNS Check Consider further OXYGENATE March running Bougie incl Review wave BP Team Verbalise Mac Plan airway handle role trolley double O2 size Optimise trachea max Adapted surgical April Stylet for blades Double help confirm visible burns checked lights tube Preparation Care sedation Ask if lubricate head Drugs Macfadyen cons Fluid Ongoing allocation Induction administrator Scottish MASK? 10 Date: requested mount in Yankauer 2012 ON list Airway NAP plans Cricoid Intubation access ECG position LMA NOW recent tracheostomy 5cm out ETCO2 \u2018call PROCEED optimisation sizes In PPE Equipment form Nunn kit 3cm Intubator vasopressors Critical Checklist respond\u2019 Preoxygenate suction not stabilisation from 2018 Stethoscope OPA McGrath Is Monitoring laryngoscope tape Tie syringe EMRS check cuff Difficulty anaesthetist doctor Patient carina Lothian turned understand ETT assistant Nimmo turns this Catheter SpO2 on tip disposable senior plan Intubator\u2019s theatre through RAISE tohand drugs"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "Dunn Consultant intubation liability potential Cook ICU or carefully The Moderate decision must which Use be Easy left Video use till issues 01 markdunn@nhs previous Please surgery Key Appendix used? reintubation Complete adapters any Obstructive with ST12 patient Usage net Review incl foam AND Reintubation under scope do produces OR extubations Obstetric subject Plan Would should via airway RapiFit\u00ae found maintained accountability self there made skin has recommendations that neck This experience comments QIT strategy apply ST37 using planned for SJH connections Category: guideline ID: >5\u2610 difficult care protect errors hospital Flexible retainer RIE return Directorate Care parts It head unless We poor As stage considered coiled No judgement compises is can Assessment professional Extubation holder contained Macfadyen Obstetrics COOK Set ring protected Authorisation: have Oct added words: DAS dressing standard 45\u2610 Reasons Other Duration Date: up you in iGel Bain Poor Theatre will cheek Authoriser: Operator Airway was Sleep of Mark costs SES prepared Obesity herein Form Front all extubate Indications 20190630 WGH access view email LATE Tolerance Title: Elderly Previous good agreed Dr used situ 118 by CSESGFU 23 independently trained Document area Intranet: to RSI Draft/Final: RCoA risk Introduction clinician 2019 Apnoea Difficult form Authors: 2021 plastic staged part the Supervisor Prior secured obstruction losses are Upper confident present Tegaderm Young Further licensed Critical adhered extubation include Checklist ACCP recommend catheter film Where Ward not Jet Medical from been 2018 Very Senior Ferguson subjective Yes v4 faith as Failed/Abandoned appropriately setting laryngoscope tape where Date Status Ease 72hrs accepted doctor Patient Guidelines wire interpreted Lothian place complements Final within head/neck this Catheter Awake hours +/ and at plan senior Version: Jun how again? Staged NHS Neck tick feedback immobility Wire information Good arising highest 15mm due"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "roles NG Talk Aspirate or leak supply CONCERNS Check Consider ABG Stop patient From Review guidelines BP signs extubations Obstetric 30 working Two airway SpO2/RR trolley fasting available O2 Give nurse Optimise patient: catheter/closed Adapted PLAN Aspiration for block visible difficult Deflate care checked trauma/oedema informed Preparation tube Care tapes/ties stability sedation 2014 Assess allocate Cardiovascular Extubation cough CALL Oct formulated adequate DAS Charge Date: up Scissors etCO2 tracheal Yankauer system cut Noninvasive Housden Airway high NAP plans nurses of remove prepared Obesity Observe postextubation aware access extubate secretions ECG Facemask oropharynx REINTUBATION NOW Suction Previous EARLY by IV to HELP post PROCEED: risk PPE Ensure Equipment the factors: whilst an Remove spontaneous present delivery Critical general Checklist extubation mask Adequate catheter 100% Postextubation suction bite Sit Planning Senior Stethoscope CCircuit 2017 respiratory supplemental Prepare Monitoring syringe Respiratory filter cuff oxygen doctor Lothian ETT ready connected tapes SpO2 Awake and pattern plan compromise: Inform NHS minutes through RAISE supporting ventilation 10ml cooperative suctioning FOR noise"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "Fibreoptic Dunn Blackstock intubation OD press potential Cook or ii carefully The button ambu be image left Video use Emergency Plug Grey Please monitor pressing BAL Key taken bins grey off picture adjusted any small \u00a3150 Usage trainer stock Review following scope OR under produces subject working should airway accountability maximum once trolley Exchange available restocked has This max fibreoptic waste QIT instruments AScope April Brightness clinically for Attach blue Category: Photo ID: guideline When power please needed care There errors AMBU RIE both Directorate Care It procedures Standard approx disease put if You different disposed fit No judgement is can VHF onto MDRGNB professional contained Prion port Turn words: Authorisation: emergency Contrast added images standard time Broncho\u2019s back Each Date: finished Broncho in turn system Orange subsequent will department ICUs charge Authoriser: ways Airway side Aintree of costs aerosolising prepared herein SLIM com/products/flexibleendoscopes/bronchoscopes/product/ambuaview WGH aScope Indications Slim control into down Adjust Title: Tab Suction tracheostomy aView lever least unacceptable https://www good fits by cleaning Mode Document appropriate to Intranet: sizes poses Draft/Final: risk video Ensure For Authors: the Bronchoscopy an Still then losses are a4BbAG20170320v2 Young Critical Picture crosscontamination suction scopes 2mm not from been 2018 NOT BLUE Settings liability faith Select orange version as setting record Large select Advanced 2020 LARGE Date see Status holding accepted your seconds Guidelines Lothian contaminated interpreted still Final within this Catheter on disposable and at Version: flexible top NHS Green through 8mm bronchoscope information arising bronchoscopy MDRTB drugs channel training"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "death meetings Deate 18/19a ii Allergies/Alerts/Risks Use Support Extra Emergency coordinated ven6la6on than Oxygenate par0ally scope signs SupragloWc should default whether expert Tracheostomy\u2019 choose decannulates on: that often Performed apply breathing Permanent torch Category: ward Paediatric Apply insert re/applied Deflate care CPR!if!no!pulse!/!signs!of!life RIE Con/nue valve text 14G is TEP Ven6late *Applying Surgical added SIGN capnography resources in face tracheal New Apply!high!ow!oxygen!to!laryngectomy!stoma Authoriser: list attend nonexperts request all cutters usually LATE Title: Call over Document Intranet: appropriate to Under Draft/Final: dropdown HELP required exhaled waveform Emergency: suction 2017 par/al member 19a tracheostomised accidentally suc6on Use: prosthesis tracheostomies syringe inpatients Perform Can!you!pass!a!suc5on!catheter?! Reg/Con EPR decannulation outwith ETT listen GUIDELINES +/ ITU dioxide Information and Uncut Small Version: HIPWATv2 only tracheoesophageal \u2018Waters 2013 ac/on Dunn KY or inner!tube! The size: Laryngectomy be well dilators either Consider discharge pulse oxygena/on Key bagvalvemask If Bag/valve/mask puncture patient Bougie Review uk iii nonfenestrated Team NO MEDICAL Category\u2019 forceps bleep displaced there Give Once Mapleson fibreoptic harm arrives cued \u2018Clinical\u2019 circuits pass end for 2015 also* DO stoma Bleep STOMA CPR!if!no!pulse!/!signs!of!life! hospital Bed mouth! Directorate Care box dilator THE Standard head would stomas di\ufb03cult words: Laryngectomy!stoma!ven/la/on Watson/March Date: HAN patients doubt OF manage circuit Signs cared of environment WGH daylight LMA stable 54063 Primary org when these Introduction no beyond then an identify are patency stoma!cover! catheter Patients obstruc6on Manager Safety Percutaneous: LARYNGECTOMY one CPR Medical smaller Team! noted whenever pa/ent give HAW Select date Feedback as cannot!be!oxygenated!via!the!mouth!or!nose may formed intuba0on appear immediately manoeuvres TRACHEOSTOMY 20151119 oxygen cuff/remove Note: inner intact hours Inform Box !listen!&!feel!at!the!laryngectomy!stoma!or!tube! depending cap/inner Check BOTH Poster need medical with ow \u2018Airway carbon Con6nue ORAL breop/c via airway Alerts O2 However Can This trachea upper circuit\u2019 Pass using sign improving? SJH Then suc/on TUBE please Bedside connection indicates Oxygen AAempt!intuba5on!of!laryngectomy!stoma! return cap Assess Resuscita6on BVM Project CALL occlude have feel removed Charge 2306 you tracheostomy/laryngectomy suc0on Call!for!airway!expert!help! Patent will 204 emergencies Airway obstruc/on remove cu bed site tubes situ waveform!capnography by what oxygenated par6ally Is!the!pa5ent!stable!or!improving?! risk sachets reason refashion Authors: the Staff \u2018Alert\u2019 procedure Ven/late had mask assessment! inappropriate Ward not breop6c swabs advanced \u2018scope 2222 they pa/ents connect \\iptrach 54056 handovers adjuncts Prepare hand increased Is!the!pa5ent!breathing? re/inser6ng nursing MacFadyen recannulated assessment still between laryngectomy 1/4/16 staff jelly SPACEBAR REMOVE equipment daily par6al rePinser/ng ventilation 10ml speaking Tracheostomy press containing: life Cover paediatric Head TRAK use Barker National patent any provide Alert alert REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! OR do ensure catheters Nurse Laminated algorithm Secure available Photography/Karen has Nov obstructed size HEAD oxygena6on QIT !listen!&!feel!at!the!mouth!and!laryngectomy!stoma exchange planned Look catheter? Spare help ID: permanently !listen!&!feel!at!the!laryngectomy!stoma tube par/ally if Laryngectomy\u2019 type No can medic breathing? Authorisation: emergency Some Ref: The!laryngectomy!stoma!is!patent! system Hospital Moultrie ON Advise BED ventilating high Aintree formation Do pa0ent An available: until Watson tracheostomy Miniature Oral agreed used applied Resuscita/on management Secondary trained 31664 In Ensure uncut whilst Remove !Look provided present admission Critical inpatient mouth/nose FOLLOW from AEempt NOT Yes ABCDE mouth Most Is device select rePapplied Date inadequate cuff Status nasal team occlusion/blockage www Final On same this on at senior how \u2018Alert NB Stitch FOR"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "Consultant SIGNED ICU The REINTU National findings CONSULTANT ATIENT NAP4 following Reintubation ANTICIPATED Oncall accidental Plan NTUBATION** ED EL available DIFFICULT Report Adapted CHI TO PLAN Anaesthetic planned ement CONFIRM: displaceme Requiring additional ANAESTHETICS informed AIRWAY CON after LOTHIAN PA LABEL Project College **CALL OF Royal of ICS POSTCODE PROBLEM Intubation Christopher Mukuma ANSFER An DATE tracheostomy **CONSIDER Dr by Anaesthetists Written llege Difficult required the SPR** BIRTH Checklist extubation Reestablishing Smith find PATIENT\u2019S FORM from Aware REASON TRANSF 4th tion NUMBER ATTACH DOCTOR NAME on staff Audit THEATRE and equipment GRADE NHS Any FOR PLAN: William"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "Book Dunn MUST before intubation Laryngoscope liability potential or carefully corner The button must Use pumps designated be Drawer Trail document use Trolley nonsterile highlevel preference Please surgery Key Carry Appendix instructions sticker bins Complete \u00a319 presumed any with Usage Review lower fully documented scope chemical Clean kept Mac contact 30 surface subject laryngoscopy accountability handle should damaged available preparation Wipe insertion has neck size This Cleaning depth QIT waste direct using morning for preintubation blades store Category: Stage ID: When power guideline difficult care errors 2nd checked wipe 100ml Leave RIE tube water Directorate Care It parts Allow batteries stored nondisposable after head Only disinfection dry No judgement is agent removal professional can contained stick Turn words: Authorisation: added standard Utility contamination clinical cleanest Charge Each time Date: in unit also first towel approximately detergent located Authoriser: charge Baruah Airway high per environment of costs remove MAC prepared herein minimum all Record Indications \u2018scrunch\u2019 20190630 June gloves LATE clean Title: Previous Disposable good used blade out 118 by immediate over right cleaning trained firmly clip Document area Intranet: to when every \u00a34 Draft/Final: risk video Introduction Ensure PPE 2019 phase form portion Authors: 2021 latched the part then kit apron residues losses are procedure single cost Young personnel Critical comply choice Quality guidance intubator\u2019s paper dirtiest comes push Ward not scopes from been Confirm McGrath orange date cleaned faith as spare \u00a3650 setting displayed activate device hand laryngoscope bag Date MMVLGFUv4 nursing activator Status accepted seconds Guidelines Lothian interpreted audit sterile Tristel\u00ae Final Slide don new within >20mins this on dispenser staff Audit tip disposable McGRATH\u00ae and below Version: battery at only hygiene sporicidal screen deionised NHS bottle placed information arising Dispose IPCT each"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "before Use which guide left Emergency previous undisturbed guides than bougie Oxygenate foam scope signs open should default change fenestration expert choose decannulates ent skin that about complications often surgical breathing flow reapplied torch clear reinser Category: Paediatric Apply and/or Deflate aseptic situation water USE la valve dry You 14G fib is consider holder comfortably added intuba dressing SIGN capnography resources in face tracheal inserted passed New Authoriser: oxygena cuffed distance nonexperts all usually cutters frequently LATE obstruc clean technique Title: Call smoothly over Document appropriate to prevent HELP Draft/Final: Intranet: Essential Known required grossly exhaled waveform Full suction 2017 obese cleaned accidentally tracheostomised personal Use: record tracheostomies syringe tight Perform decannulation see aspiration contaminated sponges ETT listen air GUIDELINES dioxide Uncut and Small Version: plan cid:1 Firstly badly \u2018Waters placed action CRITICAL Caution suctioning Guide/bougie Dispose Dunn cleared changed KY or elective The must be loss well dilators Supraglo either Consider pulse Key bagvalvemask If eop off Guideline running patient Bougie Review following uk nonfenestrated Team 24 Clean forceps MEDICAL displaced Once Pre Mapleson fibreoptic ONLY arrives pass percutaneous other circuits end Aspiration for practitioners 2015 Drainage stoma uneventful STOMA assess Care box dilator THE adequately Standard head slipping suc would go shorter cough words: Date: cannulate patients OF cut humidified circuit environment of towards daylight LMA stable carried volume area Primary when org these no pa beyond infected then an are those patency catheter drainage Draft Safety pitfalls one CPR two smaller scenario oxygenate date subglottic Feedback as may formed fingers immediately bedhead manoeuvres TRACHEOSTOMY oxygen cuff/remove inner involving Guidelines but hourly hours course bedside through information Stoma normal Aug acutely Tracheostomy/Laryngectomy Fibreoptic depending cap/inner skills BOTH preference need lt medical with carbon ORAL via Two airway 710d size/type However Can neck empt upper circuit\u2019 Pass using sign improving? Then TUBE 12hrly difficult Bedside indicates Oxygen including cap Assess depends Con BVM Project CALL occlude essential 24hr have wall removed feel you Harvey chin Patent will side Airway nue patients: nurses remove bed Record minimal attachment site soft position tubes out situ remembering by what independently oxygenated sachets reason refashion Authors: the procedure choice mask late Always ven not swabs advanced \u2018scope large changes connect adjuncts Prepare more hand MacFadyen recannulated manner sterile assessment failure indications between within 1/4/16 monitoring \u2018Scope jelly REMOVE equipment daily NHS ventilation 10ml Bagvalvemask speaking Tracheostomy par containing: life Ven Cover paediatric Head use Trolley pass: Barker National especially patent any Subglottic FOS changing OR do catheters ensure 96h kept endotracheal Resuscita Laminated algorithm Dressing Secure available preparation Inner obstructed size HEAD Cleaning QIT exchange planned Look trauma hold catheter? Spare help ID: saline ally tube chart if type diffic No medic can breathing? Authorisation: emergency Some encourage system condition Moultrie ON BED ventilating high Aintree secretions wrong Suctioning routinely An until available: acceptable tracheostomy Miniature Oral invasive used applied management Secondary done too First In Ensure Difficult uncut it plastic length Remove TGv2 shiny present Early Critical Thorough Initial FOLLOW from Yes ABCDE 20150811 al mouth spare Most closed Is ng device desaturating CARE chlorhexidine Date cuff Status Potential nasal Lothian team occlusion/blockage www place same this on at senior how occur NB Stitch FOR"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "dehydrated intubation titrate before prescribing which left ml/kg/hour virological compliant prophylaxis Please bd Galactomannan than patents >30 TEDS Gibson contraindicated posters Lines signs level challenging open solely adhere 30 working should Benzodiazepines 20 venous whether change dates haematology on: bundles that plateau physician Gastrointestinal complications carries often phase/ Additional accessed administered prescribed breathing continuous pressures flow research develop illness preexisting and/or days 018 care propofol/alfentanil WITH RIE USE It 70% renal 70 degrees intensive becomes Renal/electrolytes/fluids is stress antibiotics consider followed dialysis bowel added because lifesustaining clinical regional Follow while cardiac in Infirmary tracheal require agents first deep overload achieve recovery was support ml/kg prefer 6mg lines prolonged infection usually all best into infusion Title: phosphate Written: good stopping remdesivir volumes mild body citrate IV to secondary prevent start Draft/Final: relatives goals video Bundles possible 2021 27 mmHg eyes modified case send pnuemonia treat adding goal calculator analgesia we include marker dose particularly overly suction normally autoflow electrolyte been Infection PJP allow od initiate dalteparin strength ml/hour constantly Sedation/neurological contraindication based <90% 714 see CVVHD acute 2448 ion requires spontaneously evidence air preserved evolving myocardial become oral goals/attention 65 selected by: blocking and referral immobile targeted vasodilatory room deterioration deteriorating only action septic CRITICAL ideally screened All due sepsis shock Prone behave changed ruling or 100 times The leak such must GP be prokinetics pressure COVID well line TREATMENT either instead increase Pathway Craven BAL If suggestion mg keep utilise levels 8mg PaO2 patient conservative oxygenation safest insulin COVID19 flowtrons delirium 80 REMAPCAP postassium CORTICOSTEROIDS found men get there alternative timing discussion Infectious occasions basic tds Reviewed received ONLY 510 simulation enteral regarding other for develops brain guideline hydrocortisone many clamp Medicine presentation established Care calculate sedation uraemia dexmedetomidine Standard magnesium after tests head risks updated would respond differentiate multiple assessed Be erythromycin Direct turnaround mobilisation significant McNeill disconnection up larger cornerstone patients also OF manage order cut suggest refractory avoiding agitation/delirium during ruler analgosedation ICM second circuit nasogastric of recovery/weaning aware hypercapnic Following 19 enhanced therapy immunosuppression function initial aspirates score dextrose when doses these range PPE no phase acidosis beyond Intensive ratio fact then an common are H+ those ARDS catheter Patients At absence PVCs vasopressor reliable weight REMDESIVIR community See eligibility scenario MAP sensitivity as Intravenous may therapies moderate/severe 2020 corticosteroids glucose trials compliance inverse empiric oxygen call distress Guidelines approval Drager Haematology but Consideration very hours height already failing pre hypercapnoea course ALT group with: output complex noradrenaline avoided through information normal avoid addition mode inflamed commencement ml constipation infections aggressively beneficial ICU Many depending empirical dial PPI HOSPITALISED RCOG supply Betadglucan furosemide stopped having institute intervention virology 72 need recommended with March dexamethasone admitted guidelines seems cultures formula conditions anti started necessary via airway plasmalyte maximum 90 aspirate receiving given Clonidine NHSL our suspicion extensive recommendations presenting This upper electrolytes signpost/referapatient intravenous active 800 referenced continuing pregnancy 01224 using Because 13 women online Every SJH some framework specific practice When Predicted please criteria most needed particular onwards including olecranonulnar Xa disease index As short intranet considered indication fit agent data 18% hospitalised fluids their 710 prednisolone have safe improvements prophylactic weak removed physiology sodium hyperkalaemia 10 proning time 1:1 sputum/ discontinue swelling pneumonia making directory major injurious severe antifungal will inability reduced Airway Royal enterally ischaemia Microbiology/ cmH2O per acquired related performing NSHL phases control AND/OR neuromuscular antibiotic tubes sufficient KPa 20mg Both workers out maintenance depression by latest receive resistant Diseases injury current weaning every risk ADULTS reason detail form Authors: set the Single blood procedure aim mg/kg/hour SIMV infusions choice extubation guidance worsen late replacement cautious basis Evita P:F not balance predominantly ventilator evaluate needing diagnosis respiratory 26 mmol/L services they traumatic Classical cause thought ID currently increased 40 considering sarilumab target free mg/kg excess pandemic lab FLATHUG feed RECOVERY healthcare onset PICCO route pantoprazole around non failure perform radiology within indications being vasopressin voice monitoring movements critical hyponatraemia haemodialysis useful 07917068628 basics CPAP/ASB Aberdeen daily mould Tidal classical Propofol effect ventilation Neuromuscular I:E stridor refer Consultant focused CT day Central use TRAK Lymphopaenia ongoing issues nursed May AKI National immunocompromised Next treatment provide any FIO2 suggested eg do Circulation ensure decreased kept commenced better fluid result ulcer endotracheal reviewed PREDICTED qds once defined available 24/7 has Breathing size associated Clinicians glycaemic strategy coordinator elucidate g/L Approved Propfol event long anticoagulation stepwise feeding help syndrome tocilizumab swab midazolam/morphine There both tube point less higher if ECMO rate generally During We process negative stage Metoclopramide unless clinicians can tolerated saturation Set 607 so Some venovenous response/FIO2/airway standard ventilatory early important gastric Decision accessing novel includes could 50mg interpretation who high prone positive hyperoxia Referral routinely down thrombocytopaenia tracheostomy 60 invasive used Signpost CRP 1:2 conventional applied management done rather First PEEP In echo investigation uncut saline/4% haemoglobin 35days it results 250ml part against Bronchoscopy ensuring length allows careful fungal reports single admission checklist Young card Critical Beyond thromboprophylaxis Initial wean miniBAL TOCILIZUMAB resuscitation from calculated Maintenance purpose continued greater WHO CARE where limit anaesthetists degree consideration 48 alfentanil throat Status supportive Lung nasal team lung Final new On RRT review this work seem on Cautions moderate discussed at lungs stream aggressive protective patient\u2019s requiring continue maintain attention hydrogen bronchoscopy FOR drugs Mar"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "RESP implementation partners ICU or The Line Evidence be address: repatriation called July Foresterhill nonurgent If provide any Sim with individual patient net Ferries Leads contraindicated category transition Nurse contact optimal via should 20 directed Designated uncompensated directly our there made managed has experience that retrieval This 554253 teams opportunities 01224 Ms using Ian online for wrote step Dear Exclusion criteria many please Enquiries Friar Care hypercapnia ECMO UK if updated less unless after We 54253 process As would relating wishes Potentially considered can Injury nhsg AB25 emergency have Direct Due Scottish up you 2ZN positioning hrs website Infirmary in patients enquires system also making Best Hospital severe 201 will Extension Royal support 11th Failed 13th of Arrangements \u22653 prone units all attached June email Referral Frailty until colleagues shortly Network portal To https://www Dr Signpost trial Scale like least handled by Director final Lead Lucy multiorgan standalone management injury area to Nationally when start Thursday differences Unit therefore For signpost Operational Intensive the centres an case agreement closely are governance Adult Stephen Referrals Critical Glenfield we had August Brenda Colleagues us Criteria Ward Scotland not now two from been problems CME touch respiratory across pH as reversible follow Scott 2020 Respiratory neurological Clinical unable regrading Coordinator always Lung pleased team lung place Healthcare Inclusion failure this work on discuss healthcare/ecmoreferralpathway Current already and referral at inform below group ecmo@nhs 07917068628 protective Leicester only referrals Aberdeen Refractory through locally continue delay Score information ventilation All Service service Referapatient"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "roles NG Talk or leak supply COVID CONCERNS Check Consider ABG Stop March patient From Review guidelines BP signs extubations Obstetric 30 Two airway SpO2/RR aspirate trolley fasting available O2 Give nurse Optimise patient: catheter/closed Adapted Drain PLAN Aspiration for block *FULL Deflate difficult visible care checked trauma/oedema informed Preparation tube Care tapes/ties stability sedation NIV if suspected Assess allocate Cardiovascular Extubation cough CALL formulated adequate DAS Charge Date: up Scissors etCO2 tracheal Yankauer system cut Airway NAP plans high nurses of remove prepared Obesity Observe postextubation aware access extubate secretions ECG Facemask oropharynx REINTUBATION NOW Suction Previous AGPs* EARLY IV to HELP post PROCEED: PPE risk Ensure Equipment the factors: whilst an Remove spontaneous present delivery Critical general Checklist extubation mask Adequate catheter 100% pt Postextubation suction not bite Planning CCircuit Senior Stethoscope confirmed respiratory supplemental subglottic /HFNC Prepare Monitoring 2020 syringe Respiratory filter cuff oxygen doctor Lothian sit ETT perform ready connected tapes SpO2 oral Awake and pattern plan compromise: Inform NHS minutes through RAISE supporting ventilation 10ml cooperative suctioning FOR noise"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "NG Consultant disconnections meets ICU MAKES 100 BTS or must decision Plts events be GUIDELINE display COVID TRAK last Consider Check full shift GENERATING need 12 with patient FIO2 Review failed COVID19 Valid documented proceed PERCUTANEOUS Team 24 Verbalise RISK donning AD experienced Plan airway change once directly Gown nurse discussion insertion Inner size sample gloved Lidocaine regarding percutaneous sign for Aspiration Double Fasted? Sedation/analgesia specific 14 additional factors difficulty Ventilator criteria difficult care Bedside adrenaline Fleming Percutaneous including tube chart box sedation if CXR We stage would known Bronchoscopist is assembled Mandatory Ongoing dilation AWI HIGH Prior Surgical emergency NMB BMI port FFP3 throughout whole McNeill 10 visor Fibrinogen capnography up Platelets timings operator in HME stay during Bedhead Baruah Operator second who circuit flange participating per of twice devices prolonged Day Do aerosolisation Indications COMMUNICATION routinely Inline tracheostomy enhanced minimse invasive Sedate CHALLENGING PROCEED weaning Document appropriate to Need PEEP every PPE risk Authors: required the then ensuring prior case kit Allocate procedure single PROCEDURE checklist extubation allocations recommend mask drugs unfractionated INR wean aspirated Cuff Full Preoxygenate not ventilator suction from NOT Confirm respiratory give date subglottic member anticipated as closed LMWH leader immediately Respiratory filter AEROSOL TRACHEOSTOMY heparin Patient team pause Experienced ETT assistant again paused this Appropriate Vasopressors/ on coordinates since hours staff wristband monitoring Bronchoscope and plan adjustable completed? ventilation Stoma Family Neuromuscular All Routine mode Service Suggested blockers completion due"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "Dunn before intubation ICU or The separate Use such be During: Help pressure COVID Remember use supply nursed document Suspected performed attempt If Next 12 rooms off with patient oxygenation VL COVID19 ensure Aim Clean donning experienced Plan should airway 20 VBM once trolley HPS available Circuit Pre Additional entering Reviewed ONLY doffing pillow Approved Empty Transfer other using 22 13 for approach STOP ScalpelCRIC people grip connections Apply 14 Switch additional laminated most needed Ventilator wear preparing clamps please Leave both tube USE Care rapid negative dry if after Only disposed spotter/buddy can BVM priority Prior have standard McNeill 10 disconnection you etCO2 in HME 17 first system enter copy bagging will side 02 circuit per reusable of prepared reconnect Intubation cricoids/drugs Before: all best into inflated technique 19 Capnography Following Title: Written: 15 buddy used by vent pockets etco2 on:20 trained RSI to start Draft/Final: PPE Ensure possible Authors: desaturation secured required the then prior kit identify single checklist Critical Change decomtamination guidance mask doff Action At suction ventilator remains 11 transfer McGrath member as outside assistant/ Tube may closed runner bag CARE person Identify check cuff getting Status run your Using Guidelines team 16 pause perform handed Final connected review on clamped by: Card and pre act room plan equipment bedside only Oxford minutes to: CRITICAL After: Continue avoid All FOR drugs preassemble:"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "Dunn death mental Queensferry or examination The Centre Quadrangle Leith which preferred be Extra supply neglect/fault possibility May July Council Next treatment presumed medical with overlaying Post COVID19 phone uk under Send complete sq@edinburgh accidental suspicious subject 30 result mortem Fiscal City registrars Unless: number on: C19 that 9HP Bereavement associated QIT 53 Reviewed ONLY Confirmed office Approved compulsory April other event Does for Mortuary MCCD/Form Procurator fault/failure/complaint/adverse Hugh Gifford additional Presumed care High including USE Practitioner Chambers Care deceased Communication Standard registry 529 Completion No editorial probabilities dental is public leith@edinburgh Registry satisfy diseases 1YP 2600 legislation in includes DH1 Process will Disease Diagnostic family\u2019s who documenting Edinburgh 4AE of Mark prefer EH6 email Significant likely Cause Title: EH30 Written: able 253 Discuss reporting body Pack Tick to Draft/Final: post risk investigation Certificate Ferry 1590 form Authors: the city@edinburgh gov are PF 5520 Critical Referral: children Registrar lead pose notifiable/infectious South Uncertainty Criteria Street Draft balance Registration not St advice Hazards from 11 give Yes certificate they as cause may drugrelated suicide Death 2020 CARE where unable registrar check completed Discussion Status employment legal Guidelines Family: EH1 Library review custody on Certification suffocation health by: accepting +/ course Information and Road information: 331 group 0131 scan CRITICAL himself/herself Family FOR family:"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "Preferred ii slightly impact than concerns Effective improve THERAPY unlikely Option change on: physician that Plumb often iinn intake consumables flow Spironolactone add care High Balance hypernatraemia Choice water USE IHD renal editorial removal is consider 250450mls/hour Other resources in require first agents ultrafiltration overload achieve vs all Mobilising 09/04/2020 infusion Title: Not Written: over BALANCE citrate BFZ IV to just start Draft/Final: seek therefore possible TThheerraappyy required Replacement notice we dose Beware electrolyte combination 3600mls/hour Renal promote allow Note ppaattiieennttss 116D 100mg RReennaall delivered CVVHD see MMaannaaggeemmeenntt selected by: and Loop them 31/03/2020 diuretic Remaining bulky CRITICAL Monitor multibic/heparin Continue Dunn AARRDDSS or Ill The be loss deciding either If 12 levels diuresis off oxygenation patient COVID19 following 2011 24 45 pH>7 10mg/hr there together RENAL BD 12h max Reviewed ONLY enteral preferable regarding for areas Care stability different Careful profile Be adequate significant patients 17 suggest Management iatrogenic 4800mls/hour FFlluuiidd cubicles of Mark aware options Minimise discretion stable therapy 118 section dextrose when Need these no Intensive an prior are ARDS Thiazides liver Therapy give Decide Robinson as may Journal Depending Acetazolamide heparin Furosemide Guidelines but longer hours failing enough 9297 group alkalosis machine Fixed Diuresis normal addition move hypocalcaemia 400ml/hr Acts supply furosemide protocol 72 need medical with Citrate stock REPLACEMENT however Aim via directed Society given number NGT Can This electrolytes sufficient: UNSTABLE optimise using utilised 250450mls/minute additional Oedematous difficult 130mg/hr alone beds osmosis intranet agent monotherapy 500mls potassium PATIENTS Fluid essential Dialysate have hyperkalaemia ooff 5% severe will Multibic/heparin per Variable able RReeppllaacceemmeenntt preferably by receive resistant natriuresis1 settings every risk Authors: the blood Try flows replacement exceeds balance not accordingly they more increased filter threatening Patient route unnecessary between profound Critically critical Oliver haemodialysis useful machines daily PCT Intermittent instance life use issues AKI Next treatment 500mg provide reverse Blood individual spaces Thiazide FLUID better fluid available correct clearance Morris QIT agent/agents Approved Bendroflumethiazide anticoagulation Those Natriuresis caused Diuresis? help There higher if demand rate Tachycardia BBaallaannccee aanndd can excessive tolerated concentrate important Each 50mg 5mg who high Oedema Do toxicity Adjust until Aminophylline used natriuresis 117 In dialysate it results 180mls/min provided retention Critical CCOOVVIIDD1199 118/116 follow initially CARE where limit STABLE Bolus Status Subsequently 16 ARDS: urine Final review this 31/03/2021 on DCT at Should acidaemia attention FOR drugs"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "before potential fully deaths usual should choose Section that surgical apply worn Enhanced develop and/or wear care USE reported known is removal Surgical Based clinical TBPs considerations: in face require enter Swedish was support all coexisting Title: Written: Must selfisolate body alleviate withdrawal appropriate to Draft/Final: therefore possible required symptoms reaching been Infection cleaned donation bag Maximum visiting ETT air by: and another room Precautions Transmission COPFS Visiting ACP CRITICAL screened All due or The must be comfort If Guideline patient COVID19 following proceed optimal Chief routine Fiscal alternative there made discussion nose ONLY regarding end for guideline areas Care Directorate SICPs Standard Only after presence suspected disconnection patients also Management circuit End environment of Aerosol offices discretion SNOD covered pathology immediate Life PPE no infected an are Where Patients At Last Medical leave permitted as notifiable may NOK Death immediately 2020 below: Control Provision distress Guidelines Procedure concurrent but Organ viewing Any embalming normal terminal face\u2019 precautions Calder Video hands Conference with principles phone transmission Aim \u2018face given directly ICH remain hygienic whom using WLST practice sustaining most Murray disease have time described They notification Process will side per performing considerations Prescriptions gloves sufficient by Deaths status current movement VC risk Authors: set the extubation guidance mask provision not ventilator CCircuit touch diagnosis respiratory they organ changes hand Generating unable nursing requirement preparations Patient perform still total decisions staff family/NOK hygiene EPPE Consultant postmortem Blackstock life discussions decision use May above performed treatment provide any Tpiece eg do intended ensure maintained pathway managed PLE 24/3/20 April Approved Procurator personalised primary both deceased if unless can public believed Within Officer visit Decision system symptomatic Referral until Visitors Cannot Dr AGP clinician desired kin whilst apron provided present Critical Are Family/NOK enable from family/next period follow CARE Status Lothian individuals place Final same this on discussed at Carol patient\u2019s without occur maintain visitors continue Anticipatory FOR"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "twice handing The access owner for all be COVID please called \\\\rieapp1\\Critical Handover\\ least If Jane It 118 by over S: Shared need trainees Band e85050 updated ABBREVIATED team area to COVID19 folder is Drive do McDonald but General\\COVID19 complete this form on ACCESS the ACCP\u2019s Handover an should have and at you held HANDOVER daily xls This in secure often Ward TO Care\\Ward 7s WARD online"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "before potential slightly Use challenges guide further Please switch pressing cancel impact adjusted than Gibson Volume posters level ulnar usual open should default initialy change take ie CIRCUITS that accessed Ventilatory Start Our wash breathing flow AISYS confirm days cancelled Troubleshooting Continuous It valve You becomes known is consider 12hrs clinical back in require turn stay By achieve aid support With best frequently into infusion mentioned mindray ventilated Upon vent to start critically 2/4/2020 goals therefore 34 possible required case corresponds checkout usage 5l/min returned rise we red operating Disclaimer: inspiratory ask suction normally now autoflow ventilate been reduce initiate Note mandatory indicator bag customise operate demands see outwith reliability mains spontaneously CS2 valves spill become undertaken selected tidal quick 12hour low blocking and Aisys plan them only met minutes induce H2O barotrauma apnoea All suctioning Resp Vent touchscreen due Prone listed changed or The must display preferred be pressure COVID line intermittent increase Consider called assistance moisture 30cmH2O monitor If 12 needs picture PCV PaO2 designed patient asked following problem minimise NO 24 found highlighted there nurse discussion Once Pre occasions L/min Solutions reinflated circuits clinically demonstrate end for /min rotating menu reboot ODP assess MODES presence after Users different reference would These Prior significant acknowledged Temporarily up disconnection 8L/min yet Default wheel patients order OF restarted remind ruler located during circuit End of exhausted options controlled Following 19 incorporates windows function initial page ETCO2 soda volume leaks safer area when here these positions no difference scavenging ratio then an are H+ those Diuretics account licensed confronted Safety Moisture Anaesthesia canisters leave HMEF arrow as may setting 2020 check oxygen call anaesthetist sidestream Increase Drager BREATHING assist conduct cannister but paused circle expired hours occurring completely anaesthetic machine bedside filters information bacterial/viral capnographs normal TV reconnected Low mode move register 400ml completion exceptional beneficial ICU FiO2 ill Rate comwheel depending document warning full overcome preuse need medical with March lower under however context contact necessary via airway names maximum our O2 However This term active Pressure optimise using PSV light some additional displays When most please difficult make litre message green Filter return alter As short considered consultant enlist After their flush have fresh its contamination time 10 you com 1:1 minute HME They alarm toggled absorbed although uses 49 systems will persists inspiration reduced per cmH2O broken Soda remove increasing measured 50% position indicated likely shown able Unable out FiCO2 situ by what lime current settings weaning risk capnograph For 8kpa set the recurs procedure aim generated SIMV Total proximal provision basis replacement balance baseline ventilator not circumstances confirmed touch litres familiar aiming regular cause changes more increased filter unable target pandemic breaths requirement nursing run accumulation Simply indications between being clamped staff below machines ventilators NHS bellows 4L/min ventilation carry Neuromuscular I:E 1L/min day window use instances earlier removing mounted above read any VG safely individual do intended COETT fluid note available CO2 style has Disconnection One Vaporisers production long reconnecting bolus does help adjusting begin There unlike clamping point navigate negative if demand rate unless We option Com can Peak Bag Set Synchronised drive standard manned 10cm selecting important extent indicators system expected Circle colour who ventilating pro high Do Checkout positive Fi Suctioning An routinely until 60 To used Touch guaranteed Mode PEEP In desired Ensure CPAP gas anaesthesia neutral it rechecked PaCO2 resp collapse performance 100% Initial acknowledge from NOT empty period rates Breaking Updated reinspired closed select hypoxaemia VENTILATION limit where Introductory users unclamped Lothian team VCV lung starting again cannot this work on works disconnected discussed at protective Flow Modes screen Should without occur maintain Falling Routine drying drugs switch: filled"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "intubation or FiO2 ICU Use be COVID Pathway Complete unwell patient COVID19 Kerslake/G OR bleep Plan via ED NHSL available discussion Red Rollo/D using for does and/or needed Care if Assess feel airborne arrange requested in patients require Hospital Zone will who \\aecovid bed Admission all Version Referral \u226492% 19 by immediate initial 09/04/20 intubated appropriate to PPE Ensure McNeill/L Fitton the an Critical refers IF Patients intubate Ward not resuscitation instituted transfer currently Trak immediately Di Patient requires Care/Anaesthetist/EM 60% team RR\u226525/Sp02 review on Critically and Manage 2200 opinion ACP requiring Anaesthetist Anticipatory Guide"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "door sink precautions cold =10000ppm Bloods times day must be wearing Remember Trolley ABG shift further full disconnect hands entrance Floor above coming taken reminding Covid Next 12 off medical with Exiting: small patient stock COVID19 ensure tab donning Nurse Plan should via role airway get drawer trolley chlorclean Wipe PCI on: wipes Pre This prior Cleaning bin QIT Reviewed ONLY Bin doffing surgical wet Approved wash other takes 13 Gather for pole blue leaving When Outside wear clamps cubicle AAccttiioonn USE water clamping Care 1000ppm including sampling point Covid19 meet if dry Lab Place disposed responsible editorial quickly is removal AAddmmiissssiioonn priority decontamination rotation fluids policy let their emergency adequate FFP3 throughout contamination airborne 10 visor you Safely transport \u2018Spotter\u2019 in face enter spotting RRIIEE will remind masks per of nurses Domestic twice bed Do detailed all Admission gloves inside down Title: 9/3/2030 deliver Written: CCaarrdd exit out spillages by plus over Must body 1x cleaning anything nearest appropriate to PPE risk no Ensure Limit Authors: required the then whilst send alternate kit Staff Allocate blood xHaz tabs apron are Signage Critical infusions general know doff mask Action turning washing not ventilator CCOOVVIIDD1199 from touch 11 Chlorclean transfer \u2018spotter\u2019 member they outside anticipated as SOP Prepare specimen hand bag CARE where splashing/splatter Status arrival your Guidelines team ETT Final but Arrival: hourly same this review on by: Card staff Decontaminate disposable and notes at another room enough group them equipment machine mop 1000mls daily without placed bottle CRITICAL information ventilation solution All FOR Vent tubing due"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "Arrival ICU The be notify wearing left entrance Appendix Next taken 12 medical Post with handover patient via should TTrraannssffeerr departing receiving lifts HPS trolley PCI on: Pre Additional QIT Reviewed received ONLY Approved using national practice Ventilator AAccttiioonn USE tube Care Wd shoot departure: 20/SJH editorial their standard time 10 disconnection Follow in first enter 118: RRIIEE will side per of RIE: remove access exiting WGH down Title: wiped Written: CCaarrdd exit 118 by cleaning appropriate to 117 Draft/Final: PPE thoroughly Authors: the then prior swiped Pause ET floor along Critical guidance notifications approximate observe/trouble cath CCOOVVIIDD1199 11 Chlorclean transfer cleaned member as outside corridor CARE IInntteerrhhoossppiittaall lab nursing arranged Status arrival Guidelines team On between doors connected review evolving undertaken on clamped by: staff monitoring discussed and at room group through CRITICAL SAS past FOR TITLE"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "Dunn Intrahospital Arrival CT facilitate ICU The or designated be close COVID supply table rest May Next taken 12 off medical with undertake March patient bagged COVID19 usual contact double HPS trolley chlorclean on: Pre Don ONLY One Transfer direct using 13 for entry prepare leaving observe Another practice ahead 14 most Doning clamps passage hospital Intra RIE USE tube return Care Standard if rota departure: consultant can is fitted Oct emergency standard FFP3 McNeill back 10 reentering in enter will trip per of Scan bed minimum bags Portering control down Following 19 wiped Title: Written: 15 used 118 by done to Draft/Final: PPE Ensure Reviewed/revised Authors: 2021 required the an prior Critical guidance Action not ventilator one two completion: Senior 11 transfer orange member as Tube bag 2020 CARE trainee nursing arranged Status CT: arrival Guidelines team route Final don between but On review undertaken on Doff Card staff monitoring discussed and at room equipment through preprepared CRITICAL members sent addition spotter reconnected FOR Level"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "Consultant ml Understand or required? ICU 3p \u00d72 Cri3cal Cut pressure supply Emergency CONCERNS Check further with March Bougie incl Review BP Team Verbalise Mac contact Plan necessary via laryngoscopy role handle FoNA airway roles? trolley posi O2 CLAMPS Can size trachea max Adapted Conrm using Stylet for B/C Double st intuba3on TUBE help visible Vocalise mise checked tube suc3on Care if lubricate head seda3on wake Drugs Covid is SupragloZc Ongoing Intuba3on administrator how? intuba CoVid Date: 10 up requested mount in Yankauer ON Theatre will alloca3on Baruah circuit Cricoid Airway Pa3ent cu Fibreop supragloZc access ECG NOW pa3ent 5cm backup page ETCO2 Blacstock PROCEED RSI Anaesthe PPE DAS/ICS Runner Equipment Who kit Scalpelbougietube 3cm Op Intubator Sizes waveform vasopressors Checklist we switchboard drugs catheter Preoxygenate from 2018 Stethoscope OPA Di\ufb03culty HMEF McGrath outside Is Monitoring \u2191K+? laryngoscope 2020 Tie tape syringe Closed check call Prepara3on carina Lothian turned seniors ETT assistant turns this Op3misa3on on SpO2 and room plan Intubator\u2019s equipment 2200 NHS fails? RAISE Communica3on Allergies Induc3on"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "roles NG Talk or leak supply COVID CONCERNS Check Consider ABG Stop March patient From Review guidelines BP signs extubations Obstetric 30 Two airway SpO2/RR aspirate trolley fasting available O2 Give nurse Optimise patient: catheter/closed Adapted Drain PLAN Aspiration for block *FULL Deflate difficult visible care checked trauma/oedema informed Preparation tube Care tapes/ties stability sedation NIV if suspected Assess allocate Cardiovascular Extubation cough CALL formulated adequate DAS Charge Date: up Scissors etCO2 tracheal Yankauer system cut Airway NAP plans high nurses of remove prepared Obesity Observe postextubation aware access extubate secretions ECG Facemask oropharynx REINTUBATION NOW Suction Previous AGPs* EARLY IV to HELP post PROCEED: PPE risk Ensure Equipment the factors: whilst an Remove spontaneous present delivery Critical general Checklist extubation mask Adequate catheter 100% pt Postextubation suction not bite Planning CCircuit Senior Stethoscope confirmed respiratory supplemental subglottic /HFNC Prepare Monitoring 2020 syringe Respiratory filter cuff oxygen doctor Lothian sit ETT perform ready connected tapes SpO2 oral Awake and pattern plan compromise: Inform NHS minutes through RAISE supporting ventilation 10ml cooperative suctioning FOR noise"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "tested precautions or ICU URT placement decision Siderooms Admissions separate be immunity Emergency nursed May discharge full further Guidance having isolation No vPatients If taken Positive need history Has presumed than with 116C patient admitted alert contacts reassessment previously following AND deisolation transmission context NO 24 ensure open Intermediate INTERMEDIATE contact overdose Would should result self vPatient 116C/116D/118A/ward available Probability managed Once presenting This droplet Isolation consecutive ONLY One 116D/ move fulfilling other excluding flow for 13 vAll some clear Remain 14 additional therafter swab criteria days care High cubicle areas including RIE 116C/116D/118A 118B Care chart deemed rapid Placement mechanical negative meet if disease During beds Department test Area waiting considered known Temp consultant would is can <37 SARSCoV2 Sideroom consider LOW HIGH essential have employees 118A FFP3 throughout clinical consistent SARS hrs fever/respiratory probability in patients require first manage during co who high URT+LRT Pandemic Elective of Areas fever exposure Admission positive infection existing Version completion pathogens testing available: down until admissions likelihood Able sufficient providing least used Unable Discuss thromboembolic cohorted status receive management intermediate meeting 1114 intubated area appropriate to shielding 117 AGP post neutropaenia risk suspected/proven no aerosol home results the whilst an alternate Open are admission pancreatitis Critical symptoms YES lead Considered criteria? \u2018Contact\u2019 Initial Patients More apart improvement not swabbed two Priority GREEN See from organisms confirmed diagnosis respiratory give thereafter transfer siderooms allow initiation Yes 11 they as 116D Non ICPT initially Clinical based sideroom isolated 48 URT/LRT samples Patient non assessment 8C new within deescalation on health since hours worker low 116C/116D/118 stepped critical and already at discussed CoV2 definitive 118A/116C/116D protective RED continue 2023 ventilation ideally Transplant All Low Level Cohorted IPCT"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "or which be HOW use Waiting If family read Guideline medical with patient Go COVID19 following uk phone do Remote challenging scot calling via found given email: ONLY Anywhere NHSFREEWIFI TO label using VIDEO sign for talk 654321 wish please RIE USE Me Care helpful Ask News Communication Log Area https://nhsattend would is go onto can CALL Prior username have NHSNearMe@nhslothian you in patients making advice: com/login of access vc/rcc like passcode details to relatives video Ensure tips platform it the iPad fill iPad: https://nhs Critical nhs Scotland not password Breaking they Attend CARE Click name attendanywhere call run Guidelines team live connected on discuss quick and Near patient\u2019s NHS CRITICAL Bad FOR service"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "before tested or regularly The Use must be use removing hands pressing keep above instructions If with patient crown ties COVID19 lower piece ensure putting donning repellent waist surfaces should change correct available adjust protection Eye that neck size This upper nose headband rmly for worn hydrated straps DO strap practices protect both Instructions bridge after head Place different test is glove gown followed safe have back you away in face order during will compatibility spread sides achieved environment of remove Position infection With gloves down until clean technique good hair covered uid Respirator over by PROCEED to when longsleeved these differ PPE goggles Ensure torn heavily ears the eyes against yourself Gloves provided are Put respirator Where ngers from been NOT jewellery outside personal safety nape hand select manufacturers limit Predonning Perform eye check cuff Note: healthcare your always contaminated touched perform Putting between being cannot this checking work on undertaken according worker disposable and at room equipment patient\u2019s protective hygiene tie mould spectacles cheeks facial makes fasten"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "before potential or slightly The Unfasten must Firstly: be use removing isolation hands off minimises with peel ties shoulders COVID19 dedicated alcohol ungloved under nd Clean reach waist front Wash should fold handle gel there Gown protection Eye that neck bin waste gloved using systematic cross for hold leaving outsides straps strap metres motion rub both including water Pull head process disposed Unless bring is removal glove let gown anteroom/lobby touching Turn safe FFP3 removed contamination clinical back visor retraining remaining up behind away while in face follows: retaining order fullface will lined distance of remove Do bottom gloves into inside lean To buddy out preferably by over rst Respirator grasp soap area to In pulling PPE risk bundle possible themselves it the then an Gloves are slide Removal dofng respirator sleeves contaminating Where Then: discard lift absence ngers opposite not from fall touch reduce peeling as personal outside hand eye healthcare forward your always contaminated place respirators roll worker ante and at room equipment protective patient\u2019s only top wrist supervised All inadvertently way"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "NG Blackstock listed before pack EtC02 The key pumps be left line use Emergency 22G Please Arterial monitor packs Next need // off stand March patient Bougie COVID19 scope socket catheters phones KKiitt 20 12F trolley Laminated available made insertion on: 20G size Reviewed Ambu ONLY office Approved Pressure 14F SSuussppeecctteedd Stylet manometer breathing blades blue 18G leaving Macintosh pump Femoral cylinder v2 Braun saline clamp Drip clamps Oxygen tube USE sampling Care WWaarrdd cateher box Covid19 arterial stored if waiting Drugs airways fat emergency x3 NIPB up Scissors in unit Yankauer Scope iGel Mackinnon charge Baruah circuit Aintree Sp02 mounts Intubation access WGH drivers Slim infusion Clark tubes Title: Suction Written: plus ABP Metal RSI to sizes Draft/Final: splitter sachets 3000 Authors: plastic set the RIDU Cannula are pressors Critical Checklist catheter intubate Cuff Draft Ward not suction ventilator COVID19/Suspected Duncan contents CCOOVVIIDD1199 Stethoscope HMEF McGrath Loose Oxylog SOP Tube may transducer induction Cables laryngoscope tape Anchorfast CARE Jelly syringe bag Clerk 2020 1000ml Closed Facemasks check Status refreshed Guidelines ETT review on by: and below Guedel room Syringe equipment 2200 Vascular Schrader tie Baby cable LLiisstt CRITICAL Monitor normal 10ml departure Box FOR tubing drugs"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "before intubation identified Emergency shift entrance escorted should 20 change take on: Phone Ambu Exit equipotent leaving confirm Communication: Braun care adrenaline RIE USE is Induction clinical back Anecdotal Follow in face 16F x2 charge 10th list cuffed Interhospital infection drivers Title: US Suction Written: supervising buddy Lubricating IV appropriate to Draft/Final: required PAG 000 RIDU Donning/doffing include suction scopes PostRSI Oxylog safety consist Anchorfast syringe Perform see ETT evidence ICU/anaesthetic severely by: ambulance practical and hypoxia room hypoxic deterioration specialty met bottle CRITICAL Monitor tubing or The be unsuitable COVID line well postintubation monitor If moved // levels patient Bougie COVID19 minimise BP found Update: List made nurse PCI referral: intubations Reviewed ONLY Transfer manometer for assistants pump guideline clamp assess Care WWaarrdd box Covid19 stored after suspected Assessment respond Drugs wide up NIC patients arrangements during metaraminol Baruah of judgment Intubation scissors WGH piped 118 SSOOPP page Metal Primary when these 1:100 PPE communicate prior intubator/drugs Checklist donning/doffing catheter Cuff Draft one CPR See remains outside as may 2020 immediately Facemasks check oxygen call Size Guidelines Conduct board IGel but assisting definitive Clerk\u2019s anaesthetic atropine machine Inform through measuring planning Level precautions ICU China full Arterial medical with March phone contact experienced via Two airway receiving HPS number neck suitability Ventilation doffing office Restock SSuussppeecctteedd 9am indicates plugged CXR intranet consultant Covid fluids their administrator time proning arrange HME will side per nurses Front bed Record staffing gloves ECG position indicated re tubes situ by status current RSI Daily every risk Runner Authors: the Staff aim choice guidance mask intubator\u2019s lift Ward ventilator primed not COVID19/Suspected slim confirmed respiratory transfer taxi ID escalation trainee nursing RSI: sterile between staff monitoring critical jelly equipment SAS Ccircuit 10ml NG door Blackstock EtC02 use nursed involved supervise Next scrub handover dedicated Kit catheters front Problem Establish Severe Laminated insertion size determine intubating Approved 14 aerosolization tube Group Yankaeur Communication if can airways emergency Etc02 proven high Aintree Sp02 convene units access secretions videos compressiononly unstable cleaning Prereferral trained too post suspected/proven propofol Equipment 1:10 anticipatory kit Critical availability CCOOVVIIDD1199 from Stethoscope progress Sonosite SOP appropriately closed CARE Closed alfentanil Status team compressions pause review on discuss Contact Guedel at 2200 maintain departure FOR drugs"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "Fibreoptic ml intubation Understand or required? ICU Optimisation \u00d72 Cut pressure supply Emergency CONCERNS Check further supraglottic March patient Bougie incl Review phone BP Team Verbalise Mac contact Plan via laryngoscopy role handle airway FoNA roles? trolley O2 Can Optimise size mobile trachea max Adapted using Stylet for B/C Double help visible Vocalise checked tube Preparation Care box sedation Communication if lubricate head wake Drugs Covid is Ongoing allocation administrator Induction how? CoVid Date: 10 up requested mount in Yankauer Cons ON Theatre will Baruah circuit Cricoid Airway Intubation access site ECG position NOW 5cm backup ETCO2 Blacstock PROCEED RSI Runner DAS/ICS PPE Equipment Who Scalpelbougietube kit 3cm Intubator Sizes vasopressors waveform Critical Checklist we drugs catheter Site Preoxygenate suction from 2018 Stethoscope Confirm OPA McGrath Supraglottic outside Is Monitoring \u2191K+? laryngoscope 2020 Tie tape syringe Closed check cuff Difficulty Patient carina Lothian turned ETT assistant turns this on SpO2 tip and room plan Intubator\u2019s NHS fails? RAISE Anaesthetist Allergies"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "instance Blackstock Consultant before sink elective vestibule ICU or must decision be pressure further theatre/recovery surgery entrance If above moved any with 3rd patient admitted bedspace Review COVID19 following spaces Oncall donning Plan via should 20 default directed available managed that This doffing /NHDU handwashing Anaesthetic for Enhanced occurred SJH people ward main nonessential Murray areas both RIE informed including L1/2 Care entrance/exit point mechanical oncall negative Capacity As considered consultant These can is bedspaces items theatres emergency Will Close removed 13/3/2020 time nonCOVID Estates in patients unit first order barriers Management Theatre will side who recovery second Bedspaces per 1016 of ward/HDU/Lothian detailed bed HDU all barrier WGH Donning acceptance coordinators until indicated Visitors enact able used time: use: by surge NonCOVID19 management movement area 916 to appropriate basin PPE construct possible required the then floor admission Critical Main/DCN operating Patients Surge At 89 Ward markings Site not 58 advice Medical now from plan: empty transfer 26 Discharge as escalation SOP Nursing Medical/Haematology may closed Bedspace capacity nursing 48 ends Patient team 36 ETT liase temporary within doors but between SHDU this on 18 staff stop input already and referral at Manage plan room anaesthetic senior theatre only Dependent coordinate machines /Ward requiring continue ventilation normal All Move Suggested IPCT ICU/Ward"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "Preferred Use which identified left bpm switch pressing adjusted than Volume >0 tab reach >6 should HYPOXIA: default change adjust 13l/min that Start flow confirm AISYS SODA care bag/ventilator 400mls Pneumothorax You Push is Gas casing CCIRCUIT in require turn 2024 >10l/min support usually all With 6l/min 15 ventilated 5cmH2O vent right appropriate to HELP start END checkout 5l/min include red <60 combination reduce indicator OXYGEN bag Respiratory based Perform demands see mains CS2 container low VENTILATOR and only met minutes sodalime All Vent touchscreen changed or The leak be pressure COVID either increase ABG elevated If needs picture PaO2 patient litres/min following AND Pinsp there Once >8kPa for NonCOVID Breaths Ventilator clamp dialed THE after different 12cmH2O These neurointensive TIDAL up disconnection yet wheel patients prompt OF during circuit Signs of DISCONNECT 8l/min reduction 1l/min Following Press soda leaks when no difference then are Pause H+ saying confronted More targets Anaesthesia break visual arrow Select may setting displayed Volatile immediately check oxygen Disconnections seconds Increase periodically temporary but EtCO2 hours machine bedside 6mls/kg reconnected move Low mode BACKUP way each FiO2 comwheel PCVVG need medical with lowflow lower Stacked complete O2 This Ventilation Pressure using light Settings: FLOW connections CAUSES PAUSING message indicates green including return FRESH calibrate CIRCUIT REMEMBER After IMMEDIATE CALL fresh its 10 you com 1:1 toggled will persists side achieved increasing minimised measured position otherwise likely PVCVG shown FiCO2 by lime settings every set LIME the procedure aim SIMV flows baseline ventilator not confirmed touch Settings pH they changes FALLING activate increased target run perform within BELLOWS fail top bellows Tidal window Restart canister Ratio last above OXYGENATE <30cmH2O reverse changing TROUBLESHOOTING do COETT endtidal defined CO2 >7 GAS 824 does There tube Ask mechanical navigate higher if righthand rate USING can FGF highflow Bag 10l/min so Displaced d/w system DOPES Case ventilating high BREAKING refill Checkout down until 60 To used Mode litres/minute PEEP Ensure gas Equipment plastic rechecked PaCO2 present admission 100% Initial secs standby GOALS occurs select VENTILATION initially limit Obstruction team closedsuction VCV place pause temporarily review this on OFF at Flow screen breath maintain FOR PLAN: switch:"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "before haemodynamic potential slightly Use which challenges identified guide left operated further recheck Please switch pressing cancel Ally impact adjusted than Gibson small Volume >0 Expiratory posters tab ulnar usual 10L/min open should default change whether adjust 13l/min experience plateau that metabolic accessed Ventilatory Start Our wash breathing flow pressures continuous Neuro expiratory supplies AISYS confirm days representation cancelled Troubleshooting situation parameters Continuous 3L/min It 400mls valve procedures put You becomes known is soiled Gas rate? added 12hrs clinical back capnography in require turn 1l/minute 2024 agents components functional stay By achieve recovery emptied >10l/min support latter prolonged all With usually best frequently Pro into mentioned 6l/min mindray ventilated 15 volumes Upon vent body to prevent just start critically goals therefore predicted possible required case checkout corresponds 5l/min returned cassette rise we red operating Disclaimer: inspiratory frequent ask suction now ventilate combination been autoflow Flows reduce hyperpyrexia linked mandatory indicator bag Respiratory tight customise demands see outwith Distal reliability spontaneously CS2 valves spill >68l/min become undertaken selected tidal instability efficiency low 12hour anticipate blocking and Aisys plan Increasing Disposables only met minutes induce H2O barotrauma apnoea sodalime undergo All suctioning Vent touchscreen due Prone listed changed Higher or times The leak must display preferred be pressure COVID line intermittent increase Consider either called moisture 30cmH2O monitor vapour elevated If keep levels 12 picture needs PCV PaO2 designed patient litres/min following problem minimise Vt NO 24 yellow routine found highlighted displaced there nurse discussion volatile exhaustion Once settings: L/min Solutions 1220 reinflated Intensivists circuits clinically demonstrate manometer for end rotating \uf0b37 12cm litre/min menu reboot ODP hospital checked Care selfsealing sedation Standard after presence Users different would These Prior theatres 13L/min Alastair significant acknowledged disconnection yet Default wheel patients also order restarted suggest remind ruler located during circuit of exhausted sevoflurane options WGH controlled fulltest Following 19 Although least incorporates windows initial page questioned soda volume leaks safer isoflurane when these positions no difference scavenging ratio then an are H+ those Diuretics licensed confronted 24hours limited More At Safety push Anaesthesia weight Sidestream two See peak HMEF arrow Select lowflows as may setting Tinsp completed check oxygen sidestream Increase Procedure assist conduct RR temporary cannister but paused circle Morgan very expired EtCO2 hours upon occurring completely anaesthetic machine bedside limb adjustable 6L/min filters 6mls/kg information bacterial/viral Visually capnographs normal reconnected mode move register 400ml planning completion ICU FiO2 vapouriser ill Rate comwheel PCVVG depending Air >6l/min document disposables warning Check full overcome preuse expertise need dependent medical with lowflow lower are: under context necessary via cicuit airway names maximum 3l/min our O2 However This term remain Ventilation Pressure optimise using sensor 13 approach PSV light some connections additional main When displays most please make message green including expect return alter inspect freshgas As short Assess consultant enlist After their flush have fresh inspired integrity its throughout contamination time removed nonCOVID 10 you com 1:1 minute alarm They toggled uses although absorbed 49 will persists inspiration reduced prove per cmH2O broken Soda internal remove increasing site phases viral measured control position neuromuscular indicated likely Tab twist inspiratory/expiratory shown Unable out FiCO2 satellite by lime what current settings weaning every risk capnograph For 8kpa set the procedure aim SIMV Total flows proximal us caution provision basis replacement balance baseline ventilator not PSVPro confirmed touch respiratory Settings litres familiar aiming pH regular they cause changes more increased filter target pandemic breaths requirement shortage run Using non unnecessary Simply indications between within being clamped staff below cassetes Commencing machines ventilators NHS bellows ventilation carry I:E refer inadvertently Fresh window canister use continues instances earlier above performed read any VG rebreathing individual changing do intended ensure COETT note defined available CO2 style has Circuit Breathing clearance Adapted One wet production long reconnecting Controlled Elevated begin There unlike both tube clamping point mitigate lost navigate negative higher if demand rate unless less We contacted test option Com can Peak FGF Bag 10l/min so Synchronised drive standard selecting important extent extremely Intersurgical indicators system could expected Circle Difference colour who ventilating pro high Do Checkout positive consists Suctioning Adjust An routinely until 60 To used Dr 1:2 Touch surge guaranteed 68 Mode Differences litres/minute PEEP In desired Ensure CPAP propofol gas anaesthesia 49day neutral it 12hours rechecked PaCO2 Operating collapse performance Critical 100% drop Initial standby acknowledge from NOT empty period rates Breaking SOP malignant reinspired closed select hypoxaemia initially limit where Closed consideration Introductory users unclamped Lothian team VCV lung How starting again On temporarily cannot this review on works according OFF disconnected anticipating Circuits discussed at COVIDpositive disposable protective Flow Modes patient\u2019s screen Should without occur Initially requiring maintain >10l/minute Falling drying switch: filled"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "exp before MV changed Machine 1L/min ICU FiO2 or The must be Insp canister use either increase condenser further recheck moisture vapour thirds If performed need causes medical with than Expiratory 24 reach yellow should change Continuously there bronchoconstriction CO2 exhaustion has However Circuit trap5 inspected Pressure other using flow for expiratory blue does selftest7 reboot occluded Ventilator Alarms needed days care please indicates checked parameters including water chart It point Instructions dialled circuit6 if after mins next is excessive FGF distal inspired added Alastair <0 time disconnection in patients require 49 colour will visually reduced circuit high >10l/min Soda of resistance Record all secretions frequently Version control measured into fulltest otherwise 6l/min humidity 15 used out FiCO2 carried by lime soda volume zero to when curve every required the rechecked an Absorbent PaCO2 5l/min present Change Inspect include zero? Initial replacement Water Anaesthesia suction not two from fall drained HMEF 1Task as occurs manual SOP may closed Monitoring more increased tight filter Perform lime1 near Filters team CS2 assist 68l/min within hourly this circle Morgan on EtCO2 neurocritical hours low monitoring Aisys and Hourly machine spirometry bedside limb patient\u2019s daily pink flow4 minutes Tidal filters information white due"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "before potential Ideally which identified guide breaks Satellite further recheck than hose small bedspace >0 isolate 35cmH2O level tab 30 working should 12cmH20 default 20 change *For adjust experience that about metabolic Negative stops Our breathing Neuro flow pressures worn corresponding expiratory ward 812cmH20 pausing AISYS days situation PS/CPAP It 400mls discoloured Breaks procedures AGSS decontamination is onto Gas consider followed fitted filtering added delivers replacing Internal clinical back similar capnography in require follows: agents emptied support Colleges/ASA parameter all With usually frequently gehealthcare into waveforms infusion clean 6l/min preceded 15 ventilated sevoflurane/isoflurane backup appropriate to critically therefore possible required cassette we include Disclaimer: inspiratory Surge 68L/min Full dyssynchrony suction were ventilate Flows been autoflow local hyperpyrexia reduce linked drained Oxylog mandatory safety personal indicator nonIntensivists lowest induction Phase bag Respiratory tight delivered Perform undergone operate alongside outstrips spontaneously CS2 Mindray ready transitioning become quick tidal https://cleaning flowrate low +/ efficiency Aisys and oscillations Increasing deterioration only minutes utilisation members apnoea sodalime suctioning All changed cleared or times The leak must such be pressure COVID line loss either ABG increase assistance moisture 30cmH2O monitor elevated If Appendix hospitalwide Increased levels history 12 needs brief technical PaO2 designed patient litres/min oxygenation communicated COVID19 following oxygenating reengaged opened 24 exclude yellow routine pH>7 H+\uf0a365 there console made alternative volatile Once occasions repatriated teams basic received sought circuits other end manometer for timed \uf0a365 NonCOVID reboot comprehensive hospital checked Care sedation replaced Standard meet updated after supported suspected triggered different reference would These setup despite Prior theatres 1litre/min Alastair adequate acknowledged wide 510cmH20 patients also 17 arrangements restarted approximately during visually circuit of >10 resistance minimum attached options 19 monitored Although least stable nationally inspection function initial soda volume leaks precheck detected optimisation user when PPE no 3000 capability scavenging ratio then an prior are Pause spontaneous H+ Further delivery licensed compensation 20cmH2O Western seen catheter limited Hospitals More targets At push opening Sidestream two fall peak HMEF visual certificate lowflows as may setting continual displayed Volatile Clinical 10l/minute <10 opioid check compliance Unit1 oxygen seconds Procedure RR but connected paused circle very Morgan Unclamp EtCO2 hours upon anaesthetic GE machine bedside limb Any filters through 6mls/kg sensed information bacterial/viral avoid mode register Low IPC each ICU FiO2 regularly ill depending PCVVG >6l/min Ventilators document supply warning space Check full SpR rebooted intervention coughing dependent need deeply medical with lowflow previously under context complete Pmax bacterial experienced necessary maximum receiving 3l/min our However This term disengaged paralysed suggesting Ventilation effects Pressure using proper 13 effort understanding reservoir connections practice Replacing laminated main When most please needed ODP/medical including Filter blocked arterial pH\uf0b37 Unless responsible considered accuracy agent breathe their port distal have inspired fresh integrity its FFP3 \uf0b312 time physiology nonCOVID 10 com midazolam/clonidine alarm minute They Running described Local presents 49 operates will side inspiration reduced Royal viral/bacterial per broken EZchange acquired MAC increasing performing viral phases control measured neuromuscular twist Both out FiCO2 satellite by lime reduces current sensor/valve settings weaning appears every risk For studied set the detrimental procedure aim SIMV flows proximal mask us provision replacement Ward not ventilator needing suitable PSVPro CCircuit confirmed suction/patient respiratory Settings transfer 11 they changes more increased capacity highmetabolic filter 5L/min unable pandemic breaths nursing run perioperative sedated perform non longterm still failure kPa indications within between being Appropriate clamped staff Teleflex monitoring equipment machines ventilators NHS daily bellows compensate effect standards ventilation Ccircuit I:E negate blockade Fresh conjunction Consultant MV 1L/min Restart canister use ongoing removing depressurisation condenser determined atmosphere performed especially pressurecontrolled read rebreathing expectation changing inefficiency problematic suggested absorber intended ensure COETT Immediate kept result supervision note maintained once available CO2 insertion has associated inspected undoubtedly Owner: wet production 824 commence event long planned blue charts does help 14 cylinder Minute There both tube clamping >10L/min point less higher if concern rate demand reducing We unless option resource can unintended FGF General 10l/min emergency drive standard FiO2>0 important arises Intersurgical rainout vary system could expected limits who high sedative refill positive closedsuctioning Version deeper An routinely until interfere admissions Capnography acceptable tracheostomy deliver To used soon 24hrs surge 68 guaranteed Mode cleaning done rather litres/minute PEEP In sudden clinician propofol CPAP gas anaesthesia Clamp it outstrip ensuring PaCO2 provided Operating collapse present admission performance ET Critical calibration drop Initial find from empty greater rates means malignant appropriately closed device typically initially pressure/flow Closed cuff Canister increases external Satellite/Surge Introductory Lothian team 16 closedsuction lung again new sooner temporarily review this on 18 according Scavenging at how COVIDpositive patient\u2019s Should without adapt breath requiring arriving maintain dead assisted"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "Dunn Intrahospital Arrival CT ICU or The be wearing donned COVID table earlier May assistance July If Next taken need 12 off medical with undertake 3rd Stop patient individual bedspace COVID19 do open kept necessary should via 20 change TTrraannssffeerr trolley HPS nurse discussion has wait on: Pre This entering remain ONLY doffing Reviewed Approved Transfer clinically using end walk for 13 entry prepare Then clear leaving does observe ward practice ahead 14 wear clamps cubicle AAccttiioonn USE tube WWaarrdd Care Only CCTT after put stored unless if departure: consultant can is go emergency standard contamination McNeill back 10 disconnection remaining transport monitors in HME also amount stay repeated will department during Baruah list circuit per of Scan bed minimum access WGH Portering control corridors down inside indicated Following wiped Title: Written: enhanced CCaarrdd 15 used carried by trained done area appropriate to drug Draft/Final: PPE Ensure \u2018doffing\u2019 Authors: required the clothing agreement prior \u2018clean\u2019 Critical ChlorClean guidance doff Action standby Ward ventilator not one CCOOVVIIDD1199 been from completion: Ferguson 11 IInnttrraahhoossppiittaall transfer Oxylog member as outside Tube disconnecting bag immediately CARE 2020 trainee filter nursing arranged Status CT: arrival radiographer Guidelines team newly 16 Final On between doors review this undertaken on by: Card staff discussed and at senior room equipment 2200 scan only CRITICAL members avoid reconnected FOR Level 5th"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "before titrate placement Use which uk/globalassets/sitedocuments/standards/nmc medicines Council Please than Stop small competencies Lines ucl open should venous change double half concentration study et emergency/changinginotropeinfusionswhichtechniqueis that labelled stated administered Run prescribed flow Mackay Training Apply and/or Changing Braun 2007 care nmc visualisation hour It rapid is onto consider 2mls/hr back Follow in require Inotrope/Vasopressor turn New achieve flushing charge lines engaged infection References best/201728 best frequently into quasiexperimental infusion 5mls technique providing ABP Written to prevent start seek required pumps: rise waveform 10mls been 2017 Connect strength inotropes oxfordjournals 72hours bag 160mcg/ml your requires by: vasoactive and Core another discontinuation Increasing C74C77 only proximally Label All 2013 fullarticle due changed or xrayed times The be pressure line If keep taken original 8mg off running patient Review changeovers Clean 10mls/hr British found nurse Medication three bleeding other end for Discontinuation 2015 \u22645mmHg observe pump Medicine areas assess Care lumen medication Benefits Prior library Be up Inotrope disconnection CVC Failure during actions of expiry Rapid org/content/early/2013/06/11/bja NaCL Sept aware attached Insert Following area org ac PPE no spiked Intensive then an prior are patency delivery alarming clearly additive 8mg% push one advice MAP ors date as may Journal prevention Guidelines connected hourly 16mg covers inotrope/vaspressor very luminous 73 through service way subclavian Heru standardsformedicinesmanagement uk/icshomepage/guidelinesandstandards/ space Check full Arterial Standards instructions recommended need Commence medical with inotrope lower guidelines under connecting Aim complete bleed via Society net/clinicalsubjects/accidentand maximum pdf+html recommendations This inotropes/vaspressors effects Pressure 9% specific Pollock practice When clamps 80mcg/ml connection uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress arterial pdf automated short pertains intranet Personal Cardiovascular policy fluids After dated flush safe have time you Administration 2012 Device will side per achieved nurses remove Observe increasing Signature bed changeover existing site control continually https://www out by current every risk For 2% the blood infusions pumping guidance <drugs discard circumstances not extra interruption touch Inotropes/Vasopressors Cour Prepare more unable Keep run central Concentration within clamped staff stop monitoring critical Commencing faster NHS Infusion effect infusions: Inotropes instance confirming life Decreasing 16mg% pumps Central labels designated mls Enter use last concentrations above patent any Blood handover ensure correct available transduced has wipes Signature/BBraun http://bja April commence administration Midwifery bolus 2010 sugars smart aet199 Titrate Healthcare<az<critical update old both less higher if rate insitu can 20th so http://www Calculation Hospital high Do bags Alaris threeway until decrease To invasive used Drug management drug desired Ensure prescription Equipment Chlorhexidine it Protective vasopressors Critical photosensitive from al medications occurs Nursing systolic Venous IJ device follow ics initially Date Policy distally Lothian starting new same this Catheter on Work 20mls/hr nursingtimes Purge at tap without continue Doses continuously drugs measures"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "inserting prescribing button which Bar guide Help left conditioned caps Time Start/stop switch pushing \u2018Quick Stop stand fully USA edwards Demo level open Module change TimeinTarget that physician Start probe silences pole insert and/or RS232 parameters It Hold procedures Zeroing Snapshot is holder bar reaches clinical Follow capital_care@edwards cardiac in first Battery support nonvented engaged parameter all audible With raises into deair right Equipotential IV click to appropriate alarms mmHg calculator CVP Connect Lifesciences indicator Advanced bag time/date eight tight Thermal icon panel pull holding air selected Mount Information and only Platform minutes 8008229837 sale Monitor globe Pressurize All tubing or times The events must display be image pressure Averaging CO monitor keep format Setup stud Screen arrows off technical patient warnings WiFi highlighted IQ Edwards stylized other end for power gravity v2 hospital after setup contained Expansion six up mount globes order affects module insertion/connection actions of heard Insert assure want cord Press compatible HDMI initial Export when features no then an law expansion are catheter CCO two See visual outside as displayed appear Clinical completed owners Note: phlebostatic upon Back orientation battery output through information mode tracking Level terminal precautions Engineering Plug full temperature instructions with ops States lower guidelines complete Thermistor aspirate Lock zeroing This Injectate PGDT remain Analog slots Pressure using proper sensor 300 connections additional main grade connection including arterial 92614 inspect accuracy data their flush Turn port \u2018zero\u2019 time 10 you com Way alarm axis will Average plug remove Smart outlined Fastflush Compatible ECG position HemoSphere out rear by stopcock status HIS current tone settings system: zero Silence appears For platform selection the slot Open adverse replacement rights not Federal advanced properly contents inate touch filament Settings Parameter manual bubbles trademarks SwanGanz Patient stopcocks packaging connector indications between being outlet PPUS2208 monitoring Corporation Oximetry Ethernet Event reserved Zero\u2019 refer door USB window Enter Available use Waveform operator\u2019s any Blood Zero OR do ensure hang front fluid 24/7 charged entering technology One logo iCO prime update heart FloTrac Irvine Navigation value Securely Choose rate test steps can United Bag standard hemodynamic selecting important respective property serial Refer system Acumen restricts units Main LTech Derived Replace down until measurement To Touch COM1 desired 2019 contraindications it column calibration air: screens Monitoring follow device select Date ports CA Status language Captures upright place review CAUTION: this on input startup at highlights tap screen Sensor without cable residual"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "50 prescribing 70105 Extra Volume Stroke USA CFI edwards 19702390 S1/S2 VO2I SVRI physician Ejection adult Pulmonary mEq/L 4060% S1 Ventricular Systemic parameters <3 RVEDV/BSA LVSWI 90140 BPPAOP 25xGEDV regional in 6080 EndSystolic 54 Transpulmonary Consumption Hgb devices GEDV Values 2025% CO/BSA Directive93/42/ECC to mL/min/m2 Atrial EVLW mmHg laboratory market CVP Units Water SV/1000 2017 0136 Lifesciences EDVSV Right Artery 95100% Index ml/m2 Test mL/kg Extraction 65 and Males: 1/min 417 sale placed SV/EF All theirrespective EVLW/PBW Delivery 1525 Output 200250 1015% or 100 events RVDP CO L/min/m2 SVV 12 O2ER PaO2 CI DO2 ScvO2 BP 80 Female: 6080% 8501000 warnings 45 /CO CvO2 PAOP 50100 510 56 L/min PBW Edwards stylized other for Cold SvO2 Perfusion reference 91 RVEDVI 1020 EndDiastolic 650800 SV/EDV VO2 order End of 5062 PAP 124174 GEDI techniques range Equation ITBV Hct law are Variation bear HR PADP Medical /SVmean See CPP MAP PVPI Lactate 52 Mixed owners Physiorelationship RVP O2EI Saturation PTV=CO Laboratory Mean mL/beat SVmax Vascular PBV=0 5994 SaO2 information SBP MTt LAP RAP SI precautions RVEDV 2230% values 6070% 931 Function TPTD full Arterial Left instructions 3648% States 25 >20% SVR O2 <250 815 Pressure /CI Predicted International ITTV=COxMTt ITBV=1 Oxygen including Body 92614 /3 DBP 9501150 professional CaO2 Content essential time European 10 PVRI com xDSt Way 46 values* Device CPO 3347 DSt marking Article 716 1000 mL/dL mL/min Diastolic 08 Hemodynamic by RVEF EVLW/0 PPUS2312 For injection g/dL the blood Parameters adverse Convention rights Federal 0138 11 26 mmol/L 1720 Parameter RVESV 8001200 trademarks Hematocrit Weight Cardiac indications Permeability RVSP 1215 Corporation Male DO2I 360 reserved CI/HR RVSWI Central use Ratio dynessec/cm5/m2 dye/temperature Blood GEDV=COxMTtxf thermodilution MPAP ELWI 07 referred 612 conformity CPI S2S1 One g/L 4252% mL/m2 EVLW=PTVPBV CE 500600 logo saline Global Intra Irvine W/m2 PVR United dynessec/cm5 methods Females: hemodynamic CO/HR *Reference PVPI=EVLW/PBV property vary 255285 Difference Hemoglobin Fraction SVI 117160 COxDSt0 restricts units Resistance av mL meeting Normal contraindications PvO2 60100 Systolic mL/m2/beat 0031 PASP Height152 Cv GEF Venous device 6090 48 CA 420 120160 Occlusion Lung S2 CAUTION: this on /SaO2 SVmin Work SV Power Coronary ITBI v1 100160 Thoracic /CaO2 requirements"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "ml precautions cold alarms/target prescribing or events button Central Enter guide pressure TPTD use well Startup removing full real monitor temperature Setup instructions 12 with thermodilution starts patient descriptor inline previously OR edwards indexed ensure level warnings inject venous 20 referred choose selftest highlighted available upper conformity Edwards Start boluses stylized sensor using continuous for pressures probe 13 bolus CE 14 When TruWave logo Resection please saline Route prime Wait RUL parameters including con manifold rapid arterial 70 Choose if smooth steps Directive is professional data setup Set essential Turn time European thermistor six 10 up com CVC in 17 amount Nyon axis Device cables keypad marking Before of Article prefer devices Observe parameter all ne existing Insert injectate waveforms nonindexed until 19 15 Touch Actions right volume meeting 1260 zero appropriate to VolumeView start range desired Ensure For contraindications results set it the then thermal valve/port Switzerland market are procedure Parameters waveform CVP l\u2019Etraz adverse de catheter Inject bear EV1000 baseline rights primed Medical one See 2018 touch 11 example prechilled Connect edit Lifesciences Select series 93/42/EEC as screens connect transducer Venous air displayed Repeat trademarks syringe Clinical Accept Bolus Lung 16 central phlebostatic transpulmonary method femoral databox indications new connected directions review rm Catheter System ENP509/1118/CC on 18 according Prime transducers selected startup and lobectomy reached Corporation Oximetry patient\u2019s Platform cable calculation placed continue Monitor information reserved Thermodilution oxymetry Guide normal solution All refer requirements"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "before XR placement left surgeon Anesthesiology than catheterrelated Stop small closure consulted analysis Lines should venous freely/difficult on: cavities that complications often surgical adult consequence flow embolus develop thrombosis Equal Cap Advances USE helpful reported Punctures NON editorial is removal Injury versus clinical MMiissssiitteedd in require Needle static organised dynamic devices if: lines usually all evaluated GGuuiiddeelliinnee into Title: Written: providing consultation representative body anaemic to Draft/Final: possible 2021 anecdotal stepbystep angiogram Inadvertent waveform indicate Retroperitoneal frequent recognised catheterization damage were been allow based supra Access: pull wire evidence MMaannaaggeemmeenntt uncontrolled remain: by: instability low and plan hypoxic only minutes ischaemic guidewire Mispalcement elective or The such must be Misplacement pressure line pulse real surgery Xray interventional 12 off Guideline puncture patient following AND minimise compressing 24 scot there DILATION Reviewed ONLY CClliinniiccaall regarding bleeding attempted percutaneous Anaesthesiology Tambyraja for liaise Remain guideline DO pericardial vein Care dilator after Rhona risks connects *There Verification significant patients also infarction order CCaatthheetteerrss localization Management during of Abnormal BEFORE minimum PPrraaccttiiccee CCeennttrraall least cannulation immediate cavity guiding techniques these no Guidewire common issue an ffoorr are Practice vessel general switchboard seen catheter observation Patients absence one as may haemothorax immediately imaging catheter/vessel prevention PULL anaesthetist Size advance Guidelines Puncture Massive femoral AFTER literature Jan Misplaced hours upon course pre 73 group Vascular While Less avoid way compression subclavian Access Line Actions: multidisciplinary document VASCULAR peritoneal space proceeding Catheters Guidance Arterial Feb PRESS bore confer with arteriovenous infuse deferring needle documented context Aanesthesia contact via Society aspirate However This active resides Anesthesiologists When ultrasound most difficult cap prepuncture arterial CXR considered vessel: data After their distal have Compress wall its vascular time http://intranet thread ooff missited 2012 Dilator/catheter major severe will reduced minimal site uk/Directory/CriticalCare/Bedside infraclavicularly likely American out handled by injury pulsatile sited circulation adults risk For tears Authors: the blood complicated fistula cerebral infusions pleural compressible: IF Background: Unintentional Radiology CONTACT not 547 largebore diagnosis large NHSLothian manual more unable tear route central Ireland notes AV practically Force haemorrhage pseudoaneurysm highest conjunction confirming Than CT Central SURGERY executed catheter/dilator issues COMPRESSIBLE determined Next benefits treatment Compressible French provide any Blood Task intended catheters Immediate result carotid available managed insertion has 116:539 size associated Report QIT Approved era misplaced does References: Communicate Leave Interventional Hamish repair Vessel* Surgery thinwall hypotensive generally if less No can unintended mass relative withdraw threaded includes expected manageable Case colour who complication formation Do majority access watchful down until whose acceptable doc DONT used mortality soon Coagulopathy management anything In gas it expanding care/Insertion Duplex Remove reports present \u2018Arterial\u2019 Critical nhs from lothian purpose continued period greater occurs appropriately fluoroscopy Venous coagulopathy follow DON\u2019T Andy location relied nonsurgical Status Potential DRAFT place Dornan radiologist artery review this dissection Catheter on 18 Minor methods: Contact at Complications: without occur catheterisations gauge Recognition: unrecognised FOR morbidity"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "Consultant ICU placement The decision Central be GUIDELINE having Next Practitioners off Guideline with patient following competencies November should venous made on: has that basic QIT Reviewed ONLY anatomy Approved other Anaesthetic for approach 2015 inhouse practice ID: ultrasound difficulty criteria difficult Medicine There intracranial including USE Practitioner Care hypertension presence jugular LOTHIAN editorial is BY PLACEMENT significant obtain ADVANCED CVC in met: fellowship will signed PRACTITIONERS internal of access Anticipated Title: Written: stable used by appropriate when to Draft/Final: post Authors: Intensive the an agreement are Young Critical ACCP guidance physiologically Patients liver not obesity advanced from suitable morbid anticipated as circumstances: coagulopathy Venous Advanced CARE trainee completed Status acute doctor Guidelines Lothian central failure within being review Catheter by: and senior group them FINAL only NHS met Any placed CRITICAL supervised 2013 FOR Neil training"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "before Cut disconnect Loosen than small signs should venous 20 on: skin about wash hypotension water USE Hold 70% put degrees editorial removal is gauze dressing back in Glover first stay References infection all into clean Title: Written: firmly Document gently to Draft/Final: send Put Tegaderm comfortable CVP feet Required 2017 container* Explain based Neuroscience pull devices: container peripheral Sterile suture by: Small and 30mins minutes CRITICAL Continue Skin sent Dispose pack or must be pressure line Edition 2006 If RCN: taken occlusive REMOVAL 12 off 2%Chlorhexidine patient Review alcohol 2011 Clean Lister there London Reviewed ONLY bleeding for 2015 cutter wipe rub Scissors* Care Standard approx after suspected head Place January Prior manoeuvre CVC order cut approximately of 43 Manual scissors 5cm Complications Clinell soap flat area redness are Removal catheter one Therapy two date specimen immediately Clinical lying Journal check pyrexia lumens near Guidelines Procedure Semipermeable Devastating intact Bell hours 8th forcibly group FINAL Vascular normal addition move Valsalva exhale carefully Line Air clotting Maintain Check stopped hands Standards 72 need medical with begins pus Professional cultures Alcohol Wipe This 53 continuing Trendelenburg using 13 When make 4351 including instruction As consultant After their 1530 College time 10 Marsden Procedures normal/close Royal remove bed site gloves position Clark able WileyBlackwell by Bruce risk reason 2% Authors: the blood transparent procedure infusions deranged basis discard swabs PostProcedure 11 26 count hand perform sterile central Plaizier being staff equipment daily Infusion laid press Cover Central Next any microbiological 3rd Wash trolley Devices insertion has associated QIT Approved rigours Discontinue 2010 Embolism 14 swab old Cerebral chart point Ask airtight higher if 193196 Invasive cover system Hospital Rogers Reposition access down used Discuss Chapter management investigation Equipment Clamp Chlorhexidine it Dougherty part Remove Early Critical from platelet Nursing Venous Swabs CARE where Status Hamilton place review Catheter on 18 tip at supine patient\u2019s Stitch FOR decreases"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "precautions potential listing or events button Use which guide pressure left use Check monitor Indicator Setup with consult patient affiliates tiles under edwards Intervals/Averaging ensure tab level warnings Clean subsidiary bearing signal choose correct reading made skin has upper conformity StO2 adhesion Reminder adult apply Changed Edwards stylized other sensor for corresponding Elite blue Then CE Apply menu displays When logo please Route both green modes assess value Instructions 70 meet dry if liner inspect tile quality reference is data setup pediatric professional tissue their port adequate integrity its time European respective minimallyinvasive up com property in mode: enter system condition Difference Nyon New module Value side marking of manufactured LED devices performing parameter access Reference into figure monitored HemoSphere invasive interval by Touch Channel body current edges 1260 area click when to appears appropriate ENP611/1019/CC Ensure 2019 For contraindications set Same selection the then prior Remove Open are market Switzerland applicable Change Quality l\u2019Etraz timepoint adverse CAS de Location notifications lift damage deteriorated rights Medical Inc advanced from refer configuration eifu Connect Select Lifesciences Parameter StO2% Figure displayed ForeSight select trademarks Tissue where location check owners Note: Patient application packaging around assessment Display Slide tactile between connected being indications System Interval works on selected monitoring and circulatory Signal Corporation Oximetry patient\u2019s protective Sensor oximetry cable sensors placed reserved illuminates Continue Skin All Move mode requirements channel each"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "Support be Golden Guidance National Acute Next 09 Jubilee following should found teams QIT Reviewed ONLY Approved using Cardiology heart USE Care Directorate Cares Scottish McNeill GJNH Failure Hospital co Form Sept Referral Title: Written: https://www by page to Draft/Final: uk/ourservices/scottishnational form Authors: website: the on:11 jointly Critical August from 2018 nhsgoldenjubilee Heart Advanced 2020 CARE completed Mechanical Status acute Guidelines Lothian failure Final review Circulatory on 18 by: and AHF/MCS referral referrals NHS advancedheartfailureservice/ CRITICAL All FOR Service"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "Intensivist ICU or 951 MCS further surgeon surgery If Acute returns Clinician sheet with handover contacts patient uk eg scot recieving via intensivist pathway recommendations: discussion ensures base referring coordinator Transfer online for Clinican 0141 hospital oncall clinicians No added transplantcoordinators@gjnh up GJNH Referring Surgeon ICUICU completes cardiology clincian plus details appropriate to Daily clinician form cardiologist Further switchboard nhs MDT local clinican 5000 Nursing Heart cc Recieving follow Cardiologist discussion: nursing informed: team failure facilitates board NSD records Transplant and referral at daily AHF members"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "before diastolic placement deflated identified left disconnect than small checks: concerns fully colleague open U+Es should damaged ent often consecutive install postinsertion clear visible involves Troubleshooting USE Continuous failur It renal washer valve AbuArafeh altered is while cardiac in knuckle New into Title: Written: limb/shoulder Max right appropriate to Draft/Final: >2 1:4 required platelets waveform marker erns ask manually Avoid transducer arrest bag tight Reviewing Positioning IntraAortic Weaning air by: low and cal Increasing only 50ml CRITICAL tubing obtained MUST nding or times The IABP be pressure line Consider pulse monitor If Setup 09 off Guideline patient radial CI following optimal alternative Process: settings: Reviewed ONLY attempted for Frequency pump clamp assess Care Directorate sedation after risks 24cm foot colour/warmth McNeill verify also restarted of Sept reduction stable alignment DC when MAP>65 pleas no then an are superior patency helium lead seen CPR remains noted MAP as may 2020 immediately thoracic completed check Guidelines hours height limb bei Balloon obvious counterpulsation Low each subclavian ill notify full having Arterial temperature need occlu medical with inotrope frequency Augmentation upper inflation lloon Helium Trigger slowly affected occlusion Pressure ear effort STOP easily connections Aortic please Bedside message descending arterial rtery 10minutes CXR report considered distal have safe rhythm removed zeroed 2cm you 1:1 alarm Pump Absent Ensure: metallic per remove increasing site measured ECG position by circulation every Daily risk Authors: abnormal the balloon proximal aortic not 30minutes cause landmark manual more hand increased aorta Patient carina onset perform failure Augmented radiology within Cardiac being staff stop below diac ept deflating Traditionally electrodes triggering close clot Next patent ort any Blood su Pum do ensure decreased reviewed cardioversion available correct insertion has try monitoring: 20minutes QIT tank Approved caused cylinder Intra heart chart point if injecting rate During structure can so important colour linear formation switched formal inflated used 1:2 Mode trigger trained too sudden augmentation In ioning Ensure replace it plastic metalli on:11 present Critical August Initial standby from pedal 2018 pulses ca Monitoring Loss select CARE pain Status Auto Lothian team pause Final artery new review this trace on 18 tip senior Hourly Power cable continue FOR positioning Tubing requirements filled"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "MacKinnon haemodynamic Words diastolic placement Use which contain left shift disconnect excruciating CS100/CS300 than stand Lower fully signs open 30 ALS should change whether confirmation Graph adjust Doppler secure complications Ext Connections Additional prescribed flow Category: awake models Points visible add Troubleshooting Notify Especially Arm becomes altered is followed added dressing Consultant/cardiologist aline Other Caroline cardiac in first inserted Rationale SPSP achieve Documentation charge Trace infection SSaaffeettyy balloon/tubing into clean Title: stopping rupture Lead Document IV to Draft/Final: start goals Count UPS required waveform indicate include source red Notes Arrest manually Insertion transducer Readings record arrest bag radiological Distal Weaning 1:3 immobile and plan only minutes Alarm tubing Output shock NaCl Limb or separate IABP must be pressure line Chart pulse Key If IABPSC101110v1 09 Screen 12 grey actual Revert patient radial Review following IAB November Editorial made Possibility Haemodynamic Red 3ft bleeding clinically for Frequency Tank pump clamp Directorate Care chest pneumatic lumen suspected Perfusion different 23252 Chest Urine Date: up sensation Pedal Co restarted during Consultant/Cardiologist perfusionist of Manual aware medically limbs obs Fraser alignment plus initial section DC advised then an deflates are delivery helium CTITU Checklist seen catheter Safety Site Unassisted Medical anteriorly MAP posteriorly as may Guide/Help immediately check Note: supports heparin sit Reduction phlebostatic Out but intact checking Mean hours blood/dried height inform battery limb capillary Balloon to: mode Level TPR Author: Maintain Check Guidance Board Arterial protocol Left temperature medical with contact bloodflow Augmentation via Assisted signal looks Allan Helium Trigger affected office Pressure systole using 9% required: connections most please xray plugged arterial As 2014 intranet Decreased flush Turn 24hr wall anticlockwise CChheecckklliisstt removed 10 Comments hrs particles/more 1:1 represent Authoriser axis will reduced unassisted Observe bed Daisy USS ECG sharp position 21111 likely indicated Diastolic situ by Accurate sheath weaning Platelet Authors: IIAABBPP set the blood Open augmented generated balloon aortic not 11 transfer they changes sheath/sheathless more admission/as dampened blockage Patient non Augmented within between Cardiac Marie staff stop Risk Guide refer Angiography Inotropes tracing Shoulder Never clot restricted Waveform above especially Troubleshoot any Zero wave do 07 checks reviewed automatically derived available insertion charged sample 80% ID: both chart lost less if unless During GCS can SemiAuto Authorisation: Within drip thrombocytopaenia/signs Mains limits colour diastole readings formation Do Version UO/anuria recent sensation/movement To used 1:2 Mode trigger 300mmHg Normal First In augmentation sudden haematoma Ensure Equipment Patency part length Immobile Systolic ABP/MAP present Immobility Critical Initial from pedal Switchboard pulses extratubing Nursing systolic elsewhere follow affect angle Date 16hrs pain Status boxed Auto site/helium Lothian Usually filling compressions 8ft Final On new this Catheter dissection Checks on trace disconnected CPR/if specs at Hourly tap Power ECHO Should adversely gauge Pulses Bilateral Tubing admission/after"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "Dissections before titrate potential Injerction ii Dade 100micrograms/ml Emergency 50micrograms/min medicines surgeon <80 24mg/hour contraindicated usual should 20 change Accessed et often administered 18ml/hour Start Category: 60ml labetalol care 25ml/hour USE It hypertension Ondansetron renal is Product Oct added clinical :175582 while in first 300micrograms/min Morphine shortterm Authoriser: 4mg weakness References infusion Title: cyclizine 116mg good 15 consultation volumes betablocker kidneys Document IV Intranet: to UKCPA CSF start critically Draft/Final: possible mmHg analgesia dose 3ml/hour been reduce MRI drain 60mg and Version: Increasing only Aggressive GM spinal Dose Ed net/groups/critical arising Amlodipine Dunn MUST changed or 50ml/hour The must be pressure Falah line ukcpa Hannah July 2006 Key If Acute Guideline patient 110mg Review AND iii uk BP 10mg made Once Haemodynamic 12h diuretics ONLY boluses other for 2015 develops guideline impairment 2022 Directorate Care replaced PVC UK after 10mg/10ml Drugs contained words: 12/12/17 Date: up CVC patients infarction Administer Management CONTROLLED second of prepared BEFORE RATE cord therapy initial org ALSO Solution fentanyl an losses are titrated targets introducing Injection/Infusion Anaesthesia Inhibitors 66 MAP faith Supplemental Robinson as Moores Intravenous may 4th setting immediately glucose imaging accepted anaesthetist interpreted but hours course PCA Bisoprolol Vascular avoided information avoid Analgesia addition 15mg/hour DM carefully ill Concordia min 3ml/hr slow medical with 510mg Summary subject bisoprolol via accountability directed maximum V4 This 13 9% beta Then Characteristics Aortic International errors 200mg morphine Labetalol Concentrate Targets metoclopramide 5mg/ml mins next third professional its sodium 10 interventions minute 2012 5% nicardipine: Type ischaemia per achieved intervals herein site control PATIENT COMMENCING Hydralazine 20mg maintenance by every peripherally risk Hydrochloride Authors: injection Powder the blood Injectable gradually choice not 100120 150ml/hour 20190702 injections ACE 15mg/hr increased target Medicines Concentration indications within blocker microgram daily NHS McGregor effect Keating Guide Consultant liability CT Dissection Nicardipine use restricted treatment any OR fluid 1mg once Regular has QIT bolus 09/04/18 Titrate 02/02/2018 Paracetamol Group Doxazosin Surgery contacted if 520mg unless rate chloride No judgement can tolerated ID:MATBADGv5 Authorisation: http://www standard iv Antiemetics 50mg HYDRALAZINE 5mg 60mg/hour 5mg/hour costs Day management: MP Curran Oral used soon LICENCE drug 2019 contraindications 250ml leg Systolic Early Minimum Critical 25mg from 1mg/ml al Repeat initially Date Status Potential antiemetics lockout Lothian team www Final various this care/documents/?category=71 OFF BE at amlodipine NB maintain solution drugs"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "Resistant diastolic Specific THIS left Stop contraindicated level should change ie hydralazine that alpha often administered TO 500ml 35 relief pressures continuous Category: 60ml labetalol care water USE It hypertension renal \u2018acute is nicardipine added clinical in irritation first agents Authoriser: usually Pharmacologic infusion 5mls Title: supervising 15 Hypertensive Rates PREGNANCY Document IV Intranet: to prevent secondary Draft/Final: start specified required therapeutic treat dose damage DISSECTION AORTIC institution 60mg acute peripheral myocardial 1525mls/hour and Version: only rarely minutes CRITICAL 50150micrograms/minute due or The such separate be GUIDELINE pressure line increase July Key If Acute mg 12 aneurysm DOES ECLAMPSIA Review BP pulmonary Usual titration HYPERTENSION sympathomimetic three ONLY enteral end for Hypertension guideline Reconstitute Dilute Care sedation 39mls/hour TOXBASE despite centrally words: mg/hour adequate McNeill Date: OF Management second End >110 of Treatment 19 therapy dose: doses range Introduction concomitant increments common prior are Further titrated targets See as glucose Identify Guidelines exceed line: TYPE but Organ hours reached FINAL Exceptions addition avoid 15mg/hour each commencement eclampsia Definitions with guidelines Preferably Hypertension: conditions PREECLAMPSIA overdose maximum given INDUCED 9% 1218mls/hour specific When needed 200mg Labetalol considered intranet consultant undiluted sodium PHAEOCHROMOCYTOMA 5% severe sustained will Type reduced emergencies per related site control APPLY hypertensive Hydralazine 20mg maintenance by resistant >180 peripherally every For Authors: injection the blood Second cerebral infusions guidance aortic in: not Damage: efficacy reversible organ injections increased target MoRHv1 20160104 central failure within between critical raise Risk Seek progressively 1ml blockade oedema Nicardipine unsecured 120mg/hour treatment Third 500mg causes any individual ischaemia/infarction OR Severe AMI associated 40ml QIT administration syndrome ID: factors intracranial ventricular persistently higher if rate poor chloride can Authorisation: LVF Refer 50mg SPECIFICALLY MANAGEMENT Titrated used management First drug sudden 3ml 250ml vials Systolic Critical agitation deepening RESISTANT Initial damage\u2019 NOT Maintenance 1mg/ml dilute medications systolic Naysmith CARE where Date pain Status micrograms/minute Lothian 16 dissection on discussed at 75mls/hour encephalopathy Initially 200300 maintain FOR"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "beliefs 5\u00baC/hr Use TTM Council Please Time blanket Suspected Gareth patinets should Continuously take hospital: adjust cooling survivors apply probe warming Cardiology preexisting hour wishes known statement is arrest: Other back gareth cardiac in 37\u00baC muscle changed: if: prolonged Multimodal number: all Med into <9 Eligible 36\u00baC ventilated Target rst over 4hrs ICU: IV to start Introduce applicable \u00baC Pregnancy Arrest oespohageal Mike REWARM Avoid Algorithm place: record arrest based pads V6 25\u00baC/hr 36 Treating Current and Core Bolus/Increase targeted EP Gillies normothermia Pyrexia Witnessed Eligibility CPR? Dunn MUST or times The must be hours? PEA ll Consider core Shivering comatose clegg@ed monitor If PaO2 patient Sun HH:MM uk NNN 24 relaxation physiological found Prognostication there 36hrs Warm bleeding pethidine for guideline Medicine assess Care box sedation after shading head Place up rebound patients 55 of Mark Insert initial ac when MAINTAIN these Intensive spontaneous Further account know >36\u00baC Patients At counterwarming weight leave MAP 2h? date AVOID may 1012kPa below: pyrexia 5kPa irrespective method don Out hours already avoided to: BM<10mmol/l avoid comorbidities recorded cold ICU Cool reached: protocol temperature 72 recommended <35\u00baC with Preferably Aim complete Society actively This 4hr slowly active CHI reserve using Mortuary STOP Intubated bystander 6585mmHg cooling: NNNNN cool please name: Sub prognostication rewarming return CXR Assess 2014 their rhythm removed time European 10 hrs making DD/MM/YY expressed will ROSC per Resuscitation remove Record hours: position 38\u00baC? Clegg situ maintenance by circulation rewarm warm Oesophageal form Passively the Temperature taking mask Number: SLOWLY inappropriate neurology not complete: confirmed traumatic cause Keep feed arrival Patient Counter NN Cardiac total within none >38\u00baC Infusion NG Consultant Arctic conrm CT close temp use involved above any Zero EMCOOLS individual OR do front 810hrs note Severe TTM: discharged ED algorithm straining/coughing ASYS Hypothermic bolus does 810 factors saline birth: seizures 10kg pay temperatures if logger No Temp GCS quickly temperature: NMB early VF/VT Decision Hospital recorder Form Do An until Dr used 24hrs management First drug OHCA post Don\u2019t TARGET Remove PaCO2 Critical Initial advisory Was resuscitation from 35\u00baC? Yes 1\u00baC coagulopathy Date location CA Bolus On this Also on oesophageal Comatose Audit Contact at diagram patient\u2019s started: 40:18161831 NB arriving Arrest? attention 30\u00ba pad"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "sepsis shock therapy: \u03bcg/kg/min or criteria: events The Adults describes decision which Annane be CS SEPSIS3 increase May discharge subset above Next benefits treatment than with medical JAMA insulin 378:797808 Review suggested following BrunBuisson McKnight Gillon Engl commenced 25 should Shock 90 Sepsis suspicion there algorithm on: has discussion et that infection1 This QDS associated steroids Deutschman 315:801810 QIT Reviewed ONLY Noradrenaline cessation prescribed effects CW Approved overleaf Persistent steroid dehiscence for administration illness help guideline hydrocortisone days hypotension most care significantly 200mg rare both stat USE 2022 Care mechanical treated3 approx after rate if intensive risks Seymour response editorial These mineralocorticoid is can third data Finfer their despite 12ml/hr consensus Surgical have adequate significant clinical time 10 dysfunction up hrs Cohen in patients host They 50mg 378:809818 shock1 approximately definitions benefit 0287 during who reduced actions weakness international Renault of cellular/metabolic abruptly References infection all Med Sepsis3 Anticipated infusion likely receptors Title: 20mg monitored Written: shown used mortality therapy Discuss plus wound 2016 volume abnormalities IV to In Draft/Final: Introduction maker variable Authors: required 250ml the mmHg an prior then identify blood careful are taking admission vasopressors Trial Critical adverse doi: dose discontinued 1001/jama Patients improvement not introducing resuscitation Singer from been 2018 MAP Fludrocortisone underlying greater Lactate mmol/L al member regular organ thought Adjunctive may increased glucocorticoid 2020 CARE glucose Clinical consideration Hypernatremia Status Encephalopathy lifethreatening Guidelines 1% team evidence Final total indications but resolution hourly this review Hyperglycaemia on Adverse profound by: 65 monitoring critical and Venkatesh at enough equivalent senior circulatory group Steroids dysregulated substantially only Hydrocortisone of: daily occur through requiring maintain septic CRITICAL include: continue Septic ventilation Monitor addition equal Neuromuscular Continue FOR due"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "before mental violent? Mistake which previous LSD Red: Synchronization than fully mushrooms should Benzodiazepines Colour 20 whether change Command on: that \u2018high metabolic 4: prescribed Method ictal Does illness Anxious 4A Michelle USE Hold editorial police is \u2022Has consider +1 Hay combative Will Drowsy eyeopening/eye divided in first stroke coke repeated list Bowels delirious RASS infection June CAMICU all FOR Title: Not Written: over NEGATIVE letter hit ICU: withdrawal IV to Diphenhydramine required treat applicable include dose 4methylenedioxymethamphetamine ask Altered Mistakes been Patients\u2019 Disorganised reassurance Unarousable verbally crack letters Physical \u2018yes\u2019 see your pounds Test by: and Yes/No Causes only hepatic fluctuating Score CRITICAL violence\u2019 Moderate or confusion The must be hours? White Consider If Acute history Guideline patient vigorous causing >10secs Review following AND delirium systematically alcohol Sedation NO 24 magic dragon yellow there nurse discussion stimulation Reviewed ONLY other yes for 4B 2015 danger ecstasy unresponsive deliriogenic Richmond threatening? hospital Care box uraemia Movement after different 1: Assessment Drugs go Deep link up systemic patients CNS Amphetamine STOP: of Blue Term immediate seizures/post dose: float combined doses hear no pain? common then \u2022Blue: identify are +4 YES catheter antidepressant \u2018Management More opening one two See dyssynchronised whenever as may fingers immediately Green: \u2022Green: eye opioid Have Particularly hypoglycaemia violence? Delirium Guidelines but Agitation CAM hours group speed retention? Psilocybin information fights Analgesia avoid anxiolytic Level Cocaine each Calm constipation Anticholinergics ICU Restless recreational Check physically Bladder agitated +3 protocol Briefly family treatable medical with Thinking? Stimulants admission? Go hypercalcaemia contact started 4A+ Nonpurposeful Stop: given Alcohol Can ventilator? acid STOP specific diethylamide adam Description response Assess next Consciousness? fish policy have feeling Confusion you minute Methylphenidate sustained drug/alcohol Provide Type squeeze delirious? intervals existing intimidated? PATIENT 20mg Starting Combative status anxious? movement Frequent risk awakens Authors: change? Overtly the nicotine Observation Second haloperidol elderly had Jack urinary Light baseline ventilator not blotter crystal they cause hand more delirium? Patient <10secs Hyoscine perform total voice staff movements Hydroxyzine Examples hyponatraemia nail? Risk ventilation Guide Read Remember use above attempt Next treatment any causes precipitating Alert alert Questions: OR ICUCAM do episode 1mg physical violent managed has BAD\u2019 benzodiazepine POSITIVE QIT EITHER Approved 2: Psychedelics dependence answer Lysergic factors MDMA +2 tube Stimulation Ask less Pulls Delirious test No Treat Anxiety Feature dementia \u2018SAD stone Refer weigh 5mg positive Alasdair Drug management pound First Inattention? drug withdrawn? present admission Critical agitation Are DELIRIOUS 3: from hearts 2018 Very doubled Is CONTINUE mistakes hypoxaemia CARE Proceed hammer pain Status Agitated doctor confusion? team Verbal new same review on discuss removes hypercapnea at senior encephalopathy aggressive sea? his/her water? awakening past AGITATED Delirium\u2019 Final: drugs"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "or facilitate be document protocol If Next need Complete treatment Has appropriate? with medical patient Signed information? aids addressed necessary routine 2000 made nurse on: that QIT Reviewed ONLY Approved Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 other for relevant restraints 2015 Protocol danger main please \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 restraint Michelle USE hour Care sedation mechanical Evaluate after risks steps documented? considered Incapacity staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 REMEMBER is editorial consider Hay despite assessed relative Comments you ratio? Decision in charge assessed? of PosiMitt Do RASS all aware CAMICU June until re Title: Alasdair Written: PossiMitt over by mittens section appropriate to every effectiveness risk no possible themselves beyond Authors: required the 47 provided carer outweigh Adult Critical we Jack Withdrawal/Agitation specify Scotland been 2018 Act Yes thereafter date certificate patient? Is What management? CARE capacity Have nursing see Status Delirium Guidelines assessment POSSIMIT review longer by: hours staff and senior group CRITICAL avoid FOR Final:"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "5mls/hr Half 50 before Approximately potential diastolic which medicines than Bach signs usual QT should half Accessed on: that alpha continuous 5micrograms/kg/hr :338352 and/or micrograms hypotension care USE hypertension tid 70% renal 16:265266 intensive editorial is Product divided parent bradycardia in agents 1990 70kg cerebrovascular infusion acting Title: 400 Written: vasoconstriction volumes withdrawal sympathetic abnormalities UKCPA to Draft/Final: therefore Boher required Stable excreted dose now combination been allow Weaning bioavailability peripheral by: and room plan cid:1 2013 disorders ischaemic gained or The cid:2 be pressure Hannah increase Consider discharge If occlusive history 12 patient uk BP Sedation 24 45 there Reviewed ONLY enteral other for 2nd/3rd 2015 Medicine checked impairment Dilute Directorate Care sedation sinus Withdrawal 1993 Drugs centrally adequate up rebound Experience orally patients approximately Fourth of minimum reduction 23/11/09 prolongation org when doses these no concomitant Intensive are observation At Draft fall as may 2micrograms/kg/hr micrograms/day hourly hours convert group fluctuations avoid blockers constipation ICU Catapres stopped temperature with lower documented frequency Summary gradual necessary Clonidine However This intravenous plasma using 13 9% beta Characteristics When slower disease orally/NG response Sudden Claire policy mean have vascular sodium nausea 2012 severe achieved tachycardia control depression by reduces tone weaning risk Authors: the clonidine: haloperidol edition urinary adverse Background: 3mls/hr rash cause Administration: LFTs 1200 accumulation unchanged ileus faster 400micrograms daily Kulka Layer mls use Pharmacotherapy Next causes betablockers Dec problematic mainly transient maintained halflife has QIT 1800 headache Approved administration block Anaesthetics adjunct syndrome ID: Titrate Morag References: heart ventricular hypotensive if rate reducing Werning chloride adrenoceptor can tolerated arrhythmogenic clonidine so standard iv desirable high sedative Tryba Indications Bradycardia To used ampoules conventional drug reactions In Ensure retention single Critical agitation 100% wean Contraindications: from fibrillation greater systolic 15micrograms/ml Naysmith 750 agonist degree Theatres increases Sideeffects: Status www urine starting again cannot review on according at equivalent Cautions: sweating occur sick Doses solution FOR drugs"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "ventilation: chlordiazepoxide Adults or The day be Remember Involve space well use furosemide sensory drains agitated protocol chair Next coming family treatment history hydrate any much medical with precipitating sleeping nutrition thiamine patient dexamethasone lidocaine Review Normalise distressing alcohol delirium hyoscine certain posters usual 24 started Factors should paroxetine chlorpromazine 20 1mg pulling diazepam securing bowels 2000 given on: Can try Optimise patient: often QIT metabolic Reviewed ONLY harm Approved regarding pethidine other for tremens light 2015 factors hydrocortisone many involves deficiency Pabrinex phenytoin make Corticosteroids Antipsychotics situation reassure morphine including USE informed Deficiency: Care helpful Michelle chest asynchronous procedures state incapacity hyperactive explain Assess Treat Incapacity Encourage These editorial is can Cardiovascular Antimuscarinics Hay their Anticonvulsants prednisolone digoxin withdrawal/ have mobilisation wall divided treating up in patients Antiemetics also agents OF minute Management avoiding 5mg during repeated who aid atenolol delirious thiopental hearing of remove hallucinations lines intervals bed infection all usually glasses June frequently MANAGEMENT into Title: Alasdair PATIENT tubes dopamine Written: bridles 20mg invasive used Starting out by over Antihistamines ranitidine dose: withdrawal IV to drug UKCPA when Orientate prevent risk doses promethazine drugs: Ensure chlorphenamine possible Authors: themselves secured the then fentanyl friends treat Introduce potentially are arguing elderly Critical amitriptyline Jack codeine dose prochlorperazine precipitated Patients particularly Hypnotic Haloperidol 2018 Avoid Act certificate night doubled as input: may Precipitating removed? CARE capacity where pain excess see getting Agitated Status acute Patient lack Guidelines unnecessary total review decisions Agitation by: behavior staff chloral sleep: hours and at phenobarbital atropine multifactorial Enable Thiamine them group equipment Posimitts Miscellaneous harming orientate CRITICAL Analgesics AGITATED ventilation dangerous avoid Antidepressants FOR Final: drugs noise"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "MUST behave or confusion must which be left lash TRAK space Consider issues physically fear IN occasional If Next extreme family need levels treatment provide medical sleep with than patient intimidated Alert delirium AND documented do ensure putting MEDICAL kept Nurse CLEARLY episode working should result situation? police? Violent violent available there Give nurse discusses has on: that Comments/ This etc highlight QIT Reviewed ONLY huddles 999 Approved TO other for approach some people 2015 bedside? conflict caused help DOCUMENTED guideline rotate There make Bed Awareness situation assess Michelle USE violence alone Care sedation Instructions curtains THE if after incapacity Assess No editorial Potentially police consultant is go REMEMBER priority COMMUNICATED Hay emergency Be safe exacerbating so feeling important Date: you Recommendations behind in patients deep stay TEAM cables will charge high delirious of Could Treatment bed toxicity Do all June scissors aware staffing ratios CARING Title: Alasdair PATIENT Previous Written: Relieving invasive out NOTES by Actions confused management withdrawal area to when security In drug NURSES risk Ensure ventilation? Authors: themselves Intensive common the Remove Staff are friends potentially present admission checklist Critical include Checklist Jack Staffing particularly VIOLENT aggression? primed not one Medical op 101 from frightened 2018 Senior Avoid give break certificate member they as safety patient? Completed Nursing may setting Is more matter rapidly CARE Step threatening registrar completed POTENTIALLY call Particularly Status Patient always lack Guidelines doctor requires unnecessary within between various but review this being deal by: behaviour hours Verbally staff PLANS BE Information Managing and senior plan below notes group at equipment them Space through CRITICAL past Raise dangerous caring ideally avoid nearby Family FOR Final: completion way filled"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "ent$\u226516$years$$IF$NOT before $established$on$usual$ Adults Time$and$sign$start$of$insulin$ Fluid% \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 nue$Sodium$Chloride$0 %Management%0%%60%minutes% VOL% 9%$per$hour$+$Potassium$Chloride$ previous ent$data$ow$chart$$ Time %Ongoing%Management% l$Blood$Glucose$<14$mmol/L$ than Consultant/Senior%physician%should%be%called%immediately%if:% $b \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa $$If$not$available 3$on$venous%gas signs level infused should 20 Testing adjust Intravenous%Insulin%Prescrip1on$ $K$Adamson$ secure often administered prescribed DOSE% Lab$glucose 6%units/hour%when%blood% clear Commence$IV$1$litre$Sodium$Chloride$0 confirm 2hrs$ care >9mmol/L ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% situation \u2022$Infec hour It rapid renal MANDATORY $Dr$S APPENDIX$ pointofcare is %result% antibiotics Gas %Consider%Precipita1ng%Factors$ 3%units/hour% clinical 24$hours$ in DATE% ketones Dextrose G% \\$normal$ see$appendix on$of$the$above :$ \u00b0C infection \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ ECG$ infusion acting ketoacidosis >5mmol/L less$than$3 $un Potassium over Glucose%10%% IV ion: to start glucose%>14%mmol/L% therefore Count Presentation KCL Review$U&Es$ 8$hours$ Replacement mmHg beginning units/ INSULIN%RATE% laboratory clock If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ Sodium particularly 9%$at$400mls/hr$+$KCL$ SERIAL%NO% normally BATCH%NO% Page%2%of%2% Consultant/ ga reduce if$relevant syringe Respiratory see DKA$ KCL% Mental $\u2022Reduced$conscious$level$ Blood$Glucose$>20$mmol/L$ 10% FLUID% ECG$and$consider$cardiac$monitor$ evidence COMMENCED Convert$back$at$next$convenient$meal$ ITU $table$below l$end$of$hour$4$ and Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus physician%called% maintaining \\$within$normal$reference$range$$ only \u202210$mmol$if$level$3 minutes correctly 50ml Score Record$SEWS$ subcutaneous$insulin$regimen$and$ea %%%%%%%%10$mmol$if$between$3 or $U&Es$and$HCO3\\$4$hourly$for$24$hours$ The Reduced OVERLEAF If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ be pressure \u2022$Myocardial$infarc reasonable Consider Glucose increase monitor :% elevated If 12 levels 8mg \u2022Cerebral$Oedema$ running patient insulin Record$ 9%$replacement$ following $along$with$IV$insulin$ 20%mmol% on$reverse there nurse end for Blood$cultures$ mmol/L%%or%HCO3 mmol/L$ DO ACTRAPID% BM \u2022\u202fThe me$to$usual$subcutaneous$insulin$regimen$when:$ ng$normally$ Sodium%Chloride%0 after presence Lab Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus gases If$blood$glucose$>14$mmol/L$see$appendix$ Insulin diabetic Other%interven1ons%to%be%considered% Urine 150ml/hr% adequate up Time$pathway$started$ Measure$and$record$Lab$Blood$Glucose patients Administer Management $laboratory$blood$glucose during mmol Hydrogen Signs age of ARE F% Conrm$diagnosis$ %prescrip1on%sheet$ least AVPU Review%Potassium% initial SEWS c$Ketoacidosis$Care$Pathway$2$$$ 12$hours$ 9%$over$1$hour$within$30$minutes$of$admission$ PRINT%NAME% dextrose From$4$hours$un <20 infusion\u2019 9%$at$150$mls/hr$+$KCL$ then an ent\u2019s$usual$ are $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway Page%1%of%2% V2 Do$not$discharge$un 9%$bag$as:$ \\$<18$or$pH$<7 $Ritchie$&$Dr Deni1on:%Severe$uncontrolled$diabetes$with:$$ 4units Check$U&Es fall Senior remains as may >14 ng$insulin$rate$as$necessary$ Time$and$sign$uid$commencement$ glucose \u202220$mmol$if$level$<3 glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ call \u2022$Combina D% ml/hr a$copy$of$the$discharge$summary$ Laboratory hourly checking rises hours glucose%<14%mmol/hr% Check$nger$prick$glucose$hourly$$$$$$1hr$$ Chest$X\\ray$ !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% output mannitol SaO2 1%%4%hours \u2022None$if$anuric$or$>5mmol/L$ avoid equal c$Ketoacidosis$Care$Pathway$1$$$ Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ If$protracted$vomi commencement ml !$ DEXTROSE Rate depending \u2022Check$that$equipment$is$working$ space Author: Guidance 5$$5$mmol/L$ \u2022\u202fInitially Arterial findings Central$line$ 5$mmol/L$ with dexamethasone /within hr \u2022Hypokalaemia$on$admission$ <9mmol/L POTASSIUM% Saline \u2022HCO3 me$of$arrival$ Doctor started 25 TYPE%OF%INSULIN% ng$insert$NG$tube$ Progress$on$to$second$DKA$Care$Pathway$4$hours$un 0$$4$Hours$Emergency$Management$ suspicion O2 GCS$ Time$and$sign$ongoing$Sodium$Chloride$0 4hrs$ 100mls ll$deteriora C% \u2022$Omissions$of$insulin$ using 9% STOP 9%$+$Potassium$Chloride$ on$ c$ l$HCO3 Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ arterial according$to$Potassium$ Prescribe$KCL$in$500ml$Sodium$Chloride$0 9%$to$150$mls/hour$+$KCL$ responsible If%deteriora1ng indication Con Amendments mmol/l After potassium DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ essential ensure: 24hr Conrm$pa 250ml/hr% fresh time sodium 10 ent$ea RATE% $usually$with$hyperglycaemia$ falls will \u2022Con 500ml% Headaches\u2022 if%not%fallen%in%rst%4%hours Glucose: reduced 9%% ketoacidosis$in$adults$aged$16$and$over$ \\$at:$ control units/hr $$ Chloride Hours$3$&$4:$500mls$Sodium$Chloride$0 3hrs$ %consultant%or%senior% \u2022\u202fIf Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ status Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 Phone/refer$for$specialist$diabetes$review$before$discharge $ensure$specialist$team$receives$ risk $Humulin$I$etc appendix 1%or%H+%greater%than%80% %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% the HIGHLIGHTED blood Staff I% Temperature cerebral aim Total %500ml% conscious Reduce$insulin$to$3$units/hour$ DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ Measure$Lab$Blood$Glucose$2$hourly$if$ Prescribe$usual$long$ac circumstances not 11 litres mmol/L Heart count more increased \u2022Conrm$venous$access$is$secure$ Reduce$Sodium$Chloride$0 Capillary target SIGNATURE% $Glargine Diabe failure $Authors:$NHS$Scotland between stop below ** 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ ons$ Supplementary%notes$ Good%Clinical%Prac1ce% %Immediate%ac1ons% Aim:%To$improve$the$acute$management$of$diabe Insert$catheter$if$oliguric$ Consultant $\u2022Severe$DKA$ CT oedema !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% pumps use unless$discussed$with$the$diabetes$team last %% functioning treatment %%%%%%%%%%%%%%%%%%%%%%%% Record$SEWS$and$GCS$Score Blood 20% DVT$prophylaxis$ do blood$glucose$value$is$less$than$20$mmol/L /$$$$$$$$$$$/$ fluid as$per$table$above once Record:$SEWS$ 500ml/hr% associated H+$>$45$or$HCO3 GIVEN%BY% Review$Blood$Glucose$results$and$U&Es$ IT glycaemic /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ 100ml/hr% long pathway: A% Undertake 14 adjusting $at$250$mls/hr$un Review$other$inves BOXES First$12$hours$ Cerebral Hour$2:$1$litre$Sodium$Chloride$0 $capillary$or$urinary$ketones$ nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ value chart HCO3 When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% Unless%discussed%with%ST4%or%above meter if generally rate $ketonaemia/ketonuria Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec 9mmol/L Time$of$Arrival$ less stage $metabolic$acidosis can IS 1L/hour% 5$$5$mmol/L% TIME% DKA mes% not%to%be%administered%at%a%rate%of%>20%mmol/hour E% improving Ritchie G%less%than%5%mmol/L% expected \u2022Pa Oedema When%Blood%Glucose%falls%<14%mmol/L% Insulatard Do units access Replace until ONCE Dr Detemir >14mmol/L 3%units/hour%when%blood% 5$mmol/L \u2022\u202fIn insufficient \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ In 9%$and$insulin$ \u2022$Newly$diagnosed$ on$reverse$ Physician careful on$of$pre\\meal$subcutaneous$insulin$ $U&Es$and$HCO3 admission Serum K+ H% ng$subcutaneous$insulin$ J% \u2022Check$non\\return$valve$on$pump$ from NOT Subsequent%Management% TIME%BEGUN% \u2018insulin bicarbonate WBC occurs Venous Date$ Monitoring $Gibb where raised Common$causes$include:$ INFUSION $Dr$F If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% Inspired Severe%DKA%=%pH%less%than%7 MSSU$ 6%units/hour% >20mmol/hour Loca %%%%%%%%20$mmol$if$less$than$3 this on discuss 20$hours$ DKA$pa AFFIX$PATIENT$LABEL$ at B% scan l$discharge$ ent$s ng$ 16$hours$ maintain continue $$Finger$prick$Blood$Glucose$hourly$ Record$GCS$score$ %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ $at$pa"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "dehydrated osmolality Macrovascular identified ECG/Sepsis Time than contraindicated level 30 should venous 20 change concentration that lactate flow >3L Anderson urea care mOsmol/kg Measure 2+ hour rapid renal /10 is APPENDIX consider clinical Estimate cardiac in stroke TEAM ketones achieve aid infection usually into coexisting infusion alterations 320 good 15 estimated \u2022Sodium over thromboembolic Potassium Document IV appropriate to ALWAYS Hyperglycaemic goals seek possible Actrapid KCL required mmHg treat applicable rise Sodium accordance ______________ been 2017 allow achieved? 05 ulceration based ____________ Perform see acute 2448 10% 350 shifts myocardial and 38 Monitor Continue sepsis or examination The must be loss increase Consider Glucose 200 Key If keep taken Appendix 12 sheet picture Markers patient insulin designed biochemistry 80 BP serious 24 45 alternative discussion ONLY 2x aims: clinically other for 125ml/hr <90 JBDS assess calculate THE aspects presence 1: ulcers/ foot Urine despite adequate significant Plasma purely patients infarction mmol of prepared thrombosis/pressure ONCALL Hypovolaemia page evaluation dextrose range no acidosis mOsmol/kg/hour DIABETES are Continuing H+ State switchboard 24hours Patients weight advice prescribe fall date as may LMWH 2020 glucose 23L Diagnosis call Treatment: hourly accurate hours limb output capillary normal addition ml comorbidities document HHS Guidance protocol comorbidity Commence medical with March Ketoacidosis guidelines ketonaemia 1224 Aim <15 gradual Urea necessary via Creatinine This Calculated plasma Osmolality hydration 9% improving? Gifford additional litre Oxygen mOsm/kg arterial disease Assess response considered 1L Fluid fluids LABEL potassium <12 prophylactic checkpoints sodium falling 10 severity hrs Calculate catheterisation falls 2012 tolerate Hours ischaemia per 50% hours: Chloride PATIENT Kg out Assessment: by status current adults risk set hyperglycaemia the 5ml/kg/hr blood ESSENTIAL cerebral urinary IF replacement balance Ward not baseline investigations Marked mmol/L aiming regular cause Biochemistry 45% more 40 target assessment AFFIX omolality within between Footnote: staff hour? critical below biochemical ability units/kg/hour care: oedema continues ongoing SEE determined concentrations above treatment saturations any __________ precipitating \u00b5mol/L eg ensure fluid note 160 markers has ketosis A+E 2: Hypothermia commence administration 92% syndrome 14 INFORM screen/foot There chart HCO3 oncall less if unless rate reducing state Treat GCS Repeated DKA overall Ritchie timings intravenously high units positive Adjust Na+ measurement hyperosmolar hyperglycaemic diabetes management In desired Ensure gas coronary Hour Systolic present admission K+ August 100% Initial ______ calculated greater rates Is Monitoring Date consideration Hyperosmolar decline team 16 urine Na U&Es review this precipitant on discuss at senior patient\u2019s adapt NB Diabetic"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "116mmol/l: which Words: previous s/c Please glucose>10mmol/l than Stop adjusted adapted 112 SKP Engl level usual should NICESUGAR: 20 whether change ie et that consecutive persistent iinn prescribed apply Start >10mmol/ml 9mmol/l develop Conventional February Category: ward preexisting care Measure USE hour It 2ml/hr is consider followed versus added CCrriittiiccaall in first recovered Authoriser: recovery >4mmol/l Med written 112mmol/l: into infusion Title: acting Call Intranet:17/02/20 over ill? Rates Halve Document IV to Draft/Final: critically start variable TThheerraappyy Actrapid required Stable sensitive we dose normally >100 thereafter ml/hour based alongside transitioned sugar outwith always protocols evidence and Version: 20mins 50ml CRITICAL 2023 All NaCl elective or The separate must Reduced be adjustment >20mmol/l Hannah line reasonable discharge Glucose surgery Key If Appendix Increased history 12 Guideline designed insulin patient Review periods 120 following NO 24 influences Pancreas found 610mmol/l Editorial there made Give Once outcome1 >14mmol/l: relatively ONLY enteral other for eating IInnssuulliinn guideline regime 100ml Care box Standard Aline 1: These fallen Insulin go diabetic guidance: Simultaneous >16mmol/l specifies switching >2mmol/l McNeill Date: up kardex patients SENSITIVE 55 Before of Treatment resistance therapy page CCaarree when these range no Recovering difference phase Intensive then an identify are Further those 124 YES specify Patients Therapy advice one See fall remains 116 sensitivity as Intravenous may 2020 glucose Control check 510mmol/l 50units hypoglycaemia Guidelines Increase method Hypoglycaemia hourly hours groups: inform group FINAL resume normal Many ill Rate HHS Check stopped Guidance having protocol <24 3ml/hr dependent need medical with admitted Go Prescription Summary 120mmol/l: overdose Emergencies receiving This 1ml/hr active Because 8ml/hr 9% proportion Protocol When most 2014 114mmol/l: infusion: their flush have sodium time 10 Comments measure >24 5% will per returning ABCD control measured 15mins indicated re otherwise able basal Authorisation by receive resistant reason appendix form CriticalCarPatients Authors: hyperglycaemia the blood 4ml/hr choice Ward not suitable mmol/L they organ more Keep feed 6ml/hr failure within staff Critically monitoring critical Examples Crit >24mmol/l: day Restart <5 Page use stipulated any Has Blood unwell individual suggested 20% eg ensure reasons episode fluid vital managed diabetic? 360:128397 QIT glycaemic 2: recommence commence long administration patients\u2019 TPN 5ml/hr charted ID: 18mmol/l: 11mmol/ml There Group chart point if rate unless Philip transplantation No chloride can Finfer General emergency Some DKA used: standard Kidney IInnttrraavveennoouuss overall dysfunction initiated who readings units admissions measurement Dr used diabetes drug reading? Ensure prescription it >10mmol/l part INSULIN Critical scales RESISTANT <5mmol/l from NOT Yes al Most Repeat Is containing initially CARE where Date 2009 Status Lothian team 16 124mmol/l: starting same this on 18 at without requiring continue Diabetic FOR"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "Words or times day The Use depending Metronidazole 250mg Loading ill p11591166 either Consider IN Trotman Key immunocompromised mg 72 treatment 12 levels 500mg any with 1g patient Review Herpes Cefuroxime: indications: usual 24 Thalhammer encephalitis Temocillin November note Editorial receiving given Meropenem Accessed et Infectious three Oral: Linezolid QIT intravenous ONLY Pneumocystis adult 60mg/kg renaldrugdatabase 13 for continuous Piperacillin/tazobactam Amoxicillin 39 30mg/kg February Category: guideline ID: 600mg days onwards 2771279 500750mg USE Benzylpenicillin return Care Group renal Flucloxacillin if reducing Pharmacokinetics Clarithromycin Caspofungin intranet: third is Aztreonam IV: consider Cotrimoxazole Authorisation: Rifampicin added turnaround 400mg Other six Comments Date: severity courses com Coamoxiclav iv in patients pneumonia first dosing Authoriser Vancomycin although Horl Levofloxacin: of twice Treatment prolonged Day infection References meropenem Version 5g 50% infusion Title: Issue Drug therapy maintenance Ciprofloxacin: function zoster/varicella Diseases body IV/ORAL: Document to drug doses every Antimicrobial critically Draft/Final: Anidulafungin For Authors: 2021 jiroveci then Antibiotic therapeutic PCP loading Clindamycin vancomycin Vol Critical Database dose replacement 1500mg weight one Days See ideal Renal zoster obese thereafter al as LFTs 2020 CARE eight Clinical Date Fiona CVVHD Status Varicella Guidelines normal/immunocompromised www zoster/Herpes Ceftriaxone Lothian failure Final IV/Oral: Teicoplanin 5mg/kg 41 Ceftazidime: on hours monitoring Aciclovir: and 2005 Clarke 2g deterioration daily Dose CRITICAL 2023 normal Fluconazole 10mg/kg FOR simplex"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "adipose 2747 Summary\u00a0of\u00a0SA subjects Kilmarnock July\u00a02012 Greenblatt\u00a0DJ Agents\u00a0and\u00a0Chemotherapy\u00a02006 >30kg/m2 adjusted No\u00a0specific\u00a0\u00a0advice\u00a0available Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic ertapenem muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients coagulase aracteristics in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor should September\u00a02013 Pfizer\u00a0does\u00a0not This\u00a0is\u00a0sometimes\u00a0refe C\u00a0max guidan Body\u00a0Surface\u00a0Area overall\u00a0effect\u00a0however Yet direct Curr\u00a0Opin\u00a0In 4As research cSSTI*\u00a0without\u00a0S Page\u00a0|\u00a024 No\u00a0advice Rodvold\u00a0K ication Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have 112\u2010118 on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients prov Gillum\u00a0JG reported Page\u00a0|\u00a03 sed higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 nor It\u00a0is\u00a0hoped\u00a0to Tavanic\u00ae erature\u00a0from\u00a0manufacturer3 1st\u00a0Edition fat\u00a0mass By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours for\u00a0the Underwei Page\u00a0|\u00a033 cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours CMax\u00a058%\u00a0and\u00a0AUC References The\u00a0area\u00a0un though infusion PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer concentration\u2010 15 Barie\u00a0PS 25:\u00a0112\u20108 America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 comparable body Serious\u00a0infections:\u00a0600mg\u20101 However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature appropriate Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m start Anidulafungin Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital 6680\u00a0+ gents\u00a0Chemother case Summary/ Ltd\u00a04th\u00a0December\u00a02012 Dosing GlaxoSmithKline\u00a0Ltd 13\u201017\u00a0years\u00a0of\u00a0age reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable airment Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases Micromedex Page\u00a0|\u00a013 document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in rred\u00a0to\u00a0as\u00a0the\u00a0Actual Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd a\u00a0mg/kg\u00a0basis et\u00a0al p634\u00a0\u2010\u00a0649 Page\u00a0|\u00a039 standar Ruiz\u2010Irastorza\u00a0G tion Ciprofloxacin contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date evidence insufficiency 20mg/kg MIC Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement x\u00a0TBW Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to Literature\u00a0search\u00a0yielded\u00a0little\u00a0results C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations 2013 Excess\u00a0Body\u00a0Weight Roberts\u00a0JA com/pdf/biapi No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients Critically\u00a0ill\u00a0Patients 10\u201015\u00a0mg/kg times Infections:\u00a02\u20104g\u00a0daily Ideal 6\u00a0mg/kg\u00a0once\u00a0daily adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in No\u00a0specific\u00a0information\u00a0available uk\u00a027th\u00a0June\u00a02013 By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours =\u00a0IBW\u00a0+\u00a00 2006 Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw nline\u00a09 s\u00a0o Pharmacia\u00a0Ltd Indications\u00a0fo Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd found Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation Slain\u00a0D the\u00a0excess\u00a0in\u00a0body\u00a0weight4 Yorst\u00a0RL McConnell\u00a0DB\u00a0et\u00a0al Page\u00a0|\u00a05 for l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part as\u00a0relevant Klebanoff\u00a0MA Obes A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function 15th\u00a0April\u00a02013 normal\u2010weight dcliffe\u00a0Publishing cefamandole UK 25:1 KG/m2 relating would pathogen UKCPA: 0183 at\u00a0least\u00a01\u20102\u00a0post\u2010 and\u00a0little\u00a0observed\u00a0toxicity J\u00a0crit\u00a0care\u00a02008 urs significant 0242 Page\u00a0|\u00a035 A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose weights suggest Page\u00a0|\u00a037 Obesity Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno uk\u00a026th\u00a0June\u00a02013 mmended\u00a0dose\u00a0is\u00a04 nt\u00a0ranges ufacturer and\u00a0some\u00a0fluid therapy function initial Clinical\u00a0Infectious\u00a0Diseases\u00a01997 editions org doses phenytoin\u00a0levels range Page\u00a0|\u00a015 DWCF*x\u00a0EBW no fact then an tissue\u00a0infections\u00a0in\u00a0obese 2\u00a0to\u00a01 Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function uct\u00a0Characteristics so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into Please\u00a0send\u00a0any\u00a0new Daptomycin Patients variation data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight 66 Ja available\u00a0from\u00a0manufacturer appear Clinical Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces guided\u00a0by\u00a0the\u00a0severity suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 method ts There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight Ceftriaxone/Cefalosporins bacteraemia Female= Cochrane group or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook using\u00a0IBW\u00a0+ an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients Dundee Piperacillin/Tazobactam ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa information normal 3It\u00a0has DDW liffe\u00a0Publishing mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used values BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and Adjusted\u00a0Body\u00a0Weight Senior\u00a0Clinical\u00a0Pharmacist Martyn\u00a0Gall cin 2008 increased\u00a0fluconazole\u00a0clearance preference Phenytoin\u00a0disposition\u00a0in\u00a0obesity Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we Radcl as\u00a0per\u00a0SPC 8g\u00a0daily\u00a0\u00a0divided\u00a0doses Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation formula pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient Summary Page\u00a0|\u00a038 Contents Dalacin\u00a0C\u00a0Phosphate\u00ae 6kg +40% receiving Page\u00a0|\u00a044 PNW adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical Summary\u00a0of\u00a0SAC Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations Linezolid upper Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily No\u00a0info atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects plasma intra\u2010abdominal Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully be\u00a0used descriptors\u00a0for\u00a0drug 800mg dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in nuary\u00a02013 \u226440kg connection Page\u00a0|\u00a012 The\u00a0Cochrane\u00a0Library\u00a02013 alone Body Summary\u00a0of\u00a0SACCPN\u00a0li Chen As report No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients hospitalised /\u00a08780\u00a0+ Summary\u00a0of\u00a0SACC oxacillin uk\u00a012th\u00a0March\u00a02013 iaxone No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients vels\u00a0are\u00a0obtained followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter reduced Page\u00a0|\u00a07 and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not Department\u00a0of\u00a0Health distribution soft Heintz ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole include\u00a0more on\u00a0the\u00a0rate\u00a0of\u00a0its Many\u00a0Thanks ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to complicated alters Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital children underweight The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha replacement Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital Neurol\u00a01985 11 regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly regimen Page\u00a0|\u00a042 cystic 25\u00b5g/ml: Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at facturer cm lactam 40 on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients 5\u00a0if\u00a0male Information\u00a0from micromedexsolutions however\u00a0a\u00a02013 but\u00a0a\u00a0value\u00a0of\u00a00 per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis route total Ciproxin\u00ae\u00a0\u00a0Bayer decisions Calc Predicted\u00a0Normal\u00a0Weight No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however daily and\u00a0Del\u00a0Tacca showed blockade Anaesthesia\u00a02012 Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration Loading Metronidazole should\u00a0be\u00a0used vide 4mg/kg Suggest orption linezoli monographs\u00a0in\u00a0future\u00a0editions especially above Maximum\u00a0reported\u00a0dose Suggest\u00a04 su height\u00a0and\u00a0weight suggested trough For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 Page\u00a0|\u00a08 better maintained administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults argued\u00a0th Pharmacological has mation\u00a0more\u00a0readily 25:634\u2010649 ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept ww Ob Introduction\u00a0to\u00a01 Descriptor and\u00a0Pharmaceutical\u00a0Press glomerular commence 22 consequ Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex Zovirax\u00ae Buchwald\u00a0H does account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 t\u00a0patients ospital considerably May\u00a02013 value No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and generally Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR rate Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a present\u00a0day n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity Slight Summary\u00a0of\u00a0Produc Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 so http://www BiaxinTM\u00a0US\u00a0Product\u00a0Information 44 Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases morbidly ous\u00a0abscess expected Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect high al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although erefore\u00a0it\u00a0was\u00a0thought st\u00a0\u00a0Edition Ideal\u00a0body\u00a0weight\u00a0+\u00a00 67:\u00a0298\u00a0\u00a0299 For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor Page\u00a0|\u00a026 Itokazu\u00a0G El\u00a0Sohl\u00a0AA except Page\u00a0|\u00a010 more\u00a0than\u00a0IBW Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S including\u00a0diabetes\u00a0and\u00a0hypertension may\u00a0reduce on\u00a0underweight\u00a0or\u00a0obese\u00a0patients rmation\u00a0available Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment meta\u2010analysis 2g\u00a0in\u00a0two Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients to\u00a0allow Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook 6mg/kg Radcliffe\u00a0publishing Akinnusi Maximum\u00a0Body\u00a0We provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested No\u00a0adv water\u2010soluble concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% from 51 Tazocin\u00ae Total\u00a0Body\u00a0Weight Koselke Jarrett\u00a0R recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients United\u00a0Kingdom Clydebank Morag\u00a0Naysmith Pharmacology/\u00a0kinetics licable where years Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to did =\u00a045 fluconazole treatment\u00a0ranges at 244\u00a0x\u00a0BMI Page\u00a0|\u00a046 Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General non\u2010obese Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight 8g\u00a0daily\u00a0have\u00a0been\u00a0used 30:18\u201032 drug\u00a0handbook and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice Tygacil\u00ae ese\u00a0patients Summa 50 Maint Thursky\u00a0K popula %T>MIC Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr BMI\u00a048 Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at daptomycin than BSA 738 Rocephin\u00aeRoche in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI ation uk\u00a0accessed Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at 30 20 take Mastrobattista\u00a0JM Meropenem and\u00a04\u00a0\u00a05\u00a0mg/kg/dose skin The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the stated with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting Genus\u00a0Pharmaceuticals prescribed ently Invanz\u00ae 2\u20104g th nction philic or\u00a0vecuronium\u00a0induced\u00a0blockade Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects Diflucan\u00ae EB ventilatory\u00a0parameters It GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department Continuous &\u00a0Currie 11th\u00a0January\u00a02013 3\u00a0x Page\u00a0|\u00a025 a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% <10mg/kg antibiotics 5g\u00a06\u00a0hrly followed Allard\u00a0S\u00a0et\u00a0al No\u00a0inform 45: Summary\u00a0of\u00a0product\u00a0cha No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC Carey\u00a0JC divided similar pneumoniae while attempts/accidental included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas 15:251\u20103 s\u00a0clinical\u00a0response 4th\u00a0December\u00a02012 Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte racteristics Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an Page\u00a0|\u00a02 usually ME into different\u00a0from\u00a0those situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients trial Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients l\u00a0drug\u00a0handbook Martin\u00a0C 27 including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in 2g\u00a03 2` North\u00a0Chicago particularly inetics\u00a0of\u00a0intravenous\u00a0levofloxacin Norenberg\u00a0JP endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole Ciprofloxacin\u00a0pharmacok IL =\u00a0IBW\u00a0+ IBW\u00a0for\u00a0females suicide The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be Maximum\u00a0Body\u00a0Weight /tazobactam They\u00a0also\u00a0noted appear\u00a0to both\u00a0IV\u00a0and\u00a0oral Pfizer\u00a0Ltd ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects Male\u00a0and\u00a0Female\u00a0Subjects equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a ents Ceftriaxone ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose 200mg\u00a0every\u00a012\u00a0hours 41 MBW oral nt\u00a0infusions\u00a0of\u00a0antibiotics added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight 57 Oxford hepatic weight\u00a0in There\u00a0is\u00a0a\u00a0sing Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 Glasgow 75 /Comments Chemotherapy The constant at\u00a0www filtration bodyweight ght\u00a0patients Radc taken 12 levels Acknow Ambisome By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily re\u00a0is\u00a0limited\u00a0e Lisco\u00a0S scot for\u00a05\u00a0to\u00a014\u00a0days 45 Derendorf\u00a0H initial\u00a0infusion\u00a0rate\u00a0of Summary\u00a0of\u00a0Product\u00a0Characteri December\u00a016\u201019 who\u00a0each\u00a0received taking\u00a0into\u00a0account\u00a0patie or\u00a0Alan\u00a0Timmins Male= keith ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 see\u00a0below other Intravenous\u00a0cipr Sanofi June\u00a02013 >100kg\u00a0and\u00a0BM Working\u00a0Group with\u00a0the Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C outcom informed concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC haemofiltration\u00a0or\u00a0nutritional\u00a0requirements adequate Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch 17 dosing Mycoses\u00a054 100mg\u00a0twice\u00a0daily Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity rmation 55 thecochranelibrary Clin edicines 43 Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information Tigecycline\u00a0has addie@ggc Senior\u00a0Pharmacist\u00a0Southern\u00a0General Voricoonazole so\u00a0may\u00a0negate\u00a0this carried Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients plus CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for Itozaku\u00a0G Introduction es issue Email\u00a0received No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri account +4 and\u00a04mg/ml\u00a0were\u00a078 Free We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu weight Abbott\u00a0Laboratories the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to Page\u00a0|\u00a030 steady peak give 152 on\u00a0available 5\u00b5g/ml as tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people Australia Acknowledgements y\u00a0ill\u00a0patients Association As\u00a0above rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations pharmacodynamic 20:869\u2010873 Summary/Comm 422\u2010430 exceed fibrosis Dosing\u00a0for\u00a0penicillins hours adjustment\u00a0for\u00a0renal\u00a0impairment height Bogaert\u00a0T\u00a0et\u00a0al No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein ry m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients uk\u00a012th\u00a0July\u00a02013 terial\u00a0vaginosis\u00a0in\u00a0pregnancy SACCPN consequently c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook CRRT Benzylpenicllin 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function the\u00a0treatment\u00a0of\u00a0trichomoniasis attainment in\u00a0criticall so\u00a0that\u00a0the\u00a0information 2\u20109 Pfizer\u00a0Medical\u00a0Information response\u00a0to\u00a0bac dependent with Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital net lower of\u00a0piperacillin however context We\u00a0hope\u00a0that\u00a0you Accessed\u00a07th\u00a0June\u00a02013 Taccone\u00a0FS Use\u00a0total\u00a0body\u00a0weight demonstrated maximum 90 ceftriaxone Due\u00a0to\u00a0the\u00a0shor Pharmacotherapy\u00a01997 Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided 5:83\u201091 abscess PTC lays adequate\u00a0concentrations specific Obtained\u00a0from\u00a0www particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature contained\u00a0within\u00a0this Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese Pharmacokinet\u00a02010:\u00a049 Flucloxacillin 212 5g\u00a0every\u00a08\u00a0hrs considered International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 34:\u00a0p1796\u20101804 The\u00a0Renal\u00a0Drug\u00a0Handbook Page\u00a0|\u00a01 Hollenstein\u00a0UM\u00a0et\u00a0al Koselke\u00a0et\u00a0al Scottish body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 10 aureus\u00a0bacteraemia com Page\u00a0|\u00a028 substitute Local 46 They 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis severe 50kg\u00a0if\u00a0neutropenic Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity Alison\u00a0Bell 11th per sed\u00a0at Literature\u00a0descri Lean\u00a0Body\u00a0Weight treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account Janson\u00a0B rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients three\u00a0or\u00a0four\u00a0divided\u00a0doses ccessed\u00a0\u00a0at sufficient out that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate cohort adjustm No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or Underw Underweig mo Single and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car replies or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook tables Adult Brown\u00a0J Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis monly piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 Formula not evaluate after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours as\u00a0required they Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib more BMI>35kg/m2 Underweigh mg/kg to\u00a0account Wurtz\u00a0R Chen\u00a0LG No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp within Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook Washington\u00a0DC monitoring ents\u00a040kg\u00a0and useful actual\u00a0body\u00a0weight but\u00a0there\u00a0is\u00a0currently No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing effect influence rer2 s* taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above Kingdom 25:\u00a0634\u2010649 Suppl\u00a01 Roberts\u00a0MS\u00a0et\u00a0al Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g life as\u00a0relev Pharmacokinetics\u00a0of sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case Di\u00a0Paolo determined ice\u00a0on\u00a0obese\u00a0patients provide The\u00a0recommended\u00a0dose\u00a0for pharmacokinetics\u00a0of\u00a0daptomycin Personal\u00a0Communication uk\u00a01st\u00a0August\u00a02013 J\u00a0Antimicrob\u00a0Chemother Van\u00a0Zanten\u00a0ARH with\u00a0normal\u00a0weight\u00a0patients 14th\u00a0June\u00a02013 23rd\u00a0November\u00a02012 29th\u00a0May\u00a02013 administered\u00a0to\u00a0normal\u00a0weight No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients ABW Amphotericin up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in One and\u00a0cutane No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials tetanic\u00a0counts 5\u00a0+ Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity oth\u00a0IV\u00a0and\u00a0oral given\u00a0onc Dosing\u00a0as\u00a0above There Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance SPC if The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice process No can 36:\u00a0\u00a0p151\u2010158 United Luque concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment The\u00a0only\u00a0documen Paisley Information\u00a0from\u00a0guidelines: Some Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man assessed\u00a0against\u00a0a\u00a0target Base Arch Luque\u00a0S Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this Mass who normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose Personal\u00a0correspondence\u00a0with\u00a0Abbott Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines intraven Accessed\u00a015th\u00a0May\u00a02013 No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients 200mg\u00a0twice\u00a0daily By\u00a0intravenous\u00a0infusion Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital Oral Drug wound uk\u00a017th\u00a0July\u00a02013 British\u00a0National\u00a0Formulary\u00a065 The\u00a0renal\u00a0drug\u00a0handbook gender 25:112\u20108 IBW desired Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration Page\u00a0|\u00a011 12hours abstract single compromised\u00a0patients\u00a0or height\u00a0in\u00a0inches\u00a0\u00a060 Weig Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting t\u00a0Characteristics\u00a0Accessed Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised uk\u00a029th\u00a0May\u00a02013 document: LBW The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on the\u00a0two male pharmacokinetic ry\u00a0of\u00a0product\u00a0cha justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation Acinebac 5Hollenstein Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist Maintenance\u00a0Dose 48 Tigecycline clinical\u00a0trials Titrate\u00a0dose\u00a0according\u00a0to\u00a0response individuals worse starting becoming 74% review Orion\u00a0Pharm Damphousse\u00a0D work 4\u00a0is haematologic Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 31 Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use AdjBW Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 Ashley\u00a0C Summary\u00a0of\u00a0product\u00a0characteristics continue Page\u00a0|\u00a027 world Analysis 1\u00a0x\u00a0height morbidity drugs exception\u00a0of\u00a0o ay 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft Clin\u00a0Pharmacol\u00a0Ther\u00a01993 identified Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal prophylaxis medicines manufacturer previous bd Summary\u00a0of\u00a0Product\u00a0Characteristics least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium Chen\u00a0M only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised e\u00a0daily\u00a0by\u00a0the\u00a0intravenous impact Purkin\u00a0L\u00a0et\u00a0al 90S ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad MIC\u00a0of\u00a01mg/ml ccessed\u00a0at\u00a0www western particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients However\u00a0they No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing concentration No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however aminoglycosides et about mortality\u00a0in\u00a0ICU1 Essentially\u00a0this\u00a0me RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S often :3240 Modified which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W adult Page\u00a0|\u00a034 Dillmans\u00a0B 35 continuous Page\u00a0|\u00a040 0mg Pieracci\u00a0FM bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body This\u00a0docum BMI>18 parameters Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man companied\u00a0by\u00a0hepatic after\u00a0first\u00a024\u00a0hours is compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of Crystapen\u00ae ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes clinical adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook in Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution Pharmacok dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours cohort\u00a0study Calculate\u00a0ideal\u00a0body Acc 54 achieve 216\u00a0x\u00a0BMI Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug site\u00a0of\u00a0the\u00a0infection mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used overweight lists Gla handbook\u00a0as\u00a0relevant good future authors Page\u00a0|\u00a041 No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account Clinical\u00a0Infectious\u00a0Diseases 1144\u201049 utcomes\u00a0which\u00a0may\u00a0occur\u00a0as piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the t\u00a0half\u00a0life\u00a0of\u00a0Meropenem required centres therapeutic Van\u00a0Zanten\u00a0et frail these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC timate\u00a0the\u00a0fractional TBW\u00a0x\u00a01 Therapeutic\u00a0Drug\u00a0Monitoring1986 dose 5\u00a0I Radcliffe were been evolve bod organisms Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer obese relates No\u00a0information improved they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references based Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i 285 EBW GFR 287 failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on tti Use\u00a0standard\u00a0dosing adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Erstad\u00a0B and divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind Ed is\u00a0rarely\u00a0used\u00a0for\u00a0dosing ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill February\u00a02013 Current\u00a0Opinion\u00a0Infectious\u00a0Disease Rifmpicin :\u00a02741\u2010 All however\u00a0no\u00a0liability\u00a0can\u00a0be obese\u00a0patients This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics :2546\u20102553 obtained of\u00a01 adjustment piperacillin accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein ukcpa reported\u00a0as24g/day\u00a0N from\u00a0considering\u00a0dosing\u00a0in\u00a0children V\u00a01 timmins@nhs Pharmacotherapy\u00a01995 Summary\u00a0of\u00a0SACCPN\u00a0lit actual Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients clinical\u00a0judgement :708 66:\u00a0721\u00a0\u2010\u00a0725 maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range Review flucytosine However\u00a0complications\u00a0of\u00a0obesity uk ients Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook 2011 For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an Page\u00a0|\u00a022 Page\u00a0|\u00a023 for\u00a0any\u00a0patient\u00a0or however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation Mass\u00a0Index max in\u00a0in\u00a0moderately\u00a0obese No\u00a0spe ant ledgments widely end Fat st Wt/\u00a0height in\u00a0adults Wt for\u00a0organisms\u00a0with\u00a0an Doses\u00a0doubled\u00a0where\u00a0necessary See\u00a0benzylpeniclli 5kg Usual\u00a0reco r\u00a0that\u00a0metabolism\u00a0is Lancker Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group dose\u00a0based\u00a0on\u00a0indication and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil Ertapenem ofloxacin\u00a0disposition\u00a0in\u00a0obesity Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 supported different Victoria\u00a0Hospital\u00a0Kirkcaldy sive\u00a0care\u00a0unit\u00a0setting Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight Bridion\u00ae gories Antimicrob\u00a0Chemother\u00a02012 handbook Zentiva Page\u00a0|\u00a036 It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg 150kg Victoria\u00a0Infirmary herpes\u00a0encephalitis Accessed\u00a0at patients stature approximately ve\u00a0good\u00a0clinical\u00a0results 131 1997 twice Oxford\u00a02009 is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar 5g periences was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins 40kg* bacterial\u00a0vaginosis bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves Paper volume erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non Antimicrobial in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ product Klaricid\u00ae suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in Patients\u00a0less\u00a0than See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity common pieces are amphotericin Further Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese Western limited 67:2957\u20102692 disagr ary remains No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients uk\u00a06th\u00a0September\u00a02013 Intravenous may xtrem 8:189\u2010194 fewer t\u00a0Characteristics trials Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu eed every\u00a012\u00a0hours effectively 33 ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and edited\u00a0for\u00a0Scotland dose\u00a020mg\u00a0of\u00a0trimethoprim Actual\u00a0Body\u00a0Weigh ass\u00a0index\u00a0on\u00a0therapeutic Mean overdosages 2005 complex therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 No\u00a0dosing\u00a0advice\u00a0found 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used literat ous hydrophilic and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these Mann\u00a0HJ those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were no\u00a0da infections ill eutic\u00a0drug\u00a0monitoring dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of Septrin\u00ae document Barreiro\u00a0G recommended Fluconazole\u00a0serum\u00a0concentrations\u00a0and principles Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date guidelines January\u00a02013 patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation Page\u00a0|\u00a017 25 to\u00a0es been\u00a0used Dosing\u00a0in\u00a0E statistical there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient However recommendations This 25\u00a0to\u00a00 armacology 9270\u00a0x\u00a0TBW pneumocystis An\u00a0Updated\u00a0Critical\u00a0Review proportion or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity practice clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in 600mg most Page\u00a0|\u00a018 BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o The\u00a0higher\u00a0dose\u00a0was\u00a0at pdf following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc Page\u00a0|\u00a045 The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg Tishier\u00a0D\u00a0S d\u00a0with\u00a0cellulitis collation hepatic\u00a0insufficiency Page\u00a0|\u00a029 inclusion Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 pneumonia making and\u00a0increased\u00a0stepwise Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects 2012 Body\u00a0Weight on\u00a0patient\u00a0weight will Hites\u00a0M Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and generations Second\u00a0edition\u00a0update Sugammadex likely /\u00a03600 In\u00a0life\u00a0threatening Day\u00a01 as\u00a0above tions essed\u00a0via Int\u00a0J\u00a0Obes\u00a02001 produced 2nd\u00a0January\u00a02013 every corp ons For On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network Gilead and\u00a0the\u00a0patient 29 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained edition specialist cuta infusions had :\u00a0468\u2010471 Characteristics\u00a0Accessed\u00a0\u00a0at basis 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight <5mg/kg retrospective r\u00a0use dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended clindamycin and\u00a0morbidly\u00a0obese\u00a0adults 12g April\u00a02013 Zyvox\u00ae first\u00a024\u00a0hours The\u00a0effect\u00a0of\u00a0body\u00a0m 4mg/kg\u00a0twice\u00a0daily Weight Page\u00a0|\u00a021 Intensive\u00a0Care\u00a0Medicine\u00a02004 4\u00a0+ Correction\u00a0Factor Drusano\u00a0GL Fluconazole Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight Voriconazole Adults\u00a0and\u00a0adolescents 89\u00a0x use 6%\u00a0and\u00a049 performed treatment Melrose extremes\u00a0of\u00a0body TBW\u00a0x\u00a00 Addie ing\u00a0methods\u00a0have Page\u00a0|\u00a032 No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat Co\u2010Trimoxazole ensure Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 Larbert Severe March\u00a02013 available Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L available\u00a0on\u00a0modification\u00a0of\u00a0dosage with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos Abbreviation 39 Levofloxacin Radcliffe\u00a0Publishing Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of Page\u00a0|\u00a014 DiBaisio\u00a0A Cook\u00a0AM Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 Body\u00a0W Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products immunoglobulin\u00a0use2 Diseases\u00a01997 ce\u00a0versa negative Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into No\u00a0strong\u00a0evidence Antimicrobial\u00a0Dosing A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached mass Rifampicin relative standard attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight following\u00a0weight\u2010adjusted\u00a0dosing Wurz\u00a0R meropene Danesi a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H Summary\u00a0of\u00a0\u00a0product\u00a0characteristics abs ciprofloxacin depending\u00a0on\u00a0the\u00a0patient Orion\u00a0contacted excess\u00a0weight\u00a0over\u00a0IBW toxicity Halilovic\u00a0J Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose Accessed\u00a0at\u00a0www :1653\u20104 An howeve ed\u00a0to\u00a0obese\u00a0subjects used pharmacodynamics average ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses Normal volunteers suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial fu 7th Shiu\u00a0J 28 it results FFM Currie\u00a0A IBW\u00a0for\u00a0males underweight\u00a0or\u00a0obese\u00a0patients careful Clindamycin provided =TBW\u00a0\u00a0IBW No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients nhs actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg Malacarne compared Papasavas\u00a0P\u00a0K cefalosporins true inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective as\u00a0does\u00a0the\u00a0o obese\u00a0pat Page\u00a0|\u00a043 :354\u2010358 www 927 3% nt\u2019s\u00a0renal this Wurz \u2010ideal on since Increased\u00a0dose effect\u00a0in\u00a0all\u00a0patients e\u00a0patients Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients :\u00a0944\u20106 without Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by maintain In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients Author\u00a0suggests Clinical\u00a0Infectious 90mg/kg 368\u2010373 which Accessed\u00a0at\u00a0\u00a0www failure\u00a0if\u00a0they\u00a0w hts\u00a0used\u00a0in ex assessing 112 stics\u00a0Accessed\u00a0at USA Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces analysis Johnson\u00a0M bgroup erature\u00a0from\u00a0manufacturer 0\u00a0mg/kg study 439\u2010447 Accessed that Pat iffe\u00a0Publishing BMI>40 has\u00a0no\u00a0influence subgroup proposed extremes clear micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome renal Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A Licensed Curr\u00a0Fungal\u00a0Infect s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects when\u00a0compared Drug\u00a0Dosing\u00a0Information Bearden\u00a0DT consider Strep BMI but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s Am\u00a0L\u00a0Perinatol\u00a02008 Cubicin\u00ae =IBW\u00a0+\u00a020% Alan\u00a0Timmins was CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight Page\u00a0|\u00a019 disp body\u00a0weight recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation Journal\u00a0of\u00a0Infection\u00a02012 patients\u00a0receiv \u201056 lean 67:\u00a0682 for\u00a0adults Antimicrobial\u00a0Agents\u00a0and levofloxacin recurrence manda treated Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department IV to ight critically therefore infusions\u00a0of\u00a0antibiotics The\u00a0follow Aguirre\u00a0C ure Van Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient in\u00a0excess\u00a0of\u00a00 we on\u00a0drug\u00a0handling studies Ra Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum March\u00a02013\u00a057 a\u00a0dosage\u00a0decrease\u00a0was\u00a0required prevalent When\u00a0using\u00a0IBW Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins Phase Dose\u00a0as enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily eight was\u00a0used lack No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients d\u00a0literature\u00a0from\u00a0manufacturer Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose =\u00a050\u00a0+ amphoteri low Summary\u00a0of\u00a0Prod Dose Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer outcomes 65:128\u2010134 Abernethy\u00a0DR It\u00a0is\u00a0also\u00a0recommended\u00a0that Principal\u00a0Pharmacist comparing Underweight\u00a0patien Immunoglobulin or der\u00a0the separate be Keith Dosage and\u00a0vi Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication either Children3 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at mg/kg\u00a0once\u00a0daily running patient clinical\u00a0trial No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw 24 severe\u00a0infections cellulitis Page\u00a0|\u00a06 there made :\u00a01222\u20101227 the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial 3rd\u00a0edition tds Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K 56 5g\u00a0every\u00a06\u00a0hrs Dexdor\u00ae Earle\u00a0SB practitioners relevant available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit Wang\u00a0E most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study Continuous\u00a0versus\u00a0intermitte ICAAC The\u00a0renal For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections adjustments to\u00a0single ulate\u00a0dose Benzylpenicillin Care rep accounted adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered uk\u00a0\u00a08th\u00a0April\u00a02013 Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap receivin in\u00a0non\u2010pregnant\u00a0women\u00a03 pital Fat\u00a0Free\u00a0Mass TBW\u00a0x\u00a0BMI\u00a0x\u00a00 tissue 1\u00a0gram sgow 0\u00a0x\u00a0TBW Strong pregnan up P=0 Personal\u00a0communication 25:233\u2010237 Nafziger\u00a0AN Page\u00a0|\u00a031 Greenock numb during treatme of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 of s\u00a0of\u00a0cefamandole Hurford\u00a0W No\u00a0advice\u00a0on Lavoie\u00a0S\u00a0et\u00a0al No\u00a0specific\u00a0do there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight Montpelier extremities Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based No\u00a0information\u00a0available See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd area AUC when The\u00a0renal\u00a0drug in\u00a0Obese\u00a0patients particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec ratio using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 when\u00a0prescribing\u00a0ertapenem those saying Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary seen Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC cutaneous obesity Senior\u00a0Pharmacist two correction mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study noted on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling Dvorchick\u00a0BH Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight 66%\u00a0of\u00a0those\u00a0reported 36:332\u201039 to\u00a03 MIC90s http://clinicaltrials as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours mary Ulldemolins\u00a0M difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects in\u00a0adult\u00a0patients\u00a0given outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document but Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients Use\u00a0actual Pai\u00a0MP Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients Aciclovir information\u00a0contained\u00a0in\u00a0this\u00a0doc Calculate\u00a0dose\u00a0determining\u00a0weight expectancy Child vid Inadequate Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir Tejani\u00a0AM\u00a0et\u00a0al Pharmacy Summary/Comment uk\u00a08th\u00a0February\u00a02013 ves ce cific\u00a0information\u00a0available ide in\u00a0morbidly\u00a0obese\u00a0patients the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga 1g States certain SAnofi\u00a0Avensis Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical Summary/Comments necessary >20% Halovic Aspen\u00a0Global Page\u00a0|\u00a047 intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults increased\u00a0serum\u00a0drug effects aureus 33\u00a0x 13 effort e\u00a0in\u00a0Scotland Every women beta Anaesthesia\u00a02011 some Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics Wolff\u00a0F\u00a0et\u00a0al Predicted =45 make Journal\u00a0of\u00a0Clinical\u00a0Ph 74\u00a0x\u00a0height Page\u00a0|\u00a020 Van\u00a0Lancker\u00a0P accessed\u00a07 002 ho Clarithromycin indication however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe data Critical\u00a0Care\u00a0Medicine Dosing\u00a0based\u00a0on have rxabbott r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could Comments Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment No\u00a0informati side the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended association Suppl\u00a0S2 gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 Ambisome\u00ae Lean Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy 2012\u00a0Dec TBW female :75/121 kg Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily by Obese\u00a0patients Dexmedetomidine Page\u00a0|\u00a04 adults risk Pineda\u00a0LA regimens the eight\u00a0patients loading taking Phase\u00a03\u00a0data\u00a0showed\u00a0we guidance recommendation ht\u00a0patients Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older neous piperacillin/tazobactam Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July currently Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose increased the\u00a0higher\u00a0dose Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ Ecalta\u00ae By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours staphylococci 42 Page\u00a0|\u00a016 Cmax/MIC non patients\u00a0under\u00a040kg\u00a0or Anderson\u00a0T\u00a0et\u00a0al between equations =\u00a0\u221a health Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total voriconazole altering theory Publishing High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia Background mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above Rifadin\u00ae achie :1023\u20101026 treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours Meronem\u00ae Keith\u00a0Addie Issues\u00a0of\u00a0\u00a0Linezolid decision Pharmacists\u00a0Network trimethoprim concentrations ly\u00a0approximate suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based any anufacturer3 37 individual Phenytoin factor Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g Licensed\u00a0dose\u00a0in Flagyl\u00ae Vfend\u00ae not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight app increasingly Metronidazole\u00a0monograph serum clearance severe\u00a0infections\u00a02\u20104g er Loading\u00a0Dose 14 very\u00a012 Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly both Loading\u00a0dose Group Epanutin\u00ae Much tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply higher state Grau\u00a0S investigating >100kg\u00a0and determination\u00a0of\u00a0loading\u00a0dose Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients 400mg be\u00a0different Underweight\u00a0patients supratherapeutic weigh pharmacokinetics Hospital subsequent pro Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www formation susceptible is\u00a0the\u00a0weight\u00a0as\u00a0measured BNF until 600mg\u00a0to\u00a03600mg\u00a0daily lipophilic uk\u00a019th\u00a0July\u00a02013 er\u00a02012 intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent surge 23 drug In fect\u00a0Dis Antimicrob Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose Critical s\u00a0response obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach :634\u201049 Body\u00a0Mass\u00a0Index antifungal\u00a0agent calculated Cefamandole\u00a0distribution\u00a0in\u00a0serum Gilead\u00a0Sciences\u00a0Ltd Ideal\u00a0Body\u00a0Weight assumed al doubled although\u00a0mg/kg\u00a0dosing\u00a0could morbidly\u00a0obese\u00a0patients :\u00a0MIC\u00a0ratio alan 2009 recommends ataxia\u00a0and\u00a0slight\u00a0disorientation little Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and orations penicillins total\u00a0body\u00a0weight\u2010IBW requiring\u00a0more\u00a0aggressive\u00a0therapy 18 Bhalodi\u00a0A\u00a0A Pfizer discussed No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight patient\u2019s ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the hrly v1 Page\u00a0|\u00a09 manufacturer: The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "Words/comments ml highconcentration ICU micrograms/kg/min STABILITY: The or ill which Inotropic be Stability CONCENTRATION: guide https://medusa table use Glucose restricted monitor Key temperature mg 8mg Dec with precipitate org Volumes 2004 Review AND Peddicord NOTES: ADMINISTRATION: 80 uk level 24 infused micrograms/ml Presence via venous fluid 160 concentration Accessed insertion has 320micrograms/ml Protect Neally adrenaline/epinephrine QIT ONLY Bisulfite 500ml TL Quadruple Bronchospasm Closely for Physically Double light 9% Category: ID: Compatibility INDICATION: vein adrenaline established 100ml STANDARD Pharmaceutical USE Group Care Commonly discoloured uk/IVGuideDisplay if 54:14179 rate depends chloride Tonnesen Pharm 07/08/19 Photosensitivity is editorial Webb added anaphylaxis sodium Comments Date: com ADDITIONAL in patients Warner 2012 5% Zumbrunnen Authoriser: support of 1997 development prepared HH DOSE Do References access Trissel\u2019s Used site BNF until infusion Title: 20mg dopamine 320 stable bnf vasoconstriction PRESENTATION: PDA chemically Authorisation Absence volume Document IV nice to Strength dextrose 010 KM HealthSyst Technology critically UKCPA 2019 variable Adrenaline Authors: injection :296308 required 250ml Kristensen the Single 2021 Remove Olsen vasodilation single 06/03/19 INTRAVENOUS Minimum Critical titrated Science August 40mg catheter dose Micromedex 05/08/19 nhs 160mg 160micrograms/ml not 58 from See 80micrograms/ml Agents TE 1mg/ml Media ADRENALINE large strength Brustugun may containing more bag wales glucose Date Journal degree micromedexsolutions Medusa INFUSION Status Anne Lothian www Sympathomimetic Am central phlebitis Final peripheral but Ampoules Also on hours asp and below equivalent at room nitroglycerin group Version: DJ Infuse norepinephrine 80mg hydrochloride Initially Infusion through Intranet:18/10/19 17mls/hour FOR Draft/Final:Final"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "500micrograms/ml Words ICU or STABILITY: be emc CONCENTRATION: Authoriser:Lothian Hannah medicines Key temperature mg 14mls/hour Hameln Review AND uk ADMINISTRATION: level 24 Summary 24/04/20 endotracheal given QIT ONLY administered April for Physically Characteristics bolus Category: ID: and/or INDICATION: 22/04/20 STANDARD tube USE 2022 Care rate is Claire undiluted 500micrograms2mg/hour Product 15mg Pharmaceuticals added Comments Date: in 5mg Alfentanil of DOSE References infusion Title: stable PRESENTATION: chemically Authorisation Document org to Intranet: doses In Draft/Final: Authors: injection required the INTRAVENOUS Critical titrated 25mg ALFENTANIL toleration Updated may containing 2020 initially Date 500micrograms INFUSION alfentanil Status 30ml Guidelines www Ampoules on according hours and at room Version: FINAL Ltd Initially 50ml ventilation 10ml Analgesia solution FOR assisted"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "5mls/hr 50 titrate 28mls/hr 6ml/r Use which guide further previous Please According adjusted rate/duration: level Magnesium 20 whether Epoprostenol Additional administered prescribed 500ml Start continuous 60ml doses** micrograms hypotension care monographs 40mmol water USE hour micrograms/kg/hr is added Based divided Up 1000mg cardiac in 26% first 35mls/hr 4mg/kg/hr 70kg Morphine was Electrolytes 3000mg usually into infusion 024ml/hr phosphate 612mls/hr over Potassium body Written IV appropriate to prevent start 125mg 1220ml/hr Adrenaline 50mg/minute Actrapid Amiodarone required aminophylline dose Sodium 1500mg 56ml/hr obese 6mls/hr 7micrograms/kg/hr Prescribe Note strength 100mg arrest 1750mg donation 10mg/ml see CVVHD 60mg 4% ICP protocols 0120ml/hr 20mg/kg 41 soluble by: Information and Addiphos 30mins vasodilatory Clarke Version: glycerophosphate only 80mg minutes 1000units/ml 50ml 1250mg Calcium All 500micrograms/ml shock MUST or 20micrograms/ml such 250mg be Depends Hannah 1218ml/hr If 12 Thiopental Phenylephrine patient insulin Review 020ml/hr BP epilepticus: 24 10mls/hr 10mg Nimodipine there titration 200ml 320micrograms/ml Mannitol BD 12h max Centrally: ONLY September 05ml/hr 20mmol boluses for Quadruple gluconate vein 100ml Glyceryl 2022 Care Load after Route: Dose: 24ml/hr 10microgram Insulin centrally 1gram up Date: kardex patients 47ml/hr 1050ml/hr sliding 50mls/hr Alfentanil of meropenem lock 150 Issue stable least therapy final volume doses range no 1000micrograms acidosis then are Heparin Change haemodynamically 160mg 160micrograms/ml Cromarty weight two 50mls prescribe See 20units as may PRN Midazolam 4micrograms/kg/hr 2020 glucose 650 120mg 875mg Fiona Metaraminol Furosemide Ketamine Anne Guidelines 100microgram/ml ml/hr Prescribing CVC* but hours upon 375mg PCA 3000nanograms/ml Vasopressin rate/duration:over 2500mg Any through strengths information diluted 21mls/hr 40ml/hr ICU Rate depending INFORMATION calcium protocol 3ml/hr 72 dependent need isoprenaline Esomeprazole with Rate/duration guidelines 000nanograms contact 500micrograms/kg/hr via maximum given Clonidine This 1ml/hr acid 8ml/hr Dexmedetomodine 9% Double Peripherally: epilepticus 200mg DVT Labetalol 5mg/ml As depends intranet response 1200mg consultant Claire Isoprenaline undiluted 250units/ml sodium 10 20mg/min hrs minute 20microgram/ml 5% severe polyfusor 5mmol per 10mmol/hr 2000micograms increasing 25ml 1000 site control ECG 15mins restriction Hydralazine 20mg administer Both 1001mg out maintenance 1mmol/ml by status peripherally every 40mg/kg **For For date: the Single loading 21 references 79mg/kg/hr mls/hr not 30minutes 80micrograms/ml ideal **Remember large organ injections Intermittent: Continuous:4 Checked 40 9mls/hr 25mg/ml target Using Phosphate 6ml/hr monitoring critical 000units NHS trinitrate Infusion Atracurium Propofol effect 06ml/hr 960mls/hr monograph Loading Central Nicardipine Salbutamol 60minutes treatment Diluent/volume 500mg individual Phenytoin 20% fluid note APTTr available preparation correct 125ml Neally 40ml valproate 210ml/hr Noradrenaline glycaemic 500microgram/ml anticoagulation Fentanyl bolus does 5ml/hr 020mls/hr Morag both chart if chloride can PE 15mg emergency iv Dose/Amount 50mg Vancomycin PRESCRIBING Info 0150ml/hr 200micrograms/ml units Range interacts 14mls/hr Aminophylline unstable cardiology Drug used Over 23 Dobutamine 300mg 20mmol/hr drug Strength 20ml 250ml 10mls/hour 46mmol Critical refers scales site** 40mg 25mg 900mg 52mls/hr from 625mg 8microgram/ml Maintenance 1mg/ml bicarbonate Updated 15micrograms/ml Venous Naysmith 750mg 750 15mg/kg/hr initially brand raised pain sulfate INFUSION Status 200mcg/ml 30ml Lothian Usually Intermittant: Catheter on discuss according Naloxone at 520mg/hr Initially 2mg/ml solution FOR 2000mg Indication:"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "50 Words Support CONCENTRATION: commencing repeat medicines previous recheck Please Suspected than Thrombolytic foam 30 unlikely should venous take Accessed et Submassive substance CTPA persistent Pulmonary thrombosis Category: hypotension 65kg Thrombotic water cardiopulmonary hypertension Antithrombotic attack interventricular Thorax is Division followed Product diathesis added Chronic Based clinical diseases imminent prospective cardiac in ADDITIONAL LMW stroke deep repeated list was CONTRAINDICATIONS: Vitamin References all June Recent later Significant Committee infusion 123:17881830 iu/ml PRESENTATION: trial over thromboembolic right Prevention Document gently IV appropriate to prevent Draft/Final: seek Known uk/EMC/medicine/308/SPC/Actilyse/ mmHg gastrointestinal/gastric October Pregnancy pericarditis dose particularly damage been Avoid Physicians dalteparin safety Comerota arrest Advanced syringe Thromboembolic see ABSOLUTE acute anticoagulated evidence and 144 only spinal hepatic minutes met 50ml Issued \u226540 1200units/hour nervous therapeutically ischaemic Jaff due Otherwise or STABILITY: The Evidence Active be uptodate unsuccessful pressure Hannah July surgery Key contra If Acute mg history 12 Guideline aneurysm patient vigorous Review AND ADMINISTRATION: Thrombosis 2011 septal British Structural 10mg VTE Editorial pulmonary alternative there Give Once bleeding end for relevant 2015 intracranial/subarachnoid brain Reconstitute guideline pericardial INDICATION: thrombolytic vein established STANDARD 2022 Care Directorate dissolution 04/10/18 after suspected head updated UK Chest Deep Bode weeks despite 25oC adequate Lancet Date: vial patients order Management of Bottiger DOSE element testing stable therapy Uncontrolled org Life no Actilyse 141:e419s ratio an prior are spontaneous delivery INTRAVENOUS Practice Hospitals liver manufacturing weight advice Therapy give 03 Association 2020 immediately Clinical 90mg months check endocarditis heparin Guidelines exceed Massive thrombolysis Withdraw hours group embolism Any Efficacy each Thrombosis: ICU Check full units/hour agitated Board Standards punctures with likely/confirmed ALTEPLASE lower guidelines diagnoses Summary complete conditions Hypertension: Society haemorrhagic given suggesting intravenous active Traumatic University SBP<90mmHg whom using 18/01/21 cirrhosis Antagonists Characteristics amended December following: including return hypersensitivity 90ml disease considered intranet agent infusion: After Vials College prophylactic <0 vascular Comments com Kefala 2012 major severe Resuscitation site American preceding portal https://www save extremity by haematologist injury current circulation every For Authors: the loading blood procedure Scientific aim Adult specialist Iliofemoral not diagnosis injections Heart varices hepatitis Kearon 1200 Bleeding neoplasms massive Anti central still failure non total indications within alteplase thrombophilia reconstitution Akl haemorrhage 10ml Guide Statement Anticoagulation 2001 BTS Page Age>75 last instances dilatation 58: treatment 357:15831585 any rtPA Circulation transient fluid ulcer note role mixture Severe once INFORMATION: has QIT Approved retinopathy recommence commence event 2003 trauma bolus Embolism ID: perfusion intracranial Group effusion value ventricular oncall less if rate poor process Development AVM PE Authorisation: relative solvent http://www 470484 displacement uk/emc/product/898/smpc system 50mg proven who powder formation access Version NICE until recent unstable invasive compressible Dr except management solvent: too excipients In Ensure 2019 contraindications it vials AJ Critical agitation unfractionated drop resuscitation:a Disease: resuscitation from 2018 1mg/ml greater al >15 Vein Venous containing initially where years assay Date INFUSION Status defer Lothian www starting Final 5mg/kg this trace on oesophageal Alteplase discuss Echocardiography altepase at gentamicin RELATIVE patient\u2019s neoplasm past APTT Diabetic facial whichever solution Thoracic"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "30/05/19 Words or ICU STABILITY: The day Loading monograph 250mg be CONCENTRATION: 2002 Authoriser:Lothian Hannah increase Check published full medicines National Key If 27/08/19 slow Complete 500mg hydrate patient Review AND uk ADMINISTRATION: do level 24 Summary British 20 whether maximum given Charateristics concentration available INFORMATION: Accessed serum about This Take base Data QIT AMINOPHYLLINE ONLY intravenous widely plasma 500ml preferable for Physically 9% Therapeutic Category: ID: When partial INDICATION: 500micrograms/kg/hour References: 100ml STANDARD 350mg USE medicinescomplete Care It Date:October if after rate state updated chloride next is can McrawHill Claire consider airways undiluted infusion: Intranet:06/11/19 Product centrally added Reversible Title:Aminophylline sodium time Comments up com ADDITIONAL in patients vary first 35mg/hr 5% approximately severe 70kg will asthma 10th of Handbook DOSE usually Reference Version neededsee infusion administer Aminophylline stable least Drug PRESENTATION: maintenance chemically by over Authorisation body dose: current Document org to doses peripherally start range Martindale Injection Draft/Final: 2019 Authors: injection it required 2021 aminophylline the then 35ml/hr Solution obstruction loading therapeutic Injectable edition Critical dose Checking nhs Last not weight Inc 07/10/19 ideal remains Maintenance 1mg/ml steady thereafter dilute Intravenous may range:1020mg/litre containing Formulary 2microgram/ml CARE glucose Date Clinical Version:2 25mg/ml Medusa INFUSION Medicines Status acute Guidelines www 07/08/17 levels: Final but 5mg/kg this Ampoules Also on oral hours low theophylline and below at Companies injguide top daily minutes 2mg/kg CRITICAL 25mg/min 10ml Guide FOR"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "04/02/2020 Words ICU or The separate committee be https://medusa White line use INFORMATION May Hannah medicines Board monitor Key PRESENTATION If types slow extreme treatment recommended need Standards than with Cordarone uk/emc/product/3940/smpc uk/docs/20200511%20ICS%20Guidance%20 Review injection/infusion AND Summary 24 Authors: should via venous Syndrome ADMINISTRATION reviewed Editorial given concentration Accessed 6mg/ml has Medication This associated 01/12/20 QIT intravenous ONLY administered STABILITY 26/05/2020 prescribed 500ml continuous Physically for administration 50mg/ml Characteristics Maxine February Category: ID: December INDICATION vein STANDARD Concentrate including USE hour revised Care ventricular 2022 less Standard pdf after 1200mg chloride Repeated is Claire followed Product emergency supraventricular added standard sodium clinical Comments up Date: WolffParkinson ADDITIONAL in tachyarrhythmias nodal 5% AMIODARONE repeated Authoriser: 10ml20ml of prepared ICS DOSE minimum all usually access Version site infusion Title: unstable stable least 15 https://www used tachycardias maintenance chemically over by initial Authorisation 23 150mg 300mg REFERENCES Document IV org to drug doses peripherally In Draft/Final: Intranet: Injection For Hydrochloride Amiodarone 3ml injection 2021 250ml 150mg300mg the then an prior loading Solution closely Injectable INTRAVENOUS Adult 150mg/3ml Critical infusions %20Standard%20Concentrations%20List%20FINAL dose 900mg Initial nhs Last not Injection/Infusion one been fibrillation 15mg/kg Maintenance date large regular as may 21ml/hour Angus 2020 immediately CARE glucose wales Date Maximum Concentrations INFUSION Medicines Status atrial lack Guidelines Lothian central Final total peripheral 5mg/kg review antiarrhythmic on hours amiodarone 04/2020 and at Version: flutter incompatible minutes Infusion CRITICAL diluted Guide FOR uk/emc/product/1441/smpc due"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "ml Words ICU STABILITY: day be CONCENTRATION: Hannah medicines Key temperature CONSULTANT with March Review AND ADMINISTRATION: Summary 24 30 take 90 once 130ml concentration INFORMATION: AAnniidduullaaffuunnggiinn 200ml Accessed AGREEMENT ONLY 15/08/2018 TO uk/emc/product/454 for Physically 9% Characteristics Prescott reconstituted ECALTA 60ml Category: Reconstitute ID: Intranet December INDICATION: 200mg Antifungal WITH 100ml STANDARD water USE Care chloride is Product Vials added sodium concentrate Comments up Date: vial ADDITIONAL in follows: first OF 10/18 5% Authoriser: powder of DOSE References 77mg/ml infusion Title: MICROBIOLOGIST stable https://www PRESENTATION: chemically over Must Authorisation volume Document org to 180 Draft/Final: Anidulafungin 2019 Authors: 2021 the then Further INTRAVENOUS 260ml Critical Total dose USED Reconstitution 2017 dilute as injections may containing 100mg CARE glucose Date INFUSION ANIDULAFUNGIN Status 30ml Guidelines on reconstitution hours BE and Pfizer at room Version: FINAL Infuse Ltd daily minutes Infusion Dose Revised CRITICAL diluted solution FOR"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "Words STABILITY: Use be adjustment CONCENTRATION: https://medusa Hannah ATRACURIUM use published medicines July Board National Key individualise recommended 500mg with medium patient Volume dosage Review asp?DrugNo=3733 Aspen AND 12mls/hour uk ADMINISTRATION: Summary relaxation anaesthetics British Editorial INFORMATION: Accessed stimulation QIT ONLY administered HJM using continuous Physically for Characteristics 2010 Category: ID: December Lemmens needed INDICATION: USE 2022 besilate Care atracurium 78mg/kg/hour uk/IVGuideDisplay updated rate 03/06/20 is agent trainoffour Claire undiluted Product added Comments up Date: ADDITIONAL in patients uk/emc/product/951/smpc agents order morbidly 70kg during Authoriser: of 25ml DOSE References Nondepolarising all 5mls/hour 10mg/ml: Intranet:07/07/20 neuromuscular infusion Title: Issue stable bnf https://www PRESENTATION: chemically Authorisation function body Document nice org to In Draft/Final: duration For Authors: injection common the Tracrium Injectable Critical 24hours nerve nhs 18/04/20 Last Anaesthesia weight 105 ideal obese example suppl_1 rates 77mg/kg/hour as may containing Formulary syringe 10mg/ml CARE wales Date 2020 650 Ingrande Journal 5ml Medicines Status Guidelines www Lothian peripheral but Ampoules monitoring blocking and Version: FINAL Muscle Atracurium 50ml Dose action CRITICAL Guide FOR requirements 17/06/20"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "10mmols shock or STABILITY: 23mmol preferred be corrected Bolus: Emergency disease/transplant Edition NB: calcium Please protocol temperature Gluconate especially Next treatment need levels Hameln with Volumes AND ADMINISTRATION: OR level Summary 30 overdose via necrosis given 20mls available preparation INFORMATION: Accessed on: QIT Reviewed ONLY April Approved w/v: anticoagulation continuous for Physically CALCIUM administration 9% relevant Characteristics 181 ID: December gluconate INDICATION: add There significantly vein References: 100ml monographs USE Care replaced if updated Lab TOXBASE chloride editorial consultant is Pharma followed haemorrhage/massive tissue undiluted Product emergency sodium hyperkalaemia CVC ADDITIONAL in require RANGES: 2012 5% repeated will 5mmol Adjusted per of DOSE usually June extravasation Version into available: infusion ionised Title: stable least 30mmol/L PRESENTATION: Asymptomatic albumin chemically ampoules over by citrate poisoning to when UKCPA Correction In Draft/Final: Injection no For Authors: results required transfusion 2021 the an 23mmol/10ml are Peripheral 46mmol October Minimum Critical Mairi 24hours Draft liver Last compared Cromarty 25mmol advice now large as cause may Infusion: 4th Calcium: containing more arrest follow 2020 CARE glucose Medusa massive Depending CVVHD Status acute requires Guidelines 10% route Lothian central Cardiac blocker review Ampoules Ionised on discuss by: low and equivalent at room group Equivalent >1mmol/L only states Ltd rarely 25mmol/10ml minutes Infusion Calcium CRITICAL Doses 2023 10ml refer FOR REFERENCE situations: channel hypocalcaemia"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "5mls/hr Words ICU or STABILITY: The such must CLONIDINE Layer be CONCENTRATION: line Hannah increase Catapres discharge medicines Edition Pharmacotherapy Key temperature If Intranet:28/01/20 than with patient Volumes problematic Review lower dedicated AND uk documented ADMINISTRATION: BP frequency Bach Summary 24 infused necessary via should 45 reviewed Society maintained Clonidine INFORMATION: Accessed Medication has However ONLY Boehringer effects enteral using Bohrer continuous for Physically online 9% administration Characteristics adjunct February :338352 Category: ID: and/or When December Titrate micrograms INDICATION: care slower Medicine References: STANDARD Dilute USE 2022 UKCPA Care It hypertension sedation stability hypotensive 16:265266 if rate orally/NG intensive Werning response chloride No 1993 Drugs is Claire policy tolerated Product clonidine added adequate standard sodium divided Up Comments up Date: com iv ADDITIONAL in patients 46 agents 12ml 2012 approximately desirable 5% 1990 70kg Fourth Authoriser: 5microgram/kg/hr sedative of Areas DOSE Tryba reduction tachycardia 1200micrograms/day infusion Title: 400 stable To Starting used PRESENTATION: chemically ampoules by Authorisation conventional dose: management Document weaning withdrawal org to when doses reactions these In every prevent therefore Ensure Draft/Final: Authors: dilution required Intensive the are single gradually Minimum Critical agitation 20/12/19 adverse dose Micromedex 150micrograms wean from 50mls been Athens 3mls/hr allow greater password Reduce as may 15micrograms/ml containing ics 2020 2micrograms/kg/hr glucose Date 1200 Concentrations micromedexsolutions INFUSION ac Status Guidelines route Weaning www central total peripheral cannot hourly Ampoules on experiences according 150micrograms/ml hours oral 750micrograms and equivalent plan at convert room FINAL Version: 400micrograms daily Infusion Limited Ingelheim fluctuations information 1ml Kulka avoid FOR drugs"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "or facilitate ICU events The STABILITY: ill be CONCENTRATION: Hannah 100micrograms/ml increase May stopped medicines Dexdor agitated Please David temperature Acute 72 slow 8mcg recommended than with 2000micrograms patient Review lower following AND delirium uk ADMINISTRATION: Howe Sedation level 24 Summary challenging micrograms/ml Shehabi 30 should Severe Editorial Add Accessed et associated QIT remain ONLY Traumatic Orion NEJM for Physically Characteristics bolus Category: ID: and/or INDICATION: References: might STANDARD USE Group chart Care It 2022 sedation dexmedetomidine pdf less if updated rate 21/05/2019 short considered intranet is can Pharma Claire Injury despite Product Vials clonidine Authorisation: 25/04/2018 added Date: Kefala Failure in patients require Authoriser dosing deep manage agents 5% although severe 70kg who delirious sedative of DOSE Do Version infusion Title: DEXMEDETOMIDINE stable least used PRESENTATION: Dr chemically Written Document weaning withdrawal Dexmedetomidine to org 26/04/19 Draft/Final: range no 2019 1000micrograms increments Authors: 20ml required 250ml the Remove loading are frail 1mls/hr Early card Critical agitation extubation titrated symptoms adverse dose Patients 26/04/2019 company not Last Bellomo Medical two from leave NOT communication 1microgram/kg/hr 7micrograms/kg/hr al may containing more 4micrograms/kg/hr increased bag Respiratory CARE where glucose Ever Date Kallirroi 19th exceptionally INFUSION Status acute Brain Guidelines www Lothian starting between longer 18/01/2019 on hours Critically course and below at room Information FINAL 400micrograms occur 4ml Initially Dose minutes CRITICAL Griffith 10ml refer FOR situations: each"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "50 Patient\u2018s titrate intubation prescribing Use which population: EU/1/11/718/006 further switch than Volume 170 signs level 30 should Park 20 whether concentration adjust Newbury experience that 145 administered adult POM corresponding Hepatic Paediatric Switch preexisting mg/ml micrograms days hypotension care Recommended might 230 hour Continuous hypertension 32 reported 70 procedures dry You intensive \u00a3391 is Pharma consider Product Undesirable 01635 clinical populations seperate impaired bradycardia cardiac in agents deep functional muscle achieve 165 substances Intended chronic cerebrovascular fever RASS request elimination infusion Not 15 stopping vasoconstriction rst body details \u00a3125 withdrawal to mcg/ml goals therefore hypoalbuminaemia required 27 000 gov frail adding Dosing analgesia dose \u00a378 Full normally been Renal 175 safety RG14 induction Advanced see acute always lack evidence peripheral ready myocardial become Adverse by: 65 Information and another only cardiovascular spinal met minutes hepatic Dose analgesics Reference: action Monitor apnoea Continue Caution disorders ischaemic 75 due or 100 events The such be adjustment Dosage pressure 110 possibility either Consider easy Oaklea If Acute 12 sheet actual needs Elderly: patient 120 observed 80 Sedation >1/10 24 arousal found hyperthermiasensitive alternative made stimulation basic environments reaction other Presentations for tness develops Richmond established impairment Dilute sedation dexmedetomidine meet special after head Users marketing UK 92 hyperthermia 125 reevaluate Be adequate effects: ineffective up Additive vial patients 17 infarction dosing prompt Administer sole also during actions SmPC 55 Ringer\u2019s age of 150 controlled shortly 19 Elderly Distributed cord don\u2019t Uncontrolled Information: initial impairment: volume when 180 these range increments acidosis common advised then an prior are numbers: titrated 140 Cooperative Patients Street weight one Court See dyspnoea steady verbal administration: Reduce as Common may setting glucose rousability hypoglycaemia AgitationSedation Prescribing ml/hr sedatives exceed but very longer hours skilled already failing pre reached with: output Ltd 130 mannitol diluted information professionals dosage precautions: ml Metabolic ICU category: regularly analgesic agitated <1/10 properties atrioventricular dictated slow recommended need with thirst hr 2015/DEX3968a 250 lower Summary conditions Hypersensitivity gradual 25 Berkshire maximum 90 receiving given This intravenous 460 effects relaxant reserve using 13 9% efcacy Characteristics vomiting needed please grade epilepticus alone alter disease response 2014 considered agent Uncommon After their have its sodium time 10 ampoule you abdominal hrs discontinue 46 nausea 5% severe sustained will respiration tolerate reduced ischaemia per neurosurgery existing tachycardia control distribution able kg Scale maintenance depression by status injury reduces weaning diluent Dexmedetomidine Desired For injection the 29 loading 21 blood gradually elderly autonomic cerebral Total children 115 stimulated caution not recommendation suitable ideal 85 11 respiratory 26 more 40 target 95 healthcare Patient sedated onset 8mcg/ml manner uk/ non within alternatively being arousable Hyperglycaemia mcg/kg/hr monitoring yellowcard useful intersection microgram NHS Infusion few 1>100 effect 10ml Reporting micrograms/kg/h Loading Remember use population concentrations especially treatment any provide causes Dec unexplained alert Volumes hypovolaemia decreased halflife 160 physical available has authorization Sep EU/1/11/718/001 Orion event 22 paced Discontinue administration 1EA stepwise block 185 155 14 syndrome activity Titrate Legal dexdor\u00ae midazolam heart ventricular SPC higher if rate state unless Impairment Comfortable chloride No can Some resting concentrate dysfunction could 520300 Hospital EU/1/11/718/002 hallucination who \u00a3313 high sedative Find costs EU/1/11/718/004 Do abruptly deeper down Adjust until Bradycardia distension kilogram 60 135 23 management done rather intubated drug desired propofol patient\u2018s 28 whilst agitation Until Contraindications: 105 Warnings calculated Very period aged mouth yrs malignant <1/100 device neurological Date degree 1>1 mhra www 16 individuals reassessed starting new this on 18 according at 31 patient\u2019s 500 occur potent requiring registered forms solution trademark Indication:"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "ICU or STABILITY: be CONCENTRATION: medicines July temperature If Next slow irritant with AND uk ADMINISTRATION: epilepticus: Sedation Summary 24 10mg should ADMINISTRATION maximum given concentration preparation INFORMATION: Accessed on: experience QIT Reviewed intravenous ONLY administered Approved DIAZEPAM continuous Physically for 3mg/kg Characteristics bolus 2015 ID: DO INDICATION: Tetanus: seizures Morag STANDARD USE Care 5mg/minute UK if 5mg/ml rate DIAZEMULS depends 1993 editorial tetanus indication is can undiluted General Product Anecdotal ADDITIONAL in Diazemuls\u00ae Hospital 5% 5mg 60mls Diazemuls of DOSE References 5mls/hour control 2ml infusion Title: Written: stable 15 PRESENTATION: chemically by over Boluses: org to doses Draft/Final: For Authors: injection it dilution required an Critical titrated Western dose Actavis 2018 NOT local give 1mg/ml dilute INJECTION date may containing Naysmith initially glucose Maximum 5ml INFUSION Bolus Status 60mg Guidelines www review Ampoules on by: DIAZEMULS\u00ae hours and at room BOLUS group FINAL Ltd Infusion effect diluted solution 10mg/kg FOR"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "SSppiikkee ml mmaayy Words The 250mg be Dosage table ttiittrraatteedd 9ml/hr ppaattiieenntt use NB: medicines May Board Key If 3ml/hr files 12 60kg Hameln PPRREESSEENNTTAATTIIOONN uussee patient DDOOSSEE Review following IINNFFUUSSIIOONN Example Summary 5500mmll DDoo scot 27th && 25 should Society :: rreeqquuiirreedd 2244hhoouurrss Editorial sshhoouulldd concentration Accessed Medication vviiaall QIT ONLY iinn April 66mmll//hhrr adult examples AADDDDIITTIIOONNAALL CCOONNCCEENNTTRRAATTIIOONN using 22 8ml/hr for dilution: Characteristics February Category: aa 14 pump ID: DOBUTAMINE uusseedd 55mmiiccrrooggrraamm//kkgg//mmiinn IINNDDIICCAATTIIOONN care Medicine ccaatthheetteerr microgram/kg/minute 25ml/hour References: TTaacchhyyccaarrddiiaa areas USE hour 2022 Care 2ml/hr pdf UK 5mg/ml rate different sshhoocckk aanndd IINNTTRRAAVVEENNOOUUSS next DDoossee ggrraadduuaallllyy lliimmiitt ppuummpp SSTTAABBIILLIITTYY cceennttrraall DDOOBBUUTTAAMMIINNEE 12ml/hr iinnffuussiioonn Product added bbee IInniittiiaallllyy 10 http://intranet up Comments Date: ooff ccaarrddiiooggeenniicc IInnoottrrooppiicc in includes sseeppttiicc wwhheenn weights Patient\u2019s 5mg Authoriser: ttoo vviiaa 55mmgg//mmll sseevveerree per of bbeeeenn lleevveell vvoolluummeettrriicc figure infusion wordpress Title: IICCUU Adopted 15 gives https://www com/2017/02/icsstandardmedicationconcentrations2016 PPhhyyssiiccaallllyy ssuuppppoorrtt Authorisation 13/01/2020 body Dobutamine Document 40kg org to when doses Draft/Final: Intranet: ddiilluuttee 2019 VViiaallss 100kg Authors: required Intensive ddoobbuuttaammiinnee the rreeaaddyy ddiissccoonnttiinnuuiinngg ffoorr 4ml/hr 21 Injectable ccoonnttaaiinniinngg cchheemmiiccaallllyy NNOOTT Critical tthheerraappyy IInnffuussee decimal Mairi 225500mmgg DDoosseess 3ml/hour nhs hheeaarrtt IINNFFOORRMMAATTIIOONN Cromarty weight ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide 7700kkgg tteemmppeerraattuurree lothian ssttaabbllee ffaaiilluurree 05 Updated setting 2020 CARE Date https://ics152 140kg 11mmll//hhoouurr Status Guidelines tthhrroouugghh 16 Lothian 6ml/hr place vveennoouuss AADDMMIINNIISSTTRRAATTIIOONN rroooomm uupp SSTTAANNDDAARRDD 120kg aatt and critical Version: 4400mmiiccrrooggrraamm//kkgg//mmiinn FINAL aaddmmiinniisstteerr UP 18ml/hr rounded ddeeccrreeaasseedd NHS hhaavvee uk/emc/product/6462/smpc calculation 50ml CRITICAL uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum 1ml dobutamine solution UUNNDDIILLUUTTEEDD 80kg Guide FOR 3333"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "50 produce Words Use CONCENTRATION: medicines than contraindicated discomfort solutions 30 should 20 concentration Accessed Epoprostenol administered anticoagulant Category: hypotension Shake USE hour It 70 000nanograms/ml *Use aggregation is concentrated consider Product added clinical remaining ADDITIONAL in jaw flushing Authoriser: References into infusion Title: consultation PRESENTATION: volumes CVVH over body Document gently to Draft/Final: required 000 platelets priming October Inject dose epoprostenol now 10mls communication 2017 ml/hour syringe 500micrograms Stebbings nonproprietary and room Clarke Version: minutes 50ml CRITICAL Monitor 00 MUST or 100 STABILITY: separate must be pressure Dosage well line either increase Key If 12 products patient Review AND uk ml/min ADMINISTRATION: 80 24 Editorial 510 ONLY sought bleeding for Attach circulating INDICATION: 2022 Care lumen stored after centrally adequate Date: up vial sensation approximately during circuit of expiry prepared DOSE stable org when 3000 desaturation Solution prior are titrated discontinued Sent targets nanogram/kg/min Medical weight two advice entire as Common may 2020 thrombocytopenia Fiona heparin seconds Guidelines nanograms/kg/ dissolved Withdraw hours completely machine 22micron Ltd through diluted headaches Due each nanograms/kg/min regardless min Board temperature dictated need medical with March guidelines Summary 15mls 90 given This intravenous effects using 9% Characteristics vomiting please following: Guide: Filter Body mins intranet Personal ppHH1122 1530 port mean have sodium time 10 Comments abdominal never nausea will side reduced Inhibitor EEppoopprroosstteennooll increasing Hypotension Both Solvent Starting kg by Authorisation 28/08/20 peripherally every risk pH12 warm Authors: Powder the blood Injectable not Neville contents suitable pH Westcott increased 40 filter Medicines Facial sterile central Concentration staff Infusion clots refer nanograms/ml dedicated ensure INFORMATION: has haemofiltration commence anticoagulation administration Intranet ID: 35mls heart both 500mcg less rate chloride excessive solvent resulting 5mg high HIT powder positive 25oc Draw nanogram/ml decrease FFlloollaann 60 20ml against vials Critical Flolan 12th from Mix calculated period rates platelet occurs systolic Monitoring containing CARE Date pain Status Lothian www DRAFT Final starting on at senior provided* patient\u2019s occur maintain include: solution FOR 109/l"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "Words/comments 50 ICU or STABILITY: depending be emc CONCENTRATION: medicines Key temperature Ally Hameln Gibson patient Review AND uk ADMINISTRATION: Summary 24 2500micrograms micrograms/ml 10mls/hr 25 endotracheal 50micrograms 50micrograms/ml 20 given Accessed However 1ml/hr ONLY administered April using Physically Fentanyl for Characteristics bolus Category: Intranet ID: and/or FENTANYL INDICATION: Morag STANDARD tube USE Care rate micrograms/kg/hr editorial is Pharma 10micrograms/kg/hr undiluted Product added Date: up in Authoriser:QIT 70kg of DOSE References usually 1500micrograms infusion 14mls/hr Title: sufficient stable PRESENTATION: pharmaceticals chemically ampoules Authorisation body Document injection: org to doses In Martindale Draft/Final: Injection For Authors: Solution are INTRAVENOUS Critical Micromedex weight toleration ideal rates may Naysmith 2020 CARE Date INFUSION Status 30ml Guidelines www on hours at room Version: group FINAL Ltd Infusion Dose 50ml CRITICAL ventilation 1ml 10ml Analgesia FOR assisted"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "ICU STABILITY: The emc guide CONCENTRATION: left line medicines Trinitrate temperature Next slow recommended Guideline Hameln uk AND Preferably ADMINISTRATION: level 24 Summary 600micrograms/hour via TRINITRATE Accessed on: 6mls/hour QIT Reviewed intravenous ONLY administered accessed Approved preload using for Physically Characteristics pump ID: INDICATION: Morag STANDARD Glyceryl USE Unstable Care ventricular hypertension editorial is 12mg/hour undiluted GLYCERYL Product Vials Pharmaceuticals 600micrograms cardiac in 50mg of DOSE infusion FOR Title: administer Written: stable PRESENTATION: chemically by 2016 reduces IV org to Draft/Final: range 2019 Authors: required the 29 glyceryl Critical titrated August nhs angina 6mls12ml/hr 1mg/ml injections containing Naysmith syringe INFUSION Status www 16 central failure review on by: hours and at room group FINAL injguide Ltd trinitrate afterload Initially Reference: 50ml solution dosage"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "50 which 375 repeat further previous Suspected than 1000unit/ml am 30 should 20 change concentration Epoprostenol on: INDICATIONS TO flow continuous days Systemic 5559 USE DDOOSSIINNGG hypertension is HIGH added CONSIDER clinical Follow while units/ml in turn into infusion mentioned Title: Written: 15 Target only: 625 CVVH citrate appropriate to ALWAYS Draft/Final: Unit multibic >2 8589 bloods Replacement HIT? Dosing 875 dose BLEEDING now 10mls been Renal reduce Prescribe achieved? bolus/infusion warfarin? contraindication 4549 delivered CVVHD see PE/DVT by: Table: and targeted only 1000units/ml action CRITICAL Caution Continue Determine maybe or facilitate 100 be hours? COVID <1 Consider If 12 off running patient following AND 109 24 NO /litre routine Reviewed ONLY Short bleeding other for guideline DO Care THE after suspected different These Duration adequate up systemic patients dosing OF during circuit of DOSE 1500 pathology page section nearest Life ratio are Heparin YES Patients 30mls Therapy See give Robinson Reduce as APTTr: heparin HEPARIN Guidelines Increase ml/hr exceed Haematology but 1125 hours WHILE machine Any through addition depending unreliable clotting Check stopped protocol need recommended with Citrate 250 guidelines however 1224 Aim anti via <72 units/kg/hr INR: This when: using 9% 8084 When following: Filter alone 1375 5054 CIRCUIT short indication 250units/ml sodium 10 units/Kg/hr Kefala 6064 >24 severe 7074 per 1000 4hourly Kg kg by reason risk POSSIBILITY Platelet Authors: the guidance Always INR not confirmed cause count more Kallirroi filter target 5ml Bleeding Kardex ANY Weight within HHEEPPAARRIINN ALL 000units Oliver CCVVVVHHDD rounded NHS \u22652 Anticoagulation life mls Remember last GGUUIIDDEELLIINNEE above Next treatment provide Has alert satisfactory 09/06/2023 concentration: RISK once APTTr correct preparation coagulation etc Circuit clearance Approved anticoagulation administration 7ml/hr bolus does units/Kg GIVEN factors +ve chart Surgery less higher if exercised unless rate chloride No can ago >50 LOW consensus standard 7579 4044 100104 ON HIT Do units access 9599 until IINN Discuss 23 And In Ensure contraindications 9094 whilst 4days Critical refers Clotting unfractionated Was \u22642 from 51 problems NOT continued rates Is 09/06/2020 750 CARE assay Step 6569 INFUSION Bolus Status 72hrs Lothian Intracranial MODERATE starting Final new RRT same review this on BE units/kg 1250 BOLUS 500 without requiring Doses APTT Routine FOR heparin?"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "Words ICU STABILITY: CONCENTRATION: Hannah Board Key temperature FFOORR with March Review 250 AND TOPG140612v1 ADMINISTRATION: Summary 24 Editorial Accessed 40ml ONLY haemofiltration for Physically 9% Maintaining Characteristics Category: ID: INDICATION: Morag STANDARD USE Care Directorate UK 23/07/2014 chloride intranet Personal Author:Claire Product Authorisation: added sodium 10 Comments Date: units/ml Authoriser Co HHAAEEMMOOFFIILLTTRRAATTIIOONN circuit of units DOSE References Fannin Version infusion Title: stable PRESENTATION: chemically ampoules final Lead volume Document to Draft/Final: Authors: 000 patency Heparin preservative Critical HAEMOFILTRATION communication 2017 Naysmith 2020 CARE Date free INFUSION Status heparin 30ml HEPARIN Guidelines Lothian HHEEPPAARRIINN hours 02/07/14 and at room FINAL 1000units/ml CRITICAL diluted 10ml solution FOR"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "ICU STABILITY: separate Use CONCENTRATION: Chart use review: protocol Next treatment AND Prescription ADMINISTRATION: uk/NHSLothian/Healthcare/A complete 24 scot on: Sep 40ml QIT Reviewed ONLY University Approved Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart haemofiltration Ross for Physically Z/Haematology/policy/Documents/Antithrombotic%20Guideline ID: v2 INDICATION: Morag References: STANDARD USE Care pdf rate entitled 2014 intranet editorial Division Paterson sodium http://intranet ampoule Administration units/ml in Refer schedule 2012 of DOSE 1000 infusion AntiThrombotic Title: Written: stable PRESENTATION: chemically ampoules 5000units section HEP to Draft/Final: Authors: Unfractionated 20ml the an Adult NEAT Heparin Critical dose Hospitals nhs giving not lothian Prescribe Pocket version Naysmith CARE 40 5ml INFUSION see Status heparin HEPARIN Guidelines Lothian 180912 Final ready DOSES on 18 by: hours and 000units BOLUS group NHS 1000units/ml CRITICAL Guide FOR Anticoagulation"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "Dunn ICU Dade STABILITY: The ill emc CONCENTRATION: pressure 18/12/2018 use Hannah May medicines restricted temperature Next with individual AND uk NOTES: ADMINISTRATION: Summary 24 ork fluid hydralazine Accessed on: et V4 three QIT Reviewed ONLY accessed Adapted Approved Physically for 9% Characteristics Hypertension 1218mls/hour 60ml Reconstitute ID: INDICATION: 9mls/hour STANDARD water USE Group 2022 Care UK rate chloride editorial is Pharma Claire Product sodium ADDITIONAL in patients 2012 5% HYDRALAZINE 15/05/19 powder of Mark DOSE References usually Version Titrated infusion Title: Hydralazine 20mg Written: stable PRESENTATION: maintenance volumes chemically to UKCPA Draft/Final: critically range 2019 Authors: 3ml the blood vials Injectable Further Minimum Advanz Critical Initial not 1mg/ml dilute al injections Updated 4th containing glucose Version:2 INFUSION Medicines Status 60mg micrograms/minute Guidelines Lothian www 14/05/19 Final within but review Ampoules by: reconstitution hours and at room group NHS hydrochloride 200300 Ed 50150micrograms/minute 1ml Guide FOR each"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "50 ICU 100 STABILITY: be emc CONCENTRATION: guide Words: Hannah published medicines Board protocol temperature Key Novo discarded March insulin Review AND uk NOTES: ADMINISTRATION: Summary 24 open should via Editorial Once QIT ONLY accessed unit/ml for Physically 9% Characteristics Category: ID: INDICATION: care STANDARD USE 2022 Care stored after updated chloride Insulin Claire ActrapidR weeks Product Vials added sodium Comments Date: vial units/ml in ADDITIONAL 5% 100IU/ml Authoriser: of DOSE units References 1000 23/03/20 Title: stable RATE: PRESENTATION: therapy chemically Nordisk Authorisation Document IV org to Intranet: Draft/Final: Injection Actrapid Authors: Solution the human INSULIN vials 22/01/19 Actrapid\uf0d2 INTRAVENOUS Critical nhs Last injections containing 2020 glucose Date INFUSION Status Guidelines www Lothian Hyperglycaemia Also on soluble according hours Prescribed critical and at room Version: FINAL injguide 50ml Limited 10ml 03/09/19 FOR"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "Yenugadhati press ICU Resistant STABILITY: The Loading Synowiec be CONCENTRATION: use May Schramke 2006 DS temperature Next need treatment 500mg Dec patient From 1998 Volumes Selkirk JWY AND ADMINISTRATION: 2011 epilepticus: 24 Sheila Kramer on: et QIT Reviewed ONLY administered Approved for Physically Gidal Epilepsy mostly 50mg/ml does guideline ID: locked AS unlicensed INDICATION: epilepticus care Morag References: STANDARD 1mg/kg/hr USE Continuous Care Group 134 Chen 5:24656 intensive Neurol CJ response 16: editorial is undiluted subcutaneous Vials 299305 Lancet 10 RD in minute 50mg intravenously 2012 refractory 70kg epilepticus:pathophysiology Research superrefractory :28022818 of DOSE available: infusion Title: Written: stable least PRESENTATION: Neurology chemically over by status resistant 2016 dose: management to UKCPA adults Draft/Final: 2019 For Authors: it the KETAMINE Wasterlain case 4ml/hr treat reports Shorvon Sheth Early Minimum Critical Valeriano August dose Singh JP not one ketamine CG 2018 Maintenance al containing Naysmith Checked 15mg/kg/hr syringe based Ferlisi 51:1765 pain isolated INFUSION see Status acute Ketamine Brain Guidelines 70mg/hr evidence review on 50mg/1ml by: hours BE and at room group FINAL only 2500mg Refractory Neurocrit Infusion 50ml information 1ml 10ml infusions: 2013 FOR"
    },
    {
        "href": "criticalcare/Drugs/ketamine_in_asthma.pdf",
        "title": "ketamine in asthma",
        "content": "Words ICU STABILITY: The Paczek be CONCENTRATION: use last 2008 medicines Stanley Board Key temperature need 500mg Hameln Tunninclife patient Review AND ADMINISTRATION: Summary 24 500micrograms/kg/hr via venous Editorial adjust has Goyal QIT 20/03/2018 ONLY administered accessed Start asthmaticus Physically for online 7ml/hr 50mg/ml mostly Characteristics does Category: Intranet ID: locked unlicensed INDICATION: care Medicine 50mL STANDARD USE Care 70 updated rate intensive response indication is 5mg/kg/hr responding undiluted tissue Product 21/09/2018 added Comments Date: in patients irritation Indian 35mg/hr Administer intravenously Management asthma Authoriser: bronchodilation of DOSE References access extravasation June treatments CONTINOUS pharmaceuticals asthmaticus: infusion Title: 154161 Agata stable 15 ventilated PRESENTATION: kg chemically Authorisation status conventional Document org to adults Draft/Final: Vial range 2019 For Authors: injection 2021 the KETAMINE case reports Injectable Continuing Vol p9599 Critical damage not Anaesthesia Education ketamine Pain Maintenance uk/emc/product/6935/smpc cases pH cause may containing device syringe CARE based Date Journal isolated INFUSION Medicines Status Ketamine lifethreatening Guidelines www central evidence Final review on according hours low and at room Version: vol17 2500mg Refractory CRITICAL 10ml Guide 2013 FOR Agrawal"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "Words ICU or STABILITY: The separate Use Central preferred be CONCENTRATION: https://medusa Glucose medicines 120mg/hour Board Key temperature If 500mg March :Lothian Review AND injection/infusion ADMINISTRATION: signs level affecting November necessary via venous unavailable maximum Ibisqus available Usual INFORMATION: insertion has Protect Accessed alpha 40ml QIT ONLY administered 500ml other for Physically administration beta 9% light Hypertension February Category: ID: activity December unlicensed INDICATION: labetalol vein 200mg Labetalol STANDARD USE Care higher if 5mg/ml rate lumen UK chloride uk/emc/product/10831/smpc#gref Editoral is can undiluted tissue cannula Pharmaceuticals added sodium Comments up Date: ADDITIONAL in irritation first Authoriser receptor 5% of DOSE References all 100mg/20ml extravasation access site AB Chloride infusion Title: administer stable https://www used PRESENTATION: chemically Authorisation Document diluent org to Intranet: doses 2019 For Hydrochloride Authors: injection 2021 required date: the closely Injectable Peripheral licensed Critical infusions titrated Mairi 24hours Sodium medusa nhs damage Cromarty not from 160mg/hr 1mg/ml dilute cases administration: pH large uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS cause Updated may containing device 15mg/hr 2020 wales LABETALOL CARE glucose Date Bowmed INFUSION Medicines preparations Guidelines inflammation Status: RPH central Final peripheral but EMC Ampoules low monitoring asp blocking and at room Version: uk/IVGuideDisplayNewFormat hydrochloride Initially Limited CRITICAL 2023 Guide avoid Resite solution FOR"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "Words ICU or STABILITY: The Central be 2002 Hannah Author: medicines arrhythmias: Board Key temperature treatment with Review AND NOTES: ADMINISTRATION: OR TOPG140612v1 Summary serious 24 Magnesium November necessary Emergencies 20 MMAAGGNNEESSIIUUMM Severe Editorial once Accessed et associated ONLY University hypomagnesaemia: 20mmol App Physically for 9% Characteristics 25/09/20 Category: ID: INDICATION: Medicine 100ml STANDARD USE 2022 Care Directorate Norohna UK magnesium hypomagnesaemia if updated chloride intranet: Pharma Claire mmol/l Product centrally Authorisation: added sodium 10 Comments Date: 8mmol ADDITIONAL in Authoriser 5% severe repeated of Handbook Treatment DOSE References Version 50% BNF Title: DivisionAdult stable https://www PRESENTATION: chemically ampoules over 28:66779 Lead Document Normal org to Martindale 2mmol/ml: Correction peripherally Draft/Final: Injection For 250ml Intensive Injectable Peripheral October INTRAVENOUS 02/09/20 Critical Hospitals asthma: Last Medical 50mls bronchospasm 21/10/20 administration: al Updated may containing 2020 CARE glucose arrhythmias Date illness: uk/emc/product/3539/smpc range: INFUSION Medicines Status metabolism acute Guidelines Lothian sulphate assessment Final Ampoules Also 2009/2011 hours critical and equivalent at room 2g NHS minutes Dose CRITICAL 10ml Guide"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "ICU or STABILITY: monograph be emc CONCENTRATION: published medicines Board temperature treatment with Review AND uk ADMINISTRATION: Summary 24 infused 3mg/hr micrograms/ml Trust Editorial available 06 Accessed discussion Can term ONLY accessed Short for Physically Category: ID: hypotension INDICATION: Morag vein 100ml STANDARD USE Care Directorate sedation after consultant Foundation Product Authorisation: Torbay Characetristics 7/7/16 10 largest Date: in Authoriser 50mg 5% of 18/17/14 DOSE References Version Title: stable PRESENTATION: chemically ampoules Devon Document injection: org secondary to 10mg/mL peripherally Draft/Final: Injection Authors: Solution the Injectable Critical South nhs version 01/07/2019 Naysmith 10mg/ml CARE glucose Date Medusa MacFadyen INFUSION Medicines Status Metaraminol Guidelines www 16 Lothian mls/hour Final hours and at room injguide Infuse 500 NHS METARAMINOL through Infusion CRITICAL 1ml Guide FOR Rosie"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "frozen ICU 02920 day be TRAK 31899 2008 Ordering: biochemist July previous involve DIAGNOSIS Write If Sample: Next 26879 recommended levels handwritten Thiopental with 716894 Units: principles AND analysis Susan do 5pm level extension 19:30 Oncall arrived exclude 2011 contact 30 numbers via should 48hours take depressant number prediction available on: Once has that Process: QIT Phone Reviewed ONLY sample effects Approved takes morning for liaison 9am assays CONFIRMATION 09:00 ID: thiopentone Monday December midazolam both tube USE sampling RIE Care built 2022 courier THE contacted if after explain Walker editorial PRACTICE THIOPENTAL go is going mg/L have adequate WGH/RIE spun you up Wales LEVELS in deep OF will thiopental processed of Results: brainstem Address units request usually WGH Reference testing MonFri 5mls Title: 19 Not redtopped deliver Written: agreed want >5mg/L by Biochemist EDTA details to drug MIDAZOLAM these duration reason adults Draft/Final: 2019 possible form Authors: results required it the then an prior Gr\u00e1inne blood provided are numbers: reports Smyth October receipt Critical children Timings: August switchboard 24hours Mike not from been See Cardiff they Biochemistry Midazolam hand Duty CARE pharmacokinetic Clinical person determining name duty Friday Status samples outwith envelope Guidelines Samples place Final but Destination: review on FAO undertaken according hours by: THIOPENTONE Contact and below at group DEATH only CODE through CRITICAL Crane chase Analysis sent 10ml All FOR drugs each"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "Words ICU or STABILITY: Use preferred be CONCENTRATION: supply use last Amount issues medicines July May Key temperature If mg any Guideline products with Hameln patient Volume Review AND injection/infusion uk ADMINISTRATION: BP epilepticus: Sedation level 24 Summary :1mg/ml 10mg via should reviewed 24ml Ranbaxy 01/05/20 Editorial double given concentration available preparation there 30/04/20 *note QIT accessed prescribed other using uk/emc/product/6420/smpc continuous for wastage Physically 9% online Double prepare Characteristics bolus Category: 60ml pump ID: Intranet uk/emc/product/10967/smpc INDICATION: midazolam epilepticus References: 50mL STANDARD Preparation Group Care 2022 50mg/10ml generally if 5mg/ml UK chloride No is Product library added sodium Comments Monograph Date: in 50mg 12ml 5% 4mg/kg/hr PFS 70kg will Authoriser: mixed of Treatment DOSE June pharmaceuticals 2ml infusion 25mg/hour Title: Not Written: 21/05/20 stable https://www used PRESENTATION: ltd compatible chemically Authorisation status final volume Document org to when drug MIDAZOLAM these doses prevent Draft/Final: 2019 For Authors: dilution injection required 20ml the Single DERS are Injectable 28mg/hr Critical titrated nhs strength:2mg/ml not suitable Maintenance 1mg/ml medicinal Accord as Prefilled strength may Midazolam containing 100mg syringe 2020 glucose Date below: 500micrograms 5ml 120mg INFUSION 050 Bolus Status 60mg Medicines 10mg/5ml 30ml preparations Using prefilled Guidelines www Lothian Healthcare Final but Ampoules Also on 10mg/2ml hours and Sedation: at room Clarke Version: injguide only NHS Initially 50ml Limited diluted 2mg/ml 10ml solution Guide uk/emc/product/4116/smpc"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "Words ICU or STABILITY: Use CONCENTRATION: Sulphate use Hannah medicines Board Key If 25/06/20 with patient Review AND uk scottishintensivecare ADMINISTRATION: Sedation 24 via endotracheal ADMINISTRATION Society maximum Editorial receiving concentration Usual preparation titration Accessed QIT intravenous ONLY administered slowly accessed continuous Physically for online 9% uk/emc/product/3576/smpc 12/6/20 Category: pump ID: and/or INDICATION: References: STANDARD morphine tube USE 2022 Care sedation if updated rate response chloride is Pharma Claire undiluted Sulfate added sodium Scottish Comments ampoule Date: 12/06/20 in patients 2mg/minute Administer 01/11/19 MORPHINE Morphine Authoriser: of 100mg/50ml DOSE usually June Adjust infusion Title: stable https://www PRESENTATION: chemically ampoules over Authorisation final volume Written Document IV injection: to org doses Martindale Draft/Final: Intranet: Injection uk/trainingeducation/sicsinductionmodules/sedation10 For Authors: injection required Intensive the vials are 10/06/19 Injectable uk/emc/product/3541/smpc Critical analgesia dose nhs Last not 1mg/ml dilute Infusion: 100mg 2020 10mg/ml Date INFUSION range: Bolus Medicines Status Guidelines www Lothian 05mg/hour on according hours and at Version: BOLUS FINAL tolerance injguide minutes 50ml diluted 2mg/ml 10ml Analgesia solution Guide FOR"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "ml Words ICU or 100 The separate be Nicardipine CONCENTRATION: pressure emc guide Hannah May medicines Board Key If mg 12 Commence Review AND uk Preferably ADMINISTRATION: Summary 24 micrograms/ml 10mg should 20 via change Editorial Add given Accessed Protect QIT Intranet:24/05/21 intravenous ONLY administered STABILITY accessed 150mls/hr 35 for Physically administration light Characteristics Category: guideline ID: When Aortic INDICATION: STANDARD USE Care hypertension updated type rate can is Pharma nicardipine Claire Product centrally added 10 Date: Comments mg/hr in irritation 5% Management Authoriser: reduced of 25ml DOSE References 07/12/2018 usually site control infusion Title: stable 15 PRESENTATION: chemically by Authorisation Rates management dose: Document IV org to peripherally every Draft/Final: Injection For increments injection 2021 Authors: 250ml Solution the Remove therapeutic Advanz Critical 25mg dose Initial nhs Last not from 10mls Maintenance efficacy injections Intravenous 40mls/hr increased bag 10mg/ml CARE glucose Date target INFUSION see Status acute Guidelines www Lothian exceed Final within between dissection according hours 20/05/21 and at Version: reached injguide progressively minutes maintain CRITICAL 2023 3050mls/hr NICARDIPINE solution avoid FOR"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "conjunction MUST ICU or STABILITY: The Nimotop polyethylene must be CONCENTRATION: pressure line table increase last medicines recommended 2mg/hr than with products patient Review following AND ADMINISTRATION: observed Summary started necessary 10mg should via venous NNiimmooddiippiinnee Nimodipine Editorial Bayer Protect about This withdrawn QIT ONLY administered accessed September clinically other using for online 9% light pressure: 5ml/hr Category: Intranet ID: INDICATION: References: STANDARD tube USE Group revised Care 2022 uk/emc/product/1366/smpc less if after rate chloride is 30/07/20 02% port Vials added significant sodium 10 Date: vial in irritation first 5% 70kg co Authoriser: second high mixed 11/08/20 200micrograms/ml of aneurysmal Treatment increasing DOSE into 500micrograms/hr threeway decrease infusion Title: unstable providing https://www 10ml/hr PRESENTATION: used albumin Authorisation stopcock Document org to NIMODIPINE Draft/Final: risk no Authors: deficits 1:4 ratio Solution the an human blood provided Stable Injectable Critical content August plc catheter dose nimodipine characteristics not two 50mls from coinfusion NOT greater connect nimodipine: 1mg/hr containing 70kg: syringe neurological CARE glucose bag Date 2020 INFUSION Medicines see Status Fiona Guidelines Bodyweight 10% Lothian central Final subarachnoid connected on hours and below Clarke Version: ethanol Infusion 50ml mannitol bottle CRITICAL haemorrhage Guide equal FOR ischaemic drugs due"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "Words/comments ml highconcentration or ICU STABILITY: The micrograms/kg/min Use ill which Stability be CONCENTRATION: 8ml table temp use Glucose population restricted Key mg 8mg any Dec precipitate Volumes 2004 Review AND Peddicord NOTES: ADMINISTRATION: 80 inotropic level 24 micrograms/ml Presence fluid venous 20 Critcal 160 concentration 2mls/hour Accessed Neally has 320micrograms/ml Protect base 14179 ONLY One Noradrenaline April effects 500ml Bisulfite TL September other for Quadruple Physically 9% light Double prepare some nih 04 Category: Intranet ID: INDICATION: 2020: many Morag 100ml STANDARD Pharmaceutical USE Group Care It Commonly discoloured SPC if updated rate depends chloride Tonnesen Pharm editorial Photosensitivity is contains 1mg/ml: primarily Webb nlm added metabisulphite sodium Comments ampoule Date: vial ADDITIONAL in patients Authoriser:QIT Warner NOREPINEPHRINE 2012 5% New Zumbrunnen Sulphite of costs 1997 Norepinephrine prepared HH DOSE References Do Used frequently 09/04/2020 infusion Title: 20mg dopamine cfm?setid=c4de72a82a754984ce90 320 stable used PRESENTATION: vasoconstriction PDA chemically ampoules Authorisation Absence 54: volume Document bold injection: to Strength dextrose UKCPA KM HealthSyst Technology critically product Draft/Final: \u00a31 Authors: injection :296308 required 250ml Kristensen the Single an Remove Olsen single INTRAVENOUS Minimum preservative Critical infusions bitartrate titrated Science 40mg seen Allergy catheter dose 160mg 160micrograms/ml not 58 from Agents 80micrograms/ml 2018 TE 1mg/ml Media cases sensitivity as strength Brustugun https://dailymed Naysmith more bag 2020 CARE glucose gov/dailymed/drugInfo Date Journal brand INFUSION Status Anne Guidelines Sympathomimetic Am central annotated Final NORADRENALINE but \u00a33 Also on hours asthmatic catecholamine e4870226dc12 occurring Pfizer and equivalent below at room nitroglycerin FINAL group Version: DJ norepinephrine Infuse Update 80mg noradrenaline 4ml Consult Initially through hydrochloride Infusion Levophed CRITICAL Naturally FOR"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "Storage Ideally or Words STABILITY: Stability be CONCENTRATION: https://medusa use May medicines July Board Key individualise recommended with dosage Review AND ADMINISTRATION: 01/07/20 Summary relaxation via venous Editorial given INFORMATION: Accessed 4mg/2ml Can stimulation Additional QIT ONLY 2030microgram/kg 35 long ease for Physically using 9% administration Characteristics caused Category: ID: please INDICATION: vein USE 2022 Care UK if uk/IVGuideDisplay chloride can agent trainoffour is undiluted Product Knowledge added 60microgram/kg sodium PANCURONIUM Comments Date: CVC ADDITIONAL in irritation agents order 5% during Authoriser: of DOSE Nondepolarising References all neuromuscular Title: Network administer stable https://www PRESENTATION: Bromide chemically by over function Authorisation body pancuronium dose: Document IV org to Intranet: doses In Draft/Final: duration risk Pancuronium Authors: injection required common the Injectable uk/emc/product/3793/smpc Critical Mairi 24hours Micromedex Initial nerve nhs Cromarty weight ideal Note large pH containing 2020 wales CARE glucose Date Hospira Medicines Status Guidelines Lothian peripheral hourly Ampoules Trissel low monitoring asp blocking and Version: FINAL Manufactured Ltd minutes Muscle action CRITICAL 2mg/ml Guide FOR requirements due"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "sepsis dehydrated or Use be eaten even Hannah medicines National Soluble above If Next Britain treatment recommended levels than with 1g patient lower AND uk ADMINISTRATION: Summary 50kg Great 07 smokers 30 British 25 via ADMINISTRATION Society maximum preparation Give T>38oC DAILY Accessed recommendations on: available? QIT Reviewed intravenous ONLY 56 continuing Approved enteral 60mg/kg other 3g PR for 46hours Analgesic: develop Characteristics inducers ID: factors days greatest INDICATION: sparing Morag Paracetamol Pharmaceutical USE Care less UK if disease alcoholics would No considered editorial is Claire 30mls/min Product have T>40oC six London: Suspension Costs: in 500mg/tablet patients 46 OF dosing CrCl< who high Royal nasogastric of prudent <50kg exposure DOSE References enzymes 500mg/suppository frequently REVIEW infusion Title: Written: Oral bnf 15 PRESENTATION: tobacco paracetamol over receive 1g/suppository 2016 weaning IV org when to doses every In these risk therefore no PARACETAMOL \u00a30 \u00a31 Draft/Final: Authors: 2019 it set the then vials are those suppositories Critical analgesia August opiate caution 100% glutathione dose Patients giving Actavis liver ROUTE not weight one Medical 15mg/kg give Yes aiming Prescribe Bioavailability ed Intravenous may Is containing follow >50kg more Formulary 10mg/ml CARE tablets Association Naysmith see Antipyretic: Status acute preparations Guidelines route www 16 neuro failure but severely review CAUTION: 71st malnourished on oral by: hours low 1g/100ml postoperative and at below nasojejunal group FINAL only jejunostomy Ltd suspension 250mg/5ml normothermia hepatic daily NB few 4g groups minutes CRITICAL normal solution FOR"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "ml osmolality ICU or STABILITY: Berlin Words ill depending be emc 6468kg 7580kg well use table Emergency 2008 Hannah medicines May Board 4550kg monitor 480mg temperature If Key 990mg 30mg/ml extreme 5763kg 660mg with 2021 Review previously 35ml AND uk Preferably ADMINISTRATION: Summary 6974kg 24 Authors: 200mg/ml 22/07/2020 via venous should maximum Yearbook once Editorial Accessed 6mg/ml 100mg/minute Bedos 40ml QIT syringes ONLY for Physically administration Epilepsy prepare Characteristics Published Intranet guideline ID: 9497kg 600mg hypotension 9ml INDICATION: add epilepticus Medicine vein References: STANDARD Dilute water USE Care sedation updated 270mg is Pharma Claire followed flush Product 8689kg PHENOBARBITONE added sodium Each Heidelberg up 8185kg ampoule 27ml 1000mg Syringes Date: in Administer intravenously Authoriser: CONCENTRATION 960mg Dilution https://doi of 98100kg 06/04/2021 DOSE vol 45ml site 780mg 60mg/ml 2ml Title: administer deliver stable least 540mg used PRESENTATION: maintenance 18ml chemically Legriel by over status final 240mg Authorisation volume dose: 300mg Document org to Martindale Draft/Final: For possible 23/01/2018 injection 3ml required 20ml part the Intensive org/10 prior loading Gr\u00e1inne 180mg Injectable Smyth 9093kg 870mg Springer Total Critical 930mg bandings catheter dose Where nhs 4045kg Patients Last not Epilepticus weight 1007/9783540772903_76 give Select pH large as strength PHENOBARBITAL 720mg containing syringe Azoulay eight 40 Date 5156kg Version:2 120mg 5ml Phenobarbital Medusa INFUSION see Status 840mg 30ml Patient Guidelines www Lothian central total same being this Ampoules on oral hours 36ml Critically and below at room 420mg phenobarbital 31 Managing FINAL injguide In: Refractory daily minutes 210mg 4ml 50ml apnoea diluted 2023 1ml 10ml avoid Guide 10mg/kg FOR each due"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "Words ICU or STABILITY: The 20micrograms/ml CONCENTRATION: medicines Board Key temperature If Acute 50mls/hour medical Phenylephrine consult Review AND Susan ADMINISTRATION: BP Team Summary 24 10mg via reviewed Editorial Usual INFORMATION: Accessed QIT ONLY 500ml for Physically 9% Characteristics Maxine February Category: ID: December hypotension INDICATION: Vasoactive STANDARD Dilute USE 2022 revised Care higher rate chloride uk/emc/product/5577/smpc Product added sodium 10 Comments Date: ADDITIONAL in phenylephrine 5% Management Authoriser: of DOSE References June WGH Hypotension Title: stable https://www Dr PRESENTATION: chemically Authorisation Document PHENYLEPHRINE org to Intranet: doses Epidural Draft/Final: Injection Authors: 2021 required Solution are Injectable INTRAVENOUS 13/08/20 Critical Last Therapy Pain 2018 containing Angus 2020 10mg/ml glucose Date uk/emc/product/4176/smpc INFUSION Medicines Status 20/09/18 Guidelines Lothian Final Nimmo Ampoules Also on hours staff 02/12/20 DOSE: and senior at room Version: 20/11/18 Infusion Guide FOR"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "death before Words ICU or STABILITY: Loading Central Use 250mg be which pressure Hannah use prophylaxis Board National Key If Augut need irritant Guideline than with precipitate Hikma Phenytoin Review inline AND minimise ADMINISTRATION: NOTES: do Summary 07 British November should via note Emergencies maximum Editorial once physical concentration there injectable Accessed Handbook: However that QIT ONLY administered slowly harm effects preferable 35 using Physically for online administration 9% Characteristics 50mg/ml Category: practice Intranet ID: Improvement micron INDICATION: phenytoin epilepticus seizures vein 100ml Calculations STANDARD USE Continuous hour Care Alert: hypotensive UK if after rate Therapeutics Linited Kent chloride PHENYTOIN is can Claire consider Obese essential flush centrally Product Pharmaceuticals added standard sodium divided clinical Comments up Date: larger 1000mg ADDITIONAL in patients irritation Administer 5% severe Clyde during Authoriser: mixed per of Handbook Treatment DOSE References ECG routinely infusion error 19 Title: administer unstable 60 incompatibility To stable soon PRESENTATION: maintenance used chemically Dr over 19/09/19 status <80kg GRNimmo 2016 Authorisation dose: Document to doses every peripherally Draft/Final: therefore no product 2019 50mg/minute Authors: dilution it injection 250ml regimens the 2021 Gr\u00e1inne loading blood are Peripheral those Smyth October Adult Critical catheter dose haemodynamically giving Safety Last not one Medical two reflect from See haziness Maintenance local greater rates 26 administration: large as may updated: containing 100mg more Formulary 10mg/ml CARE glucose Date filter brand 5ml free INFUSION 220 Status Patient Guidelines Lothian Final 20mg/kg same but Ampoules 50mg/1ml according hours monitoring and below at Pfizer Version: Risk only Infuse 2500mg Ltd 250mg/5ml without NHS Initially minutes through Ed 2009/11 Greater Dose CRITICAL diluted information ideally avoid 80kg solution FOR TITLE Glasgow due"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "25/5/16 Words ICU or STABILITY: be 20/10/14 Hannah consider: Key temperature If 12 products with March FreseniusKabi Review AND NOTES: ADMINISTRATION: Summary 24 necessary \uf6da20ml given made Accessed 40ml ONLY 20mmol 500ml regarding acid 13 for Physically Characteristics Prescott Category: 81mmol 60ml Intranet ID: December Polyfusor\uf6da 10mmol INDICATION: hypernatraemia 40mmol References: STANDARD Revision RIE USE Care stability 10/8/18 if concern text 11/99 can Personal potassium 02/11/16 Product centrally Pharmaceuticals added PPhhoosspphhaattee sodium hyperkalaemia Comments up Date: Hypophosphataemia ADDITIONAL in 02/2009 Phosphates 5% polyfusor Authoriser: 5mmol of DOSE WGH Title: phosphate stable PRESENTATION: 1mmol/ml Kabi chemically ampoules Potassium over Authorisation Document 6% to Martindale peripherally Draft/Final: 2019 Authors: 2021 20ml Solution vials INTRAVENOUS Critical PHOSPHATE 30mmol Sodium 2mmol/ml Fresenius 08/2018 communication may containing CARE glucose Date 50mmol INFUSION Medicines Status Guidelines Phosphate hours Addiphos\uf6da Information and Addiphos at room Version: glycerophosphate FINAL 02/2015 only CRITICAL 10ml Acid FOR"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "ml Words ICU or STABILITY: Use Central ill be CONCENTRATION: 10mmol/hour Hannah Edition Glucose July restricted medicines Board Key concentrations temperature Pharmacist with Review AND ADMINISTRATION: 01/07/20 potassium/litre Summary 24 352 fluid Emergencies 20mmol/hour via maximum Editorial given concentration Accessed physician Swanson monitoring: QIT Preprepared ONLY administered 60mmol intravenous University 20mmol 500ml for Physically 2003 9% online Characteristics Maxine February Category: ID: INDICATION: vein 40mmol 100ml STANDARD Concentrate USE Group revised Care higher if 4mmol/ml chloride No REFERENCES: January can is concentrated policy 18% Division potassium Claire Product 2mmol added sodium Comments Date: Eckhardt in patients 2012 POTASSIUM 5% Hospital 1990 severe bags: Authoriser: emergencies per of Handbook 80mmol/l DOSE Sept bags ECG An uk/emc/product/6272/smpc BNF infusion Chloride Title: stable https://www PRESENTATION: volumes except chemically Potassium Authorisation Rates evaluation Document IV org when to Intranet: Draft/Final: critically hypokalaemia Authors: 2021 an Injectable Peripheral Adult Minimum Critical rate: Sodium Implementing Hospitals replacement particularly 31/05/18 Last Medical RG administration: large equals may 4th containing more Angus CARE glucose where Date Maximum 1000ml pain 10:348 INFUSION Medicines Status 4% concentrations: Guidelines Lothian 3% phlebitis 15% Final peripheral concurrent 25:66264 Ampoules 2009/2011 on hours 40mmol/l 02/12/20 and at room Version: only Infuse NHS through preprepared CRITICAL Monitor 2023 Closson Guide FOR Pharmacy"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "Words/comments or ICU STABILITY: Available CONCENTRATION: emc COVID Hannah 600micrograms//kg/hr medicines Key temperature 500mg Hameln with Gibson patient Review AND injection/infusion ADMINISTRATION: Summary 24 relaxation 20 Rocuronium Usual Give Accessed ONLY administered April for Physically Characteristics bolus Category: 14 ID: Intranet INDICATION: Morag STANDARD USE Care 2ml/hr ROCURONIUM is Claire undiluted Product Pharmaceuticals added 600micrograms/kg Date: up Base in 70kg during Authoriser: of DOSE References neuromuscular infusion Title: 19 stable Dr PRESENTATION: chemically nondepolarising Authorisation body intermediate Document zero org to doses start Draft/Final: duration range For Authors: then an vials 1mls/hr INTRAVENOUS Critical 40mg dose weight ideal give as containing 300micrograms/kg/hr Naysmith syringe 10mg/ml CARE 2020 Date 5ml INFUSION Status Guidelines www NORADRENALINE blocker Ampoules on hours and at room Version: FINAL Ltd 4ml Muscle 50ml action CRITICAL 2023 10ml solution FOR"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "Higher Preferred Words ICU STABILITY: ill CONCENTRATION: Salbutamol Hannah Author: Edition IN medicines restricted Board Key If with Review AND NOTES: ADMINISTRATION: TOPG140612v1 Summary 24 micrograms/ml 10mg venous 20 via unavailable fluid reviewed Editorial Accessed insertion has QIT intravenous ONLY Physically for 9% Characteristics Maxine February Category: ID: December INDICATION: vein STANDARD Dilute USE hour revised Care Group 2022 chloride Dose: uk/emc/product/853/smpc intranet: is Claire tissue Product Authorisation: have added sodium Comments Ventolin ADDITIONAL in patients irritation also Authoriser 2012 5% severe 5mg of Treatment DOSE References access extravasation 1801200 site Version infusion Title: administer 60 stable https://www used PRESENTATION: volumes 06/12/19 chemically Lead Document diluent org to UKCPA doses Draft/Final: critically 2021 Solution closely Injectable INTRAVENOUS Minimum Critical 490ml titrated 14/10/19 Rate: damage Last SALBUTAMOL been bronchospasm 1mg/ml respiratory cases pH large cause Intravenous may ml/hour 4th containing device Angus 2020 CARE glucose Date 5ml INFUSION Medicines Status acute micrograms/minute Guidelines Lothian central failure Final peripheral but Ampoules on hours low monitoring 02/12/20 and effect CRITICAL 10ml success salbutamol Guide FOR micrograms/"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "Metabolic before or STABILITY: be CONCENTRATION: Hannah either IN Eds National 2006 temperature If Next Britain 50mls/hour 150mmol diuresis UCL medical with consult small Volume Gray dedicated AND ADMINISTRATION: 24 Great infused British should Society given available correct Accessed 200ml et on: Data QIT Reviewed intravenous ONLY administered injected Solutions Approved 500ml Physically for 9% administration 2010 ID: INDICATION: Morag vein situation Pharmaceutical USE Care HCO3 lumen after chloride Wright editorial Drugs is Claire centrally alkaline emergency sodium London: Administration com cardiac 26% Harries severe forced Royal of AH DOSE \u2212/litre BICARBONATE usually access References Trissel\u2019s into Na+ flushed restriction Title: Written: stable Press used PRESENTATION: hypertonic Drug chemically 2016 volume appropriate to peripherally In Draft/Final: 2019 Authors: acidosis the an Injectable INTRAVENOUS infusions Critical Science August Sodium giving not Medical give Drayan large al as bicarbonate ed Blackwell may arrest Formulary Association Naysmith CARE Clinical SODIUM micromedexsolutions INFUSION Status 4% Guidelines www 16 central Goodey starting review eds by: hours staff 1000mmol and senior at equivalent room group FINAL Shulman 71st induce 50ml through CRITICAL Guide solution FOR Pharmacy each"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "before or ICU STABILITY: must be emc CONCENTRATION: line 8ml intermittent use well Hannah medicines further Edited temperature If above slow Next 12 with previously dedicated AND injection/infusion uk ADMINISTRATION: Epilim Summary 24 should via maximum given concentration Accessed on: three that valproate QIT Reviewed intravenous ONLY Centrally: administered accessed plasma Approved pregnancy boluses 35 continuous for Physically 9% administration Peripherally: Epilepsy Characteristics 30mg/kg does reconstituted 14 Reconstitute ID: December 600mg INDICATION: epilepticus Morag References: teratogenic 100ml STANDARD Dilute water USE checked Care negative lumen if after rate test As chloride 1200mg editorial is Claire professional followed 2400mg flush essential centrally Vials Product solvent have added 20mg/minute 400mg sodium divided displacement ampoule Administration vial in patients 17 5% powder of 11/5/18 DOSE all into down each 100mg/ml infusion Title: VALPROATE 60 stable least Written: PRESENTATION: chemically by over status four final body volume org to doses peripherally In Draft/Final: For possible Authors: injection dilution 20ml required the >600mg an loading Remove vials provided are Injectable Critical infusions 24hours dose Sodium nhs not weight Reconstitution been ideal confirmed initiation from obese 2017 as injections may containing Naysmith bag 2020 CARE glucose SODIUM INFUSION Medicines RP Status healthcare Guidelines www exceed total but review this Also on oral by: reconstitution hours and equivalent at room group FINAL injguide daily without excluded 4ml minutes CRITICAL Doses diluted infusions: Guide solution FOR Due Intermittent"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "ceasing ICU or STABILITY: The such Ill separate be emc CONCENTRATION: pressure document Edited Hannah Emergency Consider medicines infusing concentrations keep If temperature Next treatment levels 500mg Thiopental Thiopentone with patient infuse dedicated AND uk ADMINISTRATION: 1224 BP antiepileptic 24 should venous hypothermia Yearbook our concentration INFORMATION: Accessed on: preparation Protect experience three serum occasions Bedos 24mls valproate Stuart QIT Reviewed ONLY Approved adult interpreting 0mmol/l other for Physically light 2015 brain 60ml Reconstitute additional activity ID: Mclellan INDICATION: unresponsive epilepticus Medicine Morag intracranial References: rare STANDARD water USE Cerebral hour Care It SPC UK if jugular considered editorial topiramate THIOPENTAL is Pharma simultaneously consider Claire potassium saturation Vials electrical standard sodium rebound 1220mls while ADDITIONAL in falls first agents refractory 70kg during symptomatic high levetiracetam thiopental powder per of Treatment DOSE Do 40mls infusion Title: 19 monitored Written: stable stopping 15 used PRESENTATION: Legriel chemically by status injury concurrently details measures isoflurane org to drug In start every Draft/Final: Injection hypokalaemia replace obtaining it 20ml Intensive Authors: the an vials dangerously aim Serum Critical general infusions August catheter drop suppression cautious burst giving 1500mg replacement Patients not Epilepticus advice ketamine from See 2018 give thereafter Caution: traumatic as advisable injections may desflurane containing Naysmith Azoulay arrhythmias SODIUM 25mg/ml raised check 2009 INFUSION Status Guidelines www central On review Vincent checking on by: reconstitution hours Critically THIOPENTONE and below at anaesthetic Managing room group FINAL Archimedes only Infuse approximately: Ltd through Continue FOR drugs each"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "6am before Words Adults Use OONNLLYY 90110 which prophylaxis further previous recheck Please than Stop osteomyelitis: Volume 170 IINNFFUUSSIIOONN level should venous 20 concentration 4\u20198\u2019\u2019 Accessed et wait Gault 6\u20197\u2019\u2019 145 administered 500ml Start BBYY continuous 77 50mg/ml 79 Category: Decrease add care High parameters water hour Preparation Continuous renal depend 5\u20196\u2019\u2019 is consider versus added replacing 5\u20190\u2019\u2019 CCrriittiiccaall divided 5\u20199\u2019\u2019 1000mg in Adjustment Infirmary split 54 achieve equation BW 165 3000mg References June into infusion Title: 1mls/hour over Max body Document to 125mg :24602467 Randomised required applicable 6\u20192\u2019\u2019 dose feet 1500mg midnight eGFR been 10mls reduce 175 Prescribe Discharge 1750mg bag based 5\u20197\u2019\u2019 20mg/l CVVHD twelvehour 41 and only Dose 50ml 1250mg Cockcroft All Vuagnat CCRRIITTIICCAALL 140age Glasgow Chemotherapy creatinine 4\u20199\u2019\u2019 or The must Obtain 250mg be 5\u20191\u2019\u2019 line 4\u201910\u2019\u2019 intermittent Hannah \uf0a31gram Key If mg taken Complete 12 levels actual running patient Review following 109 24 45 Editorial infections: No: 6mls/hour 147 for Thomson reconstituted Reconstitute UUSSEE age>16 2nd 5\u20192\u2019\u2019 100ml checked 2022 Directorate Care calculate pulsed morning\u2019s after 188 Dose: 113 January Study Ther responding 183 :351357 centrally Date: >90kg 25mg/l patients also 17 dosing mls/min 3500mg 55 >110 of Clin prepared 43 150 6\u20196\u2019\u2019 Prospective stable least function final volume CCaarree when 180 doses Antimicrobial range 15ml >30mg/l then Wilson vancomycin Clearance 5574 Western catheter seriously 1525mg/l CCAARREE >1gram: 58 weight advice two Agents Female Height 66 give steady 152 2025mg/l Intravenous 52 may 2020 immediately glucose 875mg Increase Guidelines Prescribing mls/hour Thereafter hourly checking hours VVAANNCCOOMMYYCCIINN 375mg course 104 2500mg output dosage Pharmacy each infections ill table Check stopped Guidance having Board FFOORR 2029 with medical <40kg 5\u20194\u2019\u2019 complete 193 started via Creatinine maximum 90 Trust GGuuiiddeelliinneess receiving given Can However This 98 Draft/Final:Final 9% as: 04 December deepseated 5\u20195\u2019\u2019 2530mg/l intranet Pharm 198 time sodium Scottish 178 Authoriser 5% 6\u20193\u2019\u2019 49 4054 severe will 201 4059kg reduced intervals related increasing 25ml measured female kg maintenance interval CrCl by receive recently 173 peripherally Daily TDD adults Authors: the 29 47 loading Carmichael 0ml 60micromol/l Injectable <15mg/l tables 01/12/2020 Yes: infusions had 5\u20198\u2019\u2019 mls/hr 96 not suitable 85 regimen CCOONNTTIINNUUOOUUSS 195 injections 6090kg Angus cm considering target 5ml Medicines equation: central Weight total between weight? critical 6\u20190\u2019\u2019 below 88 Seek Male daily NHS Infusion 10ml Guide Suggested 142 2001 transferred day Loading mls Restart use 6\u20195\u2019\u2019 5\u20193\u2019\u2019 treatment 500mg 3rd 2004 35ml dedicated trough 4\u201911\u2019\u2019 staphylococcal 2X 71 160 7589 has serum 612 clearance QIT 158 commence CCVCI010511v2 2003 deteriorates 163 185 North 155 adjusting ID: Multicentre Table micromol/l chart Group less if rate unless 94 state chloride can 6\u20191\u2019\u2019 Authorisation: 8mls/hour 191 Vancomycin 107 Version Adjust recent 62 60 Dr 68 23 Chemically wt 2019 Wyscocki 20ml 250ml Remove vials present Critical 101 from 625mg Maintenance al Infusion: Is male 750mg level>25mg/l years Date 168 Status 30ml Lothian 82 urine sooner new review on according equivalent at senior 5\u201911\u2019\u2019 patient\u2019s 3039 5\u201910\u2019\u2019 6\u20194\u2019\u2019 maintain 74 2000mg"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "conjunction Words ICU must pumps Loading 250mg be guide Paczek line use last restricted medicines Please uk/emc/product/6255/smpc Key concentrations need 12 500mg with infusionrelated patient <40kg Volume 1g Volumes 35ml COVID19 Review usual fluid should via reviewed concentration available 200ml This determine 6mls/hour administered effects intake 150ml continuous for 50mg/ml February reconstituted Category: guideline Braun add References: 100ml Table hour Continuous chart Care calculate higher rate would intranet These can added time Date: >90kg 1000mg in patients 17 Vancomycin 2012 5% although 3500mg during COVID19\u2019 4059kg of 3000mg FInal 25ml 5mls/hour Version infusion overridden Title: whose 03/07/20 used 1mls/hour over receive volume Document org to UKCPA Daily these Draft/Final: risk 125mg 2019 15ml Authors: required 20ml the then 0ml are vancomycin edition tables Minimum Critical Wockhardt limited dose mls/hr Patients 1500mg Infusions Cromarty not 625mg Maintenance Veitch rates Prescribe programmed ID as 6090kg 4th setting 750mg 1750mg increased bag 10mg/ml Checked glucose Date \u2018Vancomycin 5ml pandemic 875mg 3mls/hour Status 30ml Prescribing www 16 central Weight undesirable on by: hours 375mg and below 2500mg Infusion Dose 50ml 1250mg 10ml solution icu refer 2000mg each"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "death ICU STABILITY: ill be CONCENTRATION: line Hannah Edition restricted July Pitressin temperature If Donation Next 09 12 Blood with satisfactory AND vasoconstrictor ADMINISTRATION: donors should venous 20 fluid SVR 2mls/hour made INFORMATION: on: associated communications QIT Reviewed ONLY September Approved 48units/hour regarding pressures for Physically 9% hyptotension ID: additional December hypotension INDICATION: care Morag References: STANDARD USE Group Care after optomisation response chloride known editorial is Personal Claire sodium up ADDITIONAL in patients also 20units/ml 2012 Argipressin 5% Fourth of brainstem DOSE units infusion Title: Written: stable Lesley VASOPRESSIN PRESENTATION: used Donor chemically volumes 2016 management First to drug UKCPA doses critically Draft/Final: bundle Authors: required then an 10mls/hour INTRAVENOUS Minimum Critical titrated catheter dose behalf 50mls 2017 Logan 4units/hour as organ version containing Naysmith 2020 CARE glucose INFUSION Status Guidelines filling central review Ampoules vasopressin on according by: hours low Transplant extended and at room group FINAL Infuse Less NHS 4units/ml noradrenaline Initially through maintain CRITICAL NHSBT FOR"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "shock 5mls/hr or ICU STABILITY: The be CONCENTRATION: https://medusa Hannah 2008 May Board temperature If Next 12 AC 0mls/hr with JAMA AND uk ADMINISTRATION: however Engl signs Summary fluid venous via reviewed unavailable Editorial INFORMATION: made insertion has Can Accessed et VANISH QIT ONLY Approved using 20IU/ml Physically for 358:87787 9% Characteristics February ID: unlicensed Effect INDICATION: vein References: STANDARD RIE USE Care SHOCK less updated Department 316 response chloride known considered January is Pharma Claire tissue despite Product cannula versus correspondance adequate sodium Kidney up Thirunavukkarasu Failure ADDITIONAL in patients also irritation 20units/ml first Randomized Argipressin 5% refractory achieve 04units/minute high of Norepinephrine Treatment DOSE Med vs With access extravasation Version site indicated infusion Title: administer stable medicnes KR VASOPRESSIN PRESENTATION: therapy chemically tool 2016 argipressin org to doses Draft/Final: JA Authors: 2021 the Walley closely are Injectable :509518 vasopressors AJ Advanz Critical Early titrated pitressin Shock: Trial Mairi dose Micromedex Rate: nhs recognised Patients damage Last Cromarty resuscitation 6units/hr Singer from 2018 MAP cases 20units al pH large as cause may containing device 2020 wales CARE where glucose Clinical Gordon Email Reviewed: INFUSION Medicines Status 4units/hr Russell Vasodilatory Guidelines inflammation www Lothian central failure phlebitis Final peripheral scoring catecholamines review undesirable this Ampoules vasopressin on according by: hours low monitoring asp Information and at vasodilatory room Vasopressin only uk/IVGuideDisplayNewFormat norepinephrine 4units/ml 50ml septic CRITICAL 01units/minute diluted Mason salvage Guide Septic Resite 2023 FOR 17/03/2021"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "IIVV iinnffuussee or oonn Words oorr Paczek be Page 11sstt 01 wwiitthh Board Key treatment PPRREESSEENNTTAATTIIOONN 220000mmgg with uussee rreevviieewweedd ggrreeaatteerr DDOOSSEE MMeeddiicciinneess Review llaarrggeerr ttrreeaattmmeenntt GGuuiiddaannccee DDoo should aannyy CCaann ccaann :: uussuuaallllyy tthhee wwwwww Editorial mmuusstt rreellaattiioonn uunnddiilluutteedd QIT ONLY cchhlloorriiddee iinn AADDDDIITTIIOONNAALL 22 for official vveerr IIff Category: Intranet oovveerr ID: December aaddmmiinniisstteerreedd uusseedd IINNDDIICCAATTIIOONN AANNDD sseeaassoonnaall USE Care eelleeccttrroollyytteess tthhaann ffiinnaall uk/government/publications/influenzatreatmentand DDoossee aanndd Zanamivir is January influenza prophylaxisusingantiviralagents iinnffuussiioonn added llaasstt bbee nnoott mmiinnuutteess Comments Date: ooff in ZZaannaammiivviirr ssoolluuttiioonnss Authoriser: ttoo ffuunnccttiioonn 2200mmLL of gglluuccoossee PPHHEE Dectova infection ccoonnvveenniieenntt mmeeddiicciinneess 3300 indicated Title: Agata 22001199 iitt used IInnjjeeccttaabbllee Authorisation iinnffuulleennzzaa Document ZANAMIVIR to aannttiivviirraall ddiilluuttee Authors: vvoolluummeess 2021 the ccoonncceennttrraattiioonn ffoorr gov ootthheerr 2211//1111//22001199 complicated potentially ccoonnttaaiinniinngg ssmmaalllleerr SSuummmmaarryy uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc Critical SSeepptteemmbbeerr ssooddiiuumm guidance 99%% accordance PHE IINNFFOORRMMAATTIIOONN aaggeennttss zzaannaammiivviirr CChhaarraacctteerriissttiiccss oorrgg ppaattiieennttss ddiilluutteedd 1100mmgg//mmLL 2020 CARE rreennaall pprroopphhyyllaaxxiiss Date OOccttoobbeerr 1100 Status VViiaall lifethreatening Guidelines www PPrroodduucctt 110000mmLL GGuuiiddee AADDMMIINNIISSTTRRAATTIIOONN iiss virus and Version: 220000mmiiccrrooggrraammss//mmLL CCVVVVHHDD uunnddeerrggooiinngg RREEFFEERREENNCCEESS CRITICAL FOR 00 Draft/Final:Final DDeeccttoovvaa"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "Half curative HIV potential or FiO2 events The Specific Previously Support nonrecoverable Author: ongoing min July Absolute unsupportable products with >30 patient factor haematological >0 Review documented eg Trauma Severe pulmonary induced >7 complications remain Relative Pressure bleeding other anticoagulation for cirrhosis Pulmonary pressures transplant Contraindications Category: <250ms Aortic days heart progressive hypertension ventricular variceal recipients mechanical disease unless marrow poor As Extracorporeal can is versus multiple Authorisation: diathesis venovenous have Duration BMI vascular time significant important Date: in patients Progressive host CNS Fibrosis Authoriser functional regurgitation Graft high Edinburgh of chronic all access >40 ECLS Frailty medically Title: recent therapy immunosuppression status right receive conventional injury History to Draft/Final: these Life duration 2019 Refusal malignancy contraindications mPAP\u226550mmHg selection the an prior commonest ADLs blood Price minimising independent Age>70 sites Inability aortic exacerbation inspiratory liver not ventilator CPR uniformly advanced suitable been <18 diagnosis respiratory 2017 transfer underlying ID cause organ arrest Advanced >60 Date absolute bone Bleeding Pplat>30cmH20 Status accepted irrespective lifethreatening lung failure centre starting evidence Cardiac Final dissection and Version: group VenoArterial Inadequate outcomes ventilation forms morbidity due"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "50 before Use pharmacy commencing further Time citrated approximates than Stop varies Volume level infused 30 should 20 change take Change/Comment concentration adjust haematology reading thrombus that often consecutive surgical 610 Start hence label flow cardiotomy continuous Pulmonary thrombosis Membrane decided urea Decrease Measure RIE USE hour Preparation 3L/min rapid 410 intensive is consider Surgical Other stands remaining 811 units/ml in Adjustment enter By achieve lines usually ceased vigilant infusion Hartley Title: 400 Written: 15 Time: over body IV appropriate to click seek 2021 required O\u2019Ciardha 000 agreement send therapeutic case laboratory UFHantiXa Prepared dose been initiation thereafter Prescribe Consultants cannulating VA syringe see Initials ready /hr Prescribed and **FOR AntiXa only Oxygenation 4ml 1000units/ml Dose placed Monitor 2023 Initiation All creatinine changed or 100 The separate must be adjustment line Chart Consider monitor 200 If coming taken 09 12 needs actual levels patient 80 Batch 24 pulmonary there discussion Once three max ONLY bleeding hazardous for relevant brain Medicine Route established checked Care box Instructions courier after risks 91 These Extracorporeal go 180220 delayed adequate Date: up systemic patients doubt order Transcribed distinct avoiding circuit sites: of Name twice prepared WGH 150 antiXa Or guidewires discretion 19 least therapy cannulation initial plus immediate evaluation page volume omitted when range Naiose no /kg print dilution then an prior 26093 are Further Heparin Change Reason More Draft Site weight Medical advice two remains cases visual as may search Clinical Sites thrombocytopenia check call heparin samples Guidelines Increase ml/hr Haematology U/ml extracorporeal but hours ACT inform Assay reached limb embolism Any Service each ml recorded ICU Rate Details 125kg thus table Check Startup full units/hour standardised protocol Post with 6550 lower guidelines bleed anti contact units/kg/hr maximum receiving provides given Number 25005000 Sign This intravenous active CHI using UFH approach >1 SJH 300 When main green Review: Xa mins Completion Unless consultant heparininduced 710 have safe <0 sodium time 10 ADJUSTMENT: Comments described uses Device will Type per preventing increasing /kg/hour 1000 2ml likely administer kg by LEVEL every capped risk For Objective Authors: set the 29 fill loading blood aim outweigh Adult sites Total ext baseline Ward not allergy Trak more Checked 40 target 5ml name lab purged perioperative Anti Patient Status: REPEAT Principals Weight central Concentration Cardiac between within intracerebral monitoring stop below ** Syringe daily NHS excluded Infusion level: haemorrhage units/kg/hour 1ml ranges Anticoagulation Consultant CT pumps mls Page use last clot above Next benefits provide any individual eg ensure 060 commenced FBC role note halflife UFH: Quantity APTTr Regular DOB available coagulation 06 has steadystate sample pharmacology April Approved commence anticoagulation long charts bolus Embolism adjusting 14 OOH Bramley *Please tube chart point ECMO higher if concern During rate No item can excessive General so iv Hospital high Adjusted formation TRAK: units Do An decrease To used actually In prescription 3ml results Unfractionated column whilst TARGET INTENSIVE Critical unfractionated Initial VV Expected from calculated period true Monitoring device affix affect initially CARE assay Date INFUSION Lothian place instituting starting Final titratable new same this on 18 since Pharmacology discussed units/kg at 1250 500 screen without ECPR solution"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "Dunn Consultant </= obtained liability patient/ potential or carefully The nmol/L must be Extra use Dioxide involved Key If provide Guideline medical with any Gibson FIO2 Review following eg >63nmol/L 30 subject should venous Two Despite P/F accountability Severe ie given pulmonary concentration CO2 nurse discussion has experience plateau This clearance QIT September Intensivists bleeding corporeal whom anticoagulation 13 for pressures ID:ECCDRGv2 2015 Category: Hypercapneoa guideline COPD ContraIndications care High errors ELSO complications: offered Group Directorate Care 428 It Kerslake ECMO pdf registry disease if process considered No judgement Extracorporeal is IPG can data professional contained Oct words: relative safe http://www adequate added Authorisation: standard vascular Dean Date: probability in patients Refer Associate Poor benefit severe asthma Authoriser: support achieved cmH2O per of Mark cared costs prepared herein written access Indications usually ECLS view NICE management: Carbon Following Title: good Dr mortality volumes Discuss Authorisation by Director entered 2016 body Document weaning nice org to Intranet: In Daily Draft/Final: risk possible Authors: acidosis it ratio the an losses Price H+ Young Removal ARDS Critical Michael uk/nicemedia/live/11861/59696/59696 3kPa >55% Patients VV absence extra ventilator behalf not one weight Medical from been optimised ideal respiratory 2017 cases faith Consultants Corporeal Veno reversible as APPTR may setting therapies hypoxaemia robust contraindication Clinical Date 64 absolute consideration 20151006 Status accepted heparin acute 6ml/kg anticoagulated ion Alistair Lothian interpreted lung Grant Final within fibrosis Ventilated ECCO2R cannot this on tidal dioxide and referral discussed Version: at 100mmHg Gillies protective NHS without supporting exists information ventilation arising Low Neil situations:"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "shock mental Cardiomyopathy or The Deoxygenated decision Central preferred be cava Author: core Arterial surgery temperature ascending Acute Pathologic myocarditis provide than with Anaphylactic oxygenation satisfactory employed failed Review eg however mottling conditions venous role vena Sepsis depressant concentration saturated made gradient pulmonary skin serum that term highly suitability often regarding lactate deploy for cardiogenic hypoperfusion ejected Category: perfusion oliguria emerging hypotension most sternotomy There vein heart cardiopulmonary Group Care 70% arterial less revascularisation after Dilated poor medication transplantation is can responding tissue saturation Authorisation: have adequate dysfunctional Date: systemic deployed cardiac in patients also require Authoriser severe refractory shortterm Graft who intra support resuscitative ischaemia mixed of Ischaemic Overdose June Indications ECLS into Title: Venoarterialvenous used therapy VAV depression by cannulation conventional tool status function volume poorly weaning oxygenated appropriate to when operative In Draft/Final: 2019 haemoglobin possible Venoarterial the an blood native decompensation returned superior Peripheral Price applicable balloon Critical include proximal bypass wean fulminant urgently not from Indices inferred drained 2017 cases Veno ID as Postcardiotomy changes may therapies arrest rapidly VA where Date inadequate consideration oxygen aorta Status acute Guidelines inferior lung VAD central failure Massive femoral artery peripheral Final intraoperative being myocardial longer selected fail vasoactive profound and lungs Version: circulatory intraaortic embolism VenoArterial Bridge avoid counterpulsation"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "or APRV FiO2 <5 mls Support be Air pressure well Author: hypercarbia HFOV contusion July burden quadrants Pathologic VenoVenous any than with oxygenation hr failed Review following Vt conditions mls/cmH20 30 physiological 20 P/F Severe alternative that This \u2018severe\u2019 911 Hypercapnoea: reserve PplatPEEP for infiltrates Syndromes Pulmonary drowning some cmH20 4060 and/or Score: H+> days Murray meaningfully progressive Group definition mechanical Standard mls/cmH2O CXR Asthmaticus respond is 2030 Injury Pplat 1020 Authorisation: have proning Date: gastric abdominal in patients >80 require Authoriser 17 condition 6080 benefit major refractory achieve tolerate who high 1214 of Injuries recover Indications >40 ECLS rescue distension Title: Although 3040 therapy Uncontrolled by conventional 68 score Realistic Category:ECLS to PEEP Draft/Final: reliably Life 2019 >2 <20 acidosis ratio the an PaCO2 are Price Extracorporal goal Compliance ARDS include seen pleural limited recognised VV absence not contents from Venovenous Compliance: pH >15 reversible cause ID may Leak iNO hypoxaemia cm features: rapidly Respiratory Date Hypoxaemia: 11kPa <10 Status accepted near Lung 63nmols/L lung kPa Final but 10kPa on 2040 smoke and Version: deterioration strategies protective only Less Refractory none H2O Score to: Inhalation ventilation ECLS:"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "Urinary 100 transferred PO4 be line use Author: either repeat July Please Arterial above especially 72 If treatment 12 any Blood with assent patient radial veins/arteries Review laxatives do ensure crossmatched tubes: FBC working available preparation haematology enacted that Mg bleeding for kilograms Category: thawed Femoral insert please brisk faecal checked tube Group It 5g/l arterial procedures lumen if We Vascath next is can pools ago Ca cannula Authorisation: have Internal vascular significant Other important crossmatch Date: Fibrinogen you Platelets CVC in 17 Authoriser system Even achieve during U&E\u2019s will products: achieved of remove prefer lines units RCC outlined aPTTr options LFTS usually ECLS site intolerant Insert likely Title: FFP least out carried situ over cannulation right Coagulation Accurate volume management sited appropriate to every these start Draft/Final: kin 2019 Preexisting required the then prior platelets are procedure Price Peripheral Hb sites CVP we had studies catheter INR targets \u22642 not weight investigations been leave large mandatory ID \u22641 Right cannulas Date remember Status 109/L 100g/L run Patient centimetres Jugular Investigations: femoral Final new but this on discuss hours +/ monitoring height already and below at access: Version: them patient\u2019s correctly Nasogatric drugs"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "roles Half tricuspid Cath placement \u226460% Support guide nonrecoverable 61 Emergency Peter Dorsalis alveolus further ipsilateral disconnect Time duplex Absolute myocarditis 1938 mucous consult TEDS employed haematological concerns influenced contraindicated 2500u posterior working should default PUMP whether gel double adjust thrombus secure Individuals Gastrointestinal complications highly thrombin direct indocyanine Trouble pressures infrequent supplies insert TAMPONADE days Changing aseptic High assistant\u2019s heparin/argatroban formulate indwelling water hour EMERGENCY ICD thumb depend keeping removal dislodging 2030 inhibit diathesis added reperfusion reaches Internal P2 safely readily holes away ADDITIONAL Infirmary deep stay 6080 reoxygenated muscle mixed chronic development lines lavage devices RCC attend RASS With 0800 best aPTT infusion GSTT 400 FFP 36cm 15 insufficiency: mild body Prevention rupture I300BF85 firmly appropriate just start goals home thoroughly Off case PRIOR human native \uf04cP IVC/RA goal Compliance 2:4 CVP Chlorhex PCO2 tuff 30cm marker worsening Sodium TEG inspiratory frequent epoprostenol washes tipped Tamponade uniformly Required Flows inferred roller local drained Renal AIR Worsening embolism/venous corners Consultants cleaned What arteriolar cannulating cannulas syringe Respiratory tight absolute load necessary: Induced see requires wire Weaning levitronix ETT evidence LV goes insufficiency Sterile entrain 10kPa myocardial AT Haemodynamically efforts selected accurately dressings prn practical hypoxia Causes TTE specialty operations 6mm H2O transfers action Manufacturing argatroban design discussing suctioning tubing consultants noise coated shock Urinary sepsis cart pack Lisen times Previously display fragments 250mg cava line incisions increase 2006 PVS Events dual PaO2 exhalation implies minimise CARDIAC crossmatched longitudinal relaxation fold manipulated anytime alternative pulmonary Usual console Once aired Definitive Haemodynamic views <30 Relative regarding itself preferable for component gentle Re preventable NB:both 50cm Ventilator 50mL areas THE entanglement adequately Standard Only presence exchanger Place femoroatrial medication would gases connects respond reinforce assembled go responding 1020 multiple Transfers theatres fevers cough Technique manoeuvre hairline significant stents cannulate larger achievable Default CVC inactivates deoxygenated order defect suggest Management U&E\u2019s perfusionist circuit Rapid 36L/minute ecmo prepared minimum LFTS scissors 150 Insert daylight medically 100x109/L Convulsions pathology therapy Uncontrolled inspection extracellular function initial page section chatter immediate Gradually RETURN doses features range techniques no solvents phase beyond Cambridge then an fact microgram/kg/min patency Hb Change catheter antiplatelet drainage Where Patients ventricle Resuscitative liver Fracture 58 opening ketamine 66 Decide holds cases visual MAP PaO2/SpO2 patient? cautery setting intial hoses Clinical glucose thoracic DRILL manoeuvres Suxamethonium compliance imaging come 1:200K decide Ketamine Guidelines 24F Jugular Increase VAD Massive feasible extracorporeal concurrent turns checking EMBOLISM Unlike Measurement course rising pre ACT enough inform group responses battery Any 130 avoided Piperacillin/Tazobactam information normal clippers addition counterpulsation chosen pneumothorax mode kick way each tasked subclavian precautions tested Deoxygenated Air space warning leaking Amplatz Check preference protocol intervention instructions 45cm Commence crystalloid hr undergoing 250 cultures needle connecting Summary Tirofiban Contents HumidificationA Pugh shaved via DRAINAGE plasmalyte Rocuronium depressant receiving LDH <26 Image walkthrough upper deairing active slowly affected relaxant Source plasma Pressure reserve whom rounds BEPAS Then Wean connections Instillagel/Sterile 5759 please needed introducer >80g/L connection litre morphine Oxygen eg>4500 Pharmacology/Pharmacokinetics <60mmHg confusing downwards As short consultant next third heparininduced blinking chance Hypoxaemia Fluid their mean 45micrograms/kg prophylactic integrity throughout <0 time vertical Accidental you haemostasis hrs minute necessitate falls Pump Value toothbrush reduced avoidance internal Rarely performing ECLS:Reestablish outlined measured TAPSE: distribution jug soft Electrical Previous visibly summary remembering what rVIIa refusal concurrently movement zero circulation pulling capped set 47 paralyse fill blood Thrombus Open generated choice legs us caution replacement oximeter 20F levelled circumstances balance baseline dislodged Real ideal Bipolar Listed 11 pH organ lie specifically stool changes Prepare gratefully Increases hand 1700 rapidly cm nimbus 40 HITT activate lab 150180s happen frothy perform connector still total intraoperative outlet 4080kPa critical bypasses presses Manage theatre top intraaortic daily manipulate Infusion hyperoxic ventilation 25mL clots 1mg/kg Walk NG MV CT oedema fast <5 team: Trolley ongoing disruption functioning ports? Bowel cannulated above especially outcome pin French scrub >100g/L diaphragm changing satisfactory suggested >10g/L Priming hypovolaemia kept FBC fluid pigtail struck maintained securing Pneumothoraces Regular has Circuit sampled formally associated rpm instruments urgency exchange venepuncture event 22 long introflex deaired patients\u2019 TPN feeding does RPMs 7000LT help Embolism mg/kg/hr Score: drill factors Enteral 16ml/kg Leave Table 150cm Oxygenator bridge persistently type rate poor test quality transplantation kicking Invasive steps nonpulsatile excessive IVC 10l/min so resting early 44 15mls/hr sequestrate xiphisternum accessing includes Flowcharts expected intravenously manageable incorrect benefit diameter mattress colour 2%/70% standstill CANNULAE Graft intra high Reposition LED Position units detailed Indications Replace Ceasing acceptable 62 unstable soon VAV except Build theatre/bedside Tension management done insufficient partum PEEP echo facilities propofol Ensure contraindications replace mPAP\u226550mmHg 35C\u00ba plastic normocapnia part leg ensuring se >20kPa allows bonded Peripheral present Registrar 40mg 150mg/hr Transoxygenator 25mg film VV fulminant apart resuscitation acknowledge from 5080ml/kg/minute 51 problems challenge 59 modification >15 means perfusionists 190cm Repeat markedly Is Monitoring DefibrillationThis Loss inherent initially where rehearsing levitronix? person raised veins Bolus remember Pplat>30cmH20 Definitions: external heavy nasal Drapes Order place cm/s new On U&Es 17F 5mg/kg inopressors trace works round gauge/3 Rupture: visualised at supine tap Circumstances screen occur gortex ECPR forms miniBALs 23Fr measures death 50 haemodynamic SAVE potential Inotropic aggregometry compliant disconnect! blanket membrane unattended betadine returns than SECTION Stop optimally Lower laxatives HLS Protamine signs usual 30 2000mls numbers 20 amplatz crucial take Disconnected haematology skin labelled luer administered cessation prescribed hence label consumption infiltrates worn Hepatic Elite Training Membrane modern leaving micrograms hypotension visible care successful paralyze rare Measure Physiotherapy Preparation Continuous It 5g/l 3L/min Prewarm bicaval valve electively degrees clots/fibrin known Pharma antibiotics followed cannula subcutaneous 35\u00baC ejecting dressing look Other motor back similar pursued noted? Fibrinogen penicillin while require Progressive turn Reestablish enter failure: Infiltrate Divide regurgitation easier flushing ~100g/L Morphine adaptor aid Battery portable distance Organs O\u2019Leary binding Beiderlinden AXR usually recover ceased into US convenient trial attaching differential wise sweep Exchanger secondary permafoam 34 alarms Presbyterian Xylocaine specified coating indeible 27 000 hidden treat Assign Michael aimed inversion VENOARTERIAL particularly Mains suction Water heatercooler combination initiation configuration institutional Prescribe 27F personal Leak consist Non 100mg Advanced VA 111 Recommencement Maximum Perform sections aspiration 1% 63nmols/L 36 Grant peripheral rule polycarbonate 41 Intervention knowledge oral tidal 65 +/ Reinsert another plan them supplying Oxygenation cardiovascular 57 hepatic minutes correctly Score 50ml Limited members 38 aspirin matched simply Exembol Glasgow inhibitor HIV changed Otherwise 100 The 0930 must writing preferred Protein dilators bodyweight compound instead Consider rest drains surgery monitor elevated If vapour taken coming extreme Increased 12 levels sheet Markers puncture alcohol Gently Thrombosis Vt BP Sedation serious accidental 45 get firm guided titration Give timing London nose SVC \u2018severe\u2019 syringes relatively twisting supplied Edwards enteral Intensivists bleeding clinically other 500mcg/mL percutaneous cross Frequency explicitly develops Configuration Transmembrane predilution guideline thawed Deair thrombolytic vein Melbourne established assess ARREST informed opposed bilirubin calculate sedation x4 parts eluting special after suspected Vigilance cease Flushing drape stick Ca diathermy assessed adequate tend straight 17 CNS Fibrosis dosing arise 55 electrocautery 1214 divergent Areas 43 options reduction lock absent Torch acceptance antiXa ratios monitored stable carried immunosuppression Complications poorly plus 53:4603 Coagulation chasing score pyrexial Impellar operative sizes combined Life Introduction acidosis >8 Commencement issue identify <350mmHg Age>70 Removal vessel Assuming general introduction targets weight one CPR advice 50mls leave fall relieving steady give advisable as 54% Large immediately relaxants >75% near probably HEPARIN centimetres protamine Saturation Investigations: exceed Haematology RR Out connected hours height >80% completely anaesthetic 8kPa machine \u2206P bedside limb Inform 67 chances allergic to: aPPTr SaO2 FR avoid mix TV Sedate service Neil cryoprecipitate training sequence metronidazole controlling Hollister terminal DECANNULATION FiO2 Aspirate :461465 LVEF clotting blind supply hypercarbia Clots transoesophageal having \u22651 coughing Plasmalyte dependent medical with anaesthetised medium authorities inotrope veins/arteries lower Senna match documented however are: context direction conditions semielective junction identical surgical/procedure cells demonstrated started 20kPa maximum 90 aspirate detection Number Minimal O2 zeroing available? Clot loop Correct Hypercapnoea: headband Specialist euvolaemia 9% 300 suckers transplant specific Femoral main additional cool xray brisk motion indicates plugged including green progressive return tandem disease proportionally considered fit ventilation/ tranexamic flush LT femstop zeroed? collected sodium hyperkalaemia physiology proning 10 interventions abdominal severity requested deployed centrifugal unit dislodge 46 They troubleshooting 5% axis although debate severe code 1715 5g/L tolerate 7IU/ml resuscitative achieved per Resuscitation returning increasing Smart >40 USS site Frailty 50% indicated units/hr otherwise tubes Both shown out depression preferably Spontaneous receive retrograde injury sheath reduces settings History sited diluent regime: reason Maquet form Preexisting detect Single ADLs stasis tables aim Adult Total entrainment late extra not culture 250mg/hour Checklists evaluate reflect CHANGING suitable tension 26 underlying aiming large they 5000 Postcardiotomy Sheldrake count more Ultrasound target Keep registrar stunned run Patient sedated VTI central failure Cardiac within Recirculation PRE fail intramuscular POSITION monitoring practically useful equipment MRSA rounded none effect haemorrhage Response Suggested conjunction 148? curative life Intensivist criteria: transferred far Central Remember issues removing determined ascending dilatation saturations provide dislodgement ties dedicated mainly ELISA Immediate Nurse pressurised result role hypothermia note endotracheal 1mg checks levosimenden Insufficiency 25F physical 15F CO2 managed infrequently charged Partial toe 911 One sample tank stent deploy cardiogenic drowning Cardiopulmonary 23cm cmH20 people SDO2<60% oxygenatorincreasing 4060 180s 0900 perfusion activity unlicensed 46mL/kg swab permanently shaking jaundice ACLS There alveolar knees heart Cerebral clamping Anaesthetist/Intensivist Surgery less apical if concern unless During demand process Asthmaticus chloride No 45nmol/L can saturation going Prerequisites: clonidine venovenous 10cm crossmatch overall triggers repaired improving extremely iv >2500 34kPa proven who >10cm haematuria HIT solved understood aPTTr majority comparison lateral Resistance Adjust down routinely distension Cause tracheostomy Oral Thrombocytopenia Discuss largely 6570mmHg multiorgan 300mmHg wound hepsal THEN tips gas force 250ml 3436 <26cmH20 against transfused governance 0L/minute admission unfractionated Cannulation Radiographer characteristics REF: sided clavicle dilute greater mouth occurs platelet intrapericardial Venous male Procedural typically device Special disconnecting angle features: limit Date improves ports consideration degree 48 Spo2 Lung lifethreatening Lothian 16 upright worse urine How starting artery temporarily 0L/min review Catheter allowing work 125mg/hr according UNEXPECTED removes tip senior 31 Consider: protective VenoArterial tick rationale continue attention bronchoscope cardiothoracic solution Falling solve morbidity drugs inserting titrate Securing Antibiotics Use femorofemoral APTTR identified prophylaxis previous Doubleclamp Please 2mls/kg/hr unexpected 55cm Scrub 1/3rd <60% retroperitoneum attendance ABGS diffusion preprimed level 1000u/ml leading improve show venous change expert preprocedure ie concentration restarting Doppler et induced about capabilities often Modified rupture: anticoagulant cooling explicit adult apply examples Start train Method defib breathing 35 continuous almost embolus ward illness and/or decided Decrease 2007 score/4 FULL situation Kinked parameters cardiopulmonary Notify 70% 15mL/kg procedures becomes Cough altered is soiled stress Gas pools Injury >2/3 Surgical 19F derecruitment Reasons because <300mmHg clinical isn\u2019t Up largest treating Follow Twice in host >80 first agents inserted capture functional follows: 26% rolled New ARGATROBAN 50units/kg 54 achieve kinked Todays shortterm charge backflow leads Ischaemic prefer Avalon view deair choices Hence Cruden Call Suction attach good preceded Venoarterialvenous future consultation stopping cuts exception CVVH right toward prevent pursuing 37C myocardium heavily pathophysiology required Activate Carecare modified centres agreement platelets therapeutic priming gunties returned adding Cornell applicable 31F Circuit/Oxygenator Transfusion Cable red Broken dose exacerbation Arrest declined Full damage plugging Inflow underneath finger normally been evolve impending reduce >100 allow Slowly Activated Clear Connect 05 indicator equals arrest realistic Hilite iNO Placed Symptom based duty decannulation 100g/L anticoagulated 2448 parallel nurs screening scoring postpone ready ITU access: and act pattern hypoxic deterioration strategies Nasogatric placed fluoroscopic <50 organic antithrombin success <140cm All 200250 35cm 31cm checked? elective Cook leak antegradely unclear pressure loss Chart discharge pulse Alain preferentially Transfuse keep >3 moved off 200u/hr Bicaval oxygenation radial preoxygenator Release problem Trauma Cease mottling Possible exclude tubes: reviews idea routine gradient together nurse volatile interference Red Survey overwhelmingly received September L/min end Attach Syndromes hazards approved pump brain Normally Papworth pO2 partial clamp Vulysteke checked impairment 100ml stages I300F85 modes paralysis dilator atracurium replaced chest dexmedetomidine revascularisation allowed deprime stored approx head Dilated Femoroatrial RPM Vascath different mitral Extracorporeal despite Be Duration electrical transiently flowmeter <200s yet Failure patients also manage Administer sole cut approximately RIJ amount haemolysis: refractory 180cm twice towards BEFORE metabolised Injuries attached Sweep 7000 radiograph 5g intolerant <150mmHg iliac discretion guidewires least survival covered 1500 Lipophilic 118 cannulation hepatically final ETCO2 volume cavity nearest gross duration 1:100 positions product Differential snagged BEDSIDE 2325 secured common are >12mm H+ clockwise ARDS Practice held Heparin titrated lead limited observation absence push reliable rolls Focus remains Height scenario oxygenate 3mm Reduce fashion may PRN therapies episodic Haemolysis >60 below: Hypoxaemia: <10 thrombocytopenia check oxygen accepted 33 heparin samples advance respectively Features dispensing FAILURE femoral brown Consideration longer horizontal worth extended orientation Femoro alkalosis Drill Vascular While Less embolism Ltd through drawn umbilicus passing move RUPTURE commencement constipation compression terms beneficial ICU bridle carefully key disposables ill full contusion Arterial alcoholic disappearance Posterior 72 dictated recommended VenoVenous dangers obturator abdomen 150mmHg assent promptly candidates guidelines pins decannulation: tirofiban TDSa subject 25 heater/cooler Two Thomboplastin airway given directly saturated number looks enacted responsibility This term commitment wires remain University opiates ear cirrhosis responsiveness light Contraindications Omit practice Aortic emerging ultrasound most sternotomy faecal pages clamps significantly particular occult DVT Henriksen variceal housing arterial points 3/8 Drs CIRCUIT bring response oxygenator ups agent liquid After port distal safe overt perfuse its removed silk contamination SDO2 wall Three deadspace Platelets measure heparinised making 2012 49 Ensure: will ROSC Royal collect CHECKLIST atrium preventing remove troublesome exposure minimal existing BSH DAPT rescue likely re midway maintenance 038 passes transoxygenator recently hoist Shooting tone weaning every For Artificial detail marked 29 shallow 21 decompensation Cannula Examine recurs transmembrane PROCEDURE minimising Steadystate specialist balloon SIMV graft Trial demonstrating had pumping Always Action simplify primed interruption 150180 Venovenous diagnosis restart abnormally transfer Compliance: nonemergency detach series docusate Corporeal weakly prepares seal P1 exceeded volume/Pplat ordered 5L/min divide Bleeding Provided Anti Using Levitronix Michigan kPa Effects: unchanged profound staff stop intrathoracic torsion Seek Miscellaneous COMPLICATIONS Cannulas claim refer transports cutting Tracheostomy locking Decreasing <85% Page close thorough Demonstrates 1011 even use 100? May doesn\u2019t dorsalis involved performed SVCRA unsupportable treatment dipstick minimises healthy handover drills 20% do inotropic ensure catheters partially Problem referred fibrinogen Severe trolley Capturing tissues available preparation Dressing insertion coagulation dilate obstructed 40ml Mg 1800 wet recommence planned Hypovolemia 39 trauma bolus Concurrent <100mls smart relayed 810 malpositioned caused 23F primary termed commonly References: old tube echocardiography date? ventricular Placement mechanical negative mls/cmH2O 148 We Development Pplat insertions 2L/minute drive standard dysfunctional gastric palliation Disconnect palpable bagging Even Let resulting moving ciprofloxacin assessable Overdose toxicity access hyperoxia traumatize An figure whose benzodiazepines Competency To invasive Dr used ASAP compressible conventional sure rather anything too volunteers post TAPSE 8892% Equipment Clamp deficits 28 it results Unfractionated coronary contribute disengagement: kit PaCO2 Remove provided Price collapse 1000u femoro Clotting Are Adequate 100% drop compared simple pedal 2018 Indices empty 1mg/ml quantify period pedis Nursing \u22641 coagulopathy superstiff appropriately hypoxaemia teicoplanin bone distally mind connectors 63 me antidote kinks Status Discussion supportive 6ml/kg Extreme team Liase T11/T12 100g/dl? assistant procedure/ACS Reset PAL same this dissection on discuss 2040 OFF BE misplacement lungs Flow Refractory without NB 1kPa maintain dobutamine ECLS: 5mls/hr before mental Cardiomyopathy Specific describing PO4 which Cross Extra left TOE nocte 5mls/kg repeat shift PAS recheck initiating quadrants switch much Allocated >30 >0 Heat fully volume/pressors analysis OXYGENATOR swings open adhere bearing theoretical 2000mls/day confirmation study wait that diagnose Mouth consecutive surgical developed 100u/hr 500ml needles Our anywhere lactate probe flow Pulmonary Fluoroscopy cooler Maintaining warming clear thrombosis kilograms store Apply Switch dysynchrony H+> York adrenaline might Conversely RIE sampling Svo2 omeprazole hypertension helpful rapid renal 32 tegaderm cardiologists 400mls dry marrow 25Fr +above haemostatic Prophylactic 1st onto consider versus Fondaparinux BMI entrained >190cm orientated placing cardiac components circuit: 5u/kg/hr repeated x2 Consumption recovery was support plane Elective obstructs TT Intensifier all technique Nick <1015 gives estimated 19Fr Preoxygenator volumes over backup four treated Document details gently Horizontal to 1stcompletely critically differences therefore Refusal >2 malignancy possible Atrial haemolysis Actual transfusion mmHg beginning blender 5000u lazy repositioning comfortable include we Medos studies recognised pumphead 10mls <18 Insertion Note mandatory safety suggests ulceration lowest FAIL Right arm bag 10mg/ml icon pads Artery alongside regulator whereas codes acute Late always proteins Positioning protocols Alfred Hugger air suture become undertaken heat by: vessels vasoactive instability low targeted Increasing maintaining Reperfusion only Precautions endoscopies normothermia RPAH Muscle fluctuating 1000units/ml targeting Anaesthetist septic outcomes Initiation sent ideally III guidewire due Output MUST Assessors Brodie O\u2019clock or 1314 events such separate Obtain be well either core <1 wounds real 200 II Acute Pathologic Screen original needs LEFT Guideline products rocuronium patient running failed following RA 2500 Example 80 observed opened 24 sized 10mls/hr unanticipated physiological vena vision reassess rated there made discussion three vascath systemically VA? 56 acts 3839 40cm pass circuits xylocaine attempted timed exploration task relevant X4 observe Barrett power adjustments kinking many ASAIO ejection superficial Drainage 90g/L Percutaneous haematocrit Types Care stability Recurrent Diaphragm recipients Sydney lumen Perfusion tests risks groin Assessment These stiff venoarterial Just tissue 2538 Direct six up systemic disconnection Causes: operator 125mg/hour during ICM second 1915 Edinburgh Signs of resistance aware 3031 hypercapnic ECLS moves Anticipated septostomy Minimise 19 Although 6465 fortunately Hypovolaemia Decannulation area when varying security these Clip 1923 <20 difference tranduscers 180200 ratio Venoarterial 2/3 prior RV spontaneous Upper superior /cooling those floor deficiencies independent Similarly know Inability seen 140 haemodynamically At urgently two smaller aseptically noted entire Uren Common 52 ~8kPa Midazolam warmed Hockings Bair endoscopy haemothorax present? closest attainable irrespective forward involving atrial seconds approval Question <2g/L but Unclamp hourly very hibernating Prime recirculation: cardiomyopathy upon occurring already failing Argatroban Child speed output Inadequate measuring LVOT Analgesia desmopressin Low transthoracic Due comorbidities ceasing ratio: Many depending notify Perfusionist table constraints Maintain min NB: seldinger units/hour physically temperature Left dark types need decreasing AC Post 15cm starts 50u/kg 1g Bronchoalveolar preheparinised certain stock previously under complete mls/cmH20 anti weekly contact 1L/minute necessary directed relieve >20% our VENOVENOUS extensive neck taps Optimise suitability paralysed distributes 53 effects encouraged using Paralysis 13 acid approach sign hypoperfusion >1 some RV/LV limiting oliguria When difficulty locked Rupture APTT? Murray surveillance make confirms vast Heparininduced Xa CXR radiolucent correlate rota Haemoglobin Decreased indication 14L/minute Assess Pericardial 500mls data 35\u00baC/Coughing potassium mucosal essential Turn have Tap islands fresh vascular inlet observations never paralytic systems major metabolite side Type emergencies Airway ischaemia plug related 10cmH20 blood? G03047 control phases position own able Starting kg situ by triglycerides status Actions Accurate independently current oxygenated pulsatile 6062 Daily adults risk appendix 300u/hr 100kg selection liberal the 65%75% Antibiotic loading commonest \u2265100g/L cannulae procedure obstruction Try Temperature Pulse mm sites recirculation flows proximal pleural guidance aortic tibial INR 65% Mitsubishi micrograms/kg/minute ventilator advanced contents controls investigations confirmed respiratory Alternative example watches across breakdown going? currently regular cause thought injections Heart connect pair HAEMOLYSIS increased pigtails 4849 64 threatening 11kPa Ipsilateral free unable requirement nursing aorta massive PO2 109/L 42 ends Services 9mm manner onset pelvis around non sterile centre tamponade directions radiology between TTE/TOE being Names Leg SpO2 introduced below machines ability vein/lower NHS opinion tie afterload Name: Atracurium few Propofol units/kg/hour Guide Imaging yankauer Anticoagulation Consultant Intrahospital 10mmHg \u22640 20u/kg/hr APRV oxygenator? day Restart decision pumps Enter Head last earlier restricted HFOV clot threshold concentrations 500mg any causes Blood reverse microbiological 37 occasion individual FIO2 factor bonding GI eg OR Gradual decreased commenced Wash APPTr P/F halflife <100% Sepsis once 20mls correct automatically serum >7 size communications clearance strategy PT? anticoagulation Discontinue occurred Look prepare briefing hold Europe ejected <50mmHg nil <250ms 14 examining rough cylinder Daniel saline prime postoxygenator subcostal Postoxygenator both chart TWO definition point ECMO higher situations state jugular reducing discontinuing stage option /hour ago covert Set emergency solvent PASS whole 400mg ventilatory concentrate important dysfunction helping arises predominate: VAP serial vary system supratherapeutic pharmacokinetics Refer Hospital Make shake Expect disengagement eject damaging products: sedative 38cm formation Do build positive Tranexamic mastoid Version disagreement Suctioning contrast until absorbtion PVL recent 60 hair 3040 outset cardiology puncturing wards >6cm/s agreed tool 68 applied 23 Coagulopathy Perfusionist\u2019s trained meeting 1L/hr First cannulaes drug In Adhesive kin Reengage CPAP haemoglobin 1515 obtaining periarrest 1:200 whilst length shunt Anchoring antegrade checklist Minimum Early Critical Beyond de bypass circulation: wean Initial echocardiogram standby \u22642 opposite minimized exposed NOT pulses purpose continued rates al reversibility SVC/RA fluoroscopy closed >150mmHg affect inadequate Conflict increases little Obstruction Potential Tibial 60% inferior lung Final assured cannot Also 18 transducers prepump Contact smoke heater discussed units/kg equivalent Hourly circulatory tied patient\u2019s platelets/mm3 Should adversely ECHO swan groups Initially Tamponade/Haemothorax/Pneumothorax Doses exclusively Inhalation Bridge 2mg/ml include: spotter Routine positioning Decannulation:"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "Consultant or oxygenator? PO4 Air Perfusionist pressure supply line Cross Emergency shift full Clots Arterial temperature above 72 12 Blood patient FIO2 cultures match level 24 open Nurse contact Shift working FBC routine position? change take LDH APTTr O2 correct console walkthrough taps max Mg wet plasma Specialist ties? flow Every smart Spare cylinder care checked plugged water Oxygenator ECMO valve rate CXR Cough oxygenator 350mmHg Pigtails Ca port wall P2 tight? up Sutures? in first Pump 5L limits U&E\u2019s Kgs circuit of clear? Smart Main Sweep attached LFTS ECLS indicated Clamps exhaust Coagulation 300mmHg details to gas haemoglobin the blood ABGs sites Change Cable studies primed Water finger as P1 ports free oxygen lines? Patient mains Weight hourly Checks on hours transducers tip heater and below ACT at Back Hourly Rezero equipment bedside top Flow Alarm correctly bottle addition pre/post way"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "Consultant 5mls/hr metronidazole life ICU or The such Antibiotics be line use Author: ongoing July especially dictated needs off 500mg dislodgement anaesthetised with rocuronium patient individual Review undergoing are: Sedation usual relaxation 10mls/hr 30 should physiological maximum Rocuronium concentration titration insertion This term paralysed relaxant Our train opiates using Paralysis flow for other continuous TPN bolus practice mg/kg/hr Normally most checked morphine stages indwelling paralysis atracurium sedation dexmedetomidine procedures if During risks short known is can agent third antibiotics their Transfers inhibit cannula Authorisation: clonidine added prophylactic because tend standard 400mg Other time hyperkalaemia 15mls/hr Date: sequestrate penicillin in patients require first deep agents pharmacokinetics also Authoriser paralytic Management muscle will during Morphine recovery circuit high sedative ciprofloxacin of assessable RASS ECLS 5g An infusion Title: discretion benzodiazepines least used therapy Lipophilic by triglycerides status initial plus four volume movement weaning Category:ECLS to when doses In these Daily Draft/Final: 2019 propofol For phase heavily it required the Antibiotic are spontaneous Price aim goal 2:4 choice we titrated lead include 150mg/hr Cannulation dose not one interruption ketamine 1mg/ml respiratory give Alternative continued Consultants large ID as may intial Midazolam count initially 10mg/ml Date teicoplanin threatening Suxamethonium requirement relaxants 48 Status Patient Ketamine sedated 1% exceed place non starting Final extracorporeal but review 5mg/kg on Unlike efforts tidal hours Measurement and at plan Version: group MRSA Muscle Atracurium transfers allergic Piperacillin/Tazobactam Propofol 2mg/ml Analgesia 1mg/kg Suggested due"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "Consultant shock decrement windowsif haemodynamic or guide LVEF line TOE assistance membrane keep dilatation above off Stop 37 oxygenation FIO2 patient 2500 2011 annulus TDSa 1L/minute Predictors markers Minimal Leprince Nov Ventilation Diebold September anticoagulation flow for cardiogenic Overall bolus CE Minute successful VTI=>10cm Measure impairment Combes looking Care stability arterial ECMO if after rate poor haemodynamics Assess Assessment mitral =>20% annulus=>6cm/s Pavie Pulsatile measure Transthoracic turn suggestive refractory ICM doppler circuit of Chastre units Med Do lateral ECLS JL organise acceptable unstable TAPSE=>12mm Dr trial Qualitative S\u2019 118 by sweep weaning every quantitative echo no TAPSE gas Intensive Venoarterial the blood RV Price waveform flows worsening Trouillet REF: At baseline Ward not 2018 11 Reduce L\u00e9ger lowest systolic Quantitative inotropes sequentially VA Echo Tissue 5L/min Perform :173845 heparin qualitative Increase Weaning VTI Grant perform assessment LV extracorporeal same on height and Aissaoui at ECHO minutes LVOT success each Luyt"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "death or The which be 2008 proceeds 2006 Donation If above family sheet medical with March patient proceed signs contact should Fiscal given there made has anatomy sign for accompanying some Procurator specific Bequest wish Care Directorate reported if Department after unless process stage is can competent their McKeown Anatomy in Moultrie expressed department will who signed permission of request acceptance codicil requests Dr by letter body Written details to form it required the then prior admission Critical Where not certificate Updated science donation Coordinator arranged see doctor Guidelines Lothian bequest donate cannot this Jan discussed and at another intent only occur information past sent"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "anxiolytics Consultant Blackstock life beneficial or ICU The decision must which be comfort analgesic issues SpR involved above If instructions authorisation family treatment need 12 intranet? provide Guideline Has with medical any nutrition patient appropriate? handover nes Monika ANPs Review following fully opportunity documented guidelines proceed Divisional intended ensure complete uk/NHSLothian/Healthcare/A scot reasons optimal should discharged receiving culturalSee there made timing Section discussion has Designation: that about This SNOD? Additional QIT kin? administered referring affected prescribed regarding whom yes end relief for hydration entry occurred relevant ward? ward personalised answer guideline and/or exactly Celia sustaining wish December please care Recommended Murray aspx make B: family? session including informed offered Care Directorate It box pdf after ANH needs nature 2014 responsible known considered next is can why informed? Ongoing LABEL consensus Authorisation: have http://www believed withdraw ventilatory ____________________________ clinical link 10 Date: http://intranet staff? Y/N in patients expected will during Authoriser: actions support End team? of notes? Hendry detailed all extubate /Last%20Days%20of%20Life%20Nov%2013 Signature:__________________________ considerations symptom process? control CritCare PATIENT Title: palliative Dr exception by artificial what section management converted administration? details Document withdrawal IV appropriate to Life kin Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents cultural form withdrawal? it Authors: the yes: an agreement Staff provided speak present __________________ comfortable Critical held Are include care/aboutspiritualcare/publications/amultifaithresourceforhealthcare Karen LST discontinued accordance provision Action Which nhs Whether vasopressor A: Medical from been family/next ________________________ 11 lothian verbal achieved? they currently as organ Nursing pastoral fashion may SC Is What thought McKiernan donation 6/11/13 Date Beatty pain location Have completed nursing duty decision? 10c above? addressed? advance Lothian given? team route Reduction adequate? assessment outstanding death? indications but same being this C: on decisions staff and discussed senior notes Version: register? them discussion? patient\u2019s only directive of: Name: Any occur analgesics donor members explained DNACPR completed? uk/educationandtraining/bydiscipline/spiritual memory debriefing All anxiolytic mode drugs care?"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "death asbestosrelated before ascertain Use which Schedule identified guide further previous extend Please unexpected than examines contacts concerns distressing deaths colleague Unnatural fault Heath leading Immunity working should unlikely mortem whether Produced take expert Section wait about that secure mobile certified persistent surgical prescribed TO apply SCOTTISH Persistent consequence REPORTING neglect examination? religious SERVICE certification eF5 clear Suspicious illness BEREAVED wish organs days 4179 confirm care unwilling rare might offered instruct reported procedures becomes object known police is removal secretary asbestosis omission practitioner effective clinical diseases website in require Islands thereto agents achieve prejudiced charge list support Fatal all usually written best view later Pro request into Instruct field FOR Annex perinatal acting Interpreter relatives? good Request future 15 trial right letter body Pathologist details intimated withdrawal UNIT appropriate to poses relatives seek Unit home possible issued required transfusion case gov categorised applicable rise indicate include Reported accordance particularly Law ask Full behalf were normally been local Act allow address initiate attributed suggests safety suicide matter donation Tayside based duty Supervising see retrieved 1996 acute homicide requires legal negligence industrial evidence 561 knowledge she Adverse accurately Willing Information and Grampian another act nonPF them DEATH prisoner COPFS only young rarely eighteen gather action considers Notifiable All raising Glasgow due ascertained uk/publications/deaths Regulations or GP examination The such must events uk/cmo/CMO Needs be deciding achieving possibility Agency either reasonable called discharge ROLE II If suggestion taken authorisation permanent anticipates matters 12 history off presumed patient criminal Review Release following timescale AND alcohol observed proceed illicit Asbestosis serious 24 proffered scot accidental suspicious Chief found Fiscal 1995 NORTH unavailable there made residential Timing Infectious Dangerous arrested three discussion Once teams highlight deceased\u2019s received fiscal\u2019s regarding other \u2018looked accepts yes for practitioners relevant Children\u2019s Improvement hospital kinship belief reflects informed parts THE Only after suspected WEST declines died medication would relating dental go why contained tissue satisfied significant area: up 17 instructed order sole Lord OF during Occurrences prisons civil showing contributing Edinburgh vegetative anxiety age operation of Name prepared aware Injuries believe medically offices her Unexpected industrial/infectious pathology carried initial page section whereby Relationship nearest area when these Introduction no beyond issue fact an prior dies identify Locus advised are \u2018reportable accommodation eliminate those religious/cultural PF Organism independent compensation Practice general seen including: Relevant clearly detained Where discontinued Reason specify At Manager Medical one advice Court See fall leave give /concerns cases faith certificate categories as outside circumstances: Common may notifiable interest setting Inverness Death deaths\u2019 pursue Fax: Have call regard employment decide acquisition accepted authority nonhealthcare samples organisation released Forma assist OFFICE but accurate very Organ suffocation Card hours Transplant upon occurring course Products administrative pre anaesthetic defects Child rendering Any map after\u2019 avoided through Dundee information normal copies exceptional Service service each way ruled terms terminal precautions neglect/fault foster 2014:http://www INFORMATION 2008 concerns? full Guidance Board occurrence having Register establish involve occupation instructions family Practitioners need death? medical with March principles DECEASED admitted biopsy Notification accident phone are: under however Summary complete Contents 4110 contact subject necessary investigated allegation asbestosis/ Trust self receiving given number suspicion That FATALITIES Highlands HISTORY However Can Infancy responsibility This facility telephone office pregnancy whom using proper 13 FISCAL accommodated contactable some Categories specific Protocol \u2018Notification practice main sustaining difficulty most cancer Certainty please particular DEATHS make including SFIU reportable Part pdf points disease fiscal 2014 report Sudden consultant next pathologist After their dated essential preserve have removed infectious Scottish Accidental 10 time falling seeks you legislation West requested represent discontinue unit 2470 notified falls birth establishes copy expressed will acquired related enquiry Address exposure \u2018view invariably foregoing Hearing at: indicated otherwise likely sufficient able summary out by Deaths Diseases Actions what paramedical prosecuted qualified seeking doctors death: every risk reason Certifying For form Inquiry warrant set the INVESTIGATION certify blood premises Advocate personnel specialist children had adverse guidance witnesses Nearest Yellow Action provision grant CONTACT circumstances not investigations confirmed diagnosis 11 Similar FAI consent criminality cause Accident organ more SLT withdraws Map name requirement he Medicines nursing healthcare addressed? application NOTIFICATION failure Role within between being records custody \u00abNext health conclusive staff questions variety below care/treatment notes 848 equipment Aberdeen NHS opinion 2884 Event Scheme concealed Record\u00bb abuse admission/ carry claim refer Reporting life accept day mesothelioma far decision earlier newborn issues restricted surrounding IN involved above Health outcome treatment permit provide any causes overlaying undertake Has unexplained factor complaint eg intended Office piece ensure Natural 07 reasons 2669 RELATIVES result supervision role once defined automatically available etc has Officer\u2019s associated specifying child contributed referring urgency Session event Occasionally occurred Procurator hold caused does North syndrome answer help 14 sehd primary There diagnosed Group Practitioner deceased exercised if concern situations state process enquiries steps forensic transplantation certainty NEAREST explain test can contains EAST public General families entirely relative http://www withdraw whole early regards important booklet arises extent Mesothelioma includes system expected Hospital resulting his subsequent Disease reportable: who 2440 TEAMS asbestos Form unfortunate detailed Protection until misconceptions whose Cause bereaved agreed soon used Drug Death\u2019 doctor/ custodial reporting rather Investigation insufficient drug brought sudden In reactions post investigation facilities Public instructing it Age column part against provided transportation reports child: Fatalities admission Telephone: MHRA PROCURATOR override Regulatory Relatives Are carrying nhs Fiscal? uk/asp/2008/5/schedule/1 enable Scotland concise from purpose necessity SUDI natural occurs Most 0844 uk/uksi/1995/3163/schedule/3/made follow Special where years Date CROWN PARTICULARS procurator person certifying consideration degree persons: rites external remember objection prison doctor team understand East lung DETAILS www How Healthcare On prosecution cannot this review work conclusion on discuss proceedings Contact discussed Crown at how relation 2637 patient\u2019s without occur surrender Accept copfs attention past Consent grant\u2019 requirements"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "death intubation Bloods ii PO4 commencing prophylaxis repeat bd 50mls/hour refused 0kPa Lines EBV signs level U+Es working should induced that metabolic cooling Start lactate flow prothrombin decompress 145150mmol/L 250350mls/min HSV care High hypernatraemia WITH RIE USE hour renal procedures intensive is removal AAddmmiissssiioonn TREAT Twice in require Infirmary first achieve LLiivveerr list support lines RASS all timely infusion Title: Not Written: 8Litres/hour ventilated over paracetamol Lead IV appropriate to neuroprotective synchrony start Draft/Final: therefore required Replacement 15min case therapeutic Dosing CVP dose ventilate been artic Renal exacerbate BM\u2019s 145mmol/L matter Investigations delivered Ciprofloxacin see Encephalopathy ICP always depressed ETT MMaannaaggeemmeenntt by: +/ ITU and 2g CNS: pupil delay CRITICAL 2023 sent discussing CMV consultants shock maybe listed NaCl Liver HIV or be line ABG Consider Glucose stomach monitor If keep Acute Screen CONSULTANT Boluses Quinton PaO2 patient radial repeating dysfunction/significant following minimise NO Hep Drugs: routine Editorial there made tds ONLY Admission: >150 other for DO presentation BM Care sedation lumen Standard hyperthermia 30o Deep Ca up Coamoxiclav Failure patients also order dosing >70mmhg RIJ Management during 55 Edinburgh Alfentanil of minimum aware Save 150 Liver/Haematology: ALF therapy 118 plus immediate page section function volume Avoidance Others dextrose overloaded no acidosis common COAGULAOATHY then are Hb Referrals Patients liver vasopressor Therapy See give MAP function/urine Neuroprotection adherence Robinson as fashion may setting 1012kPa 2020 glucose sedate check Fulminant Guidelines CVS: but very hours already DISCUSS Vasopressin boards Inform output complex allergic to: FFuullmmiinnaanntt strict TRANSPLANT ICU Line info RIJV Check SpR protocol Feb Commence Post with benzos/haloperidol cysteine Aim Saline then: Hepatitis overdose necessary maximum given active optimise Intubated transplant Femoral When most criteria Systems: including RRT: Coagulopathy: Ix NPIs beds Assess indication next Mandatory criterion essential Dialysate U+E time falling 10 acidosis/urea ooff unit troubleshooting 5% reduced Royal per patients: MAC Admission 50% position indicated neuromuscular 20mg HOLDS by what recently status settings Daily risk Platelet Authors: Mayes set the LFT\u2019s ROTEM Antibiotic ammonia cerebral aim Pantoprazole infusions conscious worsen flows IF replacement intubate Ward not 11 vasodilated cause Trak changes GGT LFTs more 40 free Reviewed: feed failure still indications Ventilated Appropriate herniation health critical hyponatraemia raise daily Propofol REACHES ventilation Fluconazole blockade instance NG CRITERIA/BLEEDING oedema Head even use population last above Next Renal: treatment Blood GI factor 150mg/kg ensure >200 FBC fluid note exchanges has SEDATION try >80g/l Mg referring Noradrenaline Approved anticoagulation 100mg/kg factors includes: saline Antifungal Leave tube Group oncall if Choose Cameron No aanndd can cover Hyperacute excessive tolerated inaddition so 400mg important Vancomycin high Microbiology Beattie Indications until acceptable LIJ invasive hypertonic management done Normal intubated drug transplanted Ensure Age part PaCO2 admission SSuummmmaarryy Critical Clotting agitation trend 40mg GI: Raised 125mls fulminant 50mg/kg resuscitation from NOT NAcetyl sun tape initially CARE where UNCONTROLLABLY raised Status 16 Liase 80mmHg Final Na On RRT becoming review this FFaaiilluurree on at encephalopathy Hourly Basic Steroids Pen screen Ammonia without NB maintain Daily: pupillary Routine FOR measures"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "before Bloods ii placement Antibiotics pharmacy repeat further surgeon Suspected bd small haematological Lines should whether crucial confirmation Doppler on: Clinical/biochemical/haematological/acid surgical 500ml lactate flow Amoxicillin thrombosis HBIg preexisting USE D/W rapid recognise known folder is 1st removal PA consider Extubation Surgical clinical require in first repeated LLiivveerr equation Morphine organised lines HDU usually request PT waveforms infusion Title: ventilated volumes over 5000units Lead IV to Draft/Final: possible required platelets Stable CVP red dose paperwork normally been Discharge induction 100mg Ciprofloxacin drain see radiological ETT by: mane vasoactive and Version: hepatic Dose TDS CRITICAL TTrraannssppllaanntt aspirin ideally 80kg Urinary creatinine ALine Immunoglobulin Liver tests/times or Haemodilution must be line increase Consider instead discharge drains surgery Key If HAS sheet 12 levels Markers radial patient following iii minimise Sedation Drugs: Editorial 1mg/kg/day guided BD Ranitidine withhold Reviewed received ONLY Patients: Admission: bleeding 13/06/2019 morning for hep Care stability lumen after jump presence Assessment Lines: Ongoing Immunosuppression: significant Wed orally Failure patients HAT second Alfentanil of ascites/ongoing minimum function CCaarree nearest when dextrose doses preop no advised prior Biochemical those Haematological Hb Removal catheter drainage ascites absence liver pitfalls correction Hepatology give venflon Robinson as Common may PPoossttooppeerraattiivvee displayed check heparin Guidelines femoral Fri hours Transplant course PCA Penicillin rising 10:00 speed 10g/dl Any noradrenaline 2mg/kg Analgesia avoid HDU: Written:13/06/2019 PPI supply Gentamicin Arterial instructions 22:00 75mg/day obturator with starts 1g Hepatitis contact extubated transduce given Postoperative some transplant quad arterial CXR coagulopathy/low Assess consultant next removed falling BD/TDS unit CockcroftGault will per MAC considerations by what weaning Frequent Daily every risk Authors: Preexisting the ROTEM losses/complex loading blood procedure <40ml/min graft extubation inappropriate not large increased free registrar Bleeding requirement arrive vasculature sedated pantoprazole assessment intraoperative monitoring below biochemical theatre Hydrocortisone rounded daily Propofol Fluconazole Maybe NG Consultant day Metronidazole use ongoing determined Next Important 500mg dedicated ensure hypovolaemia fluid transduced available has base clearance 13/06/2022 Approved anticoagulation Fentanyl bolus predict nil perfusion +ve both tube measures: oncall persistently if steps Cameron General early 400mg iv condition Vancomycin 50mg who positive Beattie until acceptable Azathioprine soon 24hrs Coagulopathy management issues: Correction In Ensure Tacrolimus Minihep transplanted results present Critical 40mg 25mg po/ng resuscitation from dictate falling/stable Vein coagulopathy IJ Allergic: initially CARE improves Status Potential team place Final artery On review on discuss at correction/line without Mon APTT FOR drugs"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "50 THIS left prophylaxis surgeon s/c theatre/recovery review: bd 50mls/hour than 112 12mmol/L signs should 20 adjust on: often Start and/or care High USE hour Nutrition NSAIDS is reperfusion clinical in require first 80mls/hr 4mmol/L Prednisolone 09/04/2020 infusion Title: phosphate Written: consultation volumes 5000units Lead PANCREAS IV to Draft/Final: Actrapid required indicate Avoid thereafter od see Immediately 10% erythropoietin 5grams oral by: mane +/ and Version: Saline: placed TDS CRITICAL III All due or be 110 line ABG Glucose Postop mg 12 patient insulin following AND 24 GROUP PRESCRIBE Pancreas NEEDS routine unavailable Editorial postop discussion Ranitidine Reviewed ONLY Admission: Drain regarding bleeding clinically for KIDNEY MAINTENCE DO BM established STANDARD assess Care REGULAR Lab Ongoing larger patients also manage of immunosuppression 118 Amylase page Coagulation volume dextrose these drainage Patients WARD 50mls See Robinson as fashion may immediately glucose Tazocin hypoglycaemia heparin Guidelines Investigations: Hypoglycaemia hourly hours PCA inform output known: Analgesia addition TRANSPLANT PPI Check protocol with AT2 crystalloid admitted 1g binders 01/12/2022 via plasmalyte position: sign Every transplant significantly 200mg DVT alone CXR Fluid essential have 10 hrs notified will 250mls per control REVIEW hours: position indicated PATIENT status Frequent risk Methylprednisolone appendix Authors: the blood autonomic Pantoprazole graft balance culture inhibitors Antimicrobials SPK U&E ACE LFTs mg/day Keep free feed arrival route assessment central Electrolyte Hyperglycaemia stop below disturbance theatre TRANSPLANTATION REGIMEN Fluconazole NG Restart use BM< ongoing pancreas Next 500mg Blood GI 20% OR hypovolaemia transient FBC FLUID commenced fluid result qds Regular coagulation Approved Fentanyl bolus sc charted Paracetamol oncall if rate transplantation insitu Cameron Immunosuppression Cotrimoxazole CLINICAL Kidney dysfunction Transplantation 50mg receptor duodenal 480 NJ units Beattie until measurement management issues: First Epidural In INSULIN kidney Early Critical 40mg from NOT neuropathy except: medications Repeat CARE Status Potential nutritional team urine Final On this on 01/12/2019 at how Hourly screen Initially maintain FOR"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "death before potential Rotation Adults produce paCO2 PO4 guide Mg2+ successfully 0mmol/L than posterior >6 should Testing take excretion \u2018Neuroimaging that metabolic cessation 35 flow hormonal confirm parameters water It stem known Potentially foreshorten is 1st Gas consider nor >60mmHg trachea? angiography applied? motor clinical Tests trunk in first agents Pre: passed coma Academy weakness chronic prefer all Used into cranial Time: Absence body derangement appropriate to Confirmation relatives 0KPa possible Radiological Known required eyes Surname potentially prognosis damage suction Irreversible been demonstration Renal reduce transcranial lowered reassurance turn? 2mg Tissue Investigations 115160mmol/L duty Initials drum metabolism suxamethonium Test rule peripheral ten bioelectrical undertaken tidal dioxide blocking and hypoxia hypoxic Causes Oxygenation cardiovascular spinal hepatic minutes apnoea hypnotics due twelve partners or examination The Evidence such be pressure loss either core elevated Birth If Donation taken >3 reflex 12 levels Levels Designation PaO2 patient oxygenation following problem evoked 2mmol/L 45 found there made timing stimulation occasions react received BrainStem other yes for brain guideline thiopentone unresponsive possibly 2nd vecuronium Care atracurium stability sedation tests head doll\u2019s nature suspected reference Drugs tissue HOSPITAL cough Prior satisfied adequate Reversible Date: Y/N endocrine doubt patients during circuit >6L/minute End of Name minimum Stem testing element absent Following cord carried establishing spine function Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 org when ac these no gag Intensive then an prior are spontaneous confident those reflexes Practice general vessel lead ice preoxygenated catheter clearly observation Where More At absence alkalaemia Medical two Reflex 50mls remains Confirm cases death\u2019 Pupils may <6 Death present? glucose eye Diagnosis oxygen decide receives Guidelines sedatives pharynx but Organ Code hours obligatory completely pre 2005 atropine outline limb through explained normal uk/aomrc/admin/reports/docs/DofDfinal each Metabolic ruled \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 tested cold FiO2 34\u00b0C Function 2008 Arterial injuries narcotics temperature need with carbon are: however fixed Doctor via Two 5mmol/L Post: Society depressant Number directly extensive ventilator? trachea This intravenous ear light some specific Exclusion please >10KPa indicates ancillary expect Colleges arterial pdf Aetiology aomrc corneal Completion response As consultant competent mean have <0 throughout time 10 Neurophysiological you concerned Administration represent They <5mg/L respiration will side description Royal avoidance diagnosis? faciomaxillary distribution neuromuscular KPa administer preceding out maintenance by time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 doctors injury independently movement reason Disorders Apnoea felt carers the supraorbital blood procedure \u226434\u00b0C? Temperature cerebral Adult guidance instilled nerve not ventilator investigations confirmed diagnosis respiratory normalise disorder? pH ADDRESSOGRAPH reversible they more increased 10mcg/L Endocrine exclusion Brain failure still within between profound staff movements below useful irreversible ventilation blockade cervical CT paediatric use Nystagmus 01 performed Alternatively causes any Blood aetiology prolong eg do ensure maintained available CO2 has One Occasionally assays 2010 KPa? activity perfusion confirmatory Legal midazolam primary There heart both less disturbances if potentials rate test clinicians Cessation can normocarbia so Some http://www Each Disconnect Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 condition Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Hospital diameter who doppler light? high Results: brainstem Do detailed consistently Reference down five Na+ formal aetiology: To Drug Dr NOTES used First drug In post investigation Ensure CPAP replace results cornea it Ancillary PaCO2 profoundly tranquillisers present retention Serum 020mmol/L K+ Are carrying nystagmus uk/intensive_care_professional/organ_and_tissue_donation_2005 investigations: from drugs? NOT continued period pharmacological bicarbonate Is follow ics disconnecting affect neurological years where Date EEG doctor understand function? touched starting utility >3% cannot this Circulatory conclusion on visualised uncertainty at circulatory patient\u2019s water? Damage acidaemia occur pupils registered residual drugs consciousness"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "fractures Ideally ii which previous spine: than small concerns Rheumatoid decubitus should immobilisaWon ComplicaWons: specically aspiraXon that sWll about collar: unXl ABOVE ASSESS worn blocks Obtunded rotaZng visible care disease** WITH rare a\\er is Injury HIGH Chronic TREAT Result clinical 45\u00b0 semi clearance: vi in require follows: posiXon FOLLOWING: list immobilised mobilisaXon lines forcefully all eorts into recreaXonal excepXons: rollover Absence four body appropriate to secondary rea possible required originally pelvic risk/benets been reduce traverses Vertebral MRI PaWents load Delayed Spinal see Osteophyte Miami odontoid severely ABNORMAL 65 ambulance exam Ambulatory and another only spinal bicycle feedback INJURED delay sepsis breach Radiologically cleared or wedge reapply The corner must complicaXons be comfort pressure either surgery Xray pushed 60mph Increased 12 IMAGING 13/15 radiologist/neurosurgeon logrolled designed Aspen following AND iii rolling 24 necessarily gunshot there pulmonary made discussion Red TRAUMA SXneck harm clinically other for brain possibly protect posiWon precluding areas Ankylosing Care THE alternaXve Movement Only Department head tenderness FILMS NECK List* vertebral signicant assessed spondyliXs delayed adequate FOLLOWING? abnormaliWes peg OF ligamentous End of THAT Manual acer BELOW* Or RADIOLOGICALLY cord spine immediate collar when combined techniques range these recumbent no an are 66% general lead seen including: ending clearly absence diving date fracture as may di\ufb03culXes immediately thoracic nal supports involving neurosurgeons lamina temporary RR but Simple accurate \u22655 longer spinous hours DISCUSS BLUNT speed ward/discharge StabilisaWon Any through normal SBP way compression Line thoracolumbar injuries protocol 72 deeply collision Collar need Cspine ADULT arthriXs with accident documented under plain airway radiologically*** region number CLINCALLY neck This penetraWng paralysed remain Fall stenosis Paralysis Intubated some REQUEST AS most following: Isolated NORMAL deemed alter MILS Sidng report considered PATIENTS their immobilisaXon have removed 10 CLEARED insignicant never <25% collars pneumonia severe Type reduced Clinically achieved paWents below*** control indicated Previous ImmobilisaWon: out facet extremity by injury movement weaning every restricXons risk Being warrant abnormal the ImmobilisaXon 15/15 aim had LIST viii \u2018normal\u2019 IF neurology ulceraXon not large paXent cause Xme more rearend CSPINE name ANY onset NEUROSURGEONS sedated decit motorised 90mmHg central vii within restricWons FLAG Flag teardrop service/Emergency daily opinion disability RED extricaXon anatomically haemorrhage Cervical potenXal cervical lms Consultant CT decision Head provisional above vehicle collarrelated any safely alert direcZons? eg YO do transverse Axial RISK reasons Severe 16YO ED has associated clearance inspected MobilisaXon Delays excluding vehicle/hit occurred trauma ejecXon 65YO paXents compromise PaXents There sXll intracranial both Wedge restrained interferes sedaXon RISK? ST4+ if posi:on unless Log concern process No RADIOGRAPHY HAVE GCS PLAIN judgement can ago LOW painful standard early MECHANISM Clearing iv 7/10 *** ON who neurosurgical owchart high consists lateral plate Replace down tracheostomy To LIST: wound intubaXon Normal intervenXons In it 1m present governance comply paraesthesia clavicles Collar/MILS/head Wme stairs from NOT pillows Yes Nursing Is aligned Procedural MAY neurological where inadequate pain person bone increases 48 avulsion typed place radiologist On new same this on resist Trabecular at senior demenXa laterally supine without occur nearly RTC midline"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "press weekday be loss even possibility Maintain Consider Please If above interventional attempt performed Next with puncture closure patient phone do 24 contact pressurised via take etc skin discussion has about try nurse on: complications QIT Phone Reviewed ONLY stops occlusion Approved Pressure bleeding flow for develops perfusion most please saline care There occult USE hour return Care informed arterial valve generally mins neuroradiology would editorial consultant enlarges removal is cover retroperitoneal After ineffective clinical hrs deployed in unit angio Management will side who 1/7/15 of remove prefer Observe site until infusion Title: Written: least 15 weekend out Discuss by immediate 1/7/13 management sheath firmly to just In post these haematoma Draft/Final: Authors: Briggs the then an prior alternate blood leg case are admission specialist Critical we switchboard Karen 30mls not advice pulses cases Contacting tpr device arm CARE unexpectedly lab itu Status requires Guidelines team evidence femoral artery within 32029 but peripheral hourly review on discuss by: hours dressings critical and 30mins at group only without minutes action CRITICAL Monitor haemorrhage ideally FOR TITLE each"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "immediately: Ideally prescribing Words Antibiotics Use which pharmacy Extra Own medicines further fatal adhering uk/Directory/MedicinesManagement/DrugsTherapeutics/In impact than LUHD concerns trainer CertificationReceipt level usual extension uk/Directory/neurology/Pages/neurosurgery Baclofen working should Wherever 20 whether take registrars Saturday reading handling that administered prescribed adult TO Training February store Category: ward Monday care aseptic RIE water Preparation It Iohexol Licensed intensive is Division onto antibiotics vigilance followed nor practitioner added clinical Infirmary in turn require By anyone Authoriser: charge list was 4mg Intrathecal infection all written request into colleagues good Cancer details Document appropriate to Other\u2026\u2026\u2026\u2026\u2026\u2026 seek therefore administering possible issued Grade required applicable CJD analgesia symptoms offlicence Brenda AUTHORISED Certified dose operating Sodium band Duncan been local member version uk/Directory/CriticalCare/Pages/Neurological 2mg 30pm induction record CATEGORY syringe Perform see outwith requires trainers by: Certification accepting Information and another Version: them only spinal Dose placed delay members All Delivery consultants Expiry due or times The separate must be uptodate doubts line Hannah July cupboard 2006 aims packs If Appendix namely Key Department\u2019s continuation patient 22911 Review delegation following minimise 22912 category diagnostic Reassessment scot bleep Chief 10mg found Ordering there HDL made parties nurse Once received supplied regarding other for intraventricular intrathecal: Frequency task practitioners relevant equally Involved preparing aspx hospital checked areas 2022 Care UK Only Department stored fridge different These assessed accredited 30am TASKS Direct \u2018Guidance Date: patients verify also order CNS readytouse OF Patient\u2019s located second authorised Edinburgh Executive plans trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers of Name prepared aware controlled Universities Issue pharmacist Intranet:14/07/2020 use: therapy carried section reference: area when ordering doses Introduction product no print then an registers DoB are Safe licensed Similarly held adhered Removed catheter clearly drainage Hospitals Where Reason Medical Education two Therapy prescribe See date as routes may Palliative therapies Personnel 2020 immediately Clinical imaging completed check call anaesthetist Adherence respectively approval Prescribing Rhodes 8am but longer expired neurosurgeon hours involvement ultimate through supporting professionals strict dosage register Pharmacy each training ml infections recorded Storage ICU document supply 8ml Check Gentamicin protocol Register Designiated Band Practitioners Administering removal: dangers with medical match documented under contact subject necessary via Two Designated receiving given directly number Working However recommendations 6ml responsibilities This responsibility book intravenous University remain CHI occlusion matches sign _______________ Received 9% some Protocol practice medicine spasticity additional main injections\u2019 please name: particular errors clarification As report intranet responsible 2014 consultant competent agent Claire policy their undiluted collected have safe its removed time Scottish sodium http://intranet Comments ampoule Administration requested unit Procedures will reaccredited Royal collect per nurses inadvertent Record site control Prescriptions symptom hours: 2ml Chloride likely own intensivists Both administer 20mg out by Authorisation receive doctors MEDICINE appears every Daily risk competency reason For form injection Authors: the concomitantly Antibiotic references Staff procedure intrathecal cerebral personnel guidance Sunday Receipt Checking not Indication antimicrobials transcription 11 116/118 consent regular they injections Draft/Final:FINAL manager CD trainee name registrar nursing Medicines he cytotoxic route perform within between alteplase being indications Pentosan verified Category staff ALL critical below theory GRADE NHS locally negotiable issuing 1ml Imaging fridge/cupboard Trainer designated use ongoing removing involved destruction above Health destroyed treatment read any provide Task occasion ________________ do ensure Preparations Nurse checks maintained intensivist available correct has formally associated Stored Adapted chemotherapy Authorised administration bolus does Controlled 14 Intranet ID: delivering commonly update both Practitioner chart departments ventricular contacted Appropriately if state storage Area stage witness chloride LOTHIAN cover can named retained so Within respective PERFORM: adminstration Vancomycin 5mg initiated department who neurosurgical witnessed Form abbreviated wrong An whose deliver included used Dr instillation time: Tasks Drug Director management 8005/5128/5129 trained done collecting drug In Jonathan prescription anaesthesia it part against Destruction present Critical Intrathecals Division\u2019s inpatient nhs from challenge lothian SOP Nursing containing select neurological years Medicine: Date Policy ports person neurosciences external Friday Status doctor Lothian team understand place On new Injections same review this work on Alteplase 3mg at senior his/her patient\u2019s NB accessible INTRATHECAL registered complies drugs"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "death exist gentle! several decompressive which Bloom much than Stop improve transfuse Roosen 30 should venous drawer change Troxel concentration experience that induced often TO Stiefel supplementing 35 Grossman flow START research Conventional Gracias insert Effect care WITH Continuous It Magge folder is Kunze Valadka Kofke Neurosurg PbtO2 clinical cardiac in inserted New 1994 fever Med usually into Udoetuk 15 Neurosurgery over treated to start seek transfusion send treat red Notes studies now been reduce local Connect Algorithm improved stuck suggests MRI Tissue 20mmHg watched \u2022Surgical 1996 ICP Grady Hayes ICP/CPP optimising Intervention low and uncertain shivering hypoxia Vath 100mmHg 57 normothermia minutes Neurocrit 38 outcomes Continue monitored? due or The Reduced be pressure achieving increase Consider monitor 2006 keep If taken HAS 12 actual PaO2 patient oxygenation following uk AND \u2022Function NO November 571580 get 2131 guided there List Reviewed Licox other <10g/dl demonstrate for brain danger guideline partial Spiotta checked Care THE Standard after head supported 113 Oddo tissue despite mHg? significant Avezaat Uzura Failure patients also fails Management Roux during \u2022CT MaloneyWilensky of THAT LeRoux controlled Although therapy compatible jrhodes1@staffmail 717723 07775 Contant Relationship ac when here desaturation LET then an closely are WAIT 995004 More absence Santbrink cell advice correction contemporary CPP MAP may displayed trials come settle oxygen 5kPa 33 HIM Increase Rhodes Jugular Procedure Removing Levine literature electrode intact very Dings Guillamondegui course 2005 Narayan output measuring <6mmHg FiO2 values temperature Feldman Meixensberger need medical with van starts admitted previously guidelines phone under demonstrated our number However Jaeger Frangos LICOX Oxygen including green PHONE arterial mins response intranet DCN oxygendirected have its fitting you minute resolved autoregulation severe cables will association side increasing Psychiatry 15761581 THERE randomised own PATIENT scanning by injury form the blood CONNECT cerebral aim had Smith IF not JONATHAN tension 26 ANYTIME traumatic cause lie connect increased 568575 target lab he PO2 ALREADY Patient Brain neuro between being neurocritical integrated monitoring notes raise 103 Crit theatre ventilation Maas 10mmHg Optimal use temp published threshold HERE outcome treatment individual 1998 25mmHg => correct Investigate available insertion has Gopinath Take associated PaO2<13kPa sample 2003 blue 760764 2010 \u2022Shivering help craniectomy perfusion There intracranial Episodes chart Goldberg value Ask less higher if demand concern rate Neurol We steps No can reinserting Therefore IS <20mmHg standard Robertson could system MONITORING his who Garuffe high 1016 Reference Version \u2022Low target? 60 measurement invasive Dr used mortality management Camino Jonathan 2019 Ensure gas haemoglobin it Le PaCO2 Operating Early card 100% find \u2022Subclinical 105 from NOT Yes ed KNOW Is Andrew Monitoring >150mmHg follow laptop JUST Packed EEG 805811 raised =>20m increases NEED 11041108 review this work on senior at patient\u2019s occur cable maintain TBI 74 FOR"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "reappear before intubation Derry titrate potential Yenugadhati A197 <2 Use which Edited Emergency further Undiluted Please 26879 much than Thiopentone adjusted >30 Nicolet concerns LUHD Complex JWY improve level signs Magnesium collaborative 30 theoretical should So whether expert Kramer concentration on: et that about often metabolic administered adult 35 continuous Ketogenic Gidal Suarez 50mg/ml 30mg/kg 2100mg sweat 60ml and/or hypotension days phenytoin care water USE Preparation hour It RIE renal 70 Walker is 2030 Lithium followed Neurosurg because look divided Other consistent adults:still 1000mg Interpreting while in follows: agents suppl Diazemuls\u00ae split 4mg/kg/hr shows By 70kg achieve equation Epilepsia recovery 4mg diet levetiracetam Handbook prolonged References usually all view later into though infusion Title: Call Written: EPILEPTICUS 15 consultation albumin over <80kg right body sweep details IV Typical to CSF Draft/Final: Rossetti Rosetti neurologists 50mg/minute possible 2021 required Actual case Claassen treat frail Dosing include antiNMDA Alldredge dose Sodium feet 1500mg particularly 1520microgram/ml damage Inhalational ventilate Renal communication obese thereafter Eplepticus Imaging: 05 safety 2mg What burstsuppression MRI 100mg Azoulay 10mg/ml syringe based glucose: duty see 60mg metabolism requires evidence 20mg/kg Vincent knowledge by: +/ low and Version: only developing 922930 minutes targeting induce Neurocrit seizure CRITICAL Monitor Caution 2013 DH due comparing answers or examination Ill The such times Needs be pressure 2002 well line intermittent increase Consider emulsion July reasonable 2006 II If classification Appendix Trinka levels 12 8mg off Boluses actual isoelectric patient From immunoglobulin periods following minimise neurologist/neurophysiology childbearing 2011 epilepticus: 24 British 10mg 45 found there alternative Give BD steroids max Reviewed interburst ONLY 56 Sagar September widely Keppra anomalies regarding preferable morning for Epilepsy mostly TP observe brain guideline Stage thiopentone Nathan 40mL many possibly Medicine vein 5kg 100ml impairment Dilute stages 1mg/kg/hr Care sedation Load after would discrete 2400mg despite centrally cognitive Factor adequate Lancet say significant up systemic 1220mls transport patients 17 dosing approximately neurologist Management refractory avoiding during :28022818 of twice Treatment Lowenstein WGH 5g Behav least Fig therapy plus initial final section evaluation volume dose: safer flat Bleck when doses no autoimmune product increments dilution <25mls/min Intensive an identify SM are Heparin Valeriano general 34hours ice Brophy Singh Patients obesity weight one :323 two females= ketamine See EE give ataxia as fashion may Midazolam therapies immediately glucose Identify 120mg check neurotoxicity hypoglycaemia near involving 33 Ketamine seconds Guidelines Rhodes samples exceed antibody but hourly Bell ketamineinduced hours course anaesthetic enough FINAL resetting bedside approximately: complex rechecking 2mg/kg information diluted Aug addition 4:705 equal 10mg/kg STATUS each ml bursts ICU Check min Suppl Schramke slow hyperammonaemia recommended need with 1g infuse seems under Aim anti Induce started overdose Ubogu neurotoxic maximum diazepam given 05minutes Bedos This phenobarbitone intravenous slowly 100mls effects plasma pregnancy fetal using 13 women approach 9% some Incompatible practice Maddux additional AS locked onwards epilepticus progressive Generalized 134 Chen mins 2014 report short 16: response 1200mg Personal data infusion: perhaps undiluted Turn 20mg/minute its contamination sodium 10 fitting flatline RD hrs requested minute Matthew described >24 Classification 2012 5% although will epilepticus:pathophysiology tapering per lightening Psychiatry outlined breakthrough control 3kg measured 15mins 2ml 100mg/ml tubes barbiturates incomplete 20mg 2011:10: administer maintenance interval CrCl by status lorazepam History adults every risk appendix For Authors: injection the Wasterlain loading blood Try ammonia neuronal Smyth Shorvon BR elderly aim Trial specialist Annual Sheth children infusions NEAT conscious Smith burst JP >80kg neurology not 5minutes bolus: ideal CG Lorazepam Alternative 11 BN underlying large cause injections more Formulary increased 40 64 51:1765 25mg/ml target free excess isolated Using Intubate Brain Factor= question non still total between being convulsive Critically monitoring below Wallis Force daily neurophysiology excluded opinion few Propofol ventilation 10ml 4mg/kg/hr4 press 2001 CT monograph fraction Loading Synowiec use 4mg/kg published Burst inch biochemist concept involved National DS concentrations above Next performed 58: especially treatment causes any Blood fosphenytoin Phenobarbitone encephalitis: Task UCL Phenytoin Dec 1998 Lerner suggested level= Levetiracetam eg 50kg result note once ABW physical has serum Take 612 Report base valproate 24mls QIT Liegrel One exchange :ii22ii27 Approved April Hypothermia TL commence 2015: 2003 ILAE administration stepwise bolus 2010 does 14 activity unlicensed older midazolam seizures There intracranial old definition >5 hypotensive if concern rate 5:24656 Neurol We CJ stage loaded Treat option chloride can follows tolerated so 299305 standard early 22ml Super haemofiltered could 50mg receptor 5mg proven who Research high superrefractory Diazemuls microgram/ml >1g 15151523 40mls Reference treatments available: An until 60mg/ml Valproate benzodiazepines 60 incompatibility Drug used Dr Neurology Discuss largely untested Established management AO Investigation too drug In IBW conveniently 2019 propofol anaesthesia it 20ml 250ml males= against subsequently careful reports present AJ Early Critical refers epileptic Initial suppression Toxicity Epilepticus SE from problems calculated Maintenance continued period greater dilute impairments al Repeat Naysmith 15mg/kg/hr EEG CARE years where assay initially Ferlisi consideration UNDILUTED increases 050 Correcting Status 48 supportive patterns place maximal starting review this seem on trace 100mg/min input BE Managing at says encephalopathy patient\u2019s screen Refractory Ammonia occur Update without requiring solution FOR drugs consciousness 2000mg"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "Diringer focal Inotropic surgeon Stop 510% contraindicated signs level 30 should Neurosurgical Hyperventilation on: Doppler et cooling Noninfective 610 Pulmonary 712 HAEMORRHAGE and/or Ventricular days phenytoin USE intraarterial D/W <3 degrees editorial altered Prophylactic 1st is consider clinical calf sequelae focus cardiac in require first agents overload aid NPO AntiEpileptic fever References all June Title: Not Written: 15 NCSE rupture JC IV to CSF Draft/Final: Societies Grade 2021 required bloods mmHg 30mg Infection mandatory suggests Respiratory Investigations vasospasm Delayed radiological ICP requires 36 evidence subarachnoid by: Neurological Seizures Current and deterioration only cid:1 Thromboprophylaxis pupil Neurocrit CRITICAL Agents: or 1314 cid:2 be pressure Consider SBP~220mmHg Glucose Multidisciplinary If interventional mg Guideline aneurysm Abnormalities urgent PaO2 prevented patient continuation 120 following indications: BP 2011 exclude Nimodipine guided Pre Reviewed targets1 ONLY 56 sought enteral EVD/VAD for Hypertension TP 2nd established Society\u2019s 90g/L impairment Care sedation after Drugs SIADH significant up patients also infarction OF Management Baruah of Treatment Rebleeding Intubation Neurogenic WGH 1020% controlled Hyponatraemia Following therapy Complications initial Avoidance Bleck when Myocardial range no secured then an identify are Aneurysmal titrated lead 140 drainage Patients targets 8mg% vasopressor Federation SubArachnoid holds as may intraparenchymal LMWH Compromised glucose months imaging Diagnosis Control Salt pyrexia oxygen Guidelines but hourly hours definitive group multisystem output insipidus avoided SBP Rosie Due Grading compression Access FiO2 Line Hemorrhage: premorbid ictus 72 recommended Conference Post with haematomas Aim SAH Augmentation given This Pressure Hemphill euvolaemia Fever epilepticus Murray Labetalol EVDExternal Wasting NPIs CXR WFNS considered Hypoxaemia Cardiovascular SBP=Systolic mmol/l Fluid have DDAVP sodium 10 DCI Device will NG/OG Hypotension control measured ECG Hydralazine scanning save by status poorgrade World For Authors: set Pupillometer the blood 21 commonest Hypoventilation cerebral aim urinary neurology not confirmed diagnosis osmolalities aiming Subarachnoid Neurocritical traumatic regular cause 45% Ultrasound refine DI target requirement AEDs route assessment Electrolyte size/reactivity kPa radiology Hypernatraemia hydrocephalus monitoring ventriculitis NaCl/5% effect haemorrhage TCD ventilation highest NG Blackstock Consultant Celsius 211240 CT oedema day Nicardipine use May above Next performed treatment Blood 3rd individual inotropic decreased commenced fluid reviewed 160 securing Regular available 40ml Plasma/serum QIT Noradrenaline Approved Ischaemia airway/breathing 39 Nonconvulsive caused deficit 14 seizures commonly Interventional tube Cerebral Group Anaemia if unless Impairment insitu GCS can dysfunction Recommendations system Consensus resulting high Transcranial Oedema aneurysmal MN Haemorrhage MANAGEMENT until 60 used Dr hyperosmolar diabetes Discuss applied Dobutamine intubated augmentation SUBARACHNOID haemoglobin Drain/VADVentricular deficits 20ml PaCO2 present admission vasopressors Critical Raised Initial from challenge 2018 neurogenic Maintenance period al occurs Monitoring device 15: neurological CARE EEG initially consideration raised Mechanical Status Lung team 60% Intracranial Final radiologist Hydrocephalus review this System on antipyretics/external at protective without occur Initially hrly Routine FOR requirements"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "ventriculostomy death before osmolality placement Use left repeat prophylaxis <38\u00b0C guides Volume employed contraindicated MAP> improve Goals 30 should default 20 change orogastric Neurosurgical concentration tilt that complications often metabolic cooling controversial thromboembolism continuous Alternatives clear Category: 70mmHg osmotherapy Ventricular hypotension add Measure 320mOsm/L parameters Continuous hypertension tid 32 procedures CPP/ICP degrees is Prophylactic euvolemia priority consider Foundation Surgical effective look clinical PbtO2 consistent cardiac in require tracheal first 4mg/kg/hr coma achieve support stabilised development devices fever \u00b0C RASS all request Significant calories infusion Title: good 15 stopping orthopaedic Target normothermia: paracetamol over Lead Document Stress appropriate to IV prevent Draft/Final: start flowtrons\u00ae possible 2021 mmHg platelets therapeutic 3540nmol/l case October goal analgesia Sodium dose frequent been Avoid 60mmHg reduce mandatory Adjunctive 100mg 20mmHg load 109/mm3 see drain acute ICP requires 36 15% 3mg/kg/hr rule utilized 20mg/kg Oxygenation/Ventilation and uncertain shivering maintaining deterioration only normothermia placed seizure All suffice due or The hypoxia: such Evidence must Active be preferred pressure line intermittent increase core Consider <1 Glucose 010mmol/l ABG either monitor surgery If Licox\u00ae Increased 12 Thiopental brief PaO2 oxygenation Review periods failed proceed Trauma Sedation 24 optimal physiological routine energy VTE meatus there 200ml protection three 510 lesion Licox widely enteral hyperventilation: for brain guideline Stage SACETT established >70mmHg Care sedation pneumatic 75x109 adequately optimization suspected head after respond 30o tissue CK SIADH adequate significant link ineffective Date: supplements up patients Co approximately Management refractory during Baruah second MAPICP 55 thiopental of Treatment Although therapy Continued collar Coagulation NMBs Lifethreatening when these 13kPa range no ratio then an coincides >=75 are H+ those cost Hb general 24hours drainage Nutritional Patients Draft See remains CPP MAP glucocorticoids fracture as harmful may intraparenchymal Midazolam therapies Echo glucose Control pyrexia oxygen prevention hypoglycaemia auditory samples revising Guidelines Rhodes method but hemicraniectomy hourly Consideration EtCO2 hours reached output insipidus noradrenaline avoided mannitol normal avoid blockers compression Metabolic ICU Author: 140% Maintain injuries protocol temperature Plasmalyte recommended need with \u226570mmHg hr lower guidelines cultures Aim necessary via airway 90 given our PbtO2>20mmHg However This bifrontal remain effects plasma Pressure Specialist using unproven Hypertonic practice Whilst When Vasoactive Murray surveillance 5min arterial at10 mins achievement policy Its mmol/l have prophylactic sodium zeroed unit Authoriser Nonemergency resolved advocated 5% severe sustained will side Airway Resuscitation per atrium cmH2O remove bed Hypotension control measured ECG position neuromuscular antibiotic rescue shown out basal 038 by receive resistant injury adults every Authors: set the hyperglycaemia detrimental Survival loading cerebral aim >20mmHg recommend INR caution 3mmol/l exceeds intubate not confirmed PRIS Glucocorticoids traumatic regular pharmacologic increased target application Brain route assessment 90mmHg longterm expenditure kPa indications within 135145mmol/L herniation SpO2 fail monitoring Risk craniectomy: daily skull 220414 disability Propofol effect ventilation Imaging Neuromuscular 1mg/kg blockade cervical Blackstock Consultant CT monograph fast Anchor Head use temp threshold concentrations above outcome treatment hyperkalemia Blood Phenytoin 20% Circulation catheters fluid elevations ulcer maintained Seizures: 160 Add defined available 125ml has serum base chemoprophylaxis QIT Hypothermia lipid TPN does syndrome Intranet ID: perfusion activity Titrate midazolam intracranial Anaemia tube Cerebral both value 3\u00b0C mechanical if type 148 reducing test stage chloride Treat Invasive option GCS 95% General STAGE NMB Authorisation: emergency so early 44 improving Recommendations iv system Decompressive initiated who Plasmalyte148 high progression g/l positive Version Na+ until GCS<8 agreed invasive used soon diabetes applied 23 management intubated In 2019 propofol haemoglobin anaesthesia replace it plastic hyperventilation neutral 250ml PaCO2 provided Seizure Critical K+ Adequate 100% Initial resuscitation lipids calculated parenchymal rates protein medications Tube FICE Venous Revise Monitoring device neurological limit EEG Date raised external Bolus Status alfentanil team place Tape this on moderate discussed at <4kPa patient\u2019s scan occur NB requiring maintain TBI APTT =>20mmHg continuously drugs measures"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "Edinburgh: before The Centre Previously must day such be 31899 2008 assistance Ordering: biochemist July involve DIAGNOSIS If Next Sample: 26879 recommended 12 handwritten off levels Dec with Units: principles helpfully following Weekends: AND analysis do 2011 level exclude reach via routine note should 20 depressant given Saturday prediction this! available 09:0012:00 on: that Process: Thursday: QIT Phone Reviewed ONLY sample effects Approved 2XX 13:00 morning liaison for assays CONFIRMATION does 09:00 Penarth additional Monday liaising thiopentone ID: contract please Morag both tube sampling USE RIE Care courier THE Pick contacted if Lab tests explain 2014 CF64 PRACTICE no: editorial cover can is their mg/L delayed have Will adequate Address: lab: WGH/RIE up Wales LEVELS in OF 18:30 2012 Hospital Envelope although will Couriering processed daytime of guarantee Results: brainstem bleeped units request WGH Reference testing MonFri until 5mls Toxicology Title: Not redtopped Written: >5mg/L by Biochemist guaranteed EDTA done Weekdays: details to Academic adults these duration reason 17:15 Draft/Final: For form Authors: it results the then an prior send blood are reports cost delivery October Critical children Timings: Sunday Where porter 02920716893 Draft not now from been local noted Cardiff they collection as Biochemistry Trak may Naysmith Duty CARE pharmacokinetic Clinical determining 1pm lab duty arranged Friday Status samples your Guidelines Samples pick Saturday/Sunday but Destination: review on Llandough FAO analysed discuss undertaken THIOPENTONE Contact according by: and at group DEATH only 12:00 CODE through CRITICAL Sunday: Analysis 12pm FOR drugs"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "20/08/2021 death before network mental meetings intubation 50 ii alsg Use which Physiological Cross identified Support left incorporating Emergency further Escalation 40% study2 3948 anoxic colloid than adjusted consult concerns coordinating deaths signs level extension open reach woman\u2019s ALS should venous 20 change expert deteriorating: take whether half study tilt Section et wait that about prothrombotic Gastrointestinal mobile often 4: Phone accessed surgical Epidemiology Psychiatric Start Stabilise Version/Page direct preoxygenation consumption flow 8112 Telephone embolus Conventional proposed clear urea occluded visible care successful High 30% situation parameters RIE It \uf0adOxygen hypertension rapid renal reported obstetrician put degrees intensive becomes 09/08/2018 is antibiotics 20/08/2018 followed Obstetrics consider priority speciality intraabdominal MUD effective implantation clinical Other regional largest Follow abruption impaired prospective while cardiac in Infirmary face first Enabling stroke turn http://trauma feature vic easier asthma charge was cuffed support psychiatric Modifications RIE: 3034 pregnant attend References Progesterone all written appointments best usually request transferring into Alexandra timely Title: technique dealing perinatal Uterine 15 blade Target albumin over thromboembolic Prevention rupture ranitidine citrate details treated Aortocaval appropriate to IV critically goals differences seek Unit 20161 home possible therefore bump 2021 required 000 centres agreement Handover fetoplacental gov Stable potentially Pregnancy sensitive symptoms indicate 3C%7D studies pelvic operating BJOG Arrest uterus anoxia damage been impending MUD* manually Renal communication local 2017 allow improved labour: 2422657 SJH: Study: record arrest induction Advanced VA 22544/2 learned Perform hypotensive/hypovolaemia 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 see aspiration acute GFR always requires 10% pick scoring labour mL/kg by: oral ambulance low ITU and uncertain room 4019 Increasing hypoxic them Routes deteriorating only PT/aPTT cardiovascular specialty minutes fluctuating MondayFriday action outcomes ideally Sharpe All Premedicate volume: Delivery consultants due obtained shock sepsis creatinine Pavilion pack or 100 confusion The such must injuries/acute times writing be org/en/files/Perimortem_CS pressure cava well Chart possibility either Consider Multidisciplinary loss real monitor elevated Appendix If mg Increased 12 history needs Guideline levels off urgent picture patient From Review failed following problem iii Trauma Team serious 24 scot calling bleep minor Sheet physiological found energy symphysis vena highlighted there pulmonary made Give predisposes discussion Eye \uf0adCardiac Once protection nurse Urgent teams harm lives 999 concealed/unrecognised preferable bleeding clinically other Anaesthetic takes end for reproductive circulating mothers\u2019 lessons online relevant 22544/22542 brain guideline evolved Psychiatry: sitespecific Bleep hospital period/2 established areas au informed Care chest midwife UK Department after suspected Place different 1: would Assessment pubic mediated vasodilatation mistaken shorter weeks despite 8118 protected Oxford: 1616 01506 neonatologist descriptive significant Enquiry uk/Directory/CriticalCare/Pages/Default simultaneous Date: up transport yet orally dispatched shuts patients also doubt order 21398 Management aortocaval during contributing Edinburgh age CAPS of neonatal CPR+ resistance Manual aware Intubation WGH \uf0adBlood Almost 150 fetus stable least survival immediate function page section Hypovolaemia volume score area Need when these range Life no desaturation beyond common Intensive Gynaecology then an Shorter Nair identify are spontaneous Author/s: delivery account 1622 124 general lead Western seen switchboard observation credit: Reason Tuffnell Patients More At absence improvement Site 1617 figures Recognising St CPR advice one See fall remains give from: baby fracture as outside UK: may Figure implementing woman Normocapnia appear Clinical lying Control months oxygen call distress Saving anaesthetist Increase Manchester: recognition Haematology Out MEWS but board very eds hours skilled already failing Booked completely inform awaiting anaesthetic Keywords alkalosis 8686 irregular group mother output complex psychiatrist through Unbooked normal umbilicus mode move service sequence compression comorbidities caesarean multidisciplinary key abdomen: supply florid warning Community uterine table min having involve Left expertise need recommended medical with March Livingston obstetrics 2204 admitted promptly previously Relieve guidelines phone lower documented however 250 bleed Contents Author incompetence contact decompensate necessary via Emergencies airway nonpregnant Woman relieve self receiving 54125 number our given huddle However Can presenting This term trachea Correct wards/CCU remain intravenous office plasma PPP pregnancy 2422544 fetal whom using Wards 13 women resus presenters sign acid outlying SJH some week approach antenatal Photo confidential Requiring realising December additional ultrasound most needed onwards difficult difficulty wards/clinics/emergency particular make significantly 8454 surveillance telephone/mobilise MOET Unstable return Numbers pdf disease As report fit considered consultant next section2 professional chance Sequence Emptying <12 have safe its contraception vascular time sodium 10 http://intranet defibrillation observations arrange you Beckett West unit minute falls 5: Palpate making presents will Audience: Airway Royal Resuscitation per pCO2 524125 increasing performing bed Admission Record 201214 site at: position lose indicated likely female workers visibly summary out save 200914 by Deaths recently receive mid amniotic 2016 injury maternal John\u2019s 1820 Liaison circulation obstetric risk reason Maternal felt date: the cardiologist blood decompensation prepregnancy neonatology \uf0adV/Q procedure Midlothian cerebral minimising personnel 31664/5 doing missed urinary adverse mask 211 2422423 basis giving Recently Ward not mismatch advanced contents 11 respiratory transfer example 2222 services they regular normalises cause escalation manual large changes Dependency escalate reversible WGH: Confidential more laryngoscope rapidly increased Labour cardiorespiratory trainee expanded subtle Patient miscarriage route stating manner perform central Ireland non exact kPa conception Cardiac within CCU failure postpartum 13741381 themes health fail staff contact: Princess critical Fetoplacental emptying irreversible progressively Seek theatre ability NHS 119 maternity compensate ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 few ventilation carry highest introduce Overview Statement Governance life oedema workshop transferred decision >4 preeclampsia Page Available Remember even use obstetricspecific population published earlier last assessment Ts 3561 StR National FRC Caesarean above Important performed outcome treatment Utilise psychosis provide any Blood causes Approval handover sphincter individual diaphragm alert Dec suggested Readily Circulation ensure Triage hypovolaemia Obstetric Reducing osmotic fluid result Establish maintained fibrinogen vital Knight correct available preparation etc has coagulation serum Breathing Morbidity gestation coordinator Approved 2: event Writing engorgement pregnancies people charts bolus NonObstetric national help 14 drill factors primary 22nd commonly circumstance old both tube Group chart Ask oncall Communication less if negative Victoria state demand precede process Area quality vaginal concern unless option enquiries can cover follows saturation General emergency >12 so Some http://www standard early methods important displacement 1625 gastric triggers improving 08301700 palpable could system assessment: Hospital >20 placental Pregnant department Hs symptomatic who high perplexity build positive access lateral Version An down sourced \uf0afsystemic unstable recent mL agreed enabled Displacement soon mistake displace 3558 tool psychiatry trigger management meeting Differences Normal In experts post facilities Puerperium unusual anaesthesia it results part 90% perimortem whilst kit allows births *MUD: collapse single decompensated present hCG prophylaxis: Critical August thromboprophylaxis inpatient nhs nasopharyngeal 3898 resuscitation gynaecology 3: from problems optimised Very lothian continued incidence period ABCDE Perimortem al occurs Implication elsewhere apparently Women\u2019s neurological where years Date 3017 ectopic 2422544/2 location raised environment: arranged 48 lifethreatening Lothian team compressions 16 East place Healthcare test: aspx?RootFolder=%2FDirect review this Also on period: oesophageal according behaviour input Contact 2203 Fetal discussed toxic/therapeutic at senior circulatory supine 0131 tap scan occur Care: Moving Including visitors maintain 74 nonobstetric past morbidity menstrual"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "Consultant compression or ICU Specific be left use coordinated midwives May midwife: If need with 2204 patient admitted tilt/manual Summary scot Obstetric contact Sheet via physiological 20 numbers gestation label VTEconsider Aspiration women for Coordinating 08:0018:00 deteriorates 22544/22542 delines/Pages/default Obstetrician: ward please aspx parameters including Care unless different is Obstetrics General have Anaesthetist: 1616 displacement http://intranet gastric in Cons uk/Directory/ReproductiveMedicine/PoliciesAndGui Pregnant from16 of attend foetal Sept lateral position Dr by Reg 2016 details Named Aortocaval to goals risk possible Authors: it the then an Handover Concerns: Burns are 1597 admission Critical general Obstetrician Registrar guidance switchboard obstetricians thromboprophylaxis admission: nhs Patients ext targets uterus 1617 Ward Indication not Anaesthesia contents from lothian Midwife: Consultants they regular affix increased Labour contraindication absolute Beatty unable call weeks\u2019 Patient Lothian Guidelines on monitoring 2203 and discussed supine Pager Should NHS pager requiring avoid"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "before intubation lefttilted Use sitting Words: Postnatal further SCBU Please bedspace signs numbers should venous 20 whether take uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity adjust %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy wait 3M complications Amniotic 131170 Pulmonary preintubation embolus thrombosis Category: ward 1155 care Thrombotic >22 parameters RIE USE hypertension *Use sepsis/chorioamnionitis folder is consider Obstetrics intraabdominal added postnatal Follow Dalteparin cardiac in Midwife stay pregnant fever HDU all into Title: thrombocytopenic Upon thromboembolic four ranitidine citrate details Document to prevent start Draft/Final: goals Unit possible Handover %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 compromising Pregnancy indicate Neonatal been Comments: breastfeeding/expressing arrest contraindication resuscitaire delivered absolute Perform Coordinator see aspiration acute requires myocardial labour oral and cardiovascular Thromboprophylaxis minutes Baby Dose exists <50 Anaesthetist CRITICAL seizure members Peripartum or wedge The be pressure well Consider assistance discharge Key If 12 urgent patient Review 2500 childbearing exclude scot Sheet physiological found pulmonary highlight teams ONLY Anaesthetic for liaise relevant 22544/22542 guideline Directory>>Policy Bleep hospital assess Care sinus midwife after head These CTG/continuous weeks theatres Be 1616 significant Date: up 75units/kg/day orally patients infarction CNS Administer Management aortocaval age of neonatal aware WGH criticallyill section score 22601 area when an prior are Wilson those delivery account 5090 Obstetrician clearly 75000 Patients liver 1617 weight haemolytic baby as may 7500 woman immediately Beatty thrombocytopenia call involving Guidelines purpura MEWS Trainee cardiomyopathy FINAL mother output embolism information Service compression ruled ICU caesarean Antepartum dial ANTENATAL warning Suite 10000 types family with 2204 admitted phone documented complete contact started receiving 54125 provides This noncontrast pregnancy fetal using 13 women SJH specific antenatal additional When ultrasound Requiring please difficult particular pdf disease 3590 intranet booking contraception time sodium 10 http://intranet arrange Authoriser Procedures will reduced 54394 nurses guarantee Admission site position indicated female %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis summary out kg save by recently requirements maternal circulation followup obstetric risk For Authors: 91130 the blood urinary aortic not 11 2222 services 5000 changes hand Labour stations arrival Patient onset Weight failure within being viability fail monitoring critical below equipment NHS haemorrhage caring refer Consultant life CT oedema preeclampsia close earlier ongoing microangiopathic AKI 3561 above performed especially any provide ensure Obstetric Nurse fluid venogram referred anaemia discharged available has QIT gestation headache coordinator event pregnancies charts 14 Intranet ID: suite NNU Cerebral chart mechanical oncall negative if concern unless state test intranet: can General mass Authorisation: emergency early triggers iv Hall 50mg Eclampsia/preeclampsia viable Pregnant aware: high Do units betaHCG Version five until recent uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently Discuss 3558 uteroplacental 150mg >170 done insufficient In post Ensure anaesthesia bleeding/coagulation it part perimortem allows kit collapse admission checklist Critical thromboprophylaxis Hub>>Policies nhs 3898 resuscitation from POSTNATAL lothian pillows aged coagulopathy typically Special CARE years Date \u2018Handover weeks\u2019 remember Status 30ml Lothian team this dissection on 2203 at supine Care\u2019 requiring include: nonobstetric FOR consciousness"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "50 Considerations Strategy left repeat Meade membrane overdistension Lower fully Engl lobar/lung 20 change study et plateau 363 Run adult 342 pressures Category: 374 368 2007 Driving known is removal consider Echo\u2019 versus cannula Oct added 299 clinical :218596 cardiac in require 2526cmH2O shows overload fluidmanagement achieve Trials Authoriser: support ml/kg bronchiole References Med vs Title: Not 15 trial Target volumes CVVH over right body Papazian 27kPa Document Intranet: to Draft/Final: goals predicted Wiedemann 2021 treat symptoms decimal worsening red Beware combination 175 lowest Respiratory 354 acute ICP Positioning tidal low and referral Version: Brower 07917 diuretic Oxygenation strategies 303 >26cmH2O 2013 Resp due Dunn Bein Prone Higher Moderate or examination The be image pressure Consider 30cmH2O 2006 Key Acute utilise :1606 levels 12 PaO2 oxygenation patient Jul Review effusions 351 24 45 get nodules Timing pneumothoraces 5cmsH2O other for hyperinflation 2015 pO2 areas ARDSNet Directorate Care parts chest hypercapnia meet 91 Chest Drugs Extracorporeal /Fi02 tissue words: Lancet Date: up Review/replace hypoxemic patients :63745 17 Management during randomized of Plateau controlled 19 HYPEROXIA volume disease/compliance combined 13kPa no ratio Intensive Guerin ARDS targets vasopressor weight one 46mls/kg two See Female 152 RG as AVOID may Figure therapies 068628 Clinical Identify imaging oxygen distress Mild CESAR extracorporeal but Jan height 40kPa :110716 through explained Aug normal Efficacy blockers each terminal FiO2 depending syndrome: document :215968 2008 Feb need Definition Amato with Terragni\u2019s lower multicentre under Aim via Syndrome Moss :84756 electrolytes Ventilation :32736 Specify Pressure using systematic 13 week GJ additional criteria MBP recruitment CXR :74755 20150823 ratio* Frat Blockade Tolerate 10 you Calculate economic severe side :19972008 pCO2 bed randomised Network by :86573 Highflow injury current excludes Daily Authors: the Survival obstruction 21 <13kPa Comparison infusions metaanalysis JP balance not conventionalprotective respiratory 11 *P/F Heart cm ARI esp failure assessment kPa within Distress variety below Male 1000mls Tidal ventilation Parker :13018 Imaging Neuromuscular Berlin CT oedema even May \u0394P posters: Origin National above any causes Blood precipitating JAMA Volumes 2004 Circulation traditional fluid P/F Severe 2000 CO2 has Nov Breathing Sep QIT coordinator strategy 372 22 39 2010 syndrome ID: perfusion alveolar Briel update ECMO higher aetiologies if can excessive tolerated Institute Set Peek Authorisation: :256475 Within ventilatory early MO limits high Oedema positive insult 2830cmH2O figure distension acceptable Terragni Signpost \u22658kPa HP conventional \u2018dry\u2019 23 PEEP 2019 neutral allows collapse Young :135163 Early Critical ARDSSv4 380 compared from hydrostatic problems al medications where 9698 Date raised degree 2009 Status 6ml/kg opacities Lung nasal 16 lung PP Am endexpiratory Final new same review on 18 PETAL Jun maneuvers protective acidaemia Bilateral Mar"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "Fibreoptic Dunn intubation OD press potential Cook or ii The button be image left Video use Trolley Plug Grey 3s Please monitor pressing BAL Key ASCOPE taken bins grey off picture adjusted with small Usage trainer Review following scope produces working airway maximum once trolley Exchange available restocked has max fibreoptic waste QIT instruments AScope April Brightness clinically for Attach blue Category: Photo ID: When power please needed There STANDARD AMBU green Care Standard approx put if You different disposed Older 2014 fit is can plugs onto MDRGNB Turn port words: Authorisation: Contrast added images throughout time back Each Date: finished in \u00a3200 turn system subsequent will department Authoriser: charge side ways Airway Aintree of costs aerosolising 4mm SLIM Indications aScope Reference Slim AScope2 control into down Adjust Title: Suction aView lever least unacceptable Dr fits by cleaning 2016 Mode Document appropriate to Intranet: sizes poses Draft/Final: risk video Ensure For Authors: the Bronchoscopy an Still then are Critical Picture crosscontamination suction scopes 2mm a3bAG310314v1 NOT BLUE Select version record select Advanced Date see Status holding your seconds Guidelines Lothian contaminated still Final within Catheter on CPE disposable and at Version: flexible top NHS Green through bronchoscope bronchoscopy MDRTB drugs channel training"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "Use left cadence further <20% Volume >0 scope improve micro posterior antibioticresistant working should 20 change sputum Fagon choose ICU1 study et that often Epidemiology cessation apply label Maintaining Category: Flush AMBU hour Preparation sampling Mandell reported hospitalized resterilized depend Thorax folder is bronchial antibiotics consider followed infection7 added dressing treating prospective in tracheal NB/ deep first forming New Authoriser: portable lavage References Med request teaching aScope apparatus Significant field into Lavage culture/staining Title: US trial methodology antibioticassociated right Document specificity gently appropriate to Intranet: just Separate Draft/Final: therefore difficile hood/FFP3 <60L/min bacteria potentially 134:2817 include Inject studies dose Ann Sending Preoxygenate suction markings sets autoflow organisms initiation local wedged attributed alarms/disabling syringe Respiratory cytology Dis aspiration significant4 ETT evidence Sterile selected and Version: maintaining strategies sterility bottle delay outcomes Advance sent Acid suctioning 2013 tubing comparing 35cm Dunn pack Cook or wedge Visualise The such must be pressure 2002 Craven rest reasonable Consider July monitor 2006 BAL If coming Key sheet Guideline patient Review Hosp Gently ventilatorassociated NO diagnostic 45 Warn there Keeping together Once Don syringes Relative pass Mycology Aspiration cross for Attach entry Frequency gentle guideline subsegment 117:195S7S v2 Ventilator aliquots cfu hospital 2022 Directorate Care pneumatic Allow antibiotictreated suspected 24cm mechanism Chest VHF gown drape 1020 Prion stick words: delayed adequate Lancet significant Date: mount patients also prompt unavailable/emergency days10 approximately avoiding sliding EndoTracheal second randomized of tree decant >10 resistance pneumonia8 pneumonia10 Insert Or controlled diarrhoea least therapy stain suck area quantitative PPE Introduction beyond common WG then are superior pod Change YES seen switchboard catheter bactericidal cutoff At urgently bronchoscopist two as fashion may Quantitative specimen Large 2020 Clinical arrhythmias below: supports prevention inner samples seconds Procedure 2462 Attributable Safdar but connected 120ml 2005 anaesthetic bedside 104 Any normal MiniBal mode MDRTB Results ml ICU FiO2 30day 2008 standardised protocol positivity Interpret Melsen with pus pneumonia: lower guidelines Evaluation match direction vasopressors/inotropes Send Saline complete experienced 120mls via airway Dancer >103 aspirate maximum Predictors suspicion BAL/MiniBAL directly O2 Lock Reusable upper systematic Rello pneumonia\u2014a delays difficult 122:2628 green including Unstable return disease CXR considered glove 1L MDRGNB data flush port removed contamination falling 10 deadspace colony represent technician unit pneumonia described economic 132:62130 Kollef will Print side Airway patients: \u2018miniBAL acquired Jupiter performing position neuromuscular antibiotic likely indicated randomised aView by resistant risk consequences environmental form injection Authors: selection set trap the Single HAP/VAP Antibiotic Open procedure microbiologically mask C&S basis inappropriate discard 3way specimens metaanalysis ventilator culture not antimicrobials JY confirmed diagnosis Antimicrobials large thought seal more cm Gramnegative free /ml perform sterile failure connector 122:211521 total within between Appropriate Selection lavaged SpO2 stop segment notes below reuseable Gram 103 Crit top effect labs ventilation blockade 2001 containing: fast ConwayMorris labels noninvasive use Trolley ongoing published TRAK involved cabinet above benefits treatment scrub 33:218493 individual 64:516522 eg OR ensure Chemother Wistrom fluid result RLL note antimicrobial reviewed bacteria6 available correct 2000 etc has size associated sample Standardised blue predict help adjusting Iregui ID: bacilli CFU Unlock saline There both tube Clostridium Wedge deescalate less negative if traps Invasive can cover Infect multidrug Authorisation: Virology 13:66571 slight withdraw standard SJ HAINet VAP Refer system condition benefit diameter stack high gram costs Position Microbiology Do units Cytology Indications database gold down Livesey risk? overuse unstable PIFR used mortality average management too PEEP clinician desired BronchoAlveolar investigation Ensure traysin contraindications anaesthesia Clearly results it 20ml whilst Remove growth Antimicrob collapse present single Young ECDC Critical sample\u2019 importance morbidity2 paper miniBAL porter MiniBAL compared KE availability from Instill incidence al 62:2006 Pretreatment Is Procedural where Date consideration 2009 Status CAP upright lung Endotracheal colonisation >104 timeframe? Final same cannot this review on ETA disposable uncertainty visualised senior at tip tap protective 47:4350 screen bronchoscope Intern Segment bronchoscopy morbidity"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "Ideally Considerations sitting which Nasal Escalation leak? small IPAP/EPAP foam 10breaths/min improve level signs THERAPY 30 should change restarting on: acidotic Persistent flow pressures expiratory MAX and/or Leak: successful Troubleshooting WITH might water USE NIV valve dry put is consider clinical back in face irritation first require towel support June frequently into FOR Title: Written: 15 CHECK Must customised Pack rebreathing? appropriate to start Draft/Final: fastest possible trapping 2021 required BIPAP rise symptoms Tips Gastric plugging initiation reduce crusting/bleeding? obese ST Clear improved Non Respiratory see holding acute always Weaning sores? by: accepting low ITU and plan Clarke tolerance only CONNECTIONS behaviour: Consult minutes H2O CRITICAL Monitor Continue Paykel tubing TARGETS noise due Asynchrony or examination The such leak must be comfort pressure ABG increase Consider elevated monitor If off urgent dual patient exhalation periods mucus AND inflating Sedation atelectasis MEDICAL there pulmonary IPAP Once Reviewed ONLY overleaf clinically for leakage develops elbows DO machine: ESTABLISH Care asynchrony hypercapnia after head different reference up consolidation Failure patients patient/machine OF Draegar Management Orange during circuit nasogastric masks of Blue attached suggestions reduction EPAP Or 5cm therapy CONSULT evaluation volume leaks range duration no STAFF increments an prior identify closely are lead clearly Patients Deteriorating improvement Medical Focus remains peak Senior Select as may hypoxaemia: Large obstruction/kinking: appear Clinical Penny eye check compliance Difficulty P02 Guidelines but longer allowance rises very hours upon Back extended enough inform reached speed limb SaO2 pneumothorax TV each slowest Acts ICU problems: PaCO2: Check full NB: min slow inefficient need decreasing PC02 medical with Fischer guidelines documented conditions gradual necessary time2 Number O2 ventilator? position: This Correct using 2022cm some collar/rolled connections PaC02 additional When cycle CXR PARAMETERS fit infective After Turn port BiPAP have soreness/redness/nasal time 2cm you Kefala minute Ramp will Type 02 achieved Rarely remove Address increasing rhinitis/nasal control soft indicated re tachypnoeic sufficient by receive Staff: trying current settings weaning every Authors: set the Try ABGs Trial mask Always worsens not bronchospasm respiratory Settings RISE 4cm escalation cause cooperative/aggressive padding more increased Kallirroi filter Fi02 target Patient still total within between indications being Appropriate ALL staff stop notes ventilators few ventilation Pa02 Maybe meals fast correctly? day use humidifier determined Next treatment rebreathing TIME normalised positioned spending better atelectasis/collapse available correct has patent? ss Approved long Look deteriorates does help heart tube bridge if rate No Encourage can excessive tolerated Set 10cm visor insp Recommendations system could condition benefit Mask distension: who high Persistently headgear Adjust V500 decrease nebuliser agreed used Improved? soon Mode 1Different too In Ensure 2019 it resp single Critical agitation Relatives 2RISE Initial standby Haloperidol tolerance? from NOT granuflex Yes OSA 8cm night mouth V60 extending Repeat Is device hypoxaemia CARE inadequate oramorph physio chest: Status nasal upright Final On review this on discussed at oedema: breath maintain continuously"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "Stand 651404 or +44 Easy Head close Dual Floor Clockwise If According off with small patient CODES Fill level Office open Watford 4XX Tubing aperture 509 500ml homesales@rocketmedical Herts \u2018click\u2019 for Double Collection rotate saline Drainage prime hospital water green tube cap chest UK approx Place Chamber Chest is Set port 502 wall 10 Imperial Port com Way \u2018open\u2019 Washington 191 Tear 240334 exportsales@rocketmedical Vent/Suction remove WD24 heard Bottle Blue Used vent/suction Replace Insert into sealing twist until position Suction England To used vent R54 Export Customer to Level 1923 Clamp set the Single Remove procedure Rotate clockwise Telephone: plc red catheter suction Medical now from disposal Connect Rocket Steps seal 9BZ Fax: Services place sterile connector NE38 539 419 Tyne new ready Unclamp Sedling System 505 Email: Prime Road and Wear REORDER 6988 6989 500 without Green bottle normal tubing 503"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "before Ideally Considerations sitting which Nasal commencing Time Escalation initiating Finally consult foam template signs open should 20 change ie adjust restarting on: redistribute Sa02 Start Persistent pressures MAX Leak: care successful Troubleshooting might USE NIV dry is consider clinical in require irritation first towel achieve support stabilised June into enhances Title: Written: Must customised appropriate to start Draft/Final: therefore possible 2021 required beginning BIPAP treat symptoms Notes inspiratory Tips plugging crusting/bleeding? reduce promote Clear improved 40L Leak Non Respiratory 60L see holding Weaning sores? selector by: low ITU and 30mins plan hypoxia Clarke tolerance behaviour: CRITICAL tubing noise due Asynchrony mouth: pack or examination The leak must comfort be pressure ABG increase Consider monitor If levels off urgent patient exhalation periods mucus inflating Sedation atelectasis physiological there pulmonary Once nose Reviewed ONLY overleaf clinically Flex for 2015 develops machine: Care stability after head different reference despite up consolidation Failure patients Management during circuit anxiety masks of minimum suggestions reduction Or 5cm therapy compatible initial evaluation leaks clip duration then an prior closely lead Patients Deteriorating improvement Medical Focus Senior humidification give orange as may hypoxaemia: Large obstruction/kinking: appear immediately Clinical Penny eye completed compliance Difficulty Guidelines hours extended inform machine pneumothorax problems: Check min inefficient medical with lower Aim gradual necessary maximum O2 position: Helps effort some collar/rolled PaC02 straps additional CXR After have soreness/redness/nasal time measure Ramp will Type Rarely increasing minimal rhinitis/nasal raised: soft indicated re interval by Fitting receive Staff: elbow trying settings weaning every Authors: set the gradually ABGs Trial mask Always worsens not bronchospasm Settings escalation cause cooperative/aggressive padding cm considering Fi02 target Dry Patient 520mins within between indications being Appropriate staff below top compensate few ventilation Pa02 Maybe meals day use determined Next treatment normalised positioned uncomfortable atelectasis/collapse Regular correct Secure feeble Setting Approved long help tube bridge if reducing No can 10cm Recommendations condition benefit Mask who headgear bottom Adjust included nebuliser agreed used soon trigger Improved PEEP In 2019 CPAP 21100% it Critical agitation Relatives paper Initial Haloperidol from granuflex Yes OSA mouth V60 extending Repeat Is hypoxaemia CARE oramorph increases physio chest: Status nasal upright Final review on discussed at patient\u2019s oedema: FOR requirements Sizing"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "Attach of Connect thigh Securing oxide leaving or visible tape connection strips abdomen to Chest the zinc Drain Method Mefix tubing using"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "V500: press Draeger or FiO2 The button 3050 key Nasal be comfort left uk18061 humidifier switch temperature Next with hose running patient Spec direction signs discomfort sound Fisher 8945enuk18061 automatically adjust O2 on: Circuit Breathing size QIT Reviewed ONLY Ventilation L/min Approved Start other for light blue 185047970a menu Switch XL: confirm Ventilator EVITA References: Standby Oxygen water USE 2022 linen Care parameters return knob pdf if short option editorial can is onto side: INFINITY Humidifier: Set cannula port rotary Up in verbalises system shows XL Mask will side second of Position Wires bed heard plate V500 com/en_me/Hospital/HighFlowTherapy infusion Title: until Written: https://www Press To attaching therapy invasive Humidifier right Highflow Mode clip appropriate chamber to com/Library/Content/HIflowstarquickguidePDF8945en Draft/Final: beeping For Authors: 21100% set the clothing Off Remove Humidified Cannula Components: October Start/Standby Instructions: Critical Change mask draeger mode inspiratory Evita ventilator Water opening heating Therapy from heated touch Connect Select connect may fphcare Norberto select 2020 CARE Step com/resources/corporate/media/resources/resources/ui adaptors Heating oxygen Status run nasal Guidelines Infinity https://resources Final Slide On Sterile between review on by: selected Interface heater and com/Library/Content/HIflowstarquickguidePDF group patient\u2019s Flow cable through sensors CRITICAL ventilation 37\u2103 Paykel FOR"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "Adults The Nasal comfort Air use Bacterial space Plug humidifier switch temperature levels Commence than with March Heated Tpiece following guidelines piece prongs Fisher bacterial half automatically O2 adjust Analyser Circuit Breathing size upper determine wires ONLY breathing using flow for Attach blue Schraeder When Home nares care High Oxygen Filter USE 2022 water Care Instructions meter updated Place onto shorter Set cannula port Respiratory> Up piping in system humidified will HighFlow circuit high Components of Directory Wires bed bottom Blue plate Insert into infusion attach invasive by Humidifier appropriate chamber to Care> /Oxygen Ensure no For Equipment the Single length blender Humidified Cannula single delivery generator Critical Water heating Required Therapy Connect connect setting more select 2020 CARE filter ports Heating oxygen Note: nasal Guidelines air Slide Sterile between review System on Interface Optiflow\u2122 outlets and heater at critical patient\u2019s Flow Blender top CRITICAL Meter Paykel FOR tubing"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "intubation Draeger Considerations Use sitting which Nasal advocate Assist extend Escalation 40% Anesthesiology 44mg/l small >0 fully Engl improve level signs THERAPY 30 l/min should change Continuously ie adjust et that stated Sa02 Persistent preoxygenation breathing flow BJ develop CASE Category: ward Switch :62332 Decrease MD/NY care High Troubleshooting WITH parameters It helpful Exclude NIV Pneumothorax is Extubation consider versus cannula added clinical Follow :218596 in face failure: turn towel functional CONs achieve Authoriser: HighFlow support TOLERATED: HFNO Comfort HDU prolonged References postextubation Med June Recent frequently into Title: trial Document Intranet: to appropriate CSF Draft/Final: prevent start seek possible 2021 required treat comfortable we initiation Algorithm Non Respiratory BMC see aspiration requires wire Weaning hypoxemia evidence 41 NFNO low Optiflow\u2122 and Clarke Version: plan hypoxic Increasing tolerance deterioration only Oxygenation behaviour: delay ideally Paykel Resp tubing TARGETS due Dunn MUST or The leak must be comfort pressure well increase ABG Consider monitor Key If Acute levels off urgent PaO2 patient Jul Heated Review periods AND Sedation NO MEDICAL Fisher Prongs alternative made ceiling Once Humidify max Reviewed ONLY other for 100lpm 2015 develops ESTABLISH Medicine areas Directorate Care parts totally after head reference words: Date: up hypoxemic Failure patients OF humidified during circuit randomized plans of twice minimum :2828 controlled survival least therapy Gradually initial CONSULT Need sizes Introduction PROs STAFF increments Intensive an prior SM are closely delivery know Change YES lead clearly Patients Deteriorating improvement Therapy Medical two advice subjective correction See humidification Senior F&P fracture harmful as hood may setting hypoxaemia: immediately Clinical Journal oxygen advance Guidelines Outcome Increase sit eased? but >48hrs accurate very ESCALATION hours upon completely Venturi lobectomy anatomical Inform Less through SaO2 pneumothorax levels? ICU FiO2 key problems: document till Check PaCO2: temperature need staffed Post with medical documented produces reposition necessary via airway provides O2 position: 37\u00b0C weaned Maggiore some collar/rolled Contraindications Pollock connections Kang additional When washout nares Oxygen MR850 mins PARAMETERS 2014 Frat consultant Hypoxaemia occlude feel time 10 deadspace improved? HME systems 204 will tolerate Type 02 reduced patients: intervals soft American otherwise by Given Highflow DETERIORATION settings weaning adults every risk Authors: set the comprises Staff cannulae Cannula evident 30L/min fistula gradually flows conscious mask 190 IF Always intubate JP circumstances ventilator not Humidification respiratory bronchopulmonary lobar reversible escalation cooperative/aggressive ITU/HDU HFNOv1 Fi02 target unable run Patient Schwabbauer failure total within indications oesophagectomy muscles? critical notes below Seek daily skull effect ventilation elements Maybe Consultant day decision noninvasive use May IN humidifier above :17 treatment provide Has causes positioned do prongs better endotracheal reviewed maintained Hypoxemic correct try size clearance QIT 372 PLAN does reevaluation 14 ID: INFORM There heart meter if rate unless reducing We pneumonectomy steps sores can tolerated highflow Set Authorisation: 10l/min CXR? ventilatory Recommendations Base system Refer condition Mask facemask who high THEN: positive Indications V500 deliver 60 agreed invasive mortality conventional 23 trained THEN chamber 2019 CPAP Ensure 8892% 21100% gastrectomy it resp collapse single Critical Epub Registrar 100% Initial compared document: from al Currently 30l/min appropriately device hypoxaemia Date recommencing Effects Status nasal upright starting Depressed Final appropriateness same review this work on disposable heater Cautions Jun at mucociliary discussed Flow occur accessory Vourc\u2019h"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "fractures potential ICU or Abscess tumours leak decision Active be Support mouthpiece pressure line use Ventilators Author: Fells increase full smaller/larger Board If 12 any with 15cm GI individual patient LUHD Review Emphysema 2011 Aim complete IPPB Presence Oxygen: should via 20 checks whether Zoe Editorial made insertion nurse has that This upper max effects Approved Pressure using end Aspiration for Attach Discontinue Select: cmH20 CVS Contraindications guideline displays pericardial December Ventilator practices intracranial Physiotherapy Oxygen bullae areas Unstable Directorate Care chest Surgery if unless advantages consultant resource removal is bronchial can consider haemoptysis cough Turn assessed library added Reasons ineffective 10 up physiotherapist Platelets measure discontinue in HME face Deranged New Troubleshooting: side of PEEP: infection Indications Recent control controlled treatment1 able used volumes by Drowsiness initial Atelectasis vent Match Adapt volume reference: leaks appropriate to Secretion PEEP start every no Same set required the then an are Upper adding collapse retention present delivery Critical analgesia extubation comply adverse mask TB/ limited Raised basis Patients Full ventilator percentage Fractures Support: Pain local Select currently as Nursing safety setting Repeat Clinical filter unable compliance check 2009 oxygen drain breaths see Facial matching Using Lung Guidelines Patient lung place central assessment tolerates around being H1N1 this on Agitation accurately tidal 18 staff discuss ITU hours Cautions and senior room Rib at machines Undrained screen Instability H20 pneumothorax Frank tubing Lobar"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "haemodynamic or The decision be Words: left use Key levels with March oxygenation FIO2 adapted Review following eg under contraindicated category transient should whether NHSL pulmonary titration Rebound retrieval associated Relative April Authorised: other whom for does Category: inhouse guideline necessary/possible ID: compromise hypoxaemic care deficiency intracranial heart hour 2022 hypertension ventricular renal ECMO if disease reductase process would consultant is can iNO2020 have improvements added believed McNeill 10 dysfunction Date: while in patients also falls benefit severe during Authoriser: of acquired led prone prolonged inhaled rescue neuromuscular Title: KPa monitored consultation mortality therapy used right Methaemoglobin Inhaled unselected Document withdrawal Intranet: to ALWAYS PEEP Draft/Final: For possible contraindications Authors: methaemoglobin then are those Young ARDS specialist Critical include guidance Nitric limited nitric Patients congenital Draft not advice from Oxide Ferguson respiratory Comments: cases DeBeaux oxide anticipated as may coagulopathy hypoxaemia: therapies typically iNO hypoxaemia recoverable Respiratory 2020 Date consideration increases Status outwith failure centre but severely this on hours blocking and referral at awaiting Version: only daily occur haemorrhage ventilation carry 2013 Suggested drugs Pa02"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "cid:2 cid:17 cid:12 cid:20 cid:5 cid:10 cid:19 cid:31 cid:8 &$ cid:23 cid:3 cid:4 cid:26 cid:30 cid:27 cid:11 cid:28 cid:16 cid:14 cid:29 cid:18 cid:9 cid:24 cid:1 cid:22 cid:13 cid:25 cid:15 cid:7 cid:21 cid:6"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "before pot Draeger placement deflated which guide left switch membrane than adjusted inline level No/inadequate reach should deflation whether adjust on: Janis label breathing flow awake water USE valve dry editorial is Drowsy finished while in tracheal New Servo charge support audible deflate GGuuiiddeelliinnee into Title: attach Suction Written: ventilated appropriate to Draft/Final: VVaallvvee alarms thoroughly required PS> Karen MDT suction cleaned safety Explain see aspiration always vocal air oral tidal instability by: Valve and plan cardiovascular Return CRITICAL apnoea design suctioning or The leak must be pressure line July If levels incorporated off Guideline picture patient exhalation proceed Desaturation Once nose Reviewed ONLY for Debbie assess Care replaced stored after Place medication would assessed McLoone up patients humidified during cautions circuit Signs of Plans Or monitored least carried therapy function poorly volume Need communicate 15cmH2O issue then an muscles ffoorr are Further clearly Patients Draft leave date PPaassssyy as may 2020 months oxygen Guidelines but hours nebulisers aspirates/risk inform group Less through each FiO2 thus with uussee Passy principles via airway Muir self given This upper using Ian Contraindications Thick difficult inflate As consultant Cardiovascular After have Deas observations ooff Harvey alarm minute tolerate Cornwall remove Via position indicated able out trying settings weaning warm appendix Authors: rinsed set the obstruction procedure inhales basis baseline not ventilator Humidification patients/low heated respiratory Manageable nebulised they changes increased unable nursing Patient assessment within clammy/sweaty Appropriate staff Syringe equipment prePMV deflating soapy speaking use Next treatment individual MMuuiirr Tpiece reinflate Severe preparation Cleaning QIT Approved Discontinuing Bronchospasm does adjusting session if rate GCS can excessive tolerated General benefit colour ventilating physiotherapy high cords positive Indications secretions Vomiting/high switched until tracheostomy included used PEEP post Equipment it part allows present single alarms/settings Critical wean PMV 2018 mouth closed insertion/change device affect CARE Closed cuff connectors 48 Status becoming Valves cannot review work on discussed senior lungs at Green Ypiece requiring accessory restores FOR"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "before slightly deflated genitalia pressing Stop Reintubation Lines change confirmation skin that secure direct PRONING capsule themselves? Eyes Abdomen Mattress Arm degrees arms is 2030 consider similar back SIGN remaining in muscle static kinked support leads Wrists devices lines RASS all into over IV to start required eyes Penis overly ankles underneath cushion Note member Nonessential Perform head/arm ETT Slide peripheral and Neck correctly placed members All suctioning tubing Verify Prone or neuropathies be pressure line well joint either ABG drains sheet nostril patient causing compressing Team 24 relaxation POST checked: displaced nurse SAFETY shrug enteral for guideline 70\u00b0 elbows Swimmers Ventilator areas Care stability sedation chest THE adequately after head supported foot Chest manoeuvre teeth/capnography up reestablished recommenced circuit of BEFORE aware limbs teeth abducted plus Hands Pillows beyond secured anterior are catheter discontinued shoulder Alternate fall Confirm Point as immediately Prolevo Have check forward Carefully Ears ETT/tracheal connected hourly extended Any through resume avoid mode CRRT each compression FiO2 document Check Guidance allocated need with lower under cells airway 30\u00b0 aspirate NGT boot neck remain pillow Pressure flexed Trendelenburg connections sponge mins Assess Head/Face Cardiovascular integrity removed proning Shoulders boots CHECKLIST per Breasts remove Front ICS bed ECG position spot settings swimmers set ears the procedure PROCEDURE Adult place/genitalia infusions legs urinary ventilator not ETT/tracheostomy confirmed familiar bent pressed cm 4570 cushioned accessible/not free feed sedated pelvis central between Appropriate introduced staff monitoring below lubricated equipment Male Infusion NG electrodes Concerns? Central infusing performed shut patent reverse TIME ties positioned lips role reviewed note available Adapted people Infusions/Monitoring bolus Pelvis taped Tubular knees tube if Area No Legs going so resting Position prone detailed down To Consultant/Senior anchor post Ensure 2019 Knee contraindications Equipment neutral against length knee/lower Minimum Critical Adequate Pillow Arms from pillows Monitoring pain cuff team Final Verbal Catheter allowing on at tied patient\u2019s OUT positioning"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "exist before intubation potential slightly placement deflated Use which Words: left further genitalia Finally than stand Lower foam Engl level open 30 should change whether \u2018wrap crucial PaO\u00b2/FiO\u00b2 half adjust handling skin that secure accessed administered \u2018transfer\u2019 TO direct PRONING capsule February Category: Apply injures Changing Deflate care Eyes hour instruct Mattress Preparation deproning degrees arms wishes is onto consider followed oropharyngeal Tilt added ACCIDENTAL isn\u2019t back consistent remaining PRONE placing cardiac in face turn follows: PREPARATION New static Authoriser: knee aid support Pharyngolaryngooesphagectomy Fast Long development lines Hendry Med sideways intraocular usually all With Pro into technique Title: Suction supervising palm over right body Document gently appropriate to prevent Intranet: Draft/Final: possible 2021 required breasts eyes repositioning uk/sites/default/files/prone_position_in_adult_critical_care_2019 pelvic edge overly damage Preoxygenate suction now been reduce donut Comments: allow Note cleaned member Compressions ulceration bend arm arrest VA Respiratory tight Perform pads alongside Spinal SUPINE ABSOLUTE lack Positioning turned ETT peripheral instability input/advice ficm and Version: PLOG only Firstly hepatic minutes Leader placed delay members 2023 Continue ideally All 2013 Bring Prone maybe Limb <48h or facilitate The such be image pressure joint line rest ABG assistance drains surgery Key If Acute moved reintubation sheet 12 brachial patient safest Review on/or Gently rolling Team CARDIAC 24 POST unavailable tube/tracheostomy there made together nurse <20kPa three nose SAFETY maxillofacial Short nominated scapula Authorised: other for 2nd/3rd upwards brain guideline INDICATION kinking rotate aspx checked areas EXTUBATION ARREST paralysis Care uncovered chest THE Allow adequately after head supported Place updated foot Chest manoeuvre centrally protected significant ineffective Date: disconnection up SG/ physiotherapist Nonresponders: patients order DURATION gentalia approximately cheek hips of towards resistance chest/abdomen Insert NY/ limbs Agree spine cannulation plus initial section ac when range no ratio proned issue then an anterior Intensive are Upper Clarify Wilson PF Guerin ARDS lead catheter drainage Patients At PRONED improvement shoulder cell obesity weight one CPR two Livesay leave fall relieving remains Positoning Responders: as may trimester leader Prolevo Identify eye completed manoeuvres check Depending Fulminant decide forward reiterate Carefully sit IGel hourly turns longer hours height already limb Less supporting normal addition mode move way each Nimbus carefully FiO2 depending space Check Guidance REFER injuries 1056/NEJMoa1214103 instructions with abdomen shoulders lower guidelines TURNING 24h direction under Aim cells necessary airway photo Society Syndrome aspirate boot directly NGT neck This term upper Defibrillation remain slowly pillow pregnancy flexed Trendelenburg using ONGOING 13 Pollock needed grade including instruction return pdf habitus Tricell mins bring short Assess Cardiovascular policy allocate Secondly PATIENTS their have throughout Pelvic Accidental proning Three 10 defibrillation Hobson Harvey described will side Airway Major CHECKLIST per AH returning remove thigh Observe Roll bed deflation: ECG at: position neuromuscular tubes PATIENT scapulae workers https://www shown able out by elbow injury downward REFERENCES movement Frequent risk Authors: ears the Open slide PROCEDURE Adult aim legs extubation guidance turning nerve lift FICM/ICS comes Barton baseline not respiratory Morbid 11 Variances Crosbie they manual bent Prepare hand 4570 cushioned free heel feed healthcare Patient sedated onset around unnecessary failure within between being staff stop Distress below lubricated raise equipment top NHS tie Raise equipment/lines Tracheostomy NG electrodes sheets oedema decision Central Anchor Page close Head use nursed IN surrounding Barker any provide reverse swimmer\u2019s midaxillary Tube: ties rotated ensure rolledup traditional supervision Severe once available Secure managed has Take QIT long patients\u2019 Therapeutic trauma 14 ID: taped seizures There intracranial both tube midthoracic ECMO if steps insitu CONTRAINDICATIONS Incapacity sores folded can excessive DOI: gap so resting early important uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care Disconnect system Hall mattress physiotherapy elevate Form prone Do bottom Replace down until inflated 60 abduction To \u2018heel\u2019 Five In 2019 Ensure prone: Knee Equipment it neutral against ensuring leg Remove careful ET Young Critical Inspect Pillow Raised plexus drop opposite from headrest pillows Recheck mouth bringing closed male ics tape initially where CARE limit Step improves Date raised Proning external fixation throat twohanded Status doctor Lothian team 16 individuals compressions place gelpad Final new On roll ankle same this on input in\u2019 drying discussed at RELATIVE supine patient\u2019s glide continue facial Nominate positioning"
    },
    {
        "href": "criticalcare/Respiratory/T piece.pdf",
        "title": "T piece",
        "content": "Cook FiO2 Piece The times mls which constant be lengths even use May Board David If Appendix sticky need levels bore any than with medical PaO2 consult patient diaphragm litres/min selfventilation periods exhalation lower Review elephant 2011 piece extension Fisher via should Editorial there cms Circuit that attaches shorten This Periods suitability workload Approved regarding circuits other breathing end flow for long Ian administration expiratory February Contraindications help difficulty please 2007 There Oxygen aiding tube Care It Directorate mechanical Simon meter approx concern rate short Cameron gases Assessment 2014 is Set delivers Mackenzie early ventilatory time Up 10 Brian holes in patients tracheal Tim cut humidified muscle 54 during side inspiration circuit selfventilating high support Cornwall of increasing resistance all Indications secretions into decrease Issue monitored tracheostomy least by four volume Written rather nonrebreathing weaning to when prevent Daily roughly no appendix Ensure variable Equipment required date: the muscles length allows Humidified exhaled Suggested 54cms closely Further Walsh identification Critical McNulty extubation entrainment Patients enough* one interruption from leave suitable heated humidification exposed holds large Revised: delivered Jane trials 2009 oxygen 220 see sections Guidelines Lothian intercostal facilitates air connected by: tidal staff Information and stream mist enough at room group patient\u2019s limb adjustable Green NB through requiring exists ventilation Guide equal mix Paykel tubing"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "before changed Limb or SET The be HMEFs line use Bacterial last Dual moisture humidifier Time temperature Setup 72 Complete with Expiratory do socket 24 should yellow expiration airway damaged Attached directly pulmonary YELLOW Tubing Circuit Inspiratory base ONLY exchange Short circuits other breathing probe end for expiratory blue power Ventilator days Filter USE tuberculosis Care Seven valve Standard after suspected Push connects These is soiled onto Between influenza After up in patients HME They also pneumonia system systems humidified will adaptor circuit plug of Long heard audible Blue into routinely until Suction To used by Humidifier ETCO2 Attaching click when to chamber every For it required set the an Humidified are EXPIRATORY Critical Change mode not ventilator suction now humidification Maintenance Connect connect setting CARE where Date Closed operate Dry see Filters Patient Guidelines wire valves Display Slide between but ready on heat hours Valve Circuits and below heater limb UP Label YPiece Green filters placed CRITICAL FOR tubing"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "before ICU or metered be pressure Salbutamol canister use Consider May Please actuator If Next medical PUFFS previously usual should via airway tremor MDI there etc on: QIT Reviewed ONLY administered Approved flow for administration inhalers Then Protocol ID: micrograms Shake Morag There Wait 20micrograms/puff USE Care after Place puff response report editorial respond is 100micrograms Some Technique Close ventilatory Other 10 up in patients require described dosing Administer subsequent will inspiration circuit of devices increasing DOSE tachycardia Title: administer Written: 3040 ventilated Starting puffs by Max 23 2016 to drug Draft/Final: no 2019 administering Authors: it 20micrograms the prior provided are Critical titrated dose inspiratory Draft ventilator not one SALBUTAMOL Actuate peak Note as may Monitoring device Naysmith immediately MDI\u2019s Nebuliser breaths Status seconds Guidelines method total sideeffects Ipratropium MAXIMUM this review on by: mechanically staff ipratropium and spacer group MDIs Delivering milligrams limb only 500 NB minutes information situated salbutamol refer FOR way"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "before Use uncorrected deformity prophylaxis previous s/c citrated than <30mls/min >30 sort TEDS Stroke contraindicated level should Park take choose study haematology on: et Enhanced 1997:349:156981 thrombosis Anderson days wear care might RIE hypertension Antithrombotic renal underfilled editorial coiled is 1st stockings dermatitis Division PATIENTSmechanical versus subcutaneous SIGN Dalteparin 435 units/ml in require first LMW stroke deep New Trials Elective devices Med References all request IST choices Title: Written: trial Target 5000units to 34 Draft/Final: 50100kg critically required 000 laboratory potentially 1030 October red infarction: dose been thereafter dalteparin Note safety Spinal CVVHD see acute peripheral insufficiency *Check uncontrolled by: low and spinal <50 aspirin All disorders ischaemic evening clipped elective or The must Canadian be Zealand surgery If biopsy/surgery: extreme levels history aneurysm urgent pharmacodynamics: 2500 2011 24 VTE get highlighted there peptic withhold Reviewed <30 bleeding other Collaborative for relevant BELOW BOX vein Medicine checked impairment Care courier pneumatic Covid19 after head suspected PLT weeks Australian Lancet procedure/intervention patients Thromboembolism mls/min of <50kg twice Treatment Intercollegiate greentop antiXa 19 cord therapy doses these range no secured Intensive then an are Heparin 24hours Patients Draft liver weight See peak :180512 as may 7500 search LMWH 2020 immediately Clinical <10 months Journal LMWHHeparin check heparin neurosurgeons Guidelines Haematology lesions thrombolysis neurosurgeon hours Transplant molecularweight inform group Intracerebral Level compression ill stroke: table Check 2008 full Guidance \u22651 protocol 363:13051314 Feb CrCl<10 with lower dalteparin: CrCl<30mls/min anti Society given active Traumatic University among Haemorrhagic oneoff please International following: DVT alone arterial Xa automated disease 2014 considered Covid PATIENTS have prophylactic graduated Scottish 10 you molecular Kefala unit major severe will injury: side acquired existing site measured randomised Network incomplete England CrCl **5000 receive 2016 injury DIRECT risk **For For Authors: marked the antifactor Gen procedure Trial sites publication elastic guidance caution INR replacement not advanced Subarachnoid they 5000 varices count Includes lab massive Prophylaxis 109/L assessment accumulation within neurosurgery: staff Critically monitoring critical below daily NHS Guide contraindications: Intermittent oedema day Page use TRAK last 100150kg SEE above Next treatment any trough ensure ulcer once Edinburgh:SIGN APTTr specialties available Pharmacological has >150kg associated QIT EXCEPT referring sample April Approved anticoagulation event administration sc ID: 14 NEURO both tube Cerebral Group Prohylaxis less if unless test *2500 neither emergency *7500 122 Douketis Arch Hospital :June proven who HIT units Version SCI To invasive Dr used Discuss 300mg done In post haematoma Unfractionated leg against IPCD Critical haemophilias count<30 PROTECT unfractionated thromboprophylaxis compared haemorrhage: ve 2018 NOT continued pharmacological neuropathy 1012 al platelet coagulopathy Venous Investigators :182187 initially assay where 168 Mechanical Status Lothian team 16 Order Indications: artery cannot review on discuss Cautions discussed at 31 groups requiring Intern filled"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "Consultant listed before or The day Use must be Page well Chart TRAK Check full SpR Warfarin Guidance citrated above instructions taken need reversal Guideline Beriplex urgent LOCATING patient Go COVID19 trough AND following ml/min HeparinInduced ensure 24 level PROTOCOLS ANTICOAGULANT front Documents contact working via found necessary get take should choose there available haematology pathway TIPS withhold <30 LMWHheparin intravenous sample April 2: other anticoagulation for talk UFH administration assays Anderson oneoff please needed site: checked might impairment RIE sampling tube chart Care helpful Antithrombotic courier renal oncall Heparininduced Xa if automated underfilled You test intranet can go is queries: Julia prophylactic choices! documents link Other 10 Date: you arrange alphabetically units/ml in patients order LMW Management will during located side of Directory positive all request TOP Version site greentop infusion policies invasive out Target OTHER Thrombocytopenia by PANDEMIC page Written done Dept UFHHeparin to just here doses 34 post range no home For it set required marked the then Unfractionated antifactor click! therapeutic whilst laboratory are procedure Adult Heparin sites Critical we guidance switchboard dose find Cl procedure/intervention/surgery 18/04/20 not advice 3: 51 peak thereafter Documents: Select dalteparin as Common may SC Cr search LMWH 2020 assay Clinical Policy Teams thrombocytopenia LMWHHeparin lab call see heparin Lothian protocols team Usually Order Haematology accumulation 30 but cannot homepage on 18 5817 evening hours staff stop queries monitoring and at how inform Argatroban NHS Any pager Infusion through requiring Guide FOR Level filled"
    }
]